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Numerous studies have assessed the effects of single 
fatty acids on various aspects of lipid metabolism, 
particularly cancer. Established cell lines have largely 
been used for this purpose. The choice of control cells, 
however, has often been inappropriate. There is also a 
surprising lack of knowledge of the effects of fatty 
acids in the ‘real world", in which normal cells in vivo 
are presented with mixtures of dietary fatty acids. 
Before transformed cells can be used as models of 
disease states, it is essential to fully understand 
fatty acid metabolism in normal (control) cells. Only 
then can experimental findings be extrapolated to the 
clinical situation with some certainty. This thesis has 
therefore, assessed the effects of exogenous fatty acid 
mixtures on the growth/viabi1ity of normal mammalian 
tissues all cultured under standard conditions, and 
attempted to elucidate the mechanisms underlying such 
effects.
As different mammalian species exhibit different fatty 
acyl desaturase capabilities, cells from three species 
were chosen, viz. rat, Man and cat, with desaturase 
capability decreasing with species, respectively. A wide 
range of different cell types from each species were 
studied due to the known differences in their 1ipid
profi1es and metabolism. The cells studied in the rat 
and cat included those derived from the cerebral cortex, 
white adipose tissue. skin. lung, skeletal muscle and 
aortic endothelium, while the human cell types 
obtainable included those derived from skin, skeletal 
muscle and lung. Erythrocytes and lymphocytes were 
studied in all 3 species.
Each of the cultured normal mammalian tissues studied 
were shown to exhibit different proliferation rates. 
Cultured cells were dosed with fatty acid mixtures 
mimicking the fatty acid composition of dietary oils; 
these mixtures were termed ‘pesudo-oi1s', were bound to 
bovine serum albumin as carrier, dosed at concentrations 
ranging from 0 to 100mg/l, and'cultures incubated for 48 
hours. Viable cell numbers were assessed and related to 
control cell numbers at the time of dosing. This was 
termed the "cytostatic number", and its implications 
were discussed.
pseudo-Oils modulated cell viability, but the extent 
thereof varied considerably in magnitude with pseudo-oil 
and concentration dosed. Furthermore, differences in 
cell viability were shown both between tissues from a 
particular species, as well as between identical 
cultured tissues derived from different species. In 
general, pseudo-oil supplementation of cultures induced 
an overall concentration dependant growth limiting
and/or cytotoxic effect. Proliferation of certain cell 
types were, however. stimulated with some pseudo-oils, 
particularly at low to intermediate concentrations in 
the range dosed. Differences in cell viability were also 
related to the degree of pseudo-oil unsaturation; the 
two most saturated oils, meat and coconut, were in 
general, least effective in limiting and/or promoting 
cell viability, while the effects induced with pseudo­
oils rich in polyenoic fatty acids were more marked. The 
possibility that the cell viability changes induced were 
related to albumin as fatty acid carrier, or fetal calf 
serum as a supplement in the incubation medium, were 
investigated, and the possibility discounted. The use of 
pseudo-oils rather than single fatty acids, however, 
warrants consideration of fatty acid synergism and 
antagonism.
To establish the possible mechanism(s) whereby the 
dosed pseudo-oils influenced cell viability, various 
cell parameters were subsequently examined. These 
included total protein, the incorporation, desaturation 
and elongation of both pseudo-oil, and single C18, fatty 
acids, as well as the production of 1ipoperoxides and 
prostanoids.
Total cellular protein concentrations varied both 
between tissues and species, and reflected changes in 
cell number in dosed cells. However, pseudo-oils were
also shown to modulate absolute protein synthesis in 
nucleated mammalian cells, primarily by enhancing such. 
It was postulated that this related to the induction of 
lipid metabolising enzymes.
Variations in cellular fatty acid composition were found 
both between the mammalian tissues and species studied. 
Evidence to support the capability of cultured mammalian 
cells to incorporate exogenous fatty acids was shown. 
The extent of incorporation, however, varied with cell 
type, species and fatty acid structure. Desaturase 
cascade enzyme capability was also assessed by 
comparison of dosed cell FA profiles with that of 
controls. Once again, desaturation and elongation 
capability varied with different cell types within a 
particular species, independent of cell proliferation 
rates, but was generally greatest in dividing rat, lower 
in human, and least in cat, tissues. In all three 
species, however, erythrocytes and lymphocytes failed to 
efficiently perform these reactions. This correlated 
with the lower threshold for cytotoxicity in lymphocytes 
and erythroctyes than in dividing cells, although 
desaturation capability did not correlate directly with 
proliferation rates in growing cells. It was neverthe­
less clearly shown that desaturase cascade enzyme 
expression with pseudo-oil dosage was more limited than, 
and could not be fully predicted by, the results
obtained utilising 
related to synergism 
FA's.
single FA's. This phenomenon was 
and antagonism between pseudo-oil
Cultured mammalian tissues were found to vary in their 
capability to form both 1ipoperoxides and eicosanoids. 
Pico-molar amounts of total eicosanoids were quantitated 
compared to nano-molar amounts of lipid peroxides. 
Overall, lipid peroxide production was not directly 
related to control cell proliferation rates or total 
unsaturated FA levels. However, total molar eicosanoid 
concentrations in control cells and the eicosanoid:MDA 
ratio suggested a correlation with the desaturation 
capabilities of the three species, decreasing in the 
order rat > human > cat. Each cel 1 type studied 
exhibited a unique prostanoid profile, which was 
modulated (enhanced, suppressed or inhibited) to a 
greater or lesser extent with pseudo-oil incubation. 
However, no correlation between cell viability, the 
degree of pseudo-oil unsaturation, or any other 
biochemical parameter studied, except pseudo-oil 
concentration dosed, could be proven to relate to the 
changes in prostanoid levels induced with pseudo-oil 
supplementation. This implied that endogenously bio­
synthesised prostanoids were not directly responsible 
for effects induced. On the other hand, 1ipoperoxide
production genera 11y increased with pseudo-oi1
concentration dosed and was greater with pseudo-oils 
rich in polyenoic than monoenoic or saturated FA^s. 
Furthermore > 1 ipoperoxide inuoluement in the modulation
mammalian cel 1 proliteration was proposed. This, 
however, was shown not to be the sole mechanism, and 
the involvement of membrane structural changes, eg. 
fluidity was additionally suggested and discussed. 
The findings indicated that the modulation of cell 
pro 1iferation by FA's was multifactorial.
The variations found between rat, cat and human tissues 
with regard to the parameters investigated indicated 
that extrapolation of experimental results between 
mammalian tissues and species, as well as the use of 
cells from different tissues and particularly from 
different species as controls for other cells, is 
potentially misleading, and should be avoided if 
reliable interpretation of results is desired. Further—  
more, we recommend fatty acid analysis of all culture 
media prior to use, and appropriate supplementation with 
polyenoic, or at least essential, fatty acids if 
required.
Since p-oil FA composition reflected that of dietary 
oils, the data from this thesis serves as an in vitro 
model and guide to how normal genetically entire 
mammalian cells in vivo may respond when similar oils
form part of the dietary intake
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CHAPTER 1 INTRODUCTION.
1 • 1 Lipids.
1.1.1 General.
Lipids are a heterogeneous group of compounds consisting 
of fats, oils, waxes and related compounds. They are 
relatively insoluble in water, but are soluble in 
organic solvents. They are important not only because of 
their high energy value, but also because of the 
essential fatty acids they contain and the fat soluble 
vitamins they transport. Lipids act as structural 
components of membranes, as storage metabolic fuels, as 
insulating materials, and as cell-surface components 
conferring, for example, tissue and species specificity 
(Op den Kamp 1979, Spector et al 1981a and Traill et al
1984).
Almost 95/£ of dietary lipids are tr iacy 1 gl ycerol s 
(TAG's), while the remaining 5^ is composed primarily of 
phosphoglycerides (PGL's) and sterols. TAG's consist of 
a glycerol backbone to which 3 fatty acids (FA's) of 
variable length and degree of unsaturation are attached.
TAG's are the main storage form of 1ipids primari1y
stored in vivo in adipocytes for subsequent use as
fuels, or for membrane synthesis (Spector et al 1981a
and Crawford 1983). PGL's are primarily found in 
structural lipids, eg. membranes (Spector et al 1967,
contain a glycerol backbone, but with a phosphate/base 
group substituted for FA three. Typically, PGL molecules 
contain a saturated or monounsaturated FA in the 
1-position, and a monounsaturated or polyunsaturated FA 
in the 2_position (Holman 1971). PGL^s are not only the 
main components of cell membrane lipids, but also serve 
as a source of eicosanoid precursors (Spector et al 
1981a). Body PGL FA composition (the relative 
proportions of saturates, monounsaturates and
polyunsaturates) varies in response to limiting dietary 
changes (eg. Yavin 1977, Yavin et al 1979 and McGee
1981). Holman (1971) proposed that this is a homeostatic 
response, tending to minimise the changes in
unsaturation of the PGL's caused by the diet. Sterols, 
of which cholesterol is by far the most common, have a 
rigid structure, and tend to stabilise cell membranes by 
counteracting the membrane fluidising effect of
polyunsaturated FA's (Arbogast et al 1976, Stubbs 1983 
and Shinitzky 1984). The living organism/cel1 can 
satisfy its need for these lipids by synthesising its 
own de novo from other 'raw materials', by obtaining 
them intact from the diet, or by modifying dietary 
lipids to suit requirements.
1.1.2 Lipids in Foods.
Dietary lipid is derived from both plants and animals. 
Generally, foods of animal origin contain more lipid
than do those derived from plants (eg. Giangregorio et 
al 1988a). Some lipid is "visible", eg. butter, while 
other is not, eg. lipid in plant or animal membranes. 
While the amount of lipid present in a food is 
important, its quality is of greater significance.
1.1.3 Lioids in Serum.
Serum lipid levels in Man can range from 5.0 to 9.0g/l 
(Documenta Geigy 1962 and Geigy 1984), while in other 
mammalian species, between 3.0 and 20.0g/l have been 
reported (Spector et al 1981a). In serum, hydrophobic 
1ipids are transported in an aqueous environment as part 
of lipoproteins. Lipoproteins contain TAG's, PGL's, 
cholesterol and cholesteryl esters, and cultured cells 
utilise these lipids when they are supplemented (Spector 
et al 1981a).
1.1.4 Fatty Acids.
1.1.4.1 Genera 1.
The IUPAC-IUB Commission on Biochemical Nomenclature of 
Lipids (1977) designates fatty acids (FA's) as 
consisting primarily of a hydrocarbon chain with a 
terminal carbonyl group. Naturally occuring FA's usually 
contain an even number of carbon atoms (12 to 24), are 
straight chained, and may be saturated or unsaturated 
(from 0 to 6 methylene-interrupted double bonds).
There are 2 main series of polyunsaturated fatty acids 
(PUFA s) produced by mammals from the plant-derived 
essential FA's (linoleic acid and Oc-linolenic acid). All 
other PUFA's are made from these essential fatty acids 
(EFA s) by reaction sequences of desaturation and 
elongation (see section 1.3). Further, all naturally 
occurring PUFA's of benefit to mammals contain double 
bonds in the 'cis-' configuration (Crawford et al 1972 
and Mahfouz et al 1980a, 1980b).
In general, the terrestrial food chain is rich in C18 
FA's, viz. LA and ALA; the marine food chain, however, 
provides an abundence of C20 and C22 FA's, containing up 
to 6 double bonds, eg. EPA and DHA. The marine 
environment, therefore, provides more U)3 series FA's, 
compared to more u6 series on the land (Uilliams et al 
1977a, 1986).
Of the total serum lipid (5.0-9.Og/1), FA's comprise 
3.5~4.0g/l (12.0-14.Ommol/I) (Geigy 1984). Normally the 
plasma free fatty acid (FFA) concentration is about 
500jumol/l, or 150mg/l , in the range 180-1650jumol/I 
(Geigy 1984). Most FFA is carried bound to albumin, the 
concentration of which is normally about 800jumol/l. 
Albumin possesses 8 binding sites for FFA's, thus 
800,umol/l albumin is equivalent to 6400,umol/l FFA. Thus, 
plasma albumin is almost never saturated with FFA's. 
Uhile the concentration of FFA's in the circulation is
low, this unesterified fraction is metabolical1y 
important. Plasma FFA's contain a mixture of long-chain 
FA^s, about 9 5 k of which is 16 and 18 carbon saturated, 
monounsaturated and dienoic FA's (Spector 1971 and 
McDaniel et al 1981).
1.1.4.2 Essential Fatty Acids.
In 1930, Burr et al established that particular PUFA's 
are required in the diet of growing rats. They described 
the development of a number of symptoms which appeared 
when fat was excluded from the diet for several weeks, 
and which disappeared when linoleic acid was 
supplemented. This FA, and alpha-1inolenic acid, have 
become known as the essential fatty acids (EFA's) since 
they either cannot be biosynthesised, or are synthesised 
in inadequate amounts, by organisms requiring them, 
and therefore, need to be supplied through the diet 
(eg. Mead et al 1976).
Plants and some invertebrate animals possess the 
intracel1ular enzymes capable of inserting double bonds 
between the w-terminal and the u9-carbon atom (Fig.
1.1.4.2.1.). Mammals cannot perform this desaturation 
step, but require the reaction products for normal 
metabolism (Holman 1968, Crawford et al 1971, Crawford 
1983). Double bonds between the u)8 and carbonyl carbons 
can be introduced by both plants and animals, and these 
double bonds are thus, non-essential. As both plants and
The formation of unsaturated fatty acids from saturated 
precursors, showing the ability of animals only to 
desaturate fatty acids in positions higher than w8 
(Crawford et al 1971).
Double bonds can be inserted here by:
Plants only ! Plants and AnimalsI
/ \  / \  / \  : / \  / \  / \
h3C/ \==/ \==/ \==/ \==/ \==/ \cooh3 6 9! 12 15
w-methyl !
From
18:0
/\ /\ /\ /\ /\ /\ /\ /\ /C00H
h3C/ \/ \/ \/ \/ V  \/ \/ \/
animals 
can make 
c is-18:lw9
/\ /\ /\ /\ /\ /\ /\ /\
H3C/ \/ \/ \/ \==/ \/ \/ \/ \C00H
but neither 
c i s-18:2w6
nor
c is-18:3u3
/\ /\ /==\ /==\ /\ /\ /\ /C00H
H3C/ \/ \/ \/ \/ \/ \/ \/
/\ /\ /\ /\ /\ /\ /\
H3C/ \==/ \==/ \==/ \/ \/ \/ \C00H
animals can make both saturated and monounsaturated 
FA's* these FA's are also non-essential. The inability 
to introduce u3 double bonds implies inability to 
convert w6 to u3 PUFA's, thus there are 2 EFA's, 
linoleic and a 1pha-1inolenic acids (Holman 1968, 1971 
and Crawford et al 1971, 1972). Mammals are, therefore, 
either directly, or indirectly, dependant on plant 
sources for their dietary EFA requirements. Although 
animals cannot make EFA's de novo. they can perform 
limited metabolic conversions on the EFA's which are 
presented to them (eg. Brenner 1971, Rivers et al 1975a 
and Horrobin 1983). The metabolism of these C18 FA's 
consists of a series of alternating desaturation and 
elongation reactions (see section 1.3), in which 2 
hydrogen atoms are removed to create a new double bond, 
followed by the addition of 2 carbon atoms to lengthen 
the chain to form C20 and C22 FA's with 4, 5, and 6 
double bonds (Mead 1968). This sequential process leads 
to the formation of 2 distinct fami1ies/series of PUFA's 
which cannot be interconverted, the w6 series and the w3 
series (Fig. 1.1.4.2.2.) (Mead et al 1976 and Kanau et 
al 1977). There is another family of PUFA's, the u»9 
series, derived from oleic acid, which is not an EFA; 
this series appears only to be significant during EFA 
deficiency (Holman 1960).
The metabolical1y important fatty acid families.
u9 series u6 series w3 series
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1 . 1 . 4 . 2 . a Diet a r y  S o u r c e s  of Essential Fatty Acids
and their' Derivatives.
The to3 series FA's are found m a i n l y  in marine fish oils 
and terrestrial leaf lipids, while the w6 series are 
found mainly in terrestrial see d  oils (eg. Garcia et al
1965, Wi l l i s  et al 1976, McCa n c e  et al 1978, Gibson et 
al 1981a, G i a n g r e g o r i o  et al 1938a and H o r robin 1990). 
T hese i n v e s t i g a t i o n s  s h o w e d  that 18:2w6 is a b u n d a n t  in 
meat, o f f a l , seed oils and dairy products, with lower 
a m o u n t s  found in o live and linseed oils. 18:3w6 is rare, 
but is n e v e r t h e l e s s  m e t a b o 1 i c a 11y important. Human milk 
c o n t a i n s  0 . 3 - 1 . 0 %  18:3w6, c o m p a r e d  to 8 . 0 - 9 . 0 %  18:3w6 in 
e v e n i n g  p r i m r o s e  seed oil and 18.7% 18:3w6 both in bor—  
age and b l a c k c u r r a n t  oils. M o d e r a t e  2 0 : 3w6 amounts are 
f ound in organs and human milk, while red meat, egg yolk 
and certain s e a w e e d s  cont a i n  high 20.*4w6 levels. Seeds, 
grains, green leafy plants, linseed and some fish oils 
are 18:3u3~rich, while long chain w3 PUFA's, e s p e c i a l l y  
2 0 : 5w3 and 22:6w3, are a b u n d a n t  in marine oils.
It is often o v e r l o o k e d  that when a terrestrial mammal 
eats the t i s s u e s  of a n o t h e r  organism, the cell m e m b r a n e s  
of those t i s s u e s  s u p p l y  E F A " s  and p o s t - J 6 - d e s a t u r a t i o n  
■fatty a cids (PDFA^s). H e r b i v o r e s  get a p r e p o n d e r a n c e  of 
1 8 : 3u3 from the green leaf material in their diet, a lot 
of .18: 2w6 from s eeds on a seasonal basis, but none of 
the PDFA p r o d u c t s  of the EFA's. The co m b i n a t i o n  of
direct incorporation, chain elongation and desaturation 
results in a profile of FA's in the liver PGL's which 
includes both parent (plant) and long-chain FA 
derivatives, but which is weighted towards the parent 
acids. Carnivores get a preponderance of 18:2u6, as well 
as its PDFA derivatives, with minimal amounts of w3 
FA's. When carnivore eats herbivore, it consumes lipids 
that already contain long-chain FA's, and its liver FA 
profile shifts in favour of the long-chain PUFA's. Thus, 
there is a progression of the FA's through the food 
chain (Fig. 1.1,4.2.3.) (Crawford et al 1971).
1.1.4.2.b The Importance of Essential Fatty Acids.
The current theories of cellular function depend heavily 
on membrane function, and thus indirectly on the FA 
composition of those membranes. Williams et al (1974) 
showed that the physical state of membrane 1ipids are 
altered when the FA composition of the cell membrane was 
changed. By modulating membrane PGL structure, EFA's 
confer and dictate the membrane properties of fluidity 
and flexibility, which are key determinants of membrane 
permeability and of the behaviour of membrane-bound 
enzymes and receptors (eg. Burns et al 1979 and Spector 
et al 1985). .
EFA's also serve as substrates for the desaturase 
enzymes, which produce longer— chain, more unsaturated 
FA's. These FA's are important, themselves, but three of
The progression of fatty acids through the food chain 
(Crawford et al 1971).
Vegetation mainly 18:3u3 and some
i seasonal 18:2u6
!eaten byIIIi
4-
Herbivore higher 18:2u6 levels, much
! less 18:3u3, some 20:4u6,
1 22:5u6, 20:5u3 and 22:6u3II
!eaten byIIII
4-
Carnivore similar 18:2u6 levels,
very little 18:3w3, more 
20:4w6, 20:5u3 and 22:6w3
them also are the precursors of the eicosanoids 
(Crawford 1983).
Many authorities suggest that EFA intake should be a 
minimum of 1.0-1.5% of total calories (eg. Holman 1971), 
although the FAO/UHO (1977) suggested a minimum intake 
of 3.0/J in adults, and 5.0'S in children, pregnant and 
lactating women.
1.1.4.2.C Abnormalities in Essential Fatty Acid
Metabolism.
Abnormalities of EFA metabolism can result from 
deficient dietary intake, or an intracel1ular block of 
the desaturase enzymes primarily responsible for the 
conversion of the precursor FA to its biologically 
active product. In the latter case, even a substantially 
increased dietary intake of EFA's will not alleviate the 
resultant metabolic abnormalities.
Experimentally induced EFA deficiency induces 
characteristic symptoms in mammals, which usually
include some, or all, of the following (eg. Crawford et 
al 1972, Rivers et al 1974a, 1974b, Sinclair 1974 and
Davidson et al 1987a)J
a) Increased metabolic rate 
c) Dry scaly skin 
e) Dull encrusted eyes 
g) ‘Wire* hair
i) Reproductive abnormalities
k ) Irri tabi1ity
m) Maidigestion/malabsorbtion
b) Impaired growth
d) Poor coat condition
f) Lassitude
h) Hair loss
j) Open skin lesions
1 ) Haemorhage
n ) Death
intake , or blockade of
derivative formation, leads to general systemic 
deterioration, especially the central nervous and 
cardiovascular systems, ultimately causing death 
(eg. Davidson et al 1987a). However, all symptoms prior 
to death are reversible by the administration of 
EFA's/PDFA's, thus highlighting the critical importance 
of these substances for the maintenance of normal 
cellular function.
Three techniques have been commonly used to assess EFA 
status: measurement of cis-LA intake, measurement of 
tissue and/or blood LA levels, and measurement of the 
triene/tetraene (20:3u9/20i 4u6) ratio. In most species, 
a ratio of 0.4, or 'less, is considered normal (Holman 
1960, 1971). The use of 20:3w9 as a marker of dietary 
EFA deficiency, however, is only valid for species 
exhibiting an intact desaturase cascade (Holman 1977 and
Sprecher 1977)
1.1.4.2.d Essential Fatty Acid Deficiency in the
Etiology of Disease.
Many human diseases involve EFA deficiency or distortion 
of EFA/PDFA equilibrium. In an in depth review, Holman 
(1986a) reported that EFA/PDFA equilibrium may be 
distorted by many factors, including the level of 
dietary FA^s, non-optimal intake/uptake of essential 
nutrients, hormonal effects, and drug therapy. As many 
of these factors can be assessed, it is possible to re­
establish the equibibrium by therapeutic manipulation.
High levels of EFA intake have not been shown to induce 
any harmful side effects (Anon 1973), and have been 
shown to reduce both plasma cholesterol and platelet 
aggregation, and to have anti-thrombotic properties 
(eg. Dyerberg et al 1978, 1982 and Dyerberg 1986). 
Considerable evidence exists that suggests EFA 
involvement in a wide variety of other abnormalities and 
diseases states (eg. Mead et al 1976, FAO/UIHO 1977, 
Crawford 1980, Horrobin 1982, 1983, Sinclair 1982 and 
Horrobin et al 1983), including the following:
Poor skin condition 
Cardiovascular disorders 
Diabetes
Acrodermatitis enteropathica 
Abetalipoproteinemia 
Cystic fibrosis
(eg. Hansen 1933)
(eg. Sinclair 1956)
(eg. Mercuri et al 1966) 
(eg. Cash et al 1969) 
(eg. Barnard et al 1970) 
(eg. Rivers et al 1975b)
Multiple sclerosis (eg. Field et al 1978)
Cancer (eg. Carrol 1 et al 1979)
Schizophrenia (eg. Obi et al 1979)
Artherosc1erosis (eg. Sinclair 1980a)
Hyperactivity (eg. Colquhoun et al 1981)
Sjogren-Larsson syndrome (eg. Holman et al 1982)
Uene et al (1975) observed that EFA deficiency is 
characterised by a series of changes in the FA pattern 
of the PGL's. The levels of EFA's fal1» but are 
counterbalanced by an increase in monounsaturates, and 
by the production of 20:3w9 (Collins et al 1971 and 
Holman 1960, 1968, 1971). The ratio's of 18:lw9/18:0 and 
20:3u9/20:4w6 thus increase. Peifer et al (1959) showed 
that EFA deficient rats fed a coconut oil diet (rich 
in 1 auric acid) exhibited poor growth, suggesting 
impairment of EFA metabolism. Similarly, cholesterol 
addition to EFA deficient diets induces early onset of 
EFA deficiency symptoms (Takasugi et al 1966), while 
animal studies indicate that dietary trans-octadecanoic 
acids exaggerate the signs and symptoms of EFA 
deficiency (Privett et al 1977 and Hill et al 1979).
Tissue culture can be used to model EFA deficiency in 
mammalian tissues at a cellular level. Bailey et al 
(1973a) showed that cells lose most of their LA and AA 
when grown in FA-free medium, and dependant on the cell 
type, 20:3u9 accumulation may occur (Bailey et al 1973a
and Hyman et al 1981a). Uhile studies ' have shown that 
normal cell growth and function in vivo requires EFA's 
(eg. Gerschenson et al 1967), some reports indicate that 
some cell lines can grow normally in 1ipid—free medium, 
and with no EFA's detectable in cell lipids (eg. Evans 
et al 1965). Takaoka et al (1971) showed that in 10 
cell lines cultured in lipid free medium EFA's were not 
detected, that monounsaturated FA levels increased, and 
no imparement of growth or mitochondrial function was 
detectable. Bailey et al (1973a) suggested that EFA's 
were not essential for normal cell division, and that 
EFA-deficient cultured cells show normal growth rate 
and morphological appearance. Similarly, respiration, 
mitochondrial function and other physical and metabolic 
characteristics were not significantly different from 
controls. However, the cell membranes were less stable 
than controls, and thus the long term stability of EFA 
deficient cells in vitro is debatable.
1.1.5 Lipid and Fatty Acid Uptake.
Only monoacylglycerols (MAG's) can be absorbed 
unmodified through the intestinal wall, while remaining 
dietary lipid must first be digested to form FFA's and 
MAG's. This means that of the FA's absorbed from dietary 
intake, only one definitely remains in its original 
position in the TAG molecule, while all the others have 
the potential for re-arrangement during absorbtion
(Clement 1980). Subsequent to absorbtion into the brush 
border of the jejunum, FA's are resynthesised into 
TAG's, and chylomicrons formed by addition of 
apoproteins, cholesterol and PGL's. These chylomicrons 
then enter the lymphatic system, and subsequently the 
general circulation.
In the capillaries of adipose tissue or muscle, 
lipoprotein lipase hydrolyses the TAG's of the 
chylomicrons, and the FFA's are absorbed into the cells, 
where TAG's are resynthesised using glycerol-3-phosphate 
derived from glycolysis. Subsequent mobilisation of 
TAG's produces FFA's again, which are transported in 
plasma bound to albumin (Spector 1975), which complex is 
freely dissociable. The liver posseses albumin receptors 
which bind the FFA-albumin complex prior to FFA uptake 
by hepatocytes (Uleisiger et al 1981); all other tissues 
take up FFA's readily without the need for specific 
receptors (Spector 1968, 1971).
Spector et al (1981a) report that cultured cells also 
hydrolyse TAG's contained in lipoproteins by the enzyme 
lipoprotein lipase. Cells take up both FFA's and TAG's, 
and in vitro studies indicate that FA uptake into cells 
occurs in a two stage process involving two FA "pools’ 
(Goodman 1958, Spector et al 1965a, Switzer et al 1965, 
Bailey et al 1973b, Brenneman et al 1974, Howard et al 
1974, 1976, Shohet 1976, Ueyman et al 1977, de la Llera 
1979, Dise et al 1980 and Morand et al 1982a, 1982b,
1985). Initially, albumin-bound FFA is in equilibrium 
with a membrane surface pool (FI) of freely exchangeable 
FFA's. In an energy requiring process, FA's from the FI 
pool can then be transposed to a "deeper", non- 
exchangable, inner membrane pool of FFA (F2). Studies 
with erythrocyte ghosts showed that the uptake of 
radiolabel1ed palmitic acid was significantly greater in 
the presence of CoA and ATP, than with ATP alone (Morand 
et al 1985). The synthesis of acetyl CoA occurred inside 
these ghosts, suggesting that acyl-CoA synthetase was 
located in the inner layer of the plasma membrane. The 
presence of long chain acyl CoA synthetase in plasma 
membranes of a range of cel 1 types has since been shown 
by Davidson (1986). Once the FA is across the plasma 
membrane, an intracel1ular FA binding protein 
facilitates its movement into the cytoplasm and its 
subsequent metabolism (Ockner et al 1974, Mishkin et al
1977 and Brandes et al 1983).
1.2 Lipids in Cells.
Intracellular FA levels in cultured cells reflect a 
combination of both exogenous FA incorporation and de
novo synthesis (Bailey et al 1972 and Howard et a 1
1974). Thus, 1 ipid composition is regulated by
interaction between intracel1ular metabolism and trans­
membrane permeability. Llhen extracel 1 ul ar FA's are 
depleted, TAG's, and possibly PGL's, act as sources of 
intracel1ular lipid; however, de novo synthesis often 
occurs simultaneously (Bailey et al 1972 and Howard et 
al 1974).
Although most cultured cells synthesise lipids from 
amino acids and glucose in the incubation medium, cells 
derive most of their requirements by uptake if a source 
of lipid is available (Spector et al 1981a). Numerous 
studies have shown that cultured cells derive most of 
their 1ipids from the serum present in the growth medium 
(Mackenzie et al 1970, Bailey et al 1972, Howard et al 
1974 and Spector et al 1981a). Under conditions in which 
adequate amounts of lipid are available to cultured 
cells from the incubation medium, endogenous (de novo) 
FA synthesis is minimal (eg. Bailey et al 1972). When 
cells are cultured in a lipid-free, chemically defined 
medium, however, increased rates of FA synthesis are 
seen (eg. Bailey et al 1972). These studies thus 
indicate that cultured cells have the capability to
selectively regulate de novo FA biosynthesis.
Generally, the FA compositions of a variety of cells 
grown in medium containing serum reflected the FA 
composition of the medium (eg. Gerschenson et al 1967). 
Rothblat (1969) reports that under standard culture 
conditions, serum FA's contributed 80-95^ of the FA 
carbon incorporated into cellular glycerides in UI-38 
human fibroblasts. FA supplementation has also been 
shown to modify the FA composition of many different 
cultured cell types, and both TAG's and PGL's may become 
enriched with the FA's supplemented (Glaser et al 1974, 
Horwitz et al 1974, Spector et al 1979, 1980a, 1980b, 
Hyman et al 1981b, Kaduce et al 1982, Needleman et al 
1982, Bourre et al 1983).
The degree of fluidity of cellular plasma membranes has 
been shown to be an important factor in many cellular 
processes, including mitogenesis (Ferber et al 1975), 
differentiation (de Laat et al 1977), proliferation 
(Cheng et al 1979) and transformation (Hilgers et al 
1978), while interactions between esterified and non­
ester if ied FA's modulate membrane structure (Jeffcoat 
1979 and Stubbs et al 1984). Spector et al (1985) 
describe how altering the physical properties of the 
membrane with supplementation of different FA's affects 
carrier mediated transport, receptors, membrane bound 
enzyme activity, phagocytosis, endocytosis, exocytosis, 
cytotoxicity, eicosanoid production and cell growth.
Since biological membranes perform a wide variety of 
functions, including transport, signal transduction, 
endocytosis, secretion, and also act as permeability 
barriers, the functional integrity of membranes has been 
recognised as critical to cell survival (Lodish et al 
1979, Op den Kamp 1979 and Storch et al 1985). Complex 
membrane structures have evolved to perform such 
functions, and the importance of 1ipids in the 
physicochemical properties of biological membranes has 
been extensively studied (eg. Shinitzky et al 1976, Op 
den Kamp 1979, Storch et al 1985).
1.2.1. Cellular Triacylglycerols.
Excess 1ipid/FA in the culture medium inhibits de novo 
lipid synthesis (eg. Bailey et al 1972). In parallel, 
others have shown an accumulation of 1ipid/FA in cells 
under such conditions, which appears as cytoplasmic 
droplets of TAG and cholesterol esters (Mackenzie et al 
1967, Rothblat 1969, Schneeberger et al 1971, Spector et 
al 1979, 1981a and Miller et al 1980). The studies of 
McGee (1981), examining the neutral lipid FA composition 
of neuroblastoma x glioma hybrids (NG 108-15), showed 
that in the absence of added FA, little neutral lipid 
could be detected in the cells. However, upon addition 
of unsaturated FA's, a large accumulation of neutral 
lipids occurred, and the FA composition of this lipid 
reflected the exogenously supplied FA to a greater exent
than did the PGL's. Gavino et al (1981a, 1981b) showed 
that treatment of human skin fibroblasts with PUFA's 
increased the numbers of cytoplasmic lipid droplets and 
lysosomes, while TAG and cholesterol doubled when cells 
were grown in medium containing 20/J, compared to 10/£, 
FBS. Although FA's exchanged with fatty acyl groups of 
the PGL fraction, the total FA content of the PGL's 
remained unchanged. This supported the hypothesis that 
microsomal fatty acyl intermediates can be shunted into 
neutral lipid droplets when cells are stimulated to 
accumulate lipid.
The accumulation of TAG has been suggested to occur 
because the FA's present in the culture medium are in 
excess of that required for PGL synthesis (Rothblat 
1969), or may reflect over loading of the cells ability 
to degrade lipids (Morand et al 1985). The extent of FA 
accumulation and TAG droplet formation appears to vary 
with cell type. Llhen human foreskin fibroblasts or 
guinea pig aorta smooth muscle cultures were incubated 
with PUFA's, fibroblasts accumulated much less FA's 
than did smooth muscle cells (Gavino et al 1981b). This 
accumulation reverts rapidly after the removal of the 
supplemented FA from the culture medium. Spector et al 
(1980a) showed that 45% of TAG's in human skin 
fibroblasts were degraded within 4 hours after transfer 
of cells to a medium containing either 10JJ FBS, or lipid 
depleted serum. In parallel, Denning et al (1983) showed
that uithin 6 hours after removal of supplemented FA's, 
TAG levels fell by 40*J in bovine aortic endothelial 
cells. Nevertheless, both TAG and cholesterol 
accumulation have been shown to cause cell damage 
(Howard et al 1974).
1.2.2 Cellular Phosphoglycerides.
PGL's, as major components of cell membranes, are rarely 
utilised as metabolic fuels, except in pathological 
circumstances (Rothblat 1969). This, however, does not 
imply metabolic inertia. Spector et al (1967), using 
Ehrlich's ascites cells, showed rapid turn over of 
membrane PGL FA's, mainly in the phosphatidylcholine 
fraction. The work of Peterson et al (1969, 1970) not 
only implied cycling of cellular PGL, but also showed an 
exchange of cellular PGL between membrane structures of 
adjacent cells. There are reports that exogenous FA 
dosage can lead to extensive alterations in cell 
PGL FA composition (eg. Spector et al 1979, 1985), 
with changes as large as 40 fold reported in the 
monounsaturated:polyunsaturated FA ratio in membrane 
PGL's when FA's were added directly to serum-containing 
culture media (McGee 1981). On the other hand, human 
umbilical vein endothelial cells exhibited reductions in 
PGL LA, from 27^ to 12^, during the first 48 hours after 
transfer to a medium containing 20% FBS (Spector et al
1980b). Spector et al (1981a) reported that cells
regulate the PUFA content of their PGL's to between 15% 
and 50%, and that an increase in PGL FA polyunsaturation 
may be responsible for controlling cell growth. This 
supports previous studies which also indicated a 
possible role for PGL's in the regulation of cell 
division, based on the fact that membranes contain 
nearly all of the PGL's that occur in cells and that 
membrane structures are intimately involved in DNA 
replication in mammalian cells (Spector et al 1967, 
Hanaoka et al 1971, Mizuno et al 1971, Cunningham 1972
and Manzoli et al 1974).
1.3 Fatty Acid Desaturation and Elongation,
Since the first description of the oxidative 
desaturation of FA's in animals (Bernhard et al 1959) 
and in bacteria (Bloomfield et al 1960), several reviews 
have been devoted to the subject (eg. Brenner 1971, 
1974-, 1982, James 1977, Jeffcoat 1979a and Jeffcoat et 
al 1984). In mammals, cis-FA's can be converted to 
longer chain, more unsaturated derivatives by a process 
of sequential desaturation and chain elongation. The 
subsequent FA products are important as themselves, as 
wel1 as being the precursors for many other essential 
biochemicals involved in metabolism. This cascade is 
under strict metabolic control, both directly and 
indirectly, and serves as a mechanism for regulating the 
lipid composition of cells.
1.3.1 The Location and Mechanism of Fatty Acid
Desaturation and Elongation.
Mammalian long chain FA's are desaturated and elongated 
in membrane bound vesicles formed from the endoplasmic 
reticulum (microsomes) (Ayala et al 1973 and Brenner
1982). The enzymes responsible, the fatty acyl
desaturases and elongases, are integral proteins of the 
microsomes. They are tightly bound to the inner 
microsomal membrane and require an intact membrane 
structure for their activity (Bloomfield et al 1960,
Nugteren I960, 1962, 1965, Stoffel 1961, Oshino et al 
1971, 1972, Ayala et al 1973, Brenner 1974, 1982 and 
Fulco 1974).
Unsaturated FA's are synthesised aerobically from 
saturated FA's by a microsomal, 3 component enzyme 
complex, consisting of NADH-cytochrome bs reductase,
cytochrome bs ancj .^ he terminal desaturase enzyme, often 
referred to as the cyanide sensitive factor (Holloway 
1963, Gellhorn et al 1964, Holman 1964, Oshino et al 
1966, 1971, 1972, 1973, Brenner et al 1969, Holloway 
1971, Shimokata et al 1972, Strittmatter et al 1974, Lee 
et al 1977, Okayasu et al 1976 and Brenner 1982). This 
process requires both ATP and Mg2+ (Nugteren 1962, 
Brenner 1974 and Cook 1978a).
Desaturation requires prior activation of FA s to acyl — 
CoA, via plasma membrane acyl:CoA synthetase (Brenner 
1971). This enzyme has been demonstrated in several rat 
and human tissue plasma membranes by Davidson et al 
(1986a, 1986b), is non-rate-limiting, and shows a 
substrate preference of w3 PUFA s > u6 PUFA s > w9 
monoenoics > saturated FA's. This activity profile 
mirrors that of the desaturase enzymes (Kanau et al 
1977). Not only is acyl-CoA formation many times more 
rapid than desaturation (eg. Pande et al 1968, Marcel et 
al 1972 and Sprecher 1981), but the NADH-cytochrome bs 
electron transferring system is common to all the 
desaturases (Brenner 1982). In addition, the electron
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flux generated is many times greater than the
requirements of the desaturases (Sprecher 1981 and
Brenner 1982), thus the enzyme itself is the rate
limiting factor (Brenner 1971 and Raju et al 1972).
The enzymes which catalyse these desaturations appear to 
have a Coenzyme A binding site, which recognises the 
fatty acyl-CoA substrate. It seems likely that the 
methylene chain of the FA fits into a restrictive cleft 
of finite length (Brett et al 1971 and Do et al 1975). 
For the full activity of these enzymes to be expressed* 
cytoplasmic protein factors are required (Catala et al 
1975, 1977, Jeffcoat et al 1976, 1977a, 1978 and Leikin 
et al 1979, 1986, 1989). Crude microsomal preparations 
showed delta-9-, delta-6- and delta-5-desaturase 
activity, which activities were lost with repeated 
washing, but were then restored by the addition of 
cytoplasmic proteins.
Chain elongation of unsaturated FA's occurs at the 
carboxyl terminal, while desaturation occurs between the 
carboxyl group and the first double bond from the 
carboxyl group. Thus, the number of carbon atoms 
between the methyl terminal and the double bond nearest 
this remains constant (Davidson et al 1985a).
Since microsomal membranes contain lipids, the 
composition of which may be modulated (eg. Nervi et al 
1968 and Garg et al 1988a, 1988b, 1988c), it has been
suggested that the microsomal lipid composition may be 
involved in regulation of the desaturase enzymes 
(Garda et al 1984, 1985 and Kurata et al 1980), Membrane 
PGL's may also serve as sources of enzyme substrates 
(Pugh et al 1984).
1*3.2 The Biosynthetic Pathway of Unsaturated
Fatty Acid Synthesis.
The desaturase cascade primarily consists of three 
desaturase enzymes, delta-6-desaturase (J6D), delta-5- 
desaturase (45D), and delta-4-desaturase (J4D) (Fig.
1.3.2.1.). These enzymes, and especially A 6D , are the 
rate limiting steps in the desaturase cascade (Marcel et 
al 1968, Brenner 1974, Hassam et al 1975 and de Gomez 
Dumm et al 1976). The first enzyme is specific for C18 
FA s, the second for C20 FA's and the third for C22 
FA's, and the enzymes exhibit greater activity with u3 
than with u6, and least activity with u9 substrates 
(Brenner et al 1966, Mead et al 1976 and Kanau et al 
1977). It is also apparent, since mammals cannot 
interconvert w3, u6, and u9 FA's (eg. Crawford et al 
1972), that the desaturase/elongase pathway will produce 
3 distinct families of related compounds (Crawford 
et al 1971, Sprecher 1977 and Sinclair 1984). Different 
products of the pathway do, however, compete with each 
other (Holman et al 1963, Holman 1964 and Mohrhauer et 
al 1963a). This competition can be displaced in either
direction, and the FA favoured in this competition is 
dependant on relative substrate levels. In general, u3 
inhibit the metabolism of u6 and u9 FA's, and w6 inhibit • 
that of w9 (eg. Bernert et al 1975). Consequently, the 
metabolites of oleic acid are only found in trivial 
amounts under normal physiological conditions. The 
ability not only to distinguish clearly between FA's, 
but at the same time to appreciate the relationships 
between members of a homologous series, is therefore, 
vitally important.
Uithin any unsaturated FA metabolic pathway, rates of 
desaturation are generally slower than those for chain 
elongation (Bernert et al 1975, Brenner 1971, Sprecher 
1977 and Naughton 1981), and there is evidence that the 
desaturation rate for membrane-bound substrate may be 
greater than that for exogenously added FA's (Aeberhard 
et al 1981). Thus, misleading conclusions may arise 
about enzyme activity when isolated enzymes are assayed 
(Aeberhard et al 1981 and Hill et al 1982). Furthermore, 
the elongation steps are generally easily reversible, 
thus retroconversion probably depends on substrate 
availability, while the desaturation steps are usually 
not reversable in vivo (Mead et al 1960, Stearns et al 
1967, Ayala et al 1973 and Gavino et al 1981b).
Although a number of different pathways for desaturation 
and elongation have been reported (eg. Brenner 1971 and
Gurr et al 1971), the preferred route appears to be the 
one described (Fig. 1.3.2.1.), with initial desaturation 
followed by chain elongation (Marcel et al 1968, Bernert 
et al 1975 and Sinclair 1984). Other pathways appear to 
be of minor importance in mammals (Brenner 1971, Ullman 
et al 1972, Lands et al 1977 and Sprecher 1981).
1.3.3 The Desaturase Enzymes.
1.3.3.1 J-6-Desaturase♦
A6D is the first, and rate-limiting, enzyme of the 
desaturase enzyme cascade (Stoffel 1961, Holloway 1963, 
Marcel et al 1968, Oshino et al 1972, Brenner 1974, 
Hassam et al 1975, de Gomez Dumm et al 1976, Mead et al" 
1976, Kanau et al 1977 and Sprecher 1981). This enzyme 
catalyses the formation of 18:3u6 and 18:4u3 (Fig.
I.3.2.I.), is essential for the full expression of EFA 
biological activity (Frankel et al 1975), and requires 
zinc (Huang et al 1982).
Okayasu et al (1981) isolated and purified the enzyme 
from rat liver microsomes and showed it to be a single 
polypeptide chain of 66000 Daltons. The liver enzyme 
exhibits the greatest activity, especially during 
prenatal brain growth, when PUFA requirement is high, 
and maternal supply may be limiting (Brenner 1971, 
Sinclair 1974, 1975a, 1975b, Naughton 1981 and Novelot
et a 1 1986).
The regulation of J6D has been reviewed extensively by 
Jeffcoat (1979) and Brenner (1982), and evidence to date 
indicates that A6D exhibits a particular substrate 
specificity pattern (Brenner et al 1969). As with the 
other desaturates, A6D is more active with u3, than with 
u6 or u9, substrates (eg. Kanau et al 1977). This may 
reflect a selective mechanism whereby the much lower 
dietary levels of u3 FA's are preferential 1y utilised. 
A 6D activity is extremely sensitive to slight changes in 
the metabolic and physical environments (Cook 1979), and 
has a circadian rhythm (Actis Dato et al 1972). In vivo 
and in vitro studies indicate that ^6D is inhibited 
very easily by a wide range of different factors. These 
are summarised in Figure 1.3.3.1.1., and include 
dietary, hormonal and pathological factors. While A6D is 
the rate limiting step and is easily inhibited (eg. 
Brenner 1982), few factors inhibit/suppress elongation. 
In fact, while conditions such as diabetes and 
malnutrition suppress A6D activity, elongation is either 
conserved or enhanced (Gellhorn et al 1964, Peifer et al 
1965, Brenner et al 1968a, Ayala et al 1973 and Holman
et al 1981).
Fig. 1.3♦3.1.1.
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Dietary
Moderate food restriction (1) 
EFA deficiency (1)
Fat-free diet (1)
Carbohydrate deficient diet (1) 
Protein rich diet (2)
Hormonal
Lou insulin levels (1) 
ATP (1)
Other
Temperature decrease (1)
LA
Activators
+
-» A6D +GLA
Inhibitors
Suppressors
Dietary 
Fasting (1)
Protein deficiency (3)
High glucose levels (4)
High carbohydrate levels (2) 
High cholesterol levels (5) 
High saturated FA levels (6) 
High trans-FA levels (7)
FA reaction products (1)
Patho1ogi ca1 
Diabetes (8) 
Transformation (9) 
Atopic eczema (10)
Hormonal
cAMP mediated mechanisms (11) 
Glucagon (11)
Thyroxine (12)
Epinephrine (13)
Other
Temperature increase (1) 
Zinc deficiency (14)
Mg2+ deficiency (15) 
Alcohol (16)
Aging (17)
(1) eg.
(2) eg.
(3) eg.
(4) eg.
(5) eg.
(6) eg.
(7) eg.
(8) eg.
(9) eg.
(10) eg.
(11) eg.
(12) eg.
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(15) eg.
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Brenner (1982) 
de Gomez Dumm et al (1970) 
de Tomas et al (1980) 
Brenner et al (1968a)
Garg et al (1986)
Brenner et al (1966)
Cook (1981)
Gellhorn et al (1964)
Dunbar et al (1975)
Manku et al (1982a) 
de Gomez Dumm et al (1975a) 
Hoch (1981)
de Gomez Dumm et al (1986) 
Huang et al (1982)
Mahfouz et al (1989)
Nervi et al (19800 
Bordoni et al (1988)
45D catalyses the conversion of 20:3w6 and 20:4w3 to 
20:4u6 and 20t5w3, respectively (Fig. 1.3.2.1.). As with 
46D, J5D activity varies depending on animal species 
(Marcel et al 1968, Danon et al 1975, Rivers et al 
1975a, 1976, Stone et al 1979 and Chapkin et al 1984). 
The enzyme is more active with w3, than with w6, 
substrates (eg. Kanau et al 1977), and thus exhibits a 
much higher affinity for 20:4u3 than for 20:3w6. Thus, 
20:4w3 is rapidly converted to 20:5u)3, while only some 
20:3w6 is converted to 20:4u6. 20:3u6 and 20:4w6 are the 
precursors for the 1- and 2-series eicosanoids, 
respectively, while 20s5w3 is the precursor for 3-series 
eicosanoids (eg. Crawford 1983 and Lands 1986). Thus, 
the activity of J5D may regulate the balance between the 
different series of eicosanoids. Indeed, J5D has been 
suggested to act as a secondary regulatory point in the 
desaturase cascade (Castuma et al 1972).
The regulation of J5D has been reviewed by Jeffcoat 
(1979) and Brenner (1982). Many of the inhibitors of 46D 
are also effective inhibitors of J5D. Large intakes of 
cholesterol, oleic acid and ethanol inhibit 45D function 
(Lowry et al 1966, Alfin Slater et al 1968 and Nervi et 
al 1980), and there is also evidence that excess vitamin 
A suppresses this reaction (Huang et al 1985). As in the 
case of A 6D, a low protein intake inhibits, and a high
protein intake stimulates, J5D (Castuma et al 1972, de 
Gomez Dumm et al 1972, Mercuri et al 1979 and de Tomas 
et al 1980). Contrary to A 6D, however, EFA deficiency 
induces decreased J5D activity (Peluffo et al 1976 and 
Brenner et al 1982). Rats maintained on a fat-free diet 
exhibit a significant reduction of J5D activity compared 
to animals on a balanced diet (de Gomez Dumm et al
1983). In contrast, 18:2u6 supplementation of an EFA 
deficient diet increases J5D activity to almost control 
levels, while 45D activity is not affected by dietary 
carbohydrate (Jeffcoat et al 1977b and Castuma et al
1982). Jeffcoat et al (1977c) have, however, found that 
triolein is a very good activator of J5D, but a 
depressor of J6D.
Unlike A 6D , J5D does not appear to be suppressed by cell 
transformation (Dunbar et al 1975). In diabetes, the 
activity of J5D is only slightly reduced (Gellhorn et al 
1964, Brenner et al 1968, Peluffo et al 1971 and Castuma 
et al 1972). Insulin increases J5D, but most other 
hormones decrease its activity. Like J6D, J5D activity 
is reduced by glucocorticoids, epinephrine and dibutyryl 
cAMP (de Gomez Dumm et al 1979, 1980). It has been 
reported that J5D activity is lost in Man after puberty 
(eg. Dyerberg et al 1980a and Horrobin 1982, 1983), 
although Mest et al (1983) report the opposite.
The formation of 22:5u6 from 20*4w6 via J4D (Fig.
1.3.2.1.) has been studied considerably less than the 
desaturation of 20:5u3 to 22:6w3, and J4D has been 
studied much less than A 6D and J5D. FA's of 22 carbons 
are, however, important as they contribute considerably 
to the 1ipids of cel 1 membranes in general, and brain 
cells in particular (eg. Svennerholm 1968). Desaturation 
and chain elongation of 20:4u6 to 22:5w6 has been 
demonstrated in 1iver microsomes of rats fed a fat-free 
diet (Hagve et al 1984). A separate study feeding 
radiolabel1ed CiaCD-20:5w3 showed the formation of 13% 
22:6u3 in rat hepatocyte microsomes, but no AdD activity 
with 014CI]-22:4u)6 as substrate (Hagve et al 1986). 
Testis AdD activity appears to be greater than in the 
liver (Clejan et al 1982), but activity has been shown 
to be absent in many cell lines, including the C1300 
neuroblastoma (Yavin et al 1975). This may be surprising 
since neural tissue is reported to contain large amounts 
of PGL 22:6w3, but may reflect a requirement for dietary 
supply. Traces of J4D activity have, however, been 
reported by others in human skin fibroblasts (eg. 
Aeberhard et al 1978). While the varied AdD activities 
found in these studies may reflect experimental 
differences, it is more likely that AdD activity varies
with cell type.
It appears that many factors influencing A6D alter AAD 
activity in a similar manner, eg. zinc deficiency (eg. 
Clejan et al 1982). While a diet rich in LA has been 
found to cause depletion of long chain u3 FA's (Lepran 
et al 1981), a number of workers have also found that 
EFA deficiency depletes cellular C22 FA's (Dunham et al 
1978 and de Schriver et al 1982), while low levels of 
C22 FA's have been demonstrated in many pathological 
states, including diabetes (eg. Brenner et al 1968a).
1.3.3. A- J9-Desaturase ♦
A9D catalyses the conversion of either de novo 
synthesised or dietarily derived 18:0 to 18:lu9 (Fig.#
1.3.2.1.) (Bernert et al 1975, Brenner 1982, Sinclair
1984). The enzyme consists of a three-component protein 
and the rat liver enzyme has a molecular weight of 53000 
Daltons (Strittmatter et al 1974).
Control of J9D activity shows a different pattern from 
those of A6D or J5D (Brenner 1974, Jeffcoat 1979a and 
Nervi et al 1980). For example, A9D is not inhibited by 
ethanol, as are both il6D and J5D, and is only modulated 
significantly by dietary composition. A high protein 
diet decreases A9D activity (Peluffo et al 1984), while 
a high cholesterol diet enhances its activity (Garg et 
al 1986). The activity of A9D is depressed by fasting 
(Inkpen et al 1969 and Oshino et al 1972) and also by
diets containing cis-linoleic acid (Jeffcoat et al 1977, 
1978, 1979, Brenner 1982 and Sinclair 1984). Conversely, 
A9D activity is increased dramatically by feeding diets 
high in carbohydrate (de Gomez Dumm et al 1970, Peluffo 
et al 1971, Oshino et al 1972, de Tomas et al 1973, 
Brenner 1982 and Sinclair 1984). A fat-free diet also 
enhances A9D activity (Paulsrad et al 1970, Brenner 1974 
and Jeffcoat et al 1977), but addition of EFA's to a 
fat-free diet inhibits the enzyme (Jeffcoat et al 1977, 
1978 and de Gomez Dumm et al 1982). Saturated FA effects 
on A9D activity are less clear, with both increased 
(Inkpen et al 1969 and Mercuri et al 1974) and decreased 
(Jeffcoat et al 1977a) activities reported, possibly 
reflecting differences in experimental design. While the 
rate of delta-9-desaturation is markedly depressed in 
diabetics, this reflects low levels of the desaturase 
rather than impairment of activity (eg. Gellhorn et al 
1964, Brenner et al 1968b, Peluffo et al 1971, Castuma
et al 1972 and Prasad et al 1979).
Cascade.
Brenner (1974) showed that 18:2w6 and 18:3w3 compete for 
46D, with 18:3u3 being the preferred substrate. 18:3u3 
inhibits the metabolism of u6 FA s by competitively 
inhibiting J6D (Mohrhauer et al 1963b, Brenner et al 
1966, 1977 and Garg et al 1988a), while 18:2w6 only 
weakly inhibits conversion of 18:3w3 (Holman et al 1964 
and Actis Dato et al 1970). Thus, dietary 18:3u3 may 
decrease the amount of 20:4u6 in tissues primarily by 
limiting J6-desaturation of 18:2u6 (Holman et al 1963 
and Mohrhauer et al 1963a). Budowski (1981) reported 
that a diet rich in linseed oil depressed 20:4w6, and 
raised 18:2w6, concentrations in liver PGL's of chicks 
and in plasma lipids of both rats and chicks. In 
parallel, constant dietary 18:2w6 levels, with 
increasing 18:3u3, decreased the proportion of 20:4w6 in 
rat liver and plasma FA's (Hwang et al 1980). However, 
competitive inhibition between u3 and (*)6 FA's depends 
largely on the dietary ratio's of these FA's (Holman et 
al 1964 and Cook et al 1987). Kramer (1980) suggested 
that dietary 18:3u3 only inhibits J6-desaturation of 
18:2u6 if the 18:3u3 content of the diet is greater than 
15^, further implicating the importance of dietary EFA 
levels in the control of desaturation. Nevertheless, 
both 18:2w6 and 18:3w3 inhibit 18:lw9 desaturation, thus 
preventing 20:3u9 synthesis (Brenner 1966, 1969, 1982
and Holman 1986b). However, when 18:2u6 and/or 18:3w3 
levels are low, the inhibition is removed, and 18:lu9 is 
metabolised to 20:3w9 (Brenner et al 1965a, 1965b and 
Sprecher 1981). While it has been suggested that 20:3u9 
could substitute for long chain U)3 and U)6 FA's in 
maintenance of cell membrane flexibility during EFA 
deficiency (eg. Horrobin 1983), it is known to inhibit 
prostaglandin synthesis (Okazaki et al 1974, 1978), and 
also may block J5D activity (Lowry et al 1966).
Chang et al (1973) used rat liver microsomes to show the 
effect of double and triple bonds in FA inhibition of 
stearic acid desaturation. The position of one cis- 
double. bond in an 18 carbon FA chain affected the 
ability of that acid to inhibit stearic acid 
desaturation. The isomers found to be most inhibitory 
were those of cis-octadecenoic acid; in those cases in 
which both cis- and trans-isomers were tested, the 
trans-acids were either equally, or less, inhibitory 
than the corresponding cis-isomers (Chang et al 1973). 
Kinsella et al (1981) reported that the trans-isomers of 
18:1, other than elaidic acid, can be desaturated by J9D 
to yield trans,cis dienes. Dietary trans-18Jlu9 also 
inhibits conversion of 18:lw9 to 20:3w9 and of 18:2w6 to 
20:4w6 by acting as a competitive inhibitor of the 
desaturase (Kinsella et al 1981).
The decrease in monounsaturated FA's in rat tissues
(16: lu)7 and/or 18:lw9) induced by diets containing high 
levels of 18:2u6 and/or 18:3u3, is consistent with PUFA 
inhibition of A9D activity (Mahfouz et al 1984 and Pugh 
et al 1984). U11 man et al (1971a) prepared microsomes 
from male weanling Sprague-Dawley rats and investigated 
the role w6 FA's play in inhibiting the u9-desaturation 
step. 18:2u6, 20:3u6 and 20:4w6 inhibited A 9 -  
desaturation of 18:0, while 20:3u6, 18:3w3 and 20:4w6 
inhibited J5-desaturation of 20:2u9. Uhen Garg et al 
(1988b) studied A9D activity in liver microsomes of rats 
fed diets enriched with either saturated FA's, 18:3w3 
(linseed oil), or 20:5w3 and 22:6w3 (fish oil), both 
linseed and fish oils inhibited J9D activity, with fish 
oil being more effective.
Both 18:2w6 and 20:3u6 suppress 18:2w9 formation, but 
20:4w6 does not (Brenner et al 1966, 1969 and Mohrhauer 
et al 1967). 20:4w6 does, however, inhibit desaturation 
of EFA's (eg. Irvine 1982), thus high dietary levels of 
this FA may inhibit J6D. 20:4w6-rich foods, such as red 
meat, may well inhibit desaturases by negative feedback, 
and this can generate an imbalance of both PDFA's and 
eicosanoids (Crawford et al 1970). In contrast, while 
18:3u6 only weakly inhibits 18:3u3 desaturation, it 
effectively inhibits desaturation of both 18:2w6 and 
18:lu9 (Brenner 1971, 1974 and Cook et al 1987). There 
is also monounsaturated FA involvement in the control of 
polyenoic FA desaturation. Dhopeshwarkar et al (1963)
demonstrated that dietary monoenoic FA's suppressed LA 
desaturation, while Mahfouz et al (1980a, 1981) showed 
that 1iver microsomal desaturation of both LA and DGLA 
were inhibited by positional isomers of 18:lu9.
Long chain u3 FA's also inhibit/suppress desaturation; 
both EPA and DHA act as analogues of AA to inhibit A6D  
by a feedback mechanism, and DHA is a highly effective 
inhibitor of A6D (eg. Garcia et al 1965, Brenner et al 
1966, 1967, Brenner 1974 and de Schrijver et al 1982). 
Studies suggest that EPA is less effective than DHA in 
inhibiting A 6D (Brenner et al 1966, Alfin-Slater et al 
1968 and Bernert et al 1975), but more effective than 
DHA in inhibiting conversion of DGLA to AA via J5D 
(Nassar et al 1986). Still other studies showed that 
1iver microsomes from rats fed EPA showed depressed A6D  
activity (Kurata et al 1980), while DHA decreased 0A, LA 
and ALA desaturation (Brenner et al 1966). While EPA 
effectively inhibits desaturation of 20:4u3 by feedback 
mechanisms, DGLA desaturation is also inhibited (Garcia 
et al 1965 and Alfin-Slater et al 1968). Others showed 
competitive inhibition of A6D in liver microsomes of 
rats fed linseed or fish oils (Garg et al 1988a), 
apparently by competition with 18:2w6 for A 6D. Fish oil 
was significantly more inhibitory than linseed oil. In a 
subsequent study, Garg et al (1988c) showed that J5D 
desaturation of DGLA to AA was greater than control 
levels in rats fed linseed oil and lower in those fed
fish oil. These studies demonstrate that while both 
linseed and fish oils limit J6D, only fish oil limits 
J5D; the lower levels of AA when linseed oil was fed 
thus reflects reduced J5D substrate formation due to 
suppression of A 6D.
Ulhile desaturase cascade FA's have the capability to 
inhibit/suppress desaturase activity, there is also 
evidence to suggest that FA's enhance enzyme expression. 
In a series of studies on rat heart, liver, adipose 
tissue, erythrocytes and brain, Mohrhauer et al (1963a, 
1963b, 1963c, 1963d, 1963e) showed that as the amount of 
dietary 18:2u6 or 20:4w6 increased, their w6 PUFA 
derivatives increased in tissue lipids, while u3 PUFA's 
decreased. Furthermore, Holman (1971) reported that 
18:2u6 promotes desaturation of 20:3u6 to 20:4u6. On the 
other hand, Marshall et al (1982) showed that increasing 
the dietary level of 18:2u6 eventually led to a 
decreased level of 20:4w6, implying suppression of the 
cascade. Thus, the exact roles of substrate and products 
of the desaturases in the regulation of the enzyme 
activity is unclear.
Ulhile the desaturation steps are rate limiting and under 
direct control by FA substrate/product levels, the
elongation steps may a 1 so be modulated by FA's.
Christiansen et a 1 (1968) studied the effects of
unsaturated FA's on chain elongation of 18:3u6 in
enhanced the reaction, while 18:3u3 and 22:6u3 were 
inhibitory. Although 18:lw9, 20:3u3 or 20:5w3 were not 
effective, two unusual PUFA's, 18:3u7 and 17:3u6, were 
both inhibitory. The latter was the most effective, 
suggesting that the ul-w6 structure was the important 
factor. In addition, Banerjee et al (1986) showed that 
while 20:5u3 is an effective inhibitor of 20:4u6 
elongation, both 20:4w6 and 20:5u3 had the capability to 
modulate their own elongation.
The influence of trans-C18 FA's on in vivo and in vitro 
desaturation and elongation in rat brain was studied by 
Cook (1981). Linoelaidate was highly inhibitory of chain 
elongation in vitro. In vivo. both desaturation and 
elongation of linoleate were inhibited by both oleate 
and linoelaidate, while elaidate and stearate were 
stimulatory. Mahfouz et al (1980a, 1981) investigated 
the effects of trans-C18:l FA's on J9D, A 6D and J5D 
using rat liver microsomes, and showed that not only 
were these FA^s inhibitory, but the position of the 
double bond in the trans-C18:l FA appeared to be 
important in determining the degree of inhibition. 
Although chain elongation of some positional isomers of 
trans—C18?l were shown, other studies demonstrated 
considerably slower rates of elongation than A9 
desaturation (Kameda et al 1980).
and u9 FA s are an important regulatory factor for the 
modulation of desaturase cascade enzyme activity, and 
that high levels of a desaturase reaction product may 
block desaturation of other FA's of both the same and 
different families by earlier enzymes in the cascade. At 
the same time, high levels of any FA substrate may 
stimulate desaturation of other FA's in the cascade. To 
date, almost every FA substrate/product in this cascade 
has been shown to be involved in the control of overall 
desaturation/elongation. A blockade of any step, but 
primarily A 6 D t will lead to functional PDFA deficiency, 
even if EFA levels, or the triene:tetraene ratio, are 
normal. Consequently, impairment of enzyme activity and 
subsequent changes in PDFA levels have been reported to 
lead to altered membrane structure, interference with 
membrane associated processes, EFA deficiency symptoms, 
impaired eicosanoid metabolism and the perturbation of 
eicosanoid mediated responses (Blank et al 1976, 
Horrobin 1983, Cantrill et al 1984 and Jones et al
1986), involving the cardiovascular and immune systems, 
brain function and cell proliferation, among others.
1.3.5 Fatty Acid Desaturation in Disease States.
A substantial volume of evidence implicates derangement 
of the desaturase enzyme cascade in diverse clinical 
conditions. Diabetes mel1itus is one of the most common 
conditions in which J6D activity is deranged. Mercuri et 
al (1966) and de Alaniz et al (1969) demonstrated that 
the conversion of 18:2w6 to 18:3w6 was blocked, that 
20:4u6 and longer chain 22-carbon FA's were depleted, 
and that desaturation could be restored by low doses of 
insulin injected into alloxan diabetic rats. Llhile 
elongation appears to be conserved in diabetes (Ayala et 
al 1973), Poisson et al (1978) reported 70\  inhibition 
of A6D in alloxan diabetic rats, and Faas et al (1980) 
demonstrated that the conversion of 18:2u6 to 18:3u6 was 
only 50 of controls in streptoyotocin diabetic rats. 
Elevated 18:2u6 and lowered 20:4u6 levels were found by 
Jones et al (1983) in platelets from diabetic patients, 
implicating a J6D blockade, subsequently confirmed by 
others (eg. Horrobin 1983 and El-Boustani et al 1986). 
EFA requirements are considerably enhanced in diabetes, 
since excess 18:2w6 is required to overcome the partial 
J6D blockade (Peifer et al 1965).
Defective desaturase, particularly A 6D, function has 
also been implicated in pathological conditions such as:
Cancer eg. Yavin et a 1 (1975)
A1coholism eg. Nervi et al (1980)
Liver cirrhosis eg. B1 ond et al (1981)
Scaly dermatoses eg. Ziboh (1981)
Pre-menstrual syndrome eg. Brush (1982)
Crohn's Disease eg. Holman et al (1982)
Cystic fibrosis eg. Holman et al (1982)
Atopic eczema eg. Manku et a 1 (1982b, 1984)
Hypercholesterolemia eg. Garg et al (1986, 1988a)
Atopic asthma eg. Rock 1in et a1 (1986)
In most of the above, plasma 1inoleate levels are
raised, while J6D products are low, indicating enzyme 
blockade. In an extensive report, Horrobin (1982a) 
indicated that in some of these conditions, oral 
treatment with GLA produced significant improvements in 
both the biochemical and clinical state, further 
supporting the suggestion of J6D impairment.
1.3.6 Fatty Acid Desaturation in Mammalia.
Some species of the Rodentia show marked ability to 
desaturate PUFA's, and EFA's in particular (Brenner 
1971, 1974 and Sinclair 1974). Desaturation capability, 
however, varies considerably between different rat 
tissues. Brenner (1971) showed that the percentage 
desaturation of LA to GLA in isolated microsomes from 
young rats was 20% in adrenals, 14% in liver, 6% in 
testes and less than 2% each in heart, kidney and brain. 
No desaturation could be detected in lung or epididymal 
fat (Brenner 1971), although Gellhorn et al (1964) found 
that rat adipose tissue was able to desaturate SA to OA. 
45D is active in the rat, but appears to be more active 
in the mouse (Anon 1979, Stone et al 1979 and Blond et 
al 1981). Both species, however, exhibit greater J5D 
activity than other mammalia, eg. rabbit, guinea pig or 
Man (Stone et al 1979). J5D catalyses a slow reaction 
(eg. Bernert et al 1975), and rat tissues such as testes 
(Ayala et al 1973) and adrenals (Brenner et al 1967 and 
Takayasu et al 1970) often accumulate DGLA, particularly 
in the fed state. Danon et al (1975) showed that while 
DGLA levels are generally low in the rat, an increased 
ratio of DGLA to AA, with only a small increase in AA, 
was found when DGLA was fed. Thus, it appears that 45D 
activity is not stimulated by DGLA-rich diets. Little 
attention has being focussed on J4D, although the enzyme 
has been found in rat testes by Bridges et al (1970)
and Ayala et al (1973), who also showed retroconversion 
of 22:4w6 to 20:4u6.
Rivers et al (1975a) published biochemical evidence 
indicating that the cat lacked J6D; this confirmed the 
obligate carnivore nature of the domestic cat. Numerous 
subsequent studies showed that GLA is essential for the 
cat (MacDonald et al 1983a, 1984). Other species of the 
Felinae, such as the lion and cheetah, have been shown 
to exhibit a similar enzyme deficiency (Rivers et al 
1976 and Davidson et al 1986c, 1986d). The lack of A6D 
is thus probably a feature common to the Felinae as a 
Family. At least one wild species of the Canidae (the 
wolf) appears to possess an active form of A 6D, while 
some breeds of domestic dog, however, appear to have 
impaired A6D activity (Horrobin et al 1990 and Lloyd 
1990). The exact extent of the deficiency within the 
Carnivora is thus, not certain. Frankel et al (1978) 
showed that while chain elongation was unimpaired, the 
cat also lacked J5D. Stone et al (1979) similarly 
provided evidence to suggested the absence of J5D, but 
this has been largely contradicted by other in vivo 
studies, which showed signs of J5D and J4D activity in 
the cat (Rivers et al 1978, Sinclair 1979, Kane et al 
1981, MacDonald et al 1983a, 1984 and Davidson et al 
1989, 1990). Thus, it appears that PDFA's can probably
be metabolised by the cat to form eicosanoids and their
precursors.
The presence of long chain PDFA derivatives of LA and 
ALA in vegans suggests that Man can metabolise parent 
EFA's (Sanders et al 1978). While human liver has been 
shown capable of desaturating C14C3-LA and CiaCT-ALA, 
the rate is slow (de Gomez Dumm et al 1975b). Others 
also report limited J6D activity in Man (Dyerberg et al 
1980 and Horrobin 1983). Humans also exhibit limited 
J5D activity, even in liver (Willis et al 1976, Anon 
1979, Stone et al 1979, Blond et al 1981 and El-Boustani 
et al 1986). This may reflect limited A6D activity, 
although numerous studies suggest that J5D itself is not 
very active. Despite administering large doses of DGLA 
to humans, both Kernoff et al (1977) and Willis (1981) 
found only a small rise in AA levels, while the ratio's
of DGLA and PGEi to aa and its products increased 
significantly. Horrobin (1983) reported that while
administration of GLA to humans significantly raised 
DGLA, AA levels were only marginally raised. Even 
administration of large amounts of ALA resulted in only 
a small change in EPA and DHA (de Gomez Dumm et al 
1975b, Blond et al 1981, Mest et al 1983 and Neuringer 
et al 1984), implying suppressed J4D function. This 
limited desaturation capability makes the extreme 
"Western* human very close to being an obligate 
carnivore. In addition, since Eskimo's appear to either 
lack or have suppressed A6D and J5D, and exhibit 
elevated LA and DGLA, and decreased AA, levels (Gibson
et al 1981b and Sinclair 1981), it has been suggested 
that they may be obligate carnivores, the human 
equivalent of the cat (Sinclair 1981),
The lack of A 6D makes the cat an ideal experimental 
model for assessing the relative importance of different 
PDFA's in metabolism. Other animal models possessing an 
active form of this enzyme are, unlike the cat, 
difficult to make deficient in specific FA's since they 
are capable of endogenous PDFA production from their 
plant derived precursors. The cat, however, can be made 
PDFA-deficient by dietary modification, even when fed 
the classic EFA's, without this being redressed by in 
vivo production. This species therefore serves as a 
model for the extreme "Western‘ human. Further, the cat 
also shows a very close degree of genetic homology with 
Man between all gene loci mapped to date, and exhibits a 
very high incidence of hereditary diseases paralleling 
similar conditions in humans (O'Brien 1986).
While different mammalian species exhibit different 
desaturase capabilities, no quantitative data is 
available to date on the relative contribution of 
individual organs to their own, or total, body PDFA
trequirements, or whether the tissue distribution of 
desaturases varies in different species of the mammalia. 
The available evidence suggests that the desaturases are 
not distributed evenly between tissues (Gellhorn et al 
1964 and Brenner 1971), implying dependence of some
tissues on others in vivo for a supply of PDFA's (eg. 
Nervi et al 1965, Cook et al 1978a, Chapkin et al 1984, 
1986a, 1986b and Ziboh et al 1987); thus, the assessment 
of desaturation potential in vivo may not necessarily 
reflect the desaturation capability of the particular 
tissue studied, but may reflect PDFA's transported from 
tissues exhibiting desaturation capability to tissues 
exhibiting limited or no desaturation potential.
1.3.7 . Fatty Acid Desaturation in Cultured Cells.
Menkes (1972) showed that rat brain cells cultured 
in a lipid-free medium take up exogenous C14C3-palmitic,
C1aC3~stearic and CiaC3-lignoceric acids, and such could 
be desaturated and/or elongated. Desaturation in brain 
in vivo has not been conclusively proven, although the 
J9D desaturation capability of brain cells in vitro 
under specific culture conditions implies that this 
enzyme may be inactive in the brain in vivo. and 
activated, at least partly, when brain PUFA levels are 
depleted.
Dunbar et al (1975) showed that normal human lung 
fibroblasts (UI-38) readily desaturate and elongate 
PUFA^s via A6D and J5D. There also is evidence that 
human skin fibroblasts exhibit A 6D, J5D and even some 
J4D activity in culture (Dunbar et al 1975 and Aeberhard 
et al 1978). Rosenthal et al (1983a, 1984) showed that
49-, A 6 - and 45-desaturation of CiaCD-stearate, C14CD- 
linoleate and CiaCU-}r-eicosatrienoate, respectively were 
enhanced by prior growth of human skin fibroblasts in 
lipid-free medium. These workers also showed that 
addition of exogenous FA's to the culture medium 
modulated desaturase activity, depending on the FA and 
the particular desaturase. A9D activity was enhanced 
with elaidic acid, but was not modulated upon dosing the 
incubation medium with either myristic, pentadecanoic, 
palmitic, stearic, trans-vaccenic (trans-18:lw7) or 
linoelaidic acids. Addition of cis-vaccenic, oleic or 
linoleic acids, however, inhibited A9D activity in the 
order 18:2u)6 > 18:lu9 > 18:lu7. On the other hand, both 
elaidic and linoelaidic acids were effective inhibitors 
of 46-desaturation, while trans-vaccenic acid was only 
half as effective in inhibiting A 6D. Oleic, cis-vaccenic 
and f-linolenic acids only marginally inhibited CiaCT- 
linoleate desaturation. Elaidate was a potent inhibitor 
of 45D, as were all u9-trans FA's, while u7 trans-FA's 
were much less inhibitory. This supported previous 
evidence concerning the involvement of the position of 
the double bond in the inhibition/suppression of 
desaturation (Mahfouz et al 1981).
Contrary to the above, Spector et al (1980a) showed that 
when the culture medium of human skin fibroblasts was 
enriched with 18:2w6, 20:4w6 decreased by 45^, while 
20:2w6 accumulated, implying suppression of desaturase
activity. They suggested that human skin fibroblasts 
possibly could not efficiently convert 18:2u6 to 20:4u6, 
although such may also reflect the ability of these 
cells to selectively control 20:4w6 levels. Other 
reports similarly indicate that both cultured human skin 
fibroblasts and guinea pig aorta smooth muscle cells 
were unable to desaturate 18:2u6, although elongation 
was retained (Gavino et al 1981b and Morisaki et al 
1982a). Human skin fibroblasts have also been shown to 
elongate numerous other FA's, including 16:0, 18:0, 
20:0, 22:0, 20:3u6, 20:4u6 and 20:5w3 (Gavino et el 
1981a, Tsuji et al 1984 and Banerjee et al 1986).
Rosenthal et al (1983b, 1986) demonstrated that C ^ CD- 
IS :2u)6 was desaturated and chain elongated to 20:3u6, 
20:4w6 and 22:4w6 in cultured human umbilical vein 
endothelial cells, indicating J6D, J5D, and elongase 
expression. Desaturation and elongation of C 1‘q'C3-18:3w3, 
however, was more extensive than for C14CD-18:2u6. 
This supported the similar desaturation pattern found 
in human skin fibroblasts (Aeberhard et al 1978 and 
Rosenthal et al 1982). Endothelial cells exhibited 
greater fatty acyl CoA A 6D activity when grown in medium 
containing 2.5£, instead of 1 0 4 or 2 0 4 , FBS, while 
medium supplementation with 20-100juM oleate inhibited 
arachidonate synthesis by up to 6 7 4 (Rosenthal et al 
1983b). The concentration of serum and serum lipids also 
influenced desaturase activity in human skin fibroblasts
(Rosenthal et al 1982, 1983a, 1984). However, the 
mechanism by which serum inhibits desaturase expression 
awaits further clarification, although Rosenthal et al 
(1983b) suggested that serum lipids provide sufficient 
arachidonate to inhibit endogenous synthesis, at least 
partial 1y.
The evidence for desaturase capability in human 
umbilical vein endothelial cells was directly 
contradicted by Spector et al (1980b, 1981b, 1981c,
1983). They showed that these cells either exhibit very 
weak, or lack, significant A 6D activity, and implied 
that vascular endothelium requires preformed PDFA's, 
particularly arachidonate, from the serum for eicosanoid 
synthesis. The lack of detection of long chain more 
unsaturated FA's did not appear to relate to ineffective 
FA uptake as their studies showed that dosed FA's were 
taken up by these cells and incorporated into the PGL's 
selectively from a mixture of FFA's. Furthermore, 
structurally unrelated FA's did not appear to interfere 
with FFA incorporation, even when present in large 
amounts (Spector et al 1981b, 1981c). Thus the presence 
or absence of desaturation capability in this cell type 
is unclear, and may indicate that the conditions of 
culture significantly influence the results obtained.
Maeda et al (1978) studied the metabolic conversions of 
18:2u6 to 20:4u6 and 18:3w3 to 22*6w3 in six different 
cultured mammalian cell lines. These included Chang
liver cells (human adult liver cells), LM cells 
(a strain of mouse fibroblast), UI-38 cells (human 
embryonic lung fibroblasts), L5178Y cells (mouse 
leukemia cells), FM3A cells (mouse mammary tumor cells) 
and CHO cells (Chinese hamster ovary cells). Only LII-38, 
L5178Y and FM3A cells converted 18:2u6 to 20:4u6, while 
all cells converted 18:3w6 to 20:4w6. Thus, A6D was 
absent in LM, Chang liver and CHO cells, unlike J5D. 
L5178Y and UI-38 cells metabolised 18:3w3 to 22:5u3, 
whereas LM, Chang liver, FM3A and CHO cells only 
converted 18:3w3 to 20:4u3. However, 22:5w3 was produced 
by all cells lines upon addition of 20:5u3, but only 
FM3A cells formed 22:6w3. Thus, it appeared that J5D 
activity dissapeared in LM, Chang liver, FM3A and CHO 
cells, while J4D was found only in FM3A cells.
Dunbar et al (1975) and Bailey (1977) showed that normal 
diploid human fibroblasts exhibited significant fatty 
acyl A6D and J5D capability, whereas A6D activity was 
absent in several transformed mouse cell lines. Others 
showed that transformed cell lines have a greatly 
reduced ability to convert LA to GLA compared to normal 
diploid cells (Collins et al 1965, Howard et al 1974, 
Yavin et al 1975, Burns et al 1978, Maeda et al 1978, 
Morton et al 1979, Daniel et al 1980, Montaudon et al 
1981 and Horrobin 1983). Chiappe et al (1974) reported 
that in addition to A 6D , A9D was also depressed in two 
rat hepatoma cell lines, compared to normal liver. Such
transformed cells are, therefore incapable of producing 
eicosanoid precursors from EFA's, and Spector et al 
(1981a) proposed that the loss or reduction of A6D 
activity may relate to malignant transformation. Other 
studies which demonstrated A6D activity in transformed 
cells (Yavin et al 1975, Burns et al 1978 and Maeda et 
al 1978), however, suggested that the deletion of A6D 
may not be a requirement for, or a characteristic of, 
transformation, rather a side effect in some cases.
The evidence reviewed showed that while many normal and 
transformed cell types in culture desaturate FA's, 
others have been desaturase-deficient. Furthermore, 
culture conditions and the presence of exogenous FA's 
are all factors which may modulate fatty acyl desaturase
capab i1i ty.
1.4 Lipid Peroxides and Lipooeroxidation.
Lipid peroxidation can be defined as the oxidative 
deterioration of unsaturated lipids, particularly those 
containing more than 2 covalent carbon-carbon double 
bonds (Halliwell et al 1985). PUFA's are susceptible to 
oxidation, and their metabolism to eicosanoids involves 
the formation of free radicals, lipid hydroperoxides, 
and ma1ondia 1dehyde (MDA) as a breakdown product (Mead 
1976, Pryor 1976, Tappel 1980, Witting 1980, Carpenter 
1981 and Lands et al 1981). The enzymes responsible for 
lipid peroxidation are microsomal, and incorporated 
exogenous FFA's, or those released from cell membranes 
during PGL cycling, may serve as substrates for cellular 
peroxidation (eg. Mounie et al 1986). Studies on the 
mechanism of lipid peroxidation suggest that MDA and 
other peroxidation products are formed in two sequential 
steps, involving the formation of peroxy radicals or 
lipid hydroperoxides in the first instance, followed by 
formation and breakdown of cyclic endoperoxides (Pryor 
et al 1976, Dumelin et al 1977 and Svingen et al 1979).
Enzymic 1ipid peroxidation is common in most cel 1 types, 
but auto-oxidation may also occur (Pryor et al 1976, 
Tappel 1980 and Frankel 1984). When Begin et al (1986a) 
incubated culture medium without cells, but with GLA, 
AA, EPA or DHA for a period of 7 days, significant MDA 
was detected compared to control medium, which increased
in direct correlation with the number of double bonds in 
the PUFA's dosed. Spontaneous oxidation should therefore 
always be considered as a possible mechanism whereby 
1ipid peroxides are generated.
Uhen unsaturated FA's are components of complex lipids, 
eg. membrane PGL^s, they become relatively unaccessible 
to oxidation compared to FFA's. Another factor leading 
to a reduced ability for cellular 1ipoperoxidation 
includes a slow rate of PGL turnover, which limits both 
FFA incorporation and release from membrane lipids into 
the cellular pool. Beta-carotene, alpha-tocopherol,
superoxide dismutase, glutathione peroxidase and
cata1ase form the anti­oxidant and enzymic 1 inesi of
protection against free radical attack . It has been
sugested that ce 11ular peroxidases act to keep
hydroperoxidase levels low, as such may limit eicosanoid 
formation (Lands et al 1971 and Smith et al 1972). PGL's 
allow glutathione peroxidase to reduce and detoxify 
hydroperoxides in membranes, thereby protecting cell 
membranes from oxidative injury. Peroxide formation 
readily occurs in the body if PUFA's are fed in large 
amounts without appropriate vitamin E supplementation. 
It is not certain exactly how much vitamin E is required 
to prevent oxidation, but animal studies suggest 
2 .4-3.2mg/1 0 0 calories of food per day, although this 
should be increased to 3.7-6.4mg. for high PUFA diets
(Jager 1972).
Lipid oxidation products are toxic, and their reactions 
with biological cell components can affect vital cell 
functions (Mead 1976). Secondary products, such as MDA, 
are powerful cross linking agents, and react with amino 
groups of enzymes, proteins and DNA (Chio et al 1969, 
Tappel 1980, Frankel 1984 and Draper et al 1986). 
Reactions between peroxidised lipids or free radicals 
with proteins leads to changes in membrane protein cross 
linking (Beppu et al 1987), polypeptide chain scission 
(Zirlin et al 1969), destruction of labile amino acids 
(Roubal 1966a), protein polymerisation and denaturation 
(Desai et al 1963, Andrews et al 1965, Roubal et al 
1966a, 1966b and Roubal 1971), inactivation of enzyme 
activities (Wills 1961, Chio et al 1969, Garda et al 
1985 and de Groot et al 1985), disruption of biological 
membranes and release of destructive cellular enzymes, 
and the formation of age pigments in damaged membranes, 
amongst others (Chio et al 1969, Mead 1976, Tappel 1980, 
Gavino et al 1981c, Morisaki et al 1982b and Frankel 
1984). It has been suggested that the hydroperoxide free 
radical may be responsible for tissue damage (Tappel 
1975), and reviews have appeared on the biological 
effects of lipid oxides and their relevance to aging, 
strokes, atherosc1erosis, inflammation and cancer 
(Hopkins et al 1976 and Frankel 1984), although the 
nature of many interactions in vivo are not, as yet, 
fully understood.
Rapidly dividing cells, with a high mitotic index, such 
as regenerating rat liver, generate low amounts of 
1ipoperoxides compared to non-regenerating tissues; 
however, these concentrations increase when growth slows 
down, or stops (Ulolfson et al 1956). Cheeseman et al 
(1984) found lower lipid peroxide levels induced by 
tumor, than by normal, cells in vitro. even when dosed 
with potent oxidants. Their findings were consistent 
with a higher alpha-tocopherol content in tumor cells. 
Others showed that the mean 1ipid peroxide amounts 
generated by control human breast tumor (ZR-75-1) or 
normal simian kidney (CV-1) cultures over a 7 day period 
were similar, although 1ipoperoxides amounts generated 
by tumor cultures dosed with PUFA's (20mg/l GLA, AA, EPA 
or DHA) approximated to, or were significantly greater 
than, amounts induced by dosed normal cultures (Begin et 
al 1986a). Uork in our 1aboratory on a normal (HSF), two 
benign (3T6, 3T3), and a transformed (3T6D), cell lines 
showed that peroxidation of C18 FA's related to the 
number and position of double bonds in the FA chain 
(Girao et al 1988, 1989). No more lipid peroxides were 
induced by cells dosed with either saturated, cis- or 
trans-monoenoic FA's than was produced by controls, but 
the highest MDA levels were produced with 18:3oj6. 
However, as the growth rate of the cell lines increased, 
so increased incorporation and peroxidation of dosed 
polyenoic FA's in the order HSF, 3T3, 3T6 and 3T6D cells 
(Girao et al 1988, 1989). Ue suggested that this may
relate to impairment of desaturation capability in 
transformed cells, resulting in a build-up of 
peroxidation substances. Alternatively, HSF and 3T3 
cells may possess efficient mechanisms to remove excess 
lipid peroxides, or possess enzymes such as peroxidase, 
catalase and/or superoxide dismutase which remove 
different species of activated oxygen that promote lipid 
peroxidation. It was also possible that 3T6D and 3T6 
cells lost, due to enzyme loss or anti-oxidant activity, 
the relevant mechanisms for controlled 1ipoperoxide 
formation.
The biological significance of lipid peroxidation 
reactions in vivo are still unclear, but a number of 
breakdown products, including MDA, fatty aldehydes 
and alkanes, appear to be involved in the aetiology 
of cell proliferation (eg. Mead 1976 and Tappel 1980). 
Miller et al (1980) and Gavino et al (1981c) showed that 
addition of PUFA's (20:3w6, 20:4w6 or 22:4u6) to normal 
guinea pig aorta smooth muscle or human skin cultures 
induced significant and increasing amounts of MDA with 
time. The finding that 1ipoperoxide concentrations could 
be increased, and cel 1 division inhibited with PUFA 
dosage, led to the proposal that the extent of cell 
proliferation was controlled, in part, by lipid 
peroxidation. Since 90* of the MDA, or its precursor, 
remained within the cells, and only 10* was found in 
the media, such implied that dosed FA^s were
incorporated and cell growth inhibited primarily by
intracel1ular1y generated lipid peroxides (Gavino et al
1981c). When Morisaki et al (1982b) incubated primary
cultures of guinea pig aortic smooth muscle with
•
different u3, w6 , or uj9 FA's, all FA's which inhibited 
cell proliferation generated lipid peroxides. However, 
lipid peroxidation correlated with the degree of growth 
inhibition induced only with w9 series FA's. Other
studies indicated that FA preparations containing traces 
of hydroperoxy FA's inhibited cell proliferation to a 
greater extent than did pure FA's (Cornwell et al 1979 
and Morisaki et al 1984). Nevertheless, challenging 
guinea pig aortic smooth muscle cultures with 20:4u6, in 
the presence of various anti-oxidants and inhibitors of 
lipid peroxidation pathways, suggested that cell
proliferation was partially controlled by general
peroxidation reactions; peroxides generated via cyclo­
oxygenase, lipoxygenase or cytochrome Paso related 
reactions were not involved (Morisaki et al 1984). 
This supported the proposal of Cornwell et al (1979)
and Gavino et al (1981c) that general peroxidation 
reactions, rather than those involved in eicosanoid 
synthesis, may be involved in the control of normal cell 
proliferation. Inhibition of cancer cell proliferation 
by PUFA's has similarly been shown to involve lipid 
peroxides, and possibly even HPETES, while PG's and LT's 
have been ruled out as important in this mechanism
(Begin et al 1985a, 1986a, 1988).
1.5 Eicosanoids.
Eicosanoids are unsaturated derivatives of C20 FA's, 
comprising prostaglandins (PG's), thromboxanes (TX's), 
prostacyclins (PGI's), 1eukotrienes (LT's) and various 
hydroxy acids, formed via microsomal enzymes (Bergstrom 
et al 1964, van Dorp et al 1964, Samuelsson et al 1975, 
Lands, et al 1977, Horrobin 1980a, Moore 1985 and Higgs 
et al 1986). Being lipid soluble, eicosanoids act both 
as intra-cel 1ular and extra-cel 1ular hormone-like local 
messengers, which regulate numerous metabolic pathways 
and the second by second functioning of cells and 
tissues (eg. Ferreira et al 1976 and Crawford 1980). 
Eicosanoid synthesis occurs in most mammalian organs, 
but not necessarily in all cells comprising that organ 
(Christ et al 1972, Sun et al 1978 and Smith 1987). Any 
eicosanoid-forming cell usually produces more than 1 of 
these compounds, and this may be characteristic of that 
particular cell type (Hammarstrom 1981). Eicosanoids are 
involved with all body systems, have myriad effects, 
including the control of inflammation and thrombosis, 
and are often species-, sex- and tissue-dependant 
(Abdel-Halim et al 1979 and Johnson et al 1983). Thus 
far, no tissue or bodily process has been shown to be 
completely independant of eicosanoid involvement at some
point.
1.5.1 Essential___ Fatty Acid Precursors and
Eicosanoids.
There are 3 distinct eicosanoid series, each derived 
from a different C20 PUFA, containing double bonds in at 
least the u6 , u9 and ul2 positions. DGLA, AA and EPA 
are the 1-, 2- and 3-series eicosanoid precursors, 
respectively, usually provided as substrates for 
eicosanoid biosynthesis after chemical/hormonal, 
neurological, mechanical or pathological stimuli induce
phospholipase A2 release from cellular lysosomes; this 
cleaves the PUFA's from membrane PGL's in a Ca2+
dependent process (Bergstrom et al 1964, van Dorp et al 
1964, Lands et al 1968, Rahman et al 1970, Needleman et 
al 1979, Uolfe et al 1979, Schwartzman et al 1981, 
Irvine 1982, Crawford 1983, Fischer et al 1983, Spector 
et al 1983, Moore 1985, Lands 1986, Rosenthal et al 1986 
and Will is 1987).
Unesterified C20 PUFA metabolism to eicosanoids is 
catalysed either by microsomal cyclooxygenase or 
lipoxygenase (Fig. 1.5.1.), and produce either cyclic or 
non-cyclic eicosanoid families, respectively (Lands et 
al 1971, 1977, Horrobin 1980a, Kuehl et al 1981, Johnson 
et al 1983, Moore 1985, Higgs et al 1986, Lands 1986). 
Uithin each eicosanoid series, there are 4 classes, viz. 
PG's, PGI's, TX's and LT's, as well as many different 
individual compounds of each class.
The biosynthesis of primary eicosanoids.
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1‘5«2 Cyclooxygenase Products (Prostanoids).
Cyclooxygenase (hydroperoxidase) requires 1ipoperoxides 
as activators (Lands et al 1971, Smith et al 1972), 
tryptophan and heme as co-factors (Kuehl et al 1981), 
and catalyses the oxygenation and cyclisation of free 
DGLA, AA and EPA to PGG (a 15-hydroperoxy endoperoxide), 
followed by peroxidation and reduction by PGH-synthetase 
to PGH (a 15-hydroxy endoperoxide) (Samuelsson et al 
1975 and Lands et al 1977). The hydroxy group on carbon 
15 allows prostanoids to be active. Both PGG and PGH 
(cyclic endoperoxides) are unstable in aqueous solution, 
and may undergo chemical decomposition to products such 
as MDA and 12L-hydroxy-5,8 ,10-heptadecatrienoic acid 
(Moore 1985). PGH is also the precursor for all 
prostanoids.
During prostanoid (PG, PGI or TX) synthesis, two double 
bonds are lost from the precursor FA, one double bond is 
converted from cis- to trans-, and two oxygen molecules 
are incorporated, with concommitant cyclisation of the 
carbon chain. Hence, prostanoids derived from PUFA 
precursors with 3 double bonds (DGLA) have only 1 double 
bond and form part of the 1-series, while those derived 
from AA (4 double bonds) or EPA (5 double bonds) give 
rise to 2- and 3-series eicosanoids, respectively. There 
are at least 30 prostanoids and related substances, 
differing in the number of double bonds and/or chemical
structure of their rings or side chains (Moore 1985). 
Prostanoids have been implicated in numerous 
physiological and pathophysiologic processes in every 
mammalian organ system, including regulation of cell 
function, enzyme activity, intracel1ular calcium and 
cyclic nucleotide levels (eg. Crawford 1980 and Horrobin 
1980b).
1.5.2.1 Prostaglandins.
Microsomal PGH-PGD isomerase, PGH-PGE isomerase and PGH-
PGFft reductase convert PGH to PGD, PGE, PGI and PGFoc,
respectively (Fig. 1.5.1.). These are the classical and
most common PG's. Prostaglandins A, B and C are 
dehydration products of PGE, and have been reported not 
to occur naturally (Moore 1985), but this has not been 
conclusively proven. As with all prostanoids, PG's are 
not stored, but are synthesised, released, act and are 
then rapidly inactivated.
Most mammalian tissues synthesise PG's (eg. Christ et al 
1972), and total daily PG production has been quoted to 
be about lmg/d in an adult (Horrobin 1983). PGD2 
formation has been shown in many tissues, including lung 
(Christ-Haze1hof et al 1976), brain (Abdel-Halim et al 
1977 and Moore 1985) and skin (Puzicka et al 1982), and 
has been claimed to be the main PG formed from rat lung, 
stomach, intestine and skin DGLA (Nugteren et al 1973). 
Moore (1985) reported PGE2> PGFlft and PGF2a in lung,
PGE2 and PGF2a in kidney, PGD2 , PGE2 and PGF2tt in
platelets, and PGEz and PGF2a in adipocytes. Thus i t
is clear that characteristic PG ' 3  are produced in
particular tissues, and that different tissues vary in 
the types of PG's they produce. There is also evidence 
that PG production varies with species. PGD2 PGE2 and
ro'20c have been detected in rat and cat brain, with PGD2 
predominant in rat and PGE2 jn cat (Abdel-Halim et al 
1977, 1979). On the other hand, PGF2& and PGE2 are major 
cyclooxygenase products in guinea pig brain (Nicosia et 
al 1975 and Uolfe et al 1976).
1.5.2.2 Prostacyclins.
These bicyclic products of the cyclooxygenase reaction 
exhibit 2 five membered rings (Moncada et al 1976a,
1984), and are formed when prostacyclin synthetase 
catalyses the conversion of PGH to PGI (Fig. 1.5.1.). 
Most tissues produce PGI, and generally only PGI2 and
PGI3 occur (Sun et al 1978). PGI2 , the main product of 
PG endoperoxide metabolism in vascular endothelium, is a 
potent vasodilator and inhibitor of platelet aggregation 
(Moncada et al 1976a, 1976b, 1984 and Kuehl et al 1981).
However, PGI2 js unstable in aqueous solution, and has a 
half life of about 3 minutes (Herold et al 1986), but 
less than 1 minute in the vascular system (Moncada et al 
1976a, 1976b, 1984), and either undergoes non-enzymic 
hydrolysis to yield a stable inactive metabolite, 6-oxo-
(keto )PGFia> or may be converted to a stable product, 
6-oxo~(keto-)PGEit by 9-hydroxy PG dehydrogenase.
1.5.2.3 Thromboxanes.
These cyclooxygenase products contain a 6 membered oxane 
ring (Hamberg et al 1975 and Moore 1985), formed when TX 
synthetase converts PGH to TXA (Fig. 1.5.1.). TXA2 has a 
half life of only 30 seconds, and is rapidly transformed 
by spontaneous non-enzymic hydrolysis into TXB2 a 
stable, but inactive metabolite (Hamberg et al 1975 and 
Herold et al 1986). TX's are primarily involved in 
thrombocyte aggregation and vasoconstriction (Hamberg et 
al 1975 and Kuehl et al 1981), but have been reported in 
a number of other tissues, including leukocytes, lung, 
spleen, brain and kidney (Nicosia et al 1975, Uolfe et 
al 1976, Abdel-Halim et al 1977, 1979 and Moore 1985). 
Sun et al (1978) report that most tissues synthesise TX, 
but others indicate that the TX metabolic pathway has 
limited distribution, being found mainly in platelets 
(Hamberg et al 1975) and lung (Svensson et al 1975).
1.5.3 Lipoxygenase Products (Leukotrienes).
LT's are non-cyclic biologically active molecules, 
containing a conjugated triene, and are derived from 
precursor PUFA's (DGLA, AA and EPA) containing a penta- 
1,4-cis-diene system by microsomal 5'-lipoxygenase (Fig.
1.5.1.); this catalyses the hydroperoxidation of PUFA's 
to hydroperoxy derivatives, viz. hydroperoxy eicosa- 
tetraenoic acid (HPETE) (Nugteren 1975, Borgeat et al 
1976 and Taylor et al 1983). These hydroperoxides may be 
metabolised to a series of less toxic metabolites, viz. 
hydroxy eicosatetraenoic acid (HETE), or converted into 
biologically active LT's (Borgeat et al 1979, Goetzl 
1980, Samuelsson 1981, 1986 and Taylor et al 1983). As 
no ring structure is introduced, no double bonds are 
lost, thus LT's contain the same number of double bonds 
as their precursor PUFA's. 2-series LT's thus have 4 
double bonds, and are named appropriately (eg. LTA4 )^  
LT's are of interest in relation to the slow reacting 
substance of anaphylaxis (SRS-A), which is considered an 
important intermediate in acute hypersensitivity 
reactions (Samuelsson 1981).
1.5.4 The Control of Eicosanoid Biosynthesis.
Eicosanoid biosynthesis can be influenced by various 
factors, including physiological, nutritional and 
pathological (Hwang et al 1975, 1979, 1980, Brenner 1982 
and Jeffcoat et al 1984).
Lipid hydroperoxides are modulators of the conversion of 
FA's to eicosanoids; low concentrations (<1^M) seem 
essential for prostanoid formation, whereas greater 
amounts inhibit activity of enzymes including cyclo­
oxygenase and PGH-synthetase (Lands et al 1971, Cook et
al 1976, Moncada et al 1976b, Hemler et al 1978, 1979, 
Siegel et al 1979 and Kulmacz et al 1983), Inactivating 
enzymes also play a role in the control of eicosanoid 
production. Most PG's are physiologically inactivated by 
the same enzyme, 15-hydroxy-prostaglandin dehydrogenase; 
this cytoplasmic enzyme generally found in most tissues 
irreversibly converts the hydroxyl group on carbon 
number 15 to a keto group (eg. Moncada et al 1976a).
Numerous drugs have been reported to influence enzymatic 
steps in the eicosanoid pathway (Vane 1971, Kuehl et al 
1981, Horrobin 1983, Taylor et al 1983, 1986 and Smith
1989). Phospholipase A2 is inhibited by cortisol, 
glucocorticoids, corticosterone, dexamethasone and the 
anti-malarial drug, Mepacrine, all of which either 
inhibit FFA release from membrane PGL/s or bind directly 
to the enzyme. Lipoxygenase activity is inhibited by 
retinoids for example, while cyclooxygenase is inhibited 
by aspirin, paracetamol, most other non-steroidal 
anti-inflammatory agents, and reducing agents as well, 
usually by blocking enzyme oxygen uptake (Vane 1971, 
Smith et al 1972, Samuelsson et al 1975, Huttner et al 
1977, Lands et al 1977 and Kuehl et al 1981). Imidazole 
inhibits TX~synthetase, while 15-hydroxy-prostaglandin 
dehydrogenase is inhibited by carbenoxo1 one and 
indomethacin (Smith et al 1972). Animal studies indicate 
that the inhibitory effects reported are exacerbated in
EFA deficiency (Hansen 1981).
Eicosanoid biosynthesis is largely dependent on the 
size of the PUFA precursor pools, and it is generally 
believed that the relative availability of the precursor 
FFA's determines, to a greater or lesser extent, which 
eicosanoids are synthesised and the rate of product 
formation (Hong et al 1979, Irvine 1982 and Laposata
1988). There is also evidence that the size of the 
precursor pool can be modulated by dietary manipulation 
(Galli 1980, Goodnight et al 1982, Herold et al 1986). 
GLA, for example, enhances 1-series eicosanoid formation 
(Dill is 1981), while EFA deficiency depresses prostanoid 
synthesis due to unavailability of precursor FA's 
(Ueston et al 1978) and/or inhibition of cyclooxygenase 
by 20:3u9 (Ziboh et al 1974. and Dunham et al 1978). On 
the other hand, PG-synthetase activity is increased in 
EFA deficiency (Kaa 1976).
Animal studies indicate that eicosanoid synthesis is 
inhibited when dietary LA intake is increased to about 
W  (Lepran et al 1981). Others report that dietary LA 
supplementation inhibits PGI2 release from cultured 
human endothelial cells (Spector et al 1980b) and
decreases human platelet TBX2 (Needleman et al 1982), 
while enhancing PGI2 and JXB2 production in the cardio­
vascular system (Agradi et al 1981). These studies 
suggest that eicosanoid production is modulated in 
different ways in the presence of dietary LA, and varies
with cel 1 type
The Western diet does not provide an adequate balance of 
PUFA precursors for the 1-, 2- and 3-series eicosanoids, 
but rather a preponderance of AA, the 2-series precursor 
found in large amounts in red meat (McCance et al 1978 
and Giangregorio et al 1988a). Doyle et al (1982) report 
that the average AA intake approximates to 200mg/day, 
whereas the requirement for eicosanoid synthesis is only 
about lmg/d. Thus* dietary AA can more than supply all 
eicosanoid production. High AA levels, however, exert 
negative feedback control on A6D and 1imit both 1- and 
3-series eicosanoid precursor production, predisposing 
to eicosanoid imbalance. As body AA stores are high 
compared to DGLA, partial EFA deficiency leads to DGLA
and PGEi deficiency before a deficit of AA and 2-series 
eicosanoids develops. PGEi partly regulates cAMP 
formation, and this normally regulates 2-series 
eicosanoid formation by inhibiting AA mobilisation from 
PGL's (Feinstein et al 1977, Minkes et al 1977 and
Horrobin 1980b). If PGEi and thus cAMP levels fall, then 
AA is mobilised and converted to 2-series eicosanoids 
(Horrobin 1980b). EFA administration lowers 2-series 
eicosanoid production by restoring PGEi and cAMP control 
of AA (Horrobin 1980b), while manipulation of the 
DGLA/AA balance also selectively regulates eicosanoid 
biosynthesis (Horrobin et al 1984a).
18:3u3 can suppress conversion of 18:2u6 to 20:3w6 and 
20:4u6, and thus impair 2-series eicosanoid production
(Hwang et al 1975, 1980 and Marshall et al 1982), 
Furthermore, eicosanoid synthesis from u6 series PUFA's 
appears to be reduced by competitive inhibition of 
cyclooxygenase by 18:3u3 (Adam et al 1986). However, 
18:3w6, 20:3u6, 18:lw9, 20:3u9, trans-isomers of 
eicosanoid precursors, and to a lesser extent 18:2w6, 
may also irreversibly occupy the active site of cyclo­
oxygenase and inhibit prostanoid synthesis (Pace-Asciak 
et al 1968, Nugteren 1970, Lands et al 1973, 1977, Ziboh 
1973, Mathias et al 1979, Uicha et al 1979, Lands 1982, 
Morita et al 1983).
Long chain u3 series PUFA's are potent inhibitors of 
2-series eicosanoid synthesis by competing with AA both 
at the desaturase level and for binding sites on cyclo­
oxygenase (Lands et al 1973, 1977, 1981, Hamazaki et al 
1982, Lands 1982, 1986, Corey et al 1983, Fischer et al 
1984 and Croft et al 1986), as well as by stimulating 
2-series LT formation (Hwang et al 1980, Lands 1982 and 
Lee et al 1985). EPA in particular, is a poor cyclo­
oxygenase, but a relatively good lipoxygenase, substrate 
under normal conditions (Club et al 1979, Needleman et 
al 1979, Lands et al 1981, Murphy et al 1981, Spector 
et al 1983, Lokesh et al 1984 and Lee et al 1985). 
Evidence suggests that EPA, therefore, acts as a 
physiological control of eicosanoid biosynthesis 
(Marshall et al 1982, Lands 1986 and Nassar et al 1986). 
The effects of EPA on cyclooxygenase product formation,
however, are still unclear, as EPA reduces the synthesis 
of cyclooxygenase products in tissues such as human
endothelial cells (Spector et al 1983), has no effect
on the conversion of AA to PGI2 in umbi1i ca1 bl ood
vessels (Dyerberg et a 1 1980), and increases pgi2
production in rat aorta (Hamazaki et al 1982). Such
findings are a further indication that different tissues 
respond differently to particular eicosanoids.
1.5.5 Eicosanoids and Disease Processes.
Eicosanoid levels are largely dependant on the dietary 
supply and metabolism of EFA's, thus any EFA/PDFA 
imbalance could alter the eicosanoid profile. Many of 
the clinical conditions previously ascribed either to 
EFA and/or desaturase imbalance may therefore also 
relate to alterations in eicosanoid production. Impaired 
J6D expression in diabetes, for example, affects the 
negative regulation of 2-series PG production by PGEit 
thus diabetes is associated with reduced PGE* an(j 
increased 2-series PG, formation (Chase et al 1979 and 
Lagarde et al 1981).
Cancer is a pathological condition in which eicosanoid 
production may be altered (eg. Panje 1981 and Bennett 
1984, 1986). Raised blood prostanoid levels have been 
shown in the development of prostatic carcinoma, with an 
encrement in 6-keto-PGFlQ, ieveis with progression of the
disease (Khan et al 1982). Many malignant cells do not 
express A 6D , and thus produce little PGEi t but extensive 
amounts of 2-series PG's (Collins et al 1965, Dunbar et 
al 1975, Maeda et al 1978, Horrobin 1980a, 1988 and 
McLemore et al 1988). This phenomenon could explain the 
enhanced proliferation found in malignancy since PGEi 
has an anti-proliterative effect (Horrobin 1980a and 
Huttner et al 1977). Normal regulation of intracel1ular
Ca levels and movements by PGEi are also altered in 
malignancy (Horrobin 1980a).
Medical opinion recognises an imbalance of 1- and 2- 
series eicosanoids as contributary to numerous other 
clinical conditions including schrizophrenia, asthma, 
cystic fibrosis, disorders of inflammation and immunity 
(Horrobin et al 1978, Hyman et al 1978, Horrobin 1979a, 
1980b, Chase et al 1980 and Hubbard 1983). However, 
manipulating dietary EFA/PDFA supplies has shown 
significant improvements in restoring the eicosanoid 
imbalance without using drugs (Horrobin 1983).
1.5.6 Eicosanoids in Cultured Cells.
Many cultured cells produce eicosanoids (eg. Pong et al 
1977, Marcus et al 1978, Ali et al 1980, Spector et al 
1980b, 1981c, 1983, Morisaki et al 1984, van Rollins 
et al 1984, Campbell et al 1985, Milks et al 1985 and 
Durant et al 1988), especially when stimulated by agents 
such as serum, epidermal growth factor, thrombin,
bradykinin or mechanical manipulation (Dunn et al 1976, 
Hong et al 1976, Hammarstrom 1977, Hirata et al 1985 and 
Ulickremasinghe 1988). These agents appear to act by 
increasing precursor PUFA release from cellular lipids 
via cAMP (Alexander et al 1976). Serum may additionally 
stimulate eicosanoid production by providing free AA 
(Dunn et al 1976, Hong et al 1976 and Hammerstrom 1977). 
Not only are there differences in eicosanoid production 
between normal cells, but also between normal and 
transformed cells. Many normal cells produce low amounts 
of eicosanoids in the absence of stimulatory agents, 
while certain virus-transformed cells have a much 
higher basal rate of eicosanoid synthesis, despite poor 
desaturation capability (Dunbar et al 1975, Ritzi et al 
1976 and Hammarstrom 1977). In the case of SV40 or 
polyoma virus-transformed baby hamster kidney and 3T3 
mouse embryo fibroblasts, PGE2 and PGF2o( concentrations 
were higher than in non-transformed parent cells (Ritzi 
et al 1976 and Hammarstrom 1977). In addition, elevated
PGEi, PGFia, PGA, PGB and 13,14-dihydro-15-keto-PGFia 
levels were found in polyoma and SVMO-transformed 3T3
cells (Ritzi et al 1975, 1976). However, PGE2 or PGFZa 
levels were not elevated in a different clone of virus- 
transformed 3T3 cells (Hammarstrom 1977), implying that 
eicosanoid production may vary not only with cell type, 
but also with different clones derived from the same
parent cel 1.
There is evidence that PGEt and PGE2 stimulate 
prepubertal guinea pig aortic smooth muscle cell 
proliferation at low or physiological concentrations, 
and inhibit proliferation at high or pharmacological 
concentrations (Cornwell et al 1979). Other PG's such as
PGF and PGF2q( have no effect on cel 1 prol iferation at
low concentrations, but stimulate proliferation at high 
concentrations (Cornwell et al 1979 and Bettger et al 
1981). Some studies implicate that PG's exert a balanced 
effect on fibroblast growth in vitro, with a stimulatory
action of PGF^ (de Asua et a] 1975) and a negative 
action of PGE2 (Ko et al 1977 and Korn et al 1980). On 
the other hand, Durant et al (1989) were unable to 
demonstrate this effect, since both exogenous PGE2 or
increased the rate of cel 1 division in mouse 
embryo fibroblasts, as well as the maximum density 
reached at confluence. However, these PG's had no effect 
on rat hepatocyte viability, despite modulating DNA 
synthesis (Skouteris et al 1988). These studies showed 
that exogenous PG's may induce potent effects on the 
multiplication of a variety of cell types, and some 
workers have proposed that eicosanoid secretion may 
represent an autocrine mode of growth regulation for 
some fibroblasts (Taylor et al 1977 and Smith et al 
1984). However, Thomas et al (1974) and Cornwell et al 
(1979) suggested that endogenous PG biosynthesis was 
not required for multiplication of human diploid cells
in__vvtro. Later studies, using guinea pig aorta smooth 
muscle, confirmed that inhibition of cell proliferation 
with exogenous FA dosage did not correlate with enhanced 
or inhibited PG synthesis (Morisaki et al 1982b). Recent 
studies also suggested that endogenous PG secretion does 
not constitute an important mode of control of normal 
cell proliferation (Durant et al 1989).
Botha et al (1985) suggested that elevated TXA2 and/or
rL,c-i levels may be involved in the growth inhibitory 
effects induced with GLA supplementation in malignant
cells, but subsequent studies indicated that PUFA- 
induced destruction of tumor cells also does not involve 
eicosanoids, and have rather implicated involvement of 
other oxidation products (Begin et al 1985b, 1986a, 1988 
and Botha et al 1989).
Some studies have implicated 1ipoxygenase metabolites 
as mediators of normal cell proliferation (Huttner et al 
1977, Cornwell et al 1979 and Mayer et al 1984). Smith 
et al (1984) reported that 12-HETE was more potent at 
inhibiting cultured rabbit aortic smooth muscle cell 
proliferation than a range of PG's or TXB2 which either 
did not exhibit growth inhibitory potential, or were 
only weakly active. Others found 15-HPETE, but not PGE2>
PGD2 or LTBa, to be toxic to rat hepatocyte cultures, 
and increasing its concentration from 0.1 to 50,uM 
decreased cell viability from 70% to 30^ after only 90 
minutes incubation (Sakagami et al 1989).
Others believe that neither cyclooxygenase nor 
1ipoxygenase products* nor the peroxides generated from 
these pathways, or cytochrome P450 related reactions, 
are involved in the inhibition of cultured cell growth 
mediated by exogenous FA's, but rather that peroxisomal 
peroxidation of unsaturated FA's may be involved 
(Horrobin 1980a, Morisaki et al 1984 and Fujiwara et al 
1986). Still others have proposed that FA metabolism, 
anti-oxidant status and eicosanoid production all 
contribute to the regulation of cell proliferation 
(Bettger et al 1981).
The work reviewed illustrates that different cultured 
cell types exhibit a particular pattern of eicosanoid 
production, and that each cell type responds differently 
to exogenous and/or endogenous eicosanoids. Although 
some studies proposed that the regulation of cell 
proliferation may involve eicosanoids, the mechanism, 
if true, is complicated and as yet unclear.
1.6 Influence of Polyunsaturated Fatty Acids 
in Mammalian Cells In Vitro.
1.6.1 Normal Cells in Culture.
There are numerous reports that exogenous FA's modulate 
the proliferation of a variety of cultured normal cells. 
Dubin et al (1965) found that the growth of cultured 
chicken embryo macrophages could be stimulated with 
albumin-bound LA, and that the greatest proliferative 
effects were induced with a concentration of 0.07mg/l. 
They suggested that the beneficial effects of LA stemmed 
from the provision of essential elements deficient in 
the serum, such as FA's, and that inhibitory substances 
present in the serum could be removed by binding with 
the albumin present.
Later studies found that 16juM 20:3w6 inhibited the 
proliferation of human foreskin fibroblasts cultured in 
medium with 10% fetal bovine serum (Huttner et al 1978). 
Supplementation with up to 50juM 18:1<*)9 or 20:4u6, 
however, progressively enhanced cell proliferation to 
about 150% and 120%, respectively, but higher amounts 
markedly inhibited cell viability in a concentration 
dependent manner to <30% with IOOjuM FA (Huttner et al 
1978). Using human skin fibroblasts grown in medium with 
10% dialysed fetal calf serum, Spector et al (1979) 
found that 18:lu9 or 18:2w6 did not affect cell growth
when supplemented in the range 10 to IOOjuM, while cell 
viability was inhibited by about 25£ with 18:3w3 and 50^ 
with 16:0 or 20:4w6 dosage. Others reported that human 
neonatal foreskin fibroblast growth was only inhibited 
with MOjuM 20:4w6, while 20:3w6 and 22:4w6 were equally 
cytotoxic in the range 1.6-160,uM dosed (Gavino et al 
1981a). The same study showed that 20:3u6, 20:4u6 and 
22:4u6 were toxic and almost equally effective in 
inhibiting pre-pubertal guinea pig aorta smooth muscle 
proliferation. However, the effects induced varied 
quantitatively between skin and muscle, implying that FA 
modulation of cell growth varies with cell type.
The susceptibility of guinea pig aorta smooth muscle 
cell proliferation to 20:3u6, 20:4u6 and 22:4w6 toxicity 
was previously demonstrated by Huttner et al (1977). 
This group subsequently showed that while these triene 
and tetraene PUFA's inhibited cell growth, monoene 
(18:lu9) and diene (18:2w6) FA's stimulated cell growth 
in the range 20-120mM (Huttner et al 1978 and Cornwell 
et al 1979). However, saturated FA's (14:0, 16:0, 18:0) 
progressively limited cell proliferation with increased 
chain length, and the concentrations required to 
significantly inhibit growth were 220juM for 14:0, 95juM 
for 16:0 and 18;uM for 18:0.
Morisaki et al (1982b) confirmed increased cell growth 
when guinea pig aorta smooth muscle cells were incubated 
with 30, 60 or 90,uM 18:lu9, but other u9 FA's inhibited
cell proliferation in a concentration dependant manner, 
increasing in the order 18:2u9 < 20:2u9 < 20:3u9. Both 
18:2w6 and 18:3w3 were least growth inhibitory for their 
particular series and only induced inhibition at high 
concentrations, but the inhibition increased when 
desaturation or elongation products of these FA's were 
dosed. The most potent inhibitors of cell proliferation 
in the u9, u6 and u3 series were eicosatrienoic acids, 
although 20:3w9 was more potent than 20*3u6, which in 
turn was more inhibitory than 20:3u3. This implied the 
involvement of FA carbon chain length, number and 
position of double bonds in the modulation of cell 
viability. PG synthesis was inhibited by 22:4w6 and 
22:6u3, but enhanced by 18:3w6, 20:3w6 and 20:4w6, 
indicating FA modulation of PG production. Inhibition of 
cell proliferation, however, did not correlate with 
enhanced or diminished PG synthesis, and peroxides were 
implicated as possibly being responsible since all FA's 
which killed cells generated 1ipoperoxides (Morisaki et 
al 1982b).
Fetal mouse brain cell growth was modulated when Bourre 
et al (1983) dosed 18:2u6, 18:3w3, 20:4w6 or 22:6w3 at 
the time of seeding. A FA concentration of lmg/1 
was optimal for cell pro 1iferation, while greater 
concentrations were toxic. However, the extent of growth 
enhancement varied with FA, and increased in the order
22:6u3 < 18:2u6 < 18:3u3 < 20:4u6 = 20:4u6 + 22:6u3. Our
1aboratory found that C18 FA supplementation to cultured 
rat brain cells had little effect on proliteration at 
low concentrations (lmg/1), but amounts up to 100mg/l 
inhibited growth in a concentration dependent manner in 
the order 18:0, 18:4u3, 18:lu9, 18:2u6, 18:3u3 and 
18:3w6 (Davidson et al 1988a and Girao 1988).
Blood cells appear particularly susceptible to the 
effects of exogenous FA's. Ruck et al (1986) found that 
18*0 had no effect on resting human monocyte viability 
in culture, whereas 18:3u6 and 18:2w6 induced toxicity 
at much lower concentrations than 18:lu9 or 18:3u3
( ID b o =4.4 ,  5, 12 and 13mg/l, respectively). Earlier work 
by Buttke (1984) indicated that low concentrations 
(20-60juM) of saturated FA's suppressed mitogen-induced 
DNA synthesis in mouse lymphocytes, while both saturated 
and unsaturated FA's were inhibitory at high 
concentrations (100-120juM) . However, T and B cells 
responded differently, with mitogen-activated B cells 
being less inhibited by FFA's. Ueyman et al (1975, 1977) 
found that unsaturated (18:lw9, 18:2w6 and 20:4u6) and 
saturated (16:0, 17:0 and 18:0) FA's inhibited PHA- 
stimulated uptake of C14CD-uridine in human lymphocytes 
in the order 18:1 < 16:0 < 20:4 < 18:2 < 18:0 < 17:0, 
while uridine uptake was not affected by any FA in 
unstimulated cells. When saturated and unsaturated FA's 
were present together in the medium, the inhibition was
more saturated, or unsaturated, FA's were added, the
inhibition was the same, or greater, than for single
FA's. This imp1 ied that synergistic or competitive
effects may be induced by the presence of other FA's. 
Furthermore, the finding of Kitagawa et al (1984) that 
18:lu)9, 18:2u6 or 18:3w3 cause platelet aggregation at 
concentrations just below that inducing cell lysis 
OlOOjuM) suggests that certain FA's could modulate 
particular cell functions at specific concentrations.
The studies reviewed illustrate that exogenous FA's 
modulate normal cell growth and function in vitro, 
although the extent varies with the FA dosed, its 
concentration, the particular cell type and conditions 
of culture. Certain studies also suggest that factors 
other than a pure individual FA effect may be involved 
in the control of cell growth or function.
1.6.2 Transformed Cells in Culture.
Horrobin (1980a) reported that malignant cells exhibit a 
common group of metabolic abnormalities which include 
the control of calcium movements, formation, destruction 
and action of cAMP, cholesterol synthesis, control of 
glycolysis, EFA desaturation and eicosanoid synthesis. 
His group later proposed that the inability to make GLA,
and therefore PGEi (a naturally occuring endogenous 
reverse transforming agent), may contribute to the
etiology of cell transformation (Horrobin et al 1984b).
Early studies using 3 mouse ascites cell lines shoued in 
vitro anti-tumour activity with FA's of chain length 
ranging from C6 to C20 (Tolnai et al 1962). Considerable 
variations were found in the relative effectiveness of 
the FA's against the cell lines, but LA and ALA 
consistently exhibited the greatest anti-tumor activity. 
The data suggested that FA chain length, number and 
position of double bonds were important factors 
determining in vitro anti-tumor activity, while the lack 
of organic peroxide detection implied that the effects 
reflected the action of the FA's themselves.
McGee (1981) reported that PA and SA were toxic to 
neuroblastoma x glioma hybrid (NG108-15) cells, whereas 
addition of OA, LA, ALA or AA stimulated growth. There 
is evidence that these unsaturated FA's also stimulate 
the proliferation of HeLa and rodent cancer cel 1 1ines 
(Gerschenson et al 1967 and Spector et al 1981a). Others 
however, report marked inhibition of tumor cell growth 
in culture with PUFA dosage. Booyens et al (1984a) found 
that OA enhanced, while LA, GLA, ALA, AA, EPA and DHA 
suppressed, the rate of human osteogenic sarcoma growth. 
Supplementation with up to 20mg GLA/ml culture medium 
also suppressed benign kidney tumor, mouse melanoma, 
human hepatoma, human oesophageal and laryngeal 
carcinoma cell proliferation (Dippenaar et al 1982a, 
1982b, Leary et al 1982, Booyens et al 1984b, 1984c and
Cantrill et al 1986). Studies examining the influence 
of C18 FA's (l-100mg/l) on the growth of human hepatoma, 
NG105-15 neuroblastoma, SP210 mouse myeloma, mouse 3T6- 
derived (3T6D), 3T6 and 3T3 benign, cells showed that 
u9, w6 and w3 series unsaturated FA's were growth 
inhibitory, with the greatest toxicity induced with GLA 
or ALA dosage (Girao et al 1986, 1987a and Girao 1988).
Neither SA nor OA killed cultured breast carcinoma 
cells, but LA, GLA, ALA, AA, EPA and DHA each induced 
concentration dependent cytotoxicity, although FA's 
containing 3, 4 or 5 double bonds were most effective 
(Begin et al 1985a, 1987). Uhen Botha et al (1989) 
studied the effect of 50mg/l GLA or DGLA on a human 
breast cell line (NUB 1), only GLA inhibited cell 
growth, although both FA's, especially DGLA, enhanced 
PGE and PGF production. This implied that the effects 
of GLA were unrelated to eicosanoid formation, which was 
consistent with findings that indomethacin enhanced the 
growth inhibitory effects of GLA (Botha et al 1985).
The ability of certain exogenous PUFA's to enhance tumor 
cell growth in culture with particular FA concentrations 
may relate to evidence suggesting that dietary fat is 
important in the promotion, but not initiation, of 
tumorogenesis, and that unsaturated fat is a more potent 
promotor than saturated fat (Hopkins et al 1976, Carrol 1 
1984, Karmali 1986 and Hill 1987). Despite differences
in the sensitivity of tumor cells to exogenous FA's, 
studies suggest that GLA, DGLA, AA and EPA are generally 
the most cytotoxic FA's to transformed cells (Dippenaar 
et al 1982a, 1982b, Booyens et al 1984a, 1984b, Cantrill 
et al 1986 and Begin et al 1985a, 1985b, 1986b, 1986c). 
The work presented suggested that the effect of a FA on 
transformed cells in vitro related to the number, 
position and geometric configuration of double bonds in 
that FA. The susceptibility of a transformed cell line 
to growth inhibition by exogenous FAs also appears to 
relate to the particular cell line and degree of 
transformation of that cell line (Fujiwara et al 1986, 
Girao 1988 and Begin et al 1989).
1.6.3 Normal vs Transformed Cells in Culture.
Numerous studies have shown that normal and transformed 
cells take up exogenous FA's from the surrounding 
medium; once incorporated, the FA's can either be found 
in the TAG or PGL fractions, or in the free form, but 
the effects they induce vary (eg. Mackenzie et al 1964, 
Yavin et al 1974, Ueyman et al 1977, Rosenthal et al 
1978, Spector et al 1979, 1980a, 1980b and Rosenthal 
1981).
Ulicha et al (1979) found that both normal and neoplastic 
rat mammary epithelial cell proliferation was stimulated 
when the culture medium was supplemented with 0 .1-10mg/l 
unsaturated FFA's (0A, LA, ALA or AA), but inhibited by
all concentrations of saturated FFA's (PA or SA). LA and 
ALA were most stimulatory to normal cells* enhancing 
prol iferation by more than 100 'A at concentrations of 1 ,0  
and 0 .1mg/l, respectively, whereas tumor cell growth was 
enhanced most effectively with 0,5mg/l OA.
Other workers found that supplementation of culture 
medium with 20mg/l LA, GLA, DGLA, AA, ALA, EPA or DHA 
inhibited the proliferation of cancer cells derived from 
human lung, prostate or breast, but did not kill normal 
human fibroblasts, monkey or canine kidney cells, 
although the rate of normal cell division was lowered 
dependent on cell type (Begin et al 1985a, 1985b and 
1986b), EPA and AA inhibited normal cell growth with 
concentrations greater than 20mg/l, although no marked 
cytotoxicity was induced with other PUFA's, even with 
concentrations 3 fold greater than required to kill 
cancer cells (20mg/l). Co-cultures of human cancer cells 
and normal human fibroblasts resulted in overgrowth of 
normal fibroblasts by the carcinoma cells (Begin et al 
1985a, 1985b, 1986b and 1986c). However, when these co­
cultures were supplemented with 20mg/l GLA, AA or EPA, 
malignant cell growth was selectively inhibited, and 
normal fibroblasts outgrew the malignant cells, even 
when tumor cells had being growing for up to 72 hours 
longer than normal cells. Subsequent studies using 
genetically related embryonic or transformed rat brain 
cells dosed with GLA or EPA (0-60mg/l) confirmed that
tumor cells were considerably more sensitive to PUFA 
toxicity (Begin et al 1989).
A series of studies in our 1aboratory showed that C18 
FA's, dosed up to 100mg/l, were generally least growth 
limiting with normal fibroblasts (HSF), more so with 
benign lines (3T3 and 3T6), and most effective in 
limiting transformed (3T6D) cell growth (Davidson et al 
1988b). At the same time, the growth inhibitory effects 
increased with increasing degree of FA unsaturation. C20 
FA's, however, were most growth limiting with normal 
fibroblasts, less so with 3T6D, and least effective with 
3T3 and 3T6 (Giangregorio et al 1988b). Once again, the 
inhibitory effects increased with increasing degree of 
unsaturation of the FA's, although u3 PUFA's were more 
effective than w6 PUFA's, even when of equal degree of 
unsaturation, implying that the u3 configuration may be 
involved in determining the extent of cytotoxicity. The 
3 eicosanoid precursors were not markedly more effective 
than other FA's, suggesting that there was no direct 
eicosanoid involvement (Giangregorio et al 1988b).
Overall, the evidence to date suggests that normal and 
transformed cells vary in sensitivity to exogenous FA's. 
It it also clear that the extent to which FA's modulate 
cell proliteration relates to factors such as FA 
structure, the concentration dosed, culture conditions 
and the particular cell type.
1.7 Summary of Introduction and Objectives.
EFA's are the precursors for a variety of compounds, 
each performing essential functions. However, the nature 
of the compounds produced and efficiency of the 
metabolic sequences involved in lipid metabolism appear 
to be species and tissue dependent, while physiological, 
nutritional and pathological conditions can influence 
the relative concentrations of these compounds. Since 
cell culture systems provide a less variable, more 
defined, more homogeneous and easily manipulated system 
for experimentation than in vivo models, tissue culture 
systems have been used extensively to model various 
aspects of lipid metabolism.
In recent years, numerous studies have focused on 
the functional interactions between lipids and cells 
(eg. Rosenthal 1978, 1981 and Spector et al 1981a). Some 
effects have been dependant on whether the FA's were 
saturated or unsaturated (eg. Gill et al 1980); other 
effects were brought about by both saturated and 
unsaturated FA's and with no apparent correlation 
between the effect and the chain length or degree of 
unsaturation (eg. Ueyman et al 1977). There is a large 
body of evidence which indicates that normal, benign and 
transformed cells respond to exogenous polyenoic FA's 
(eg. Horrobin 1983, Booyens et al 1984a, Begin et al
1985a, Girao et al 1986, Davidson et al 1987b and
Giangregorio et al 1988b). However, two schools of 
thought have arisen concerning the effect of exogenous 
FA's on cellular proliferation, viz. those which found 
that particular FA s stimulated the proliferation of 
cultured cells (eg. Gerschenson et al 1967, Uicha et al 
1979, McGee 1981 and Spector et al 1981a), and those 
which found that FA's selectively inhibited cell growth 
(eg. Booyens et al 1984b, Begin et al 1986b, Davidson et 
al 1988b and Giangregorio et al 1988b).
To date, no satisfactory mechanism or site of action 
for such FA's has been conclusively demonstrated. 
Contrary to the original postulation that the effects 
were produced via cell membrane or membrane-related 
processes, on investigation of a large number of plasma 
membrane parameters, only changes in lipid peroxides 
correlated with FA concentrations (Girao 1988), Lipid 
peroxide quantitation showed a direct correlation 
between the degree of FA unsaturation and concentration 
of 1ipoperoxide formed (Girao et al 1988). The effects 
produced, therefore, do not appear to be directly 
associated with the plasma membrane; the initial site of 
action of these FA's is probably intracel1ulary mediated 
and probably involves the desaturase/elongase pathway. 
Considerable evidence suggests that unsaturated FA's are 
more effective in limiting cell proliferation than 
saturated FA's (eg. Cornwell et al 1979, Morisaki et al 
1982b, Ruck et al 1986, Begin et al 1987 and Girao
1988) ; thus, the ability to further desaturate dietary 
FA's may be an important factor in this process.
Fatty acyl desaturase enzymes are located in microsomes, 
as are the enzymes involved in lipid peroxide and 
eicosanoid formation. Assuming desaturase, eicosanoid 
and/or 1ipoperoxide involvement, then cells from a 
species known to exhibit high desaturase activity, 
eg. Rattus norvegicus (Brenner 1971, 1974), would be 
expected to react differently to those from a species 
lacking such activity, eg. Felis domesticus (Rivers et 
al 1975a, 1976, Frankel et al 1978, Sinclair 1979). Homo 
sapiens, however, is considered to be in an intermediate 
position (Horrobin 1983), but with the enzyme activity 
deteriorating and susceptible to inhibition related to 
age and lifestyle patterns. The inherent ability of 
tissues to respond to FA's may thus, vary dependent on 
the species concerned.
Many workers have assessed the effects of individual 
exogenous FA's as a means of limiting neoplastic cell 
growth (eg. Tolnai et al 1962, Dippenaar et al 1982a, 
Leary et al 1982, Booyens et al 1984a, Cantrill et al 
1986, Girao et al 1986, Begin et al 1987 and Botha et al
1989) . Considerably less data, however, is available on 
the effects of FA's on normal cell growth (eg. Huttner 
et al 1978, Cornwell et al 1979 and Ruck et al 1986). It 
is thus difficult to relate many of the neoplastic cell 
studies to the "real world" if similar studies have not
been performed with normal cells, particularly since the 
ability to respond to FA's may be impaired by 
transformat ion. Further, examination of the 1iterature 
illustrates that many studies have, unfortunately, 
compared the effects induced by individual FA's in a 
transformed cell line with that of a "control cell line’ 
which was either benign in origin, or normal but 
unrelated to the transformed one studied; a more valid 
comparison would be to use the normal cell type from 
which the transformed one was derived since evidence 
suggests that cells even of the same source and degree 
of transformation respond differently to exogenous 
FA's. This is clearly evident from previous studies in 
our 1aboratory which compared the effects of exogenous 
C18 FA supplementation on the proliferation of 3T3 and 
3T6 cells, both benign and originally derived from the 
same source (Swiss mouse embryo) (Davidson et al 1987c). 
Although the cells were morphologically similar, the 
effects induced by the added FA's were not alike, 
implying differences in FA metabolism. Studies have 
shown that the FA composition of different tissues, both 
within and between mammalian species, vary considerably 
(eg. de Gier et al 1961, Crawford et al 1970, 1971 and 
Horrobin et al 1984c). Evidence additionally suggests 
that cells derived from different mammalian species and 
their tissues, as well as cells of different degrees of 
transformation, possess varying degrees of desaturation
capability (Brenner 1971, Dunbar et al 1975, Rivers et 
al 1975a, Horrobin 1983), and thus would be expected to 
respond differently to exogenous FA's.
Most studies to date have ignored this fact. Booyens et 
al (1984b), for example, used benign bovine kidney cells 
(MDBK) as a control for osteogenic sarcoma (MG63) and 
eosophageal carcinoma cell lines in studying the effects 
of GLA toxicity on cultured cells, while a human 
hepatoma cell line was compared with a benign monkey 
kidney cell line (LLCMK), used as control, in a similar 
study (Booyens et al 1984c). Other studies have only 
investigated lipid metabolism in a single cancer cell 
line without a suitable normal control. For example, 
the importance of the stearoyl-CoA desaturase system in 
octadecanoate metabolism was studied in a hepatoma cel 1 
line (7288C) by Zoeller et al (1985), while Gaspar et al 
(1975) used the same cell line to study uptake and 
metabolism of eicosa-8,11,14-trienoic acid; no effort 
was made to compare with normal hepatocyte cultures. 
Fujiwara et al (1986) compared the anti-tumor effects of 
GLA on 4 neuroblastoma cell lines, without an attempt to 
relate their data to normal brain cells, while Ikai et 
al (1987) only studied inhibition of cell proliferation 
by PG's in transformed mouse epidermal cells (PAM 212) 
without examining whether similar effects occurred in 
normal epidermal cells.
understanding particular aspects of lipid metabolism, 
but it is unfortunate that they have generally ignored 
the importance of relating data to the original normal 
cell type and thus, to the ‘real world". Such 1iterature 
findings support Howard et al (1974), who reported that 
there have been very few direct comparisons of 1ipid 
metabolism between various related cell lines. Only 
recently, Begin et al (1989) commented in one of their 
articles that for valid comparisons to be made between 
normal and tumorigenic cell lines, the corresponding 
normal cell type should be used. Yet, many studies 
continue to fall short in this respect; the significance 
of such data is, therefore, uncertain in relation to the 
situation in vivo.
In the "real world", however, individual FA's are not 
consumed per se. but rather as a combination of FA's, 
derived from a variety of food sources, usually in the 
form of plant and/or animal derived lipid contained in 
the product consumed, eg. oils. Thus, cells in vivo 
are rarely exposed to individual FA's in isolation, but 
rather to combinations, with different chain lengths 
and degrees of unsaturation. Uhile knowledge of the 
behaviour of individual FA^s is essential to quantitate 
individual effects, the effects of combinations are just 
as important. Few workers have used more than one FA at 
a time, and the effects of more complex combinations 
have been ignored in vitro: animal studies, however,
in.dicate that different dietary oils influence cell 
metabolism to a greater or lesser extent (eg. Barzanti 
et al 1986). Studies to date using cultured cells have 
not examined the effects of FA mixtures which mimick the 
FA composition of dietary oils. It is thus difficult to 
relate many of the studies to in vivo where normal cells 
of all tissues are continuously exposed to FA's derived 
from a variety of food sources.
The aims of this study were, therefore, to investigate 
the effect of exogenously added FA mixtures which 
mimick the FA composition of natural oils (termed 
pseudo-oils) on the viability of a range of normal cell 
types derived from mammalian species differing in 
desaturation capability. Furthermore, since evidence 
suggests that exogenous FA supplementation does not 
modulate plasma membrane associated parameters (Girao 
1988), and the indications are that the microsomal 
desaturase/elongase, cyclooxygenase/1ipoxygenase and/or 
lipid peroxidation pathways may be involved, it was 
hypothesised that the intracel1ular processes of 
polyenoic FA metabolism may be the route whereby growth 
limitation effects are induced; thus, it was also 
decided to assess these aspects of lipid metabolism.
The direct assay of the desaturase enzymes, in vitro, by 
means of incubation of subcellular fractions with 
radiolabel1ed substrates (eg. Actis Dato et al 1972) is
the most absolute means of assessing such enzyme 
activity, and can be applied to subcellular fractions 
from any cell type. Numerous studies have been conducted 
on isolated microsomes in vitro. and the direct assay 
procedure is well documented, at least for J6D (eg. 
Brenner et al 1966, Brenner 1971, Castuma et al 1972,
Peluffo et al 1976, de Gomez Dumm et al 1975b, 1976,
1980, 1983, 1986). This assay, however, merely reflects
total enzyme activity, not the activity actually
expressed in the cel 1. An indirect assessment of
desaturase activity is more realistic and is more
relevant to normal and disease conditions since it more
closely parallels the intact organ i sm . This view
is shared by Mahfouz et al (1981) who described
difficulties in interpreting microsomal studies, and 
suggested cell culture systems to overcome this as such 
show significant parallels to the in vivo situation. The 
following year, Hill et al (1982) advocated measurement 
of relative substrate and product levels in cells 
as more accurate and reliable indications of true 
desaturase activity, rather than in vitro microsomal 
assays.
i
Three species of mammalia, viz. Rattus norvegicus (rat), 
Felis cattus (cat) and Homo sapiens (Man), were selected 
for this study. The selection of species was based on 
their known differing desaturation capabilities. The rat 
is reported to exhibit high activity (eg. Brenner 1971,
1974), Man has limited activity (eg. Dyerberg et al 
1980 and Horrobin 1983), while the cat is reported to 
be A6D deficient (eg. Rivers et al 1975a, Frankel et al 
1978 and Sinclair 1979). A wide range of tissues from 
each species were selected because of the known 
differences both in lipid profile and metabolism between 
tissues. Erythrocytes, lymphocytes, aortic endothelium, 
skeletal muscle, brain, lung, skin and white adipose 
tissues were studied in culture. By using available 
cells from all 3 species, it was intended to generate 
comparative data on the role of the desaturase enzymes, 
and the products derived from such reactions, in the 
modulation of cell proliferation both within and between 
species. Such data would direct more light on the 
involvement of these enzymes in the growth promoting or 
limiting effects of FA's.
Each cel 1 type was to be incubated with a wide range of 
concentrations of each pseudo-oil. Proliferative, growth 
limiting, cytostatic and/or cytotoxic effects were to be 
assessed. Subsequent quantitative measurements of total 
protein, FA's, lipid peroxides and eicosanoids were to 
be performed to establish the possible mechanism(s) by 
which the pseudo-oils influenced cell viability. Protein 
was to be used as an indication of cell viability and as 
to the influence of pseudo-oils on total protein 
synthesis. FA analyses would permit assessment of 
exogenous FA incorporation into cellular lipids and
desaturase cascade 
quantitation woul 
moieties, as well 
Finally, eicosanoi 
conversion of FA's 
of eye 1ooxygenase/1
enzyme capability. Lipid peroxide 
d assess the production of those 
as the cells ability to produce such, 
ds were to be quantitated to assess 
to eicosanoids, giving an indication 
ipoxygenase enzyme function.
Interpretation of the data would be performed in the 
light of the known processes of lipid metabolism, in an 
attempt to determine the possible site(s) and 
mechanism(s) of the action of the pseudo-oil FA's. By 
employing a multi-parameter approach it was expected to 
obtain a greater insight into these mechanisms; 
furthermore, by using FA mixtures, it was expected to 
get closer to the situation in vivo.
CHAPTER 2: MATERIALS AND METHODS.
2.1 MATERIALS.
2 . 1.1 Animal and Human Ethics Assurance.
The protocol and al1 procedures carried out in this 
study were approved by the University of the 
Uitwatersrand Animal and Human Ethics Controlling 
Committees. Clearance certificates obtained to use rat 
and cat tissues were assigned protocol numbers 87/21 and 
88/7, and that for human blood collection was 21/2/89.
2.1.2 Source of Animals.
Animals were obtained from the Central Animal Service of 
the University of the Ulitwatersrand Medical School, 
Johannesburg, South Africa. They included inbred strains 
of Uistar specified pathogen-free (SPF) albino male 
rats, either 2 day old, 2 week old, or adult. Cats were 
approximately 2 day old kittens, or adults.
The animals were housed in cages at constant temperature 
and humidity, and were exposed to continuous 12 hour 
1ight/dark cycles with free access to food and water.
2.1.3 Source of Human Tissues.
Blood specimens were obtained with informed consent from 
human volunteers at the University of the Uitwatersrand 
Medical School and adjoining Johannesburg Hospital.
2.1.4 Source of Cells for Tissue Culture.
Uith the exception of those acknowledged, all cells used 
in this thesis were isolated and cultured by the author. 
In most cases, young animals were used as sources of 
tissue to initiate primary cultures since cells survive 
the isolation procedure and adapt to in vitro culture 
conditions to a greater extent when obtained from young, 
than old, animals. It was generally possible to use 2 
day old rat pups or kittens to provide sufficient tissue 
from which large numbers of viable cells could be 
isolated. However, 2 week old rat pups had to be used as 
a source of white adipose cells since younger animals 
had insufficient fat to yield the cell numbers required. 
Similarly, adult rats (>300g) or cats were utilised to 
obtain maximum numbers of aortic endothelial cells, 
erythrocytes and lymphocytes.
All cells were cultured under standard conditions with 
the same batch of serum, and without the addition of 
hormones or growth factors. Liver cells were excluded 
from the study since they require various growth factors 
for optimal proliferation, and financial constraints 
prevented the inclusion of such factors in the growth 
med i a .
Following is a description of the cells used and their 
origin:
Rat erythrocytes 3
: I so 1ated
Rat lymphocytes from adu1t
: rats.
Rat aortic endothelial cells* 3
Rat skeletal muscle cells* i
i A 1 1
Rat brain cortical astrocytes i i so1ated
i from 2-day
Rat lung cells* 3 o 1d rat
3 pups.
Rat skin cells* 3
3 Iso 1ated
Rat adipose cells* 3 from 2-ueek
3 old pups.
Cat erythrocytes 3
3 I so 1ated
Cat lymphocytes 3 from adu1t
: cats.
Cat aortic endothelial cells* :
Cat skeletal muscle cells*
Cat brain cortical astrocytes
J
3 A 1 1
3 isolated
Cat lung cells* 3 from 2-day
3 o 1 d
Cat skin cel 1s* 3“1 k i ttens.
Cat adipose cells*
J
:
Human erythrocytes 3 I so 1ated
3 from adu1t
Human lymphocytes 3 vo1unteers.
Human (fetal) skeletal muscle cel Is* 3 Purchased
3 from .
Human (fetal ) lung cel Is* 3 Highveld
3 Biologicals
Human (fetal) skin cells* 3 (Pty) Ltd.,
3 South
3T3 benign Swiss mouse embryo f i brob1asts 3 Afr i ca.
*Largely take a fibroblastic morphology in culture.
While every attempt was made to obtain further human 
tissue types, ethical and logistical constraints limited 
the range of tissue, types available.
Normal cells derived from primary cultures survive only 
for a finite number of passages, afteruhich they die. 
All experimental procedures employing normal dividing 
cells were therefore executed using cells subconfluent 
in the log growth phase at the lowest passage number 
possible, but never exceeding 50 population doublings. 
Practically, this was about 10-12 passages, usually 
obtained from split ratios of 1 :2 .
As cell culture is a dynamic system in which cells are 
infinitely capable of change, prior to their use in 
experimentation, dividing cells were cultured for a few
passages in which any changes in growth rate and
/
morphology were monitored. Samples of logarithmically 
growing cells were subsequently frozen so that, if 
necessary, any changes in characteristics could be 
related to passage number and the cells re-examined.
2.1.5 Tissue Culture Media. Reagents and
Culture Vessels.
All sterile tissue culture plasticware, viz. 10ml and 
50ml centrifuge tubes, 25, 75 and 175cm2 vented culture 
flasks, 24-multi well culture plates and 1.8ml cryotubes 
were obtained from Sterilin Ltd., Feltham, England.
Hank's balanced salt solution (with 0.35g/l NaHC03
Ca2+/Mg2+ free) was purchased from Flow Laboratories 
Ltd., Scotland.
Fetal calf serum, EDTA (0.1%+O.lJ. glucose in Dulbecco 
buffer, Ca2+/Mg2+ free) and trypsin (0.25^ in Dulbecco 
modification, Ca2+/Mg2+ free) were obtained from the 
National Institute for Virology, South Africa.
Collagenase (0.3-0.4U/mg lyophilised from Clostridium 
histo1yticum) was obtained from Boehringer Mannheim 
Biochemica, Mannheim, Uest Germany.
Nylon mesh (250 and 150jum) was obtained from Nybolt, 
Switzerland, while 0.45 and 0.22jum filters were bought 
from Millipore Corporation, Massachusetts, U.S.A.
Streptomycin sulfate (750U/mg), penicillin-G (sodium 
salt 1662U/mg), bovine serum albumin (BSA) fraction V 
(essentially fatty acid free), and trypan blue were 
bought from Sigma Chemical Company, St. Louis, Missouri, 
U.S.A., while gentamycin sulphate (Garamycin lOmg/ml) 
was obtained from Scherag, Isando, South Africa.
Sterile venoject evacuated blood collecting tubes 
(uncoated or with 0.5ml 3 ,8 % Na-citrate solution as 
anti-coagulant), needles and syringes were obtained from 
the Johannesburg General Hospital.
Ficoll-Paque was purchased from Pharmacia Laboratory 
Separation Division, Uppsala, Sweden.
Dimethylsulphoxide (DMSO) was obtained from Merck, 
Darmstadt, Uest Germany.
2.1.6 Other Research Products. Chemicals and
Reagents.
100% ethanol, 1H% boron trifluoride in methanol, 2 ,6-di- 
tert-buty1-p-cresol (BHT), 1,1,3,3-tetramethoxypropane, 
malondialdehyde (MDA), thiobarbituric acid (TBA ) , 
trichloroacetic acid and Folin and Ciocalteau's phenol 
reagent were purchased from Merck, Darmstadt, West 
Germany.
Whatman (No. 1) filter paper circles (18.5cm) were 
purchased from Whatman Ltd., England.
The scintillation cocktail used was Aquagel I, obtained 
from Chemlab (Pty) Ltd., Johannesburg, South Africa.
Gasses (air, helium, hydrogen, propane and medical 
carbon dioxide) were obtained from Afrox, South Africa.
The 6 foot x 3mm ID GLC column, on 100/120 chromabsorb, 
was purchased from Anatech Instruments (Pty) Ltd., South 
Afr i ca.
Sephadex LH-20 (particle size 25-lOO^im) was obtained 
from Pharmacia Laboratory Separation Division, Uppsala, 
Sweden.
HPLC grade methanol and acetonitrile, 0.22 and 0.45*im
filters, and the Cis HPLC column (100mm x 8mm ID) were 
obtained from Waters Millipore Corporation, U.S.A.
Eicosanoids standards, viz. PGI2> TXB2 , PGFift, PGFzot,
PGp
2 , PGEi and PGD2 were purchased from Sigma Chemical 
Company, St. Louis, Missouri, U.S.A. Fatty acids, as
*95% pure free acids, were also obtained from this 
source. The fatty acids (all in the cis-configuration) 
are listed below:
10 :0 decanoic (capric) acid
12 :0 dodecanoic (lauric) acid
14:0 tetradecanoic (myristic) acid
16:0 hexadecanoic (palmitic) acid
16: 1uj9 9-hexadecenoic (pal mitoleic) acid
17:0 heptadecanoic (margaric) acid
18:0 octadecanoic (stearic) acid
18:lu9 9-octadecenoic (oleic) acid
18:2w6 9,12-octadecadienoic (linoleic) acid
18:3w6 6,9,12-octadecatr ienoic ()'-l inol enic ) acid
18:3u3 9,12,15-oc tadecatr ienoic (oc-1 inol en ic ) acid
18:4u3 6,9,12,15-octadecatetraenoic (morotic) acid
2 0:2u6 11,14-eicosadienoic acid
2 0:4u6 5,8,11,14-eicosatetraenoic (arachidonic ) acid
20:5u3 5,8,11,14,17-eicosapentaenoic acid
22:6u3 4,7,10,13,16,19-docosahexaenoic acid
The following cis-radiolabel1ed fatty acids (*95% pure) 
were obtained from Amersham International Ltd., England:
9-Cl-iaCD-18:lu9, 53.8mCi/mmol.
12-Cl-iaCT-18:2co6, 53.6mCi/mmol . 
9,12,15-Cl-iaCD-18:3w3, 53.9mCi/mmol
Methylated fatty acid standard mixtures for GLC, viz. 
GLC-3A, GLC-08A and GLC-68A, were obtained from Nu Chek 
Prep, Inc., Minnesota, U.S.A.
Unless otherwise stated, all other chemicals used were 
purchased from Merck, South Africa, or the University 
Central Stores, and were of analytical grade.
All weighing of chemicals was carried out on a Sartorius 
4-digit electronic digital balance.
2.1.7 Fatty Acid Nomenclature in Relation to
the Study.
There are 3 commonly used systems of nomenclature for 
FA's (Davidson et al 1985a):
a) ‘trivial* nomenclature, which names the FA on 
the basis of some factor other than structure. For 
example, adrenic and nervonic acids, so called as they 
were first isolated from adrenal glands and nerve 
tissue, respectively.
b) ‘systematic’ nomenclature, which names the FA 
according to the number of carbon atoms and degree of 
unsaturation. However, this creates complications in 
recognising members of homologous series as the double 
bonds are numbered from the carboxyl terminal end of the 
chain; thus when a FA is chain elongated and further 
desaturated the double bonds appear to change position 
when in fact they do not.
c) u , or n— nomenclature, which numbers the 
double bonds from the carbon atom at the methyl ("w") 
terminal. As FA's are always elongated at the carboxyl 
end of the chain, this system circumvents any 
desaturation/elongation problems and thus allows members 
of a homologous series to be easily recognised. By 
convention, FA nomenclature therefore relates the 
position of a double bond within a FA to its distance 
from the methyl, or u, terminal carbon atom.
In this thesis, the 3 systems will be used intei—  
changeably. The list in 2.1.6 includes the names of each 
FA used, and this may be used as a reference to cross­
correlate between the three systems of nomenclature. 
Unless otherwise stated, all FA's mentioned in the text 
are in the cis-configuration.
2.2 METHODS.
2.2.1 Tissue Culture.
The standard tissue culture techniques employed in this 
study uere those in general use in this and other 
laboratories around the world, and were based on the 
general methods described by Flow (1983), Freshney 
(1983, 1986) and Gibco (1984).
2.2.1.1 Sterility Procedures.
Glassware, filtration units and all instruments were 
thoroughly washed in deionised water prior to 
sterilisation by autoclaving at 15 pounds/square inch 
for 15 minutes, followed by a 10 minute drying cycle. 
Liquids were sterilised by filtration through 0.22jum 
Millipore membrane filtration units.
The tissue culture fascility was routinely exposed to an 
ultra-violet germicidal lamp at least 30 minutes prior 
to use, and continuously when not in use, to maintain a 
sterile enviroment.
2.2.1.2 Preparation of Tissue Culture Medium.
A11 culture media was prepared in our own 1aboratory 
from high grade chemicals according to reported 
specifications (Flow 1983 and Gibco 1984). The standard
medium routinely employed for culturing all cells was 
Dulbecco's Modification of Eagle's Medium (DMEM) (with 
glutamine, but without NaHC03). Powdered medium was 
appropriately reconstituted with deionised, double 
distilled water, buffered to a pH of 7.4 with sodium 
bicarbonate, and then immediately sterilised by membrane 
filtration under positive air pressure, to prevent loss 
of carbon dioxide. The media was incubated for 72 hours 
at 37°C to ensure sterility, and subsequently stored at 
2°C to 8°C for a maximum period of one month. Medium was 
free of antibiotics, and only a supplementation of 2mM 
glutamine and 10% (v/v) heat inactivated fetal calf 
serum (FCS) was routinely added for fortification. It 
appears that the presence of serum fascilitates the 
adherence of cells to tissue culture vessels, especially 
from newly established primary cultures (Bonney et al 
1974 and McGowan et al 1981). Following addition of 10% 
FCS to DMEM, this completed "growth/incubation medium* 
was again filtered through a sterile 0.22jum Millipore 
hand filter prior to use. Total protein in growth medium 
(90% DMEM+10% FCS) was assayed using the method of 
Lowry et al (1951).
2.2.1.3 Col 1 ection and Deactivation of Rat. Cat
and Human Serum.
Whole blood was collected aseptically from suitable 
adult rat, cat and human donors in sterile blood
collecting tubes and allowed to coaggulate. The plasma 
clot was removed and the serum subsequently centrifuged 
at 200xg for 30 minutes in a clinical benchtop 
centrifuge. Supernatant serum was carefully collected 
without disturbing the cell debris pellet, was 
inactivated by heating to 56°C for 30 minutes and 
subsequently cooled to room temperature. This was 
centrifuged at 200xg for 10 minutes to remove any 
particulate material, and the supernatant serum filtered 
first through a 0.45jum, then a 0.22,um sterile hand 
filter, and subsequently stored at ~20°C until used.
2.2.1.4 Tissue Dissociating Solution.
This was prepared fresh every time by dissolving 0.05^ 
collagenase in Hank's balanced salt solution (HBSS). An 
antibiotic ‘cocktail’ consisting either of lOOU/ml 
penicillin and lOOjjg/ml streptomycin, or alternatively 
200jug/ml gentamycin sulphate, was added. Gentamycin was 
the antibiotic of choice as Schafer et al (1972) showed 
that it exhibits broad spectrum bactericidal activity, 
is heat and pH stable, and does not induce any notable 
influence on cell metabolism.
Prior to use, the dissociating solution was gassed with
95% O2/5J/ cq2 for at least 30 minutes, the pH was 
adjusted to 7.4, the solution subsequently sterilised by
filtration twice through a 0 .22jum filter, and then 
warmed to 37°C.
2 .2 .1.5 Initiation of Primary Cell Cultures.
The general tissue isolation procedure employed a 
combination of mechanical and enzymatic tissue dis­
aggregation techniques as described by Sly et al (1979), 
Flow (1983) and Freshney (1983, 1986). The general 
procedure described below was used for the isolation of 
cells derived from aortic endothelium, skeletal muscle, 
brain, lung, skin and white adipose tissue. Slight 
modifications of the procedure, if necessary, were used 
for certain tissue types to ensure maximal viable cell 
yield (see 2.2.1.5.a-g for modifications).
All cell isolations were conducted between 10am and 
12 noon, as suggested by Actis Dato et al (1972), to 
minimise differences created by diurnal variations. 
During the entire tissue isolation procedure, a bunsen 
flame was kept burning close to the work area, and 
strict sterile procedures were maintained throughout.
Rats were transferred to the aseptic tissue culture 
environment and placed in a sterile plastic container 
lined on its base with adsorbent paper. This container, 
together with al1 the instruments required in the 
isolation procedure, were previously exposed to an 
ultra-violet germicidal lamp for at least 30 minutes to 
destroy any surface pathogens.
Rat pups were killed by decapitation without anesthesia
Ill
using a pair of sharp sterile dissecting scissors, while 
older rats were stunned and killed by cervical 
dislocation. Animals were placed onto a clean absorbant 
cotton pad layered over a simple cork board (cooled to 
4°C prior to use), and secured. The appropriate animal 
surface was thouroughly swabbed with 70\  ethanol.
Prior to use, disecting instruments were briefly emersed 
in 7 0 k ethanol, flamed over a bunsen (to evaporate all 
ethanol and fix any loose particulate matter), and 
cooled in ice. A second set of sterile operating 
instruments was always available as backup in the event 
of accidental contamination of the first. The required 
organ/tissue was removed surgically by making a midline 
incision at the appropriate site, using a separate set 
of sterile dissecting instruments for making incisions 
through the skin, muscle layer, into the body cavity and 
to free and lift the organ/tissue out of the animal.
The isolated organ/tissue was placed into a 25ml glass 
beaker and rinsed with preheated (37°C) sterile saline 
containing lOOU/ml penicillin and lOOjug/ml streptomycin 
(to decontaminate the organ/tissue in the event of any 
contamination either in situ in the animal, or as a 
result of the dissection and isolation procedure). The 
organ/tissue was stirred at half speed with the aid of a 
magnetic stirring bar in an Agrimatic Stirring apparatus 
at 37 C for 5 minutes, to remove as much blood as
possible
Following decanting of the saline, the organ/tissue was 
chopped into l-5mm cubes with a sterile scalpel. Any 
blood was washed off by several changes of cold saline. 
Dissociation of the tissue pieces was initiated by 
incubation with 20ml preheated dissociating solution 
(section 2.2.1.4) in a 25ml glass Ehrlenmeyer flask 
with gentle magnetic stirring (100±20rpm) at 37°C, as 
recommended by Herring et al (1983). The temperature was 
carefully monitored during the entire procedure.
Liberation of cells was manifested by an increased 
turbidity of the dissociating solution. Digestion of the 
tissue was allowed to continue for about 10-15 minutes, 
after which time the flask was briefly placed on ice to 
allow the 1arger undissociated tissue fragments to 
settle. The supernatant was gently decanted into a 
sterile 50ml plastic centrifuge tube, an equal volume of 
DMEM+10 FCS was added to terminate enzyme action, and 
this placed on ice.
The above procedure was repeated about 5 times with 
fresh dissociating solution. Generally, 90 minutes after 
initiation of the tissue dissociation procedure, most of 
the tissue was digested.
The dissociated cells obtained after 
incubation were immediately filtered 
250jum nylon gauze mesh, followed by 
150,um mesh into sterile 50ml plastic
each 10-15 minute 
through a sterile 
passage through a
centrifuge tubes.
After gentle inversion, the suspension was centrifuged 
at 100-200xg for 5 minutes in a clinical benchtop 
centrifuge with swing-out buckets, as recommended by 
Williams et al (1977b), This low-speed centrifugation 
removed most contaminating blood, while pel letting the 
1arger isolated cells.
The supernatant was decanted, packed cells were 
resuspended in warm DMEM+10* FCS, washed again at 100- 
200xg for 5 minutes, followed by a third centrifugation 
at 200xg for 10 minutes to completely pellet the cells. 
The final pellet was resuspended in 10ml DMEM+10* FCS 
containing 200jug/ml gentamycin (Williams et al 1977b), 
and plated into 25cm2 sterile tissue culture flasks with 
vented caps. Cells were incubated in a humidified 
atmosphere of 95* air/5* C02 at 37°C in a water-jacketed 
incubator (Labotec, South Africa). Time from surgery to 
plating of isolated cells was approximately 2 hours.
After allowing 3-4 hours for cell attachment to the
culture vessel, cells were examined microscopically for
\
for viability, adhesion and any microbial contamination. 
Subsequently, the contents of the flask were gently 
swirled and decanted, thus fasci1itating the removal of 
any cellular debris, non-adherent, loosely adherent or 
dead cells. Viable cells were subsequently fed with warm 
antibiotic-free 90* DMEM+10* FCS, and checked every day. 
Growth medium was replaced with fresh medium on the
second day, and subsequently every 48-72 hours (to 
remove any loosely attached/dead cells, cellular debris 
and potentially toxic metabolic products) until a near 
confluent monolayer was established.
The above technique maximises the viable cell yield, and 
thus shortens the period to which cells are exposed to 
disaggregating enzymes. Mechanical procedures were kept 
to a minimum as enzymatically isolated cells retain more 
characteristic features of the tissue in vivo. in 
contrast to mechanically prepared cells (Jezyk et al 
1969 and Ontko 1972).
Cells were allowed to divide several times, resulting in 
the formation of islands of cells which eventually 
formed a monolayer. The cell populations obtained from 
a particular primary culture were heterogeneous and 
thus representative of the whole organ/tissue in the 
"real wor1d".
Further growth and maintenance of cells were carried out 
employing the principles described by Sly et al (1979), 
Flow (1983) and Freshney (1983, 1986). The different 
cell types were cultured chronologically separate to 
avoid the possibility of cross contamination. 
Proliferating cells were regularly monitored for 
doubling time between passages.
2.2.1.5.a Modifications for the Isolation of Cat
Tissues for Primary Culture.
Cats were transferred from their cages to the autopsy 
facility of the Animal Unit at about 9am, and killed 
with an intravenous overdose (1.0ml/kg IV) of Euthanase 
solution (sodium pentobarbital). The appropriate surface 
was immediately swabbed with 70% ethanol and an incision 
made using strict sterile procedures, as before. The 
removed organ/tissue was placed in pre-cooled saline 
solution containing lOOU/ml penicillin and lOOjug/ml 
streptomycin, and rapidly transported on ice to the 
tissue culture facility, where cells were isolated as 
described previously in 2.2.1.5.
2.2.1.5.b Modifications for the Isolation of Cells
from Aortic Endothelium.
These modifications included those described by Ulechezak 
et al (1973), Bar et al (1984) and Hoshi et al (1986).
The aorta from adult animals was removed, rinsed with 
saline to-remove blood, and cut into 5-10mm pieces. The 
vessels were everted so that the endothelium was exposed 
to the dissociating solution. After each incubation 
period, the dissociating solution was pipetted 
repeatedly over the endothelial surface to dislodge the 
cells, which were collected and washed with growth
medium as before
2.2.1.5. c Modifications for the Isolation of Cells
from Skeletal Muscle.
The modifications of Bullaro et al (1976) and Koningberg 
(1979) were employed.
Skeletal muscle from the thigh was used. Following 
collagenase digestion, incubation of remaining diced 
muscle fragments with 0.1% EDTA:0.25% trypsin (1:1 v/v) 
for 30 minutes increased cell yields.
2.2.1.5. d Modifications for the Isolation of Cells
from Brain.
The modifications employed were those described by 
Poduslo et al (1975), Walker et al (1984) and Bjerkvig 
et al (1986).
Whole brain was freed from its meninges and removed from 
the animal. The cerebellum was discarded and cells were 
isolated from the cortex only. Increased cell yields 
were obtained when brain fragments were incubated with 
dissociating solution saturated with oxygen for up to 60 
minutes, followed by incubation with 0.1% EDTA:0.25%
trypsin (1:1 v/v) for a further 30 minutes. When 
necessary, remaining tissue fragments were mechanically 
disaggregated through a 250jum and then a 150,um mesh. 
The dissociating solutions and initial growth medial were 
all supplemented with additional glucose (final
concentration lg/*). This method yielded mainly glial 
cell progenators, which could be identified as largely 
astrocytes with some oligodendrocytes.
2.2.1.5. e Modifications for the Isolation of Cells
from Lung.
The modifications of Tompa et al (1979) and Kumar et al 
(1987) were employed.
Only the distal 2/3 of lungs were used to eliminate the 
bronchii, etc. Lungs were washed three times in growth 
medium to flush out as much blood from the organ as 
possible. After collagenase incubation for 60 minutes, 
remaining cells were dissociated from the diced organ 
with 0.1?i EDTA:0.25^ trypsin (1:1 v/v) for 30 minutes to 
increase the cell yield.
2.2.1.5. f Modifications for the Isolation of Cells
from Skin.
The modifications of Fujimoto et al (1977), Sly et al 
(1979) and Yen-Chow et al (1984) were employed.
Skin biopsies were obtained from the anterior abdominal 
wall and from the forearms. Any hair was shaved off the 
skin at the appropriate site prior to sample removal. 
Cell isolation was carried out as described in 2.2.1.5.
2.2.1.5.g Modifications for the Isolation of Cells
Cells from Adipose Tissue.
These modifications were 
utilised by Rodbel1 (1964)
based on the techniques 
Adebonojo (1975) and Fain
(1975).
Adipose tissue was removed from non-obese young animals 
from the supra-testicular, forearm and scapular regions, 
which contain white adipose tissue only. All procedures 
were identical to those outlined previously, but the 
dissociating solution and initial culture medium 
contained 5.0^ albumin.
Centrifugation pelleted blood, endothelial and some 
stromal-vascular cells, while the supernatant contained 
whole adipocytes, lipid droplets from damaged adipocytes 
and some stromal-vascular cells. There is evidence that 
the stroma 1-vascular fraction contains fibroblasts which 
exhibit potential to become adipocyte precursors, and 
acquire morphological and biochemical characteristics 
similar to mature adipocytes (Van et al 1976). Further, 
when mature adipocytes lost their intracel1ular lipid, 
they aquired characteristics of stroma 1-vascular cells
(Van et al 1976)
2.2.1.6 Determination of Cel 1 Viability.
Cell viability was determined using the trypan blue 
exclusion method, as described by Paul (1975). A 
suspension of 1 part cells (lOjul) to 1 part 0.1% trypan 
blue in 0.9% saline was made. After 2 minutes at room 
temperature, cell counts were performed by counting the 
number of viable cells (which exclude the dye) in an 
improved Neubauer Hemocytometer (1mm x 1mm x 0.1mm).
2.2.1.7 Trypsinisation of Cell Monolayers.
Ulhen nearly confluent monolayers of logarithmically 
growing cells were obtained, subcultures/trypsinisations 
were performed (Sly et al 1979, Flow 1983 and Freshney 
1983, 1986).
Existing medium was decanted from the tissue culture 
vessel. Sufficient sterile 0.1% EDTA at 37°C was added 
to just cover the cells, and the culture vessel returned 
to the incubator for 5 minutes; thereafter, an equal 
volume of sterile 0.25% trypsin solution at 37°C was 
added and the cells once again returned to the 
incubator. Trypsinisation was allowed to continue for a 
period not exceeding 15 minutes, during which time the 
cells were regularly monitored for detachment.
As soon as the cel Is became detached, an equal volume of 
warm DMEM+10% FCS was added to the culture vessel to
inhibit the action of the trypsin. The cell suspension 
was decanted into a 50ml sterile plastic centrifuge tube 
and centrifuged at 200xg for 10 minutes. Subsequently, 
the supernatant was decanted, cells were resuspended in 
warm growth medium and re-centrifuged. After decanting 
the supernatant, the cell pellet was resuspended in a 
small volume of growth medium and cell viability 
determined as described in 2.2.1.6. Cells were either 
diluted with warm growth medium to lxl05/ml, plated into 
sterile tissue culture flasks, incubated and allowed to 
grow until a new monolayer was established, or frozen.
2.2.1.8 Cell Freezing for Long Term Storage.
The general principles described by Sly et al (1979), 
Flow (1983) and Freshney (1983, 1986) were used. Cells 
at the lowest possible passage number from each primary 
culture were frozen for long term storage.
Following the initial trypsinisation and subsequent 
washing of cultures (2.2.1.7), the final cell pellet was 
reconstituted with a small volume of growth medium and a 
cell count was performed. Cells were frozen in sterile 
1.8ml cryotubes at a concentration between 2 and 5xl06 
viable cells/lml growth medium, in an equal volume of a 
70% DMEM:10^ FCS:20% dimethylsulphoxide (DMSO) solution 
(v/v/v), to give a final DMSO concentration of 10%,  
Cryotubes were placed in a polystyrene container and put 
into a -70°C deep freeze overnight to allow for a
cooling rate of approximately l°C/minute. Subsequently, 
cells were stored in the vapour phase of a liquid 
nitrogen container (cryobank),
2.2.1.9 Resuscitation of Frozen Cells.
Cryotubes were removed from the cryobank and thawed as 
quickly as possible in a 37°C waterbath as described by 
Sly et al (1979). The contents of the cryotube were 
added to sufficient growth medium at 37°C to dilute 
the DMSO at least tenfold. The cell suspension was 
centrifuged at 200xg for 10 minutes, the supernatant 
decanted, and the cells re-washed in warm growth medium. 
The resulting cell pellet was re-suspended in sufficient 
warm growth medium to perform a cell count (2.2.1.6), 
diluted to lxl05/ml, plated into sterile tissue culture 
flasks and incubated. Cells were fed 24 hours later and 
subsequently every 2-3 days as necessary. Uhen cultures 
reached near confluence, they were subcultured or frozen 
as described in 2.2.1.7 and 2.2.1.8, respectively.
2.2.1,10 Isolation of Peripheral Erythrocytes and
Lymphocytes♦
2.2.1.10. a Collection of Blood from Rats.
Adult rats were killed with an intraperitoneal overdose 
(l.Oml/kg) of Euthanase solution (sodium pentobarbital) 
rather than cervical dislocation so that blood vessels 
in the neck remained intact, thus maximising the volume 
of blood collected (normally 3-10ml). The thorax was 
immediately opened once the appropriate reflexes 
dissappeared, and the animal bled from the inferior vena 
cava into a sterile citrated syringe and needle.
2.2.1.10. b Collection of Blood from Cats.
Cats were anaethetised with Saffan intramuscular1y. As 
soon as the required reflexes were diminished/1ost, 
blood was drawn from the jugular vein into a sterile 
citrated needle and syringe. Cats were injected with an 
antagonist, monitored for the return of reflexes and 
subsequently returned to their cage. Cat donors used for 
this purpose were bled no more than once a week, with 
the blood collection volume not exceeding 5.0ml per 
collection per animal.
2.2.1.10. c Collection of Blood from Humans.
Venous blood from normal human volunteers was collected
into sterile citrated blood collecting tubes at the 
adjoining Johannesburg General Hospital according to 
standard clinical procedures.
2.2.1.10. d Blood Separation.
Whole blood was immediately centrifuged at lOOOrpm 
(200xg) in a Beckman TJ-6 clinical benchtop centrifuge 
for 15 minutes at room temperature. Platelet rich plasma 
was subsequently carefully removed and discarded, while 
the buffy coat and erythrocytes were carefully separated 
using sterile pipettes, and placed into separate tubes.
2.2.1.10. e Erythrocyte Preparation.
Erythrocytes were washed 3 times with growth'medium at 
3 7 ° C by centrifugation at lOOxg for 10 minutes. Cells 
were subsequently diluted with warm growth medium to 
lxl05/ml, plated into 24-multiwell plates, incubated, 
and dosed an hour later (see 2.2.3).
2.2.1.10. f Lymphocyte Isolation.
Mononuclear cell isolation was based upon the original 
principle put forward by Boyum (1968). The buffy coat 
was suspended in growth mediumtcitrate (9:1 v/v). This 
suspension was carefully layered onto Ficoll-Paque in a 
ratio of 4:3 (v/v), and centrifuged at 400xg for 30-40 
minutes at 18—20 C in a clinical benchtop centrifuge
with swing-out buckets.
The upper phase was removed leaving the mononuclear 
layer at the Ficoll-Paque interface undisturbed. The 
mononuclear layer was collected and transferred to a new 
tube. It is essential to remove as much interface as 
possible but a minimum of Ficoll-Paque and supernatant 
to reduce unnecessary granulocyte, platelet and plasma 
protein contamination in the mononuclear fraction. Cells 
were washed three times with at least 3 volumes of warm 
growth medium, at not more than 200xg for 10 minutes (to 
minimise platelet contamination) at room temperature.
The cells were resuspended in warm growth medium, plated 
into 25cm2 culture flasks, and incubated in a humidified 
atmosphere of 95* air/5* C02 at 37°C. Approximately 3 
hours later, unattached cells (lymphocytes) were pooled, 
and washed with warm growth medium at 200xg for 10 
minutes. Cells were resuspended in warm growth medium, 
diluted to lxl05/ml, plated into 24-wel1 multidishes, 
incubated, and dosed 60 minutes later (see 2.2.3).
2.2.1.11 Light Microscopy of Cells.
All cultures were examined daily with a Nikon Diaphot 
phase contrast microscope (with, camera attachment). 
Parameters monitored included any sign of contamination, 
pH of medium, cell morphology, proliferation and degree 
of confluency.
2.2.2 Experimental "pseudo-Oil" Preparation.
The fatty acid compositions of a wide range of natural 
oils* and of potential oil sources, have been reported 
by McCance et al (1978) and Giangregorio et al (1988a). 
Seven natural oils were chosen for this study as rich 
supplies either of u9, u6 or w3 series unsaturated, or 
saturated, FA's.
Individual FFA's (from the list in 2.1.6) were initially 
made up as stock solutions (lOOmg/ml) in 100'S ethanol, 
and maintained at -20°C under an atmosphere of nitrogen. 
These individual FFA stock solutions were mixed in 
appropriate proportions to mimick the FA spectra of 
different natural oils, viz. coconut oil (CO), meat oil 
(MO), olive oil (00), sunflower seed oil (SSO), linseed 
oil (LO), evening primrose seed oil (EPO) and fish oil 
(F0). These FA mixtures were termed "pseudo-oils" 
(p-oils), and their composition paralleled that of oils 
commonly ingested by humans. The p-oils were abbreviated 
to p-CO, p-MO, p-00, p-SSO, p-LO, p-EPO and p-FO, with 
each having different degrees of unsaturation, 
corresponding to the natural oil. The FA spectra of each 
p-oil was checked by GLC (see 2.2.7.2) to ensure it 
mimicked the FA spectra of the natural oils.
Working solutions of these p-oils were made up fresh 
prior to use. From the stock p-oil mixtures in lOO^ S 
ethanol, 40^1 was aliquoted into a glass vial and the
ethanol evaporated under a stream of nitrogen gas in a 
37°C waterbath. To mirror the in vivo situation as 
closely as possible, p-oil FA's were complexed with 
bovine serum albumin to facilitate their delivery to 
the cells (McGee et al 1982). This was achieved by 
adding 200,ul of a sterile 5.0% essentially FA free BSA 
(fraction V) solution in distilled water to act as FA 
carrier, and this incubated for 5 minutes at room 
temperature. To this, 1.8ml growth medium at 37°C was 
added to bring the mixture to a total volume of 2.0ml. 
The p-oil mixture was gently heated prior to use as 
recommended by Ueyman et al (1977) so that the FA's 
remained in solution during dosing, especially in the 
case of p-oils rich in saturated FA's.
2.2.3 Experimental *pseudo-Qil* Dosing.
Adherent cells in the log phase of growth were 
trypsinised as described in 2.2.1.7, and a cell count 
was performed (2.2.1.6). Each cell type was seeded at 
l.OxlO5 viable cells/ml in 24-well tissue culture plates 
in a total volume of 1.0ml growth medium. Adherent cells 
were incubated with growth medium for a period of 24 
hours prior to dosing with p-oils to allow for cell 
recovery from trypsinisation. Cells in suspension, viz. 
erythrocytes and lymphocytes, did not require this 
recovery period, since trypsinisation was not necessary.
Appropriate volumes of the albumin-bound p-oil solutions 
were added directly to the culture medium to achieve the 
indicated p-oil concentration required. Cultures were 
dosed at 10mg/l intervals with each p-oil working 
solution, to yield final p-oil concentrations ranging 
from 0 to 100mg/l. The maximum albumin concentration 
utilised as FA carrier was 0.025% (250mg/l). After 
dosing, the plates were gently swirled to evenly 
disperse the p-oil throughout the wells, and cultures 
were incubated for 48 hours at 37°C in an atmosphere of 
90% humidity, 5% carbon dioxide:95% air.
Following the incubation period, the existing medium was 
removed, cells were trypsinised if adherent (2.2.1.7), 
and cell viability determined (2.2.1.6). The percent 
cell viability at each p-oil concentration was 
calculated by assuming the mean number of viable control 
cells to correspond to 100%. The IDso was calculated for 
each p-oil with every cell type studied, and was taken 
as the p-oil concentration required to reduce cell 
viability to 50% of controls.
To ascertain the approximate concentration of p-oil 
required to prevent nett cell proliferation, the number 
of viable control cells at the end of the 24 hours 
allowed for recovery from trypsinisation was compared to 
the number of viable control cells at the end of the 48 
hour incubation period with p-oils. This was expressed
as a percentage, and 
number". Only p-oil 
viability significantly 
would be cytotoxic.
represented the "cytostatic 
concentrations reducing cell 
below the cytostatic number
2.2.3.1 Albumin Effects on Cell Viability.
The effects of albumin were investigated on cell 
viability to eliminate albumin involvement in the 
effects induced with p-oil dosage, and thus to justify 
under the chosen culture conditions the use of albumin 
as FA carrier with each of the cell types used.
Cells were set up as previously described in 2.2.3, and 
dosed with varying concentrations of albumin without 
p-oil to yield final concentrations ranging from 
0 to 250mg albumin/1 growth medium. After 48 hours 
incubation, cell counts were performed (2.2.1.6), and 
this compared to controls.
2 .2 .3.2 Varying the Albumin Concentration with a 
Fixed Pseudo-Oil Concentration.
The effect of altering the albumin concentration at a 
fixed p-oil concentration was investigated on cell 
viability to eliminate the possibility that any of the 
effects induced with p-oil dosage were modulated by 
different albumin concentrations.
Cells selected from each species were seeded as
described in 2.2.3, and dosed at the concentration 
corresponding to the ID50 for that p-oil which induced a 
significant effect on cell viability. At least 5 points 
were chosen around which to vary the albumin
concentration, keeping the p-oil concentration fixed,
viz. 2 points below, 2 points above, and the ID50 Qf the
)
chosen p-oil. The appropriate amount of albumin was 
added to the cultures to correspond to that level used 
at the points chosen, and cultures were incubated for 48 
hours at 37°C in an atmosphere of 5% carbon dioxide: 95% 
air. Cell viability was subsequently determined, and 
this compared to controls.
2.2.3.3 Effect of Serum Type on Cell Growth.
To ensure that the routine use of 10% FCS in culture 
medium did not adversely influence cell viability, cells 
derived from rat, cat and human skin were plated at 
lxlO5 cells/ml in DMEM+10% rat serum,(RS), DMEM+10% cat 
serum (CS) and DMEM+10% human serum (HS), respectively. 
The growth of these cells in DMEM containing serum from 
their own species was monitored by determination of cell 
viability after 24, 48 and 72 hours incubation, and 
compared with that of the same cells grown in
DMEM+10% FCS over a 72 hour period.
Total protein (2.2.5), lipids (2.2.6) and FA's (2.2.7) 
were quantified in the above growth media to determine 
their possible contribution to the results obtained.
2.2.4 Bulk Dosing of Cultures for Quantitative
and Qualitative Analyses.
2.2.4.1 Selection of Cells Types.
Cells from each species previously studied viz. 
erythrocytes, lymphocytes, aortic endothelium, skeletal 
muscle, brain, lung, skin and adipose tissue, were 
cultured to provide sufficient material for further 
analytical procedures.
For each available adherent cell type, frozen cell 
stocks at low passage numbers were resuscitated as 
previously described in 2.2.1.9. and each grown in bulk. 
Erythrocytes and lymphocytes were freshly isolated.
2.2.4.2 Selection of the Dosing pseudo-Qil
Concentrat ions.
For each of the cell types in 2.2.4.1, between 5-10xl06 
cells/175cm2 tissue culture flask were seeded. Each cell 
type was subsequently incubated with the appropriate 
amount of p-oil, as described before, corresponding to 
four different concentrations, viz. 0, 20, 40 or 60mg/l, 
which were found to best reflect the relationship 
between cell viability and p—oil concentration across 
the spectrum of cells studied previously.
2.2.4.3 Harvesting of Bulk Cultures.
Following the 48 hour p-oil incubation period, t.he 
growth medium was removed from each flask, and this 
centrifuged at lOOOxg for 10 minutes in a Beckman TJ-6 
centrifuge. Supernatants (spent incubation medium) from 
the same concentration of each dosed p-oil were pooled 
together and stored at —20°C until required for further 
experimentation. Prior to use, each aliquot of spent 
medium was centrifuged at 5000xg for 10 minutes.
Adherent cells were trypsinised and the resulting cell 
pellet obtained after centrifugation was combined with 
any obtained from centrifugation of the spent incubation 
medium. For each cell type, cell viability was assessed 
as described before, and compared to that previously 
obtained. The cell suspension was subsequently 
centrifuged at lOOOxg for 10 minutes. The supernatant 
was discarded and the cells washed three times by 
resuspension in 20.0ml physiological saline (0.85^) and 
centrifugation at lOOOxg for 10 minutes each; 
supernatants were discarded following each wash.
Following the final centrifugation, the cell pellet was 
resuspended and swollen in 2.0ml of a solution at pH 7.4 
containing ImM NaHC03, 2mM CaCl2 and 5mM MgCla, and 
frozen to -20°C to lyse the cells. Lysed cells were 
subsequently stored at —20 Q until required for further
analysis.
Prior to further experimentation, the frozen cells were 
thawed and homogenised with 25 strokes of a Dounce 
homogen i ser.
2.2.5 Total Protein Determination.
lOOjul aliquots of lysed cells obtained in 2.2.4.3 were 
assayed for total protein by the method of Lowry et al 
(1951). Absorbances were read at 600nm in 1cm quartz 
cells in an LKB Biochrom Ultrospec 4050. Total protein 
was calculated with reference to bouine serum albumin 
(fraction V), in the range O-lOOjug, assayed in parallel 
with the samples. The results were compared with those 
of controls.
2.2.6.1 Total Lipid Extraction.
Total lipids were extracted from aliquots of p-oils, 
DMEM+10% FCS, DMEM+10% RS, DMEM+10% CS, DMEM+10% HS and 
spent incubation media. Once small aliquots of the. 
lysed cells at each of the p-oil concentrations from
2.2.4 were taken for total protein (2.2.5) and lipid 
peroxide (2.2.9) assays, the remaining cell suspensions 
were also extracted for lipids.
Total lipids were extracted from samples with 20 volumes 
chioroformJmethanol (2:1 v/v) containing 0.01% (w/v) 
2,6-di-tert-buty1-p-creso1 (BHT) as antioxidant, and the 
lipids left to extract overnight at 4°C, as per the 
method of Folch et al (1957).
Lipid extracts were filtered into glass separating 
funnels using Whatman (No.l) filter paper circles, and 
washed by adding 20% (v/v) physiological (0.85%) saline. 
The solutions were thoroughly mixed in stoppered 
separating funnels, and the phases allowed to separate 
overnight at 4°C. The lower chloroform (lipid) phase was 
subsequently removed and taken to dryness under vacuum 
at 37°C in an all glass Heidolph rotary evaporator at 
190rpm. Resulting concentrated lipid extracts were 
redissolved in a small volume of chloroform, and 
transferred into clean 20ml screw-cap glass vials. All
extracts were diluted to 20.0ml with chloroform, stored 
as stock solutions at —20®C, and used for al1 further 
qualitative and quantitative lipid analyses.
2.2.6.2 Determination of Total Lipid Dry Ueights.
Total lipid dry weights were determined in triplicate as 
per the method of Kates (1972). Clean 7.5ml glass vials 
were kept overnight in a Salvis oven at 100°C to 
evaporate any moisture present. Empty vials were removed 
from the oven, allowed to cool to room temperature, and 
weighed in a 4-decimal digit analytical electronic 
balance to 0.5mg. Empty vials were returned to the oven 
for 1 hour and subsequently reweighed. This procedure 
was repeated until vial weight was constant to within 
±1.Omg.
1.0ml aliquots of stock lipid extract from 2.2.6.1 were 
pipetted into the empty glass vi'als and taken to dryness 
in a 37°C waterbath under a slow stream of nitrogen gas. 
The vials were returned to the oven for 1 hour at 100°C 
to ensure the chloroform was taken to complete dryness, 
then weighed and dried repeatedly as before' until the 
weight was constant to within ±1.0mg.
Total lipid dry weight was calculated by subtracting the 
weight of the empty vial from that with lipid, and 
multiplying the resultant weight by the total volume of 
stock lipid extract in 2.2.6.1.
2.2.7.1 Fatty Acid Methylation.
During methylation, FA's are removed from the glycerol 
backbone, and derivatised to methyl esters. This process 
was described by Moscatel1i (1972) and is essential as 
it increases FA volatility and thus enables these 
moieties to be separated chromatographica11y.
10.0ml of stock lipid extract from 2.2.6.1 were pipetted 
into clean glass vials and the chloroform taken to 
dryness in a 37°C waterbath under nitrogen gas. To each 
vial was added 0.2ml petroleum ether (bp 40~60°C), 
followed by 1.0ml 14% boron trifluoride in methanol.
Vials were briefly gassed with nitrogen to remove any 
air, immediately sealed and placed in a 100°C oven for 
30 minutes to facilitate FA transmethylation. The vials 
were subsequently cooled to room temperature, their 
contents washed with 1.0ml saturated NaCl solution, 
followed by extraction of the fatty acid methyl esters 
(FAME^s) with 5.0ml petroleum ether. The vials were 
sealed, shaken and the phases allowed to separate for 
at least 15 minutes at room temperature. The upper 
petroleum ether phase was removed using a pasteur 
pipette (making sure not to take up any interface), 
placed into a new 7.5ml glass vial, sealed under 
nitrogen gas and stored at ~20°C until analysed by GLC.
the Fatty Acid Methyl Esters.
In gas-liquid chromatography (GLC), volatile compounds 
are passed in a stream of inert gas (mobile phase) 
through a column in which a liquid (stationary phase) is 
immobilised on a solid support. Separation is based on 
the partition of compounds between the gas and 1iquid 
phases. The compounds emerge from the column as distinct 
peaks that can be quantitated.
All GLC analyses were performed as one group to 
eliminate between-batch variations. Prior to GLC
analysis, the FAME's from 2.2.7.1 were concentrated by 
reducing their volume to dryness at 37°C under nitrogen 
gas. The FAME's were redissolved in 500jul petroleum 
ether added down the sides of each vial, this again 
taken to dryness, and subsequently redissolved with 
lOOjul petroleum ether.
FAME's were analysed by means of a Varian 3400 gas 
chromatograph equipped with a flame ionisation detector 
(FID) and a SP-2330 column (2m x 3mm internal diameter, 
with Chromosorb 100/120 WHP—SP as support) using helium 
as carrier gas. 1 ju 1 of the concentrated FAME sample was 
injected manually onto the GLC column. The column 
temperature was set isothermally at 200°C with both the 
injector and detector set at 220°C. Run time was set at 
31 minutes. Peaks were quantitated using a Varian 4270
integrator, and the relative percentage total area of 
each FAME recorded. Identification of the FAME's uas 
made by comparison with the retention times of known 
saturated and unsaturated methylated FA standards. GLC 
analyses were often repeated at random to check the 
repeatability of the system.
2.2.8 Studies with Radiolabel1ed Fatty Acids.
2.2.8.1 Cellular Incorporation of C1 aPl~18: 2u)6
w i th T i me.
Prior to radiolabel1ed FA studies with normal cells (see 
2.2.8.2), a pilot investigation was conducted to assess 
the incorporation of dosed radiolabel1ed FA into cells 
over a 48 hour incubation period. This would ascertain 
whether sufficient radiolabel1ed FA was detectable in 
dosed cells for further analysis with the 48 hour 
incubation period routinely employed.
A rapidly growing 3T3 benign cell line was chosen for 
the pilot study since its growth rate was significantly 
faster than every normal cell type used, thus its 
metabolism was presumed to be higher. Detection of 
sufficient radiolabel in 3T3 cells 48 hours post­
incubation with radiolabel1ed FA would indicate that 
this incubation time could also be satisfactorily used
with normal cells.
3T3 cells were seeded at 1.0x10s cells/ml growth medium 
in 75cm2 flasks and incubated for 24 hours at 37°C in an 
atmosphere of 5^ carbon dioxide:95?S air. The cultures 
were subsequently dosed with 2juCi C14CD-18J2u6 bound to 
sufficient albumin to act as carrier, and incubated.
Cultures were harvested at 6, 24 and 48 hours after 
dosing. At the end of each incubation period, the spent 
medium was carefully removed and stored at -20°C. The 
cells were trypsinised as described in 2.2.1.7, and the 
resulting pellet washed 3 times with physiological 
saline. Supernatants from each washing were pooled 
together and stored at -20°C. The final cell pellet was 
resuspended in a small volume of phosphate buffered 
saline (PBS, pH 7.4) and stored at -20°C. Frozen cell 
suspensions were subsequently thawed and briefly 
homogenised prior to further analysis.
lOOjul aliquots of homogenised cells, spent incubation 
media and pooled washings from each harvest period were 
placed into separate 20ml glass scintillation vials with 
10.0ml Aquagel I scintillation cocktail and capped. 
Subsequently, the radioactivity of each fraction was 
measured in an LKB RackBeta scintillation counter. 
Standards, blanks and controls were run in parallel to 
give a measure of efficiency and for comparison to dosed
cultures.
2.2.8.2 Studies with Radiolabel1ed C18 Fatty
Acids and Normal Cells.
The cell types selected for dosage with radio1abe11ed 
C18 FA's were adherent fibroblasts derived from lung, 
skin and adipose tissue from each species, cultured from
resuscitated frozen stocks (2.2,1.9), These cells were 
subsequently trypsinised, seeded, at 1.0x10s cells/ml 
growth medium in 75cm2 .flasks and incubated for 24 hours 
at 37°C in an atmosphere of 5% carbon dioxide:95% air. 
The cultures were subsequently dosed either with 2juCi 
C1^C3-18:lw9, C14C3-18:2w6, or C14CT-18:3w3 together 
with unlabelled 18:lw9, 18:2w6 or 18:3w3, respectively,
all bound to sufficient albumin to act as carrier. The 
final FA concentration was 20mg/l. Cultures were then 
incubated for a further 48 hours, afterwhich the spent 
medium was carefully removed, centrifuged at lOOOxg for 
10 minutes in a Beckman TJ-6 centrifuge, and stored at 
-20°C. The cells were trypsinised, and the resulting 
pellet combined, as before, with any obtained from 
centrifugation of the spent incubation medium. Cells 
were washed 3 times with physiological saline, and the 
supernatants from each washing pooled together and 
stored at -20°C. The final cell pellet was resuspended 
and swollen in 2.0ml of a solution at pH 7.4 containing
ImM NaHC03> 2mM CaCl2 and 5mM MgCl2, and frozen to -20°C 
to lyse the cells. Lysed cells were stored at -20°C
until further analysed.
Aliquots (lOOjul) of homogenised cell suspension, spent 
media and pooled washings from each normal cell type 
dosed with each radiolabel1ed FA were placed into 
separate 20ml glass scintillation vials with 10.0ml 
Aquagel I scintillation cocktail, and the radioactivity 
of each fraction measured as described in 2.2.8.1.
The remaining cell suspensions were extracted for total 
lipid (2.2.6.1) and methylated (2.2.7.1), with aliquots 
of sample taken at each step of the methodology for 
analysis of radioactivity to account for any loss of 
total radioactivity which may have occured. The 
resulting FAME's were subsequently concentrated to 50jul 
in petroleum ether, and analysed by injecting 2jll of 
this solution into a SP-2330 GLC column, connected to a 
GRC Radioactive Flow Detector (FIo-0ne\Beta) having a 
split ratio of 1:1 and a detector cell size of 5.0ml. 
Radioactivity was detected utilising the 14C channel 
over a run period of 35 minutes. Quantitation of the 
peaks was made using an Acer 500+ personal computer and 
Epson LX-800 printer, and peaks identified by comparison 
with retention times of known FA standards.
Control and dosed cell samples were analysed, with 
random samples re-analysed to obtain a measure of 
reproducibi1ity between runs. Standards and blanks were 
run in parallel under identical conditions to obtain a 
measure of efficiency of the instrument.
2.2.9 Lipid Peroxide Quantitation.
The thiobarbituric acid (TBA) reaction, described by 
Gavino et al (1981c), is a commonly employed method for 
the detection of peroxidation of unsaturated lipids. It 
is dependant on the development of a red pigment 
resulting from the reaction of TBA with oxidised lipids 
and products such as malondialdehyde (MDA). Cells and 
their corresponding spent growth media at each of the 
p-oil concentrations supplemented in 2.2.4 were assayed 
seperately for MDA-equivalent material by adding 2.0ml 
of 20% trichloroacetic acid (w/v) to 2.0ml spent medium 
or to 200jul homogenised cell suspension (from 2.2.4.3) 
in 1.8ml PBS (pH 7.4). To this was added 4.0ml of 0.67% 
TBA (w/v), followed by incubation of this mixture for 20 
minutes at 97°C and subsequent centrifugation at 12000xg 
for 10 minutes at 4°C in a Beckman J2-21 centrifuge. The 
absorbance of the supernatant was measured in a LKB 
Biochrom Ultrospec 4050 at 532nm using 1cm quartz cells, 
with new incubation medium and PBS (pH 7.4) used as 
reference for spent growth media and cell samples, 
respectively. Absorbances were translated to nmoles MDA 
from a standard graph produced using 1,1,3,3-tetra- 
methoxypropane assayed in parallel with the samples, and 
results expressed as nmoles MDA/1.0x10s cells for both 
the spent incubation medium from which these cells were 
obtained and the cell samples themselves. The efficiency 
of the TBA assay was also determined.
2.2.10 Eicosanoid Quantitation.
The procedure used for the 
was based on the method 
(1984).
quantitation of eicosanoids 
described by Rydzik et al
2.2.10.1 Eicosanoid Extraction.
10.0ml aliquots of the cell lipid stock extracts from
2.2.6.1 were placed into clean glass vials and dried at 
37°C under a stream of nitrogen gas. Samples were 
reconstituted with 0.5ml chioroform:ethyl acetate (85:15 
v/v) and applied onto a l.Og chloroform pre-equi1ibrated 
LH20 column. The column was washed sequentially with 
three 1.0ml volumes of chioroform:ethyl acetate (85:15 
v/v), followed by 10.0ml chloroform (to elute FA's). 
Eicosanoids were eluted by washing the column with 
10.0ml HPLC grade methanol and collected in new glass 
vials. Samples were gassed with nitrogen and stored at 
-20°C until HPLC analysis.
2.2.10.2 Eicosanoid Analysis.
All HPLC analyses were performed as one group to 
eliminate between-batch variations. Prior to analysis, 
eicosanoid samples from 2.2.10.1 were concentrated by 
reducing their volume to dryness at 37°C under a stream 
of nitrbgen gas and subsequently redissolved in 1.0ml 
HPLC grade methanol added down the sides of the vial .
Each sample was filtered through a 0.45jum filter into a 
new 7.5ml glass vial, this again taken to dryness, and 
the eicosanoids finally redissolved in lOOjul HPLC grade 
methanol. Eicosanoids were separated by injecting 30jul 
aliquots of this solution into a 100mm x 8mm ID Ci8 
column, and separation continued for 40 minutes. The 
HPLC running buffer (mobile phase) was 2mM NH4(_|2pQa 
buffer (pH to 4.2 with 0.0174M H3Pq4};acetonitri1e 
(69:31 v/v). New HPLC running buffer was made each day, 
filtered through a 0.22,um Millipore filter and degassed 
for approximately 10 minutes before use. HPLC running 
buffer was delivered from a reservoir, at a flow rate of 
1.0ml/minute, via a LKB 2150 HPLC pump to the injector 
equipped with a 20,ul sample loop.
Absorbance detection of eicosanoids at 192nm was 
accomplished using a Walters Millipore Lambda-Max 481 LC
r
Spectrophotometer with variable wavelength adjustment 
capability. Sensitivity on the detector was adjusted to 
2.0 absorbance units full scale (a.u.f.s.). Absorbance 
changes were quantitated using a Hewlett Packard 3390A 
integrator. Eicosanoid identification and quantitation 
was accomplished by comparison with the retention times 
and peak areas of standard eicosanoids (PGl2 > TXB2 ,
PGFz*, PGEi , PGE2 and PGD2) run under identical 
conditions in known concentrations.
2.2.11 Statistical Analyses.
Results were analysed by standard statistical 
techniques, and included calculation of means, standard 
deviations (S.D.), standard error of the mean (s.e.m.), 
percentages and analysis of variance. These calculations 
were performed or\ an Apple lie microcomputer utilising
custom written software.
2.3 Observations. Justifications and the 
Efficiencies of Methodologies Employed.
2.3.1 Normal Cell Grouth in Culture.
The cells isolated from the tissues/organs in 2.2.1.5 
required less than 12 hours to attach to the culture 
vessel after initial plating and incubation. Plating 
efficiency of primary isolated cells was generally >50% 
after 3 hours initial incubation, and the proportion 
increased up until about the twelfth hour, as was also 
found by Tompa et al (1979). Thereafter, any unattached 
cells would not adhere to the culture vessel, even with 
further incubation. Light microscopy showed that most 
fibroblast-like cells adhered to the culture vessel 
within the first 6 hours after plating, followed by 
attachment of more epithelial-1 ike cells.
Erythrocytes and lymphocytes isolated from each species 
were maintained in culture over a 48 hour period, while 
all cells derived from primary cultures proliferated 
in vitro under the conditions described in 2.2.1. 
Table 2.3.1.1. lists the mean population doubling times 
calculated for each adherent cell type cultured, seeded 
at l.OxlO5 cells/ml growth medium in 2cm2 multiwell 
plates and incubated for 72 hours at 37°C in an 
atmosphere of 5% carbon dioxide:95% air. Cells derived 
from rat lung exhibited the fastest (66±5hrs), and human
The population doubling times of normal rat, cat and 
human cells, seeded at lOxlO1* cells/ml growth medium and 
cultured in 1.0ml DMEM+10% FCS for 72 hours at 37°r in 
2cm2 multiwell plates, expressed as meanls.e.m.
11
! Tissue
Population doubling time (hrs) 11111
1♦
Rat 
(n=10)
Cat
(n=10)
Human ! 
(n=10) :
11
! Adipose 11
CD 00 i+ Ul 131±11
1111111«
! Brain1i
70±6 124±12
111i11
t1
I Endothelium
11
125±7 110±6
11111111
! Lung1»
66±5 77±5
1
6917 :1111
! Muse 1e 1 1
103±11 8419
11
I4i±i2 :111l
I Skin 1 1 l 1
9616 77±8
1
7518 !11
11
muscle the slowest (141±12hrs), growth rate. The data 
in Table 2.3.1.1. compared favourably with 1iterature 
reports for similar cell types (eg. Tompa et al 1979, 
Uicha et al 1979, Dugail et al 1986 and Vignikin et al 
1989), and indicated that population doubling times 
varied with different cell types within a species and 
between similar cell types from different species.
The rate of cell proliferation in vitro was dependant, 
to a certain extent, on cell size for a particular cell 
type. Given the same surface area and cell number 
seeded, 1arger cells grew slower than cells of a smaller 
size, eg. human muscle and rat lung, respectively, 
because their growth became contact-inhibited far more 
quickly than smaller cells. Hence, cell size and the 
surface area available for growth (ie. cell density) are 
important factors contributing to the rate of cel 1
proli feration.
2.3.2 The Total Protein Content of Complete
Incubation Media.
The results obtained from the quantitation of total 
protein in DMEM+10% FCS, DMEM+10% RS, DMEM+10% CS and 
DMEM+10% HS are shown in Table 2.3.2.1.
Medium total protein concentrations ranged from 
7.2±0.9g/l for DMEM+10* FCS to 7.7±0.2g/l for DMEM+10* 
CS. Analysis of variance showed no statistically 
significant difference between the protein
concentrations of the 4 types of complete incubation 
media (F=4.667, p=0.1). Thus any differences in cell 
proliferation when rat, cat and human skin fibroblasts 
were grown in 2.2.3.3 in DMEM supplemented with 10^ 
RS, CS or HS, respectively, compared to FCS, would not 
be relatable to medium protein concentrations.
The total protein content of complete incubation media, 
expressed as g/1 growth medium (mean±s.e.m.).
Comp 1ete 
Incubation 
Medium
Protein content (g/1) 
(mean±s.e.m.) 
(n=3)
DMEM + 10SS FCS 7.2±0.9
DMEM + 10* RS 7.5±0.7
DMEM + 10?S CS 7.7±0.2
DMEM + 10SS HS 7.6±0.3
Uith the GLC column and running conditions employed in 
2.2.7.2, 20:lld9 co-chromatographed with 18:3w3. Peaks
coinciding with the retention time for both FA's were, 
however, reported as 18:3w3 since 20:1uj9 occurs rarely.
2.3.3.1 The Fatty Acid Spectra of Natural Oils
and of Potential Oil Sources.
The FA compositions of commercially available olive oil 
(00), sunflower seed oil (SSO), linseed oil (L0), 
evening primrose seed oil (EPO), fish oil (F0), and 
lipids (oils) extracted from coconut (CO) and meat 
(MO), were determined as described in 2.2.6. The FA 
spectra of these 7 plant or animal derived oils are 
listed in Table 2.3.3.1., expressed as a percentage of 
the total area recorded.
Each oil exhibited a unique FA composition, and supplied 
large amounts either of w3, u6 or cj9 series unsaturated, 
or saturated, FA's. Noteworthy amounts of 10:0 and 12:0 
were found only in CO ( 5 . 6 % and 5 3 . 1 % , respectively), 
uith significant levels of 14:0 in M0, CO and F0 (61.2%, 
2 7 . 3 % and 1 2 . 9 % , respectively). 16:0 proportions were
fairly consistent between oils, and ranged from 5 . 7 % to 
11.1?*. A small amount of 17:0 was detected only in CO 
and M0 (1.4% and 6 . 9 % , respectively), and all oils 
contained <3.0% 18:0. 18:lw9 levels ranged from 5.3% in
The fatty acid spectrum of 7 natural oils are shown. All 
values are tabulated as relative percent total area. 
Values are reported as mean±s.e.m., where "n" is the 
number of experiments.
FATTY ACID CO MO 00 sso LO EPO FO
SPECTRUM (n = 3 ) <n=3) (n=3> (n = 3 ) (n = 3 ) (n = 3 ) Cn=3>
____ m
10:0 5.610.31 - - -
12:0 53.1i2.00 - - - - 0.110.03 0.610.03
S 14:0 27.3+0.60 61.211.29 0.210.03 0.810.05 0.310.05 0.210.03 12.910.75
A
T 16:0 6.8+0.40 5.710.37 11.110.15 7.2+0.30 7.010.60 6.810.13 10.910.90
U
R 17:0 1.4±0.03 6.910.37 _ - - - _
A
T 1B:0 0 .6 ± 0 .05 2.710.15 0.2+0.03 1.610.10 1.010.10 1.710.09 0.610.05
E
S. 20:0 - - - - - -
22:0 - - - - - - -
24:0 - - - - - - -
M
0 16:1 - - - - - _ 30.5+1.90N
0. 18:1 5.310.15 1 1 . H 0 . 3 0 70.413.65 20.010.20 1 1 . 5 H . 1 5 8.710.12 1 3 . 0 H . 0 5
18:2 0. H O . O O 7.910.25 1 5 . 8 H . B 0 70.511.10 17.9il.40 72.510.22 10.710.45
18:3 - - _ _ _ 9 . H 0 . 2 9
u6
P
20:2 0.110.00 - 1.9+0.20 - - 0 . H 0 . 0 3 0.510.01
0 20:3 - 0.1+0.05 0.210.05 0.110.05 _ 0.310.05
L
Y 20:4 - 2.0+0.14 - - - - 0.210.01
S.
22:4 - 0.110.03 - - - 0.4+0.05 0.110.00
22:5 - 0 . H O . O O - - - - 0.210.01
18:3 - - - - 62.310.45 - 0.710.05
u3 18:4 - - - - - - 0.910.03
p 20:4 - _ _ _ _ _ 0.1+0.03
0
L 20:5 - 0.110.00 - - - - 1 7 . 7 H . 0 0
Y
S. 22:5 “ 0.310.02 - - - - 0 . U 0 . 0 3
22:6 - 0.110.00 - - - - 0.3+0.01
The fatty acid spectrum of 7 natural 
oils. 
expressed as
CO to 70.4% in 00, while the highest 18:2w6 levels 
occurred in EPO (72.5%) and SSO (70.5%), and the lowest 
in CO (0.1%). Only EPO, L0 and M0 provided significant 
amounts of 18:3w6, 18:3w3 or 20:4io6, respectively (9.1%, 
62.3% and 2.0%, respectively), while significant 16:lw9 
and 20:5w3 proportions occured only in FO (30.5% and 
17.7%, respectively). F0 was significantly low in 
22:6w3, whereas higher levels have been reported abroad 
(eg. McCance et al 1978). This reflected the lower 
content of 22:6w3 in local compared to foreign FO's, 
which the 1iterature confirms (McCance et al 1978 and 
Giangregorio et al 1988a).
2.3.3.2 Pseudo-Oil Fatty Acid Composition.
The data in Table 2.3.3.1. was used to prepare p-oil 
stock solutions from individual FFA^s in ethanol. FA's 
were only included in a p-oil if such contributed >0.5% 
to the total spectrum. p-0il FA composition was checked 
by GLC, and the results listed in Table 2.3.3.2. p-0il 
FA composition mimicked that of the natural oils, and 
was within ±1S.D. of the data in Table 2.3.3.1.
Pseudo-oil fatty acid spectra are tabulated as 
percent total area detected.
relatiue
FATTY
ACID
SPECTRUM
C4)
PSEUDO-OILS
CO MO 00 sso LO EPO FO
10:0 5.6 _ ■ _ _
12:0 53.1 - - - - - 0.6
14:0 27.3 62.7 - 0.8 - - 13.0
16:0 6.8 5.8 11.2 7.2 7.0 6.9 11.0
17:0 1.4 7.1 - - - - -
18:0 0.6 2.8 — 1.6 1.0 1.7 0.6
Total sats. 94.8 78.4 11.2 9.6 8.0 8.6 25.2
16:lu9 30.8
18:lu9 5.3 11.4 71.0 20.0 11.5 8.8 13.1
Total mono. 5.3 11.4 71.0 20.0 11.5 8.8 43.9
18:2u6 8.1 15.9 70.4 18.0 73.4 10.8
18:3u6 - - - - - 9.2 -
20:2u6 - - 1.9 - - - 0.5
20:4u6 2.1 — — — — -
Total poly. - 10.2 17.8 70.4 18.0 82.6 11.3
18:3u3 62.5 0.7
18:4u3 - - - - - - 0.9
20:5u3 — — — — — — 17.9
Total poly. - - - - 62.5 - 19.5
Dry Ueight of Complete Incubation Media.
The results obtained from the analysis of FA's and 
quantitation of total lipids in DMEM+10% FCS, DMEM+10% 
RS, DMEM+10% HS and DMEM+10% CS are shown in Table 
2.3.3.3., and were carried out to determine their 
possible contribution to the data obtained with cells.
Large proportions of 14:0 were present in all incubation 
media, ranging from 97.9% to 98.7%. Of the remaining 
FA's detected, 17:0 contributed 1.4%, 0.9%, 0.8% and 
0.6% in DMEM containing 10% FCS, RS, CS or HS, 
respectively, while 16:0, 18:0, 18:lu9, 18:2w6, 20:4w6 
and 22:4u6 contributed i0.5% each. Hence, the FA 
compositions of the 4 types of complete incubation media 
were similar, irrespective of the source of serum 
concerned.
Total medium lipid concentrations ranged from 0.56g/l 
for DMEM+10% FCS to 0.76g/l for both DMEM+10% RS and 
DMEM+10 % CS. Variance analysis showed no statistically 
significant difference between the lipid contents of the 
4 types of complete incubation media (F=121, p=0.001). 
Thus any differences in cel 1 proliferation when rat, 
cat and human skin fibroblasts were cultured in DMEM 
supplemented with 10% RS, CS or HS, respectively, 
compared to FCS (2.2.3.3), would not be relatable to 
medium lipid concentrations.
Fatty acid values ar~e tabulated as relative percent 
total area. Medium 1ipid amounts are expressed as grams 
total lipid per litre of culture medium. All values are 
reported as mean±s.e.m. , where n" is the number of
experiments.
The fatty acid spectrum and total lipid content of complete 
incubation medium, expressed as mean±s.e.m.
FATTY ACID 90% DMEM 90% DMEM 90% DMEM 90% DMEM
SPECTRUM + + + +
(%) 10% FCS 10% RS 10% HS 1 0 % cs
(n=3) (n=3) ( n = 3 ) ( n = 3 )
11
S ! 10 :0 _ _
A ! 12 :0 - - - -
T : 14 :0
ino•o+1•COCN 9 8 .5 ± 0 .1 5 9 7 . 9 ± 0 .19 9 8 . 7 ± 0 .21
U : 16 :0 - 0 . 1 ±0 .02 0 . 3 ± 0 .03 -
R : 17 :0 1 . 4 ± 0 .03 0 . 9 ± 0 .11 0 . 6 ± 0 .03 0 .8 ± 0 .0 7
A : 18 :0 - - 0 .2 ± 0 .0 3 0 . 2 ± 0 .09
T ! 20 :0 - - - -
E ! 2 2 :0 - - - -
S ! 24 :0ii
— — —
ll
u9  ! 14 :1 _ _ _ _
M ! 16 :1 - - - -
0 ! 18:1 0 . 1 ± 0 .0 3 0 .1 ± 0 .0 2 0 . 3 ± 0 .03 0 .1 ± 0 .0 0
N ! 20 :1 - - - -
0 ! 22 :1 - - - -
S . : 24 :1
ii
— —
lt
! 16 :2 _ __ _
u6 ! 18 :2 - 0 .1 ± 0 .0 2 0 . 5 ± 0 .07 0 . 2 ± 0 .03
P ! 1 8 :3 - - - -
0 ! 2 0 :2 - - - -
L ! 2 0 :3 - - - -
Y ! 2 0 :4 - 0 .1 ± 0 .0 0 0 .1 ± 0 .0 0 -
S . l  2 2 :4 - 0 . 1 ± 0 .02 0 . 1 ± 0 .0 3 O. l iO .O O
! 2 2 :5
li
— — — —
»l
u>3 ! 18 :3 _ _
P ! 18 :4 - - - -
0 ! 2 0 :4 - - - -
L ! 2 0 :5 - - - -
Y ! 2 2 :5 - — v - -
S . ! 2 2 :6
1i
— — — —
LIPID
WEIGHTS 0 . 56 ±0 .02 0 . 76 ±0 .04 0 . 5 8 ± 0 .02 0 . 7 6 ± 0 .06
( g/1 )
In all work conducted using radiolabel1ed FA's, the 
total counts detected (as cpm) for control samples 
approximated to that of the background.
2.3.4.1 Incorporation of C14n~18:2w6 with Time.
Benign 3T3 cells were incubated with 2,uCi C14CD-18:2u6 
for 6, 24 and 48 hours to determine whether sufficient 
radiolabel would be present in the cells for further 
analysis. The radioactivity recovered from the cells and 
corresponding spent incubation media are shown in Table
2.3.4.1. Over the time period used, there was a 
consistent increase in detection of radiolabel in the 
cells, with 5.4% of total counts detected incorporated 
at 6hrs, 23.3% at 24hrs and 49.6% at 48hrs, representing 
an uptake of approximately 1% per hour. In contrast, 
the amount of radioactivity detected in the spent 
incubation medium decreased consistently with increased 
incubation time. At 6 hours, 80.3% of total counts dosed 
were recovered, and this dropped to 59.7% and 37.3% 
at 24 and 48 hours, respectively. Significantly more 
radioactivity was detected in the spent incubation 
medium than in the cells at 6 and 24 hours, whereas the 
amount of radiolabel detected in the cells and spent 
incubation medium at 48 hours were approximately equal 
(1719951cpm and 1750940cpm, respectively). Total counts
The radioactivity ( c p i t i )  recovered from 3T3 cells and the 
spent incubation medium dosed with 2uCi C 1 aQ1-18: 2u)6 . 
expressed as mean (is.e.m.)i n=3.
FRACTION
COUNTED
INCUBATION TIME
6hr 24hr 48hr
CELLS 214335 850914 1719951
(±1212) (±819) (±5574)
INCUBATION 3774320 2805060 1750940
MEDIUM (±6400) (±16520) (±15780)
TOTAL 3988655 3655974 3470891
Total 18:2 counts dosed to medium = 4.7 x 106
recovered also decreased with incubation time, although 
a fair proportion (about 0.5xl06Cpm) of this loss was 
accounted for in the washing solutions, possibly due to 
non-specific binding. The data presented nevertheless 
indicates that incubation of cultures with 2juCi 
radiolabel1ed FA for 48 hours will yield sufficient 
radiolabel in the cells for reliable detection and 
quantitation.
2.3.4.2 Efficiencies of Radiolabel1ed Studies.
2.3.4.2. a Efficiency of the Lipid Extraction and
Fatty Acid Methylation Procedures.
The procedure for lipid extraction from cell samples 
dosed with radiolabel1ed FA's in 2.2.8.2 was monitored 
to determine whether the technique, at any step, was 
responsible for a loss of radioactivity. Upon washing 
the lipid extracts in chioroform:methanol with saline, 
insignificant amounts of radioactivity (0.03^) were 
detected in the upper phase compared to the lower lipid 
phase. Monitoring methylation steps similarly showed no 
significant loss of radioactivity.
2.3.4.2. b Efficiency of Scintillation Counter.
The efficiency of the scintillation counter in detecting 
E14C3~label was determined. Repeated analysis using 
known C14C3—standards showed counter efficiency to be
97*. The manufac turers state that EiaC0 counter
efficiency is at 1 east 90*. Since every step in
biological sample preparation a1 ways involves up to
about 5* 1oss or error, the recovery obtained was
acceptable.
2.3.4.2. c Efficiency of Radiomatic Flow Counter.
The manufacturers specifications state a 10* counting 
efficiency, which was confirmed in situ.
2.3.5 The Thiobarbituric Acid (TBA) Assay.
2.3.5.1. Sensitivity and Specificity.
The TBA reaction measures the amount of MDA formed as a 
breakdown product of FA peroxidation and eicosanoid 
biosynthesis (Flower et al 1973, Mead 1976, Pryor 1976, 
Tappel 1980 and Witting 1980). Studies have shown that 
MDA is the aldehyde that is most reactive with TBA 
(eg. Esterbauer et al 1982). Although MDA detection has 
been widely used both in vivo (Tappel 1975) and in vitro 
(Gray 1978) for the detection of lipid peroxidation, the 
reaction is, unfortunately, not specific for MDA, and 
several compounds other than MDA (eg. metal ions) give 
positive results (Tappel 1980 and Nair et al 1984). The 
quantitative evaluation of MDA is further complicated by 
its rapid binding to proteins (Draper et al 1986). Thus, 
despite the sensitivity of the assay, the results should 
merely be interpreted as a crude indication of the 
overall level of lipid peroxidation. Measurement of TBA- 
reactive material (TBARM) nevertheless continues to be 
the most widely used assay in studies involving lipid 
peroxidation (Gavino et al 1981c, Liepkalns et al 1982, 
Morisaki et al 1982b, Begin et al 1986a and Girao 1988).
2.3.5.2 Determination of the Efficiency of the 
TBA Assay.
A random medium sample from those assayed in 2.2.9, 
containing a known amount of MDA, was selected. The 
sample contained 83nmoles MDA, or 3.32nmoles MDA/2ml 
assayed. To 2.0ml of this sample was added a volume of 
1,1,3,3-tetramethoxypropane solution (at 5000nmoles/2ml) 
corresponding to the equivalent MDA concentration of the 
sample (ie. 3.32nmoles/2ml). Samples were assayed by the 
method described before in parallel with standards and 
controls. The efficiency of the TBA assay was determined 
as foilows:
Theoretical CMDAD = known CMDAJ in sample + CMDAD added
= 3.32nmoles/2ml + 3.32nmo1es/2ml 
= 6.64nmoles.
Recovered CMDA3 (mean ± s.e.m., n=6) from standard curve
= 6.634 ± 0.368nmoles MDA/2ml.
Efficiency = assayed amount 
known amount
= 6.634 
6.640
= 99.9*
Thus, the assay showed a 99* efficiency in this 
1aboratory.
2.3.6 E icosanoid Analyses.
With the HPLC column and running conditions employed in
2.2.10.2, PGFiq, co-chromatographed with PGF2ft. Peaks 
coinciding with the retention time for both PG's were,
therefore, reported either as PGFlQc + PGF2ot, or merely 
as PGFft.
CHAPTER 3: THE RAT; RESULTS AND DISCUSSION.
ERYTHROCYTES.
3.1.1 Effects of pseudo-Oils on Cell Viability.
Microscopic examination showed the rat erythrocyte 
cultures to be free of platelet or white blood cell 
contamination. Although most erythrocytes retained their 
biconcave disc shape, some lost this characteristic 
after 48 hours in culture. About 50^ of rat erythrocytes 
also lost their distinct "red" colour after 2 days in 
culture, and thus became difficult to visualise. Only 
those erythrocytes which retained their pigmentation 
were hence regarded as viable, normal and representative 
of the situation in vivo.
The effect of albumin, with final medium concentrations 
ranging from 0 to 250mg/l, were investigated on rat 
erythrocyte viability. The results showed no significant 
changes in cell viability with dosage of up to 250mg 
albumin/1 culture medium, nor were any synergistic 
effects observed (Fig. 3.1.1.1.). The effects induced 
with exogenous p-oil dosage were therefore a result of 
the FA's in the p-oil mixture and not the albumin used 
as FA carrier.
Since erythrocytes do not divide and did not require 
trypsinisation, no 24 hour post-trypsinisation recovery
Legend to Figs. 3.1.1.1-3.1.1.8.
The results are expressed as mean percent cell 
viabi1ity±standard error of the mean (s.e.m.), where *n‘ 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.1.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 3.1.1.2-3.1.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1).
A1bumin 
Concentration 
< mg/1 )
Mean ±s.e.m. n
0 100.0 3.0 12
25 101.6 5.1 12
50 95.1 4.7 12
75 98.9 6.6 12
100 101.6 5.9 12
125 95.9 4.0 12
150 100.6 4.8 12
175 96.1 5.2 12
200 91.2 7.0 12
225 98.6 6.3 12
250 94.1 5.6 12
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 5.9 6
10 78.7 6.0 6
20 108.6 6.4 6
30 180.4 7.0 6
40 199.8 7.1 6
50 174.1 6.5 6
60 124.1 3.8 6
70 62.2 6.2 6
80 42.3 5.3 6
90 40.4 7.2 6
100 7.7 00• 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.7 6
10 95.0 5.5 6
20 94.4 5.4 6
30 81.1 2.8 6
40 41.2 3.4 6
50 25.0 1.5 6
60 18.6 0.8 6
70 16.8 1.0 6
80 10.3 0.9 6
90 7.6 0.6 6
100 7.6 0.6 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 5.8 6
10 99.0 7.0 6
20 83.1 5.6 6
30 66.2 3.1 6
40 75.9 4.5 6
50 68.4 4.5 6
60 15.8 2.5 6
70 1.9 0.4 6
80 0.1 0.0 6
90 0.0 0.0 6
100 0.0 0.0 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m . n
0 100.0 6.0 6
10 63.2 2.3 6
20 37.2 1.9 6
30 45.5 2.5 6
40 38.8 1.0 6
50 18.7 4.2 6
60 1.5 0.2 6
70 4.1 0.7 6
80 4.9 0.9 6
90 4.4 1.0 6
100 8.5 1.1 6
Fig .  3«1.1.6
pseudo-Oil Mean ±s.e.m. n
Concentration 
(mg/1)
0 100.0 3.6 6
10 6.2 0.4 6
20 9.8 0.7 6
30 19.3 1.7 6
40 22.8 2.5 6
50 22.3 2.9 6
60 11.5 1.2 6
70 13.9 2.2 6
80 7.6 2.0 6
90 1.8 0.7 6
100 0.0 0.0 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 4.4 6
10 64.7 3.5 6
20 29.2 1.5 6
30 27.5 1.0 6
40 12.4 2.0 6
50 4.3 0.3 6
60 3.0 0.3 6
70 3.5 0.4 6
80 3.6 0.3 6
90 2.3 0.2 6
100 2.3 0.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 6.1 6
10 70.3 5.6 6
20 34.3 4.6 6
30 38.2 4.4 6
40 40.0 4.1 6
50 10.6 1.6 6
60 2.7 0.4 6
70 1.3 0.3 6
80 0.5 0.2 6
90 0.3 0.1 6
100 0.0 0.0 6
immediately subsequent to plating. Thus the seeding 
concentration was the cytostatic number.
All p-oils exhibited cytotoxic potential when incubated 
with rat erythrocytes (Figs. 3.1.1.2-3.1.1.8.). However, 
p-oils containing significant amounts of PUFA's, viz. 
p-FO, p-EPO, p-LO and p-SSO, induced greater cyto­
toxicity than p-oils rich in monounsaturated (p-00), or 
saturated (p-MO and p-CO), FA's.
p-CO increasingly induced cell stabilisation in the 
range 20 to 40mg/l (Fig. 3.1.1.2.). Ulith 40mg/l p-CO, 
erythrocyte morphology was maintained, all cells 
retained their biconcave disc shape and characteristic 
'red' colour, thus cell viability was about 100% of that 
initially plated. Concentrations between 40 and 70mg/l 
p-CO progressive1y lowered the number of morphological1y 
normal cells to control levels, while greater amounts 
induced considerable cytotoxocity, and relative cell 
viability was 7.7% with 100mg/l p-CO. The ID50 for p-CO 
was about 75mg/l, the highest value calculated for any 
p-oil dosed to rat erythrocytes.
Supplementation with p-MO or p-00 induced intermediate 
effects compared to other p-oils. Relative cell 
viability paralleled controls with low concentrations, 
followed by a dramatic reduction in viability with 
concentrations between 20 and 70mg/l (Figs. 3.1.1.3. and 
3.1.1.4., respectively). About 38mg/l p-MO and 53mg/l
P-00 killed 50* of cells (ID50)> while I00mg/1 
reduced viability to 7.6* and 0*, respectively.
p-oi 1
p-Oils containing significant amounts of PUFA's induced 
the greatest concentration dependent cytotoxic effects 
(Figs. 3.1.1.5-3.1.1.8. ). p-SSO, p-EPO and p-FO induced
similar effects, having ID5o values in the range 14 to 
16mg/l. Concentration dependent cytotoxicity with p-LO 
dosage was most dramatic, evident by the very low ID50 
(approximately 5mg/l). p-SSO, p-LO, p-EPO and p-FO 
concentrations greater than 20mg/l caused further 
reductions in viability, but with a more gradual effect. 
Cell viability with 100mg/l p-oil was 8.5* and 2.3* for 
p-SSO and p-EPO, respectively, while no viable cells 
were seen with this concentration of p-LO or p-FO.
Subsequent to these studies, rat erythrocytes were 
plated and dosed appropriately with 0, 20, 40 or 60mg 
p-oil/1 culture medium in sufficient quantities for all 
quantitative and qualitative analyses to be performed. 
Upon harvesting, cell numbers relative to controls were 
compared with those in Figs. 3.1.1.1-3.1.1.8., and were 
found not to be statistically different. All further 
biochemical assays were performed on these samples.
3.1.2 Effects of pseudo-Qils on Total Protein.
Total erythrocyte protein was determined for each of the 
p-oil concentrations dosed and compared with controls. 
Results are shown in Table 3.1.2.1. as jug total 
protein/106 cells seeded.
Control erythrocytes contained 13.0jug protein/106 cells 
seeded. Except for cells dosed with dOmg/1 p-CO, all 
dosed erythrocytes exhibited less total protein than 
controls. Cells dosed with 20mg/l p-00, p-MO or p-CO 
exhibited similar protein levels to controls, compared 
to very low concentrations with 20mg/l p-SSO, p-LO, 
p-EPO or ' p—FO dosage (<5.0jug/106 cells seeded). In 
general, erythrocyte protein concentrations decreased 
with increasing p-oil concentration dosed, so that cells 
supplemented with 60mg/l p-oil exhibited the lowest 
protein levels. The only significant increase in 
erythrocyte protein occurred with dosage of 40mg/l p-CO 
(23.8jug/106 cells seeded); this was the highest protein 
level measured, while the lowest was for erythrocytes 
dosed with 60mg/l p-EPO (0.5jug/106 cells seeded).
The protein content of rat erythrocytes, expressed as jug 
total protein/lQ& r^lls seeded.
pseudo- 
Oi 1
(mg/1)
CELLS
0
11
20 :ii
40 60
Control 13.0
iiiii
CO 12.3 :i 23.8 12.3
MO
i
ii.8 :i 4.8 2.0
00
i
10.1 !1 10.4 1.7
SSO
l
4.5 :1 4.1 0.6
L0
1
1.3 :i 1.8 1.7
EPO
i
3 .3 :i 1.9 0.5
F0
i
3.6 :ii
4.3 0.9
3.1.3 Effects of pseudo-Qils on the Fatty Acid .
Spectrum of Rat Erythrocytes.
Table 3.1.3.1. shows the FA spectra of rat erythrocytes 
closed with 0, 20, 40 or 60mg/l of each of the p-oils. 
FA's contributing 25.0% to the FA spectrum in control 
erythrocytes were 16:0 (16.7%), 18:0 (8.6%), 16:lw9
(5.9%), 18:lw9 (15.3%), 22:4w6 (35.3%) and 20:4u3
(6.0%). Varying amounts of these FA's were found in 
dosed erythrocytes.
16:0 and 18:lw9 proportions in dosed erythrocytes were 
generally parallel to, or greater than, control levels, 
while the opposite was true for 16:lu9. 18:0 percentages 
were more variable, but generally greater in dosed cells 
than controls. Variable amounts of 18:2u6 were also 
present in dosed cultures, but the levels of all other 
u6 and u3 PUFA's detected were generally parallel to, or 
below, control levels.
Erythrocytes dosed with p-C0 showed an increase in the 
major FA components of that p-oil being incorporated 
with concentration. The amount of 16:0 detected 
increased from 36.8% when erythrocytes were dosed with 
20mg/l p-CO, to 52.8% and 52.2% with 40 and 60mg/l p-CO, 
respectively (16.7% in controls). Changes in 18:0 and 
18:lw9 levels were small compared to controls (8.6% and 
15.3%, respectively), and PUFA levels decreased with
p-CO dosage.
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n" is 
the number of experiments. "Cp-OilH" refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of rat: erythrocytes♦
FATTY ACID 
SPECTRUM 
C 4)
CONTROLS
(n=3)
Cp-COD 
(mg/1)
20 ! 40 ! 60
Cp-MOD 
(mg/1)
20 ! 40 ! 60
: Cp-0 0 3
! (mg/1)
: 20 : 40 i 60
Cp-SSOD 
(mg/1)
20 1 40 ! 60
CP-L03 
(mg/1)
20 ! 40 ! 60
Cp-EPOH 
(mg/1)
20 40 ! 60 20
Cp-foii
(mg/1)
! 40 ! 60
S
A
16:0 16. 7±0.45 36.8 52.8 52.2 34.9 33.8 29.1
ii
15.2 15.4 20.3 19.3 17.3 25.0 21.7 16.9 31.6 20.3 33.4 28.2 33.3 26.0 18.7
T
u
18:0 8.6±0.60 7.7 8.8 9.0 10.5 12.1 13.3 3.4 6.5 5.4 9.4 12.2 8.7 14.1 10.0 9.3 10.9 13.5 10.4 4.9 2.6 1.3
R
A
20:0 0.2±0,10 - 0.1 0.1 - - - 0.2 0.4 - - 0.4 - - 0.4 - - 0.1 - - - -
T
E
22:0 0.3±0.05 0.1 - 0,1 0.3 0.1 0.1 0.2 - - 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 - - -
S. 24:0 0.7 0.5 1.0 1.0 0.7 1.0i 2.6 0.5 0.8 1.5 0.8 1.0 2.2 0.4 0.4 - 1.3 - - -
u9
M
16:1 5.9±0.05 - - 0.9 0.5 0.7 1.5 1.1 1.1 5.7 0.9 2.0 4.9 1.4 0.9 4.6 1.2 1.6 1.8 18.8 32.2 32.0
0
N
18:1 15.3±0.05 15.0 19.4 18.5 9.4 13.2 13.7 33.7 35.2 38.8 22.5 20.0 20.4 16.1 17.5 19.0 13.9 22.3 22.0 18,9 21.8 21.9
0
S.
24:1 — - - — — “ — - - - - - - - - . - - - - ! - -
18:2 3.9±0.00 *4.4 0.8 0.8 3.2 3.8 3.1 2.5 2.9 2.0 10.5 5.9 6.2 2.0 2.7 3.0 9.4 18.8 27.7 5.1 8.2 10.5
u6
18:3 - - - - 0.2 0.1 0.1 - - - - - - - - - - 0.4 1.2 - - -
p
20:2 1.0±0.00 - - - - 0.1 - - 0.7 0.1 - - - - - - - 0.1 - 0.3 0.8 1.1
0
L
20:3 1.2+0.05 0.6 0.1 0.4 1.3 0.1 0.6 0.8 - 0.1 0.6 - - 1.1 - 0.5 - - 0.2 - 0.1 0.1
Y
S.
20:4 0,8±0.05 0.4 0.4 0.4 • 0.4 1.0 - 0.1 - - 0.1 - - 0.1 - - 0.3 0.1 0.3 0.2 0.3
22:4 35.3±0.05 34.3 14.4 15.1 35.3 30.6 33.5 35.1 28.8 23.6 31.7 34.1 30.7 34.6 38.2 26.3 39.5 6.9 5.4 15.5 2.9 4.9
22:5 3.9±0.55 — 0.2 — — 1.5 0.2 - 3.5 0.2 0.2 2.8 0.2 0.4 4.5 0.1 - 0.6 - 0.1 0.2 0.1
18:3 0.3±0.00 - 0.1 0.1 0.2 0.2 0.3 - 0.2 0.1 0.1 0.2 - 0.6 1.1 2.6 - 0.1 - 0.3 0.5 0.8
u3 18:4 0.5±0.00 0.3 0.6 0.2 0.3 0.6 - 0.5 0.7 0.3 0.4 0.4 0.4 0.5 0.8 0.3 0.3 0.4 0.2 0.1 0.1 0.2
P
o
20:4 6.0+0.05 3.6 1.7 1.4 2.9 1.7 2.8 6.2 2.1 2.9 3.6 3.0 2.7 6.3 4.7 2.2 3.9 1.5 0.6 1.7 0.7 0.6
L
Y
20:5 0.3±0.00 0.1 - 0.1 - - - - - - - - - - - - - - 0.7 3.3 7.0
S. 22:5 - - - 0.1 - - - - - - - - - - - - - - - - 0.1 0.1
22:6 —■ — 0.1 — — - — — — — — — _ — — 1 . 0 0 . 1 0 . 1 0.4
34.9%, 33.8% and 29.1% 16:0 was detected when 
erythrocyes were dosed with 20, 40 or 60mg/l p-MO, 
respectively, compared to 16.7% in controls. 18:0 
percentages also increased (10.5%, 12.1% and 13.3%, 
respectively vs 8.6% in controls), but 18:lw9 and PUFA 
levels were parallel to controls, or decreased.
The major component of p-00 was 18:lw9. Uith all p-00 
concentrations dosed, 18:lu9 levels were at least double 
control levels (15.3%), and percentages increased 
slightly with increasing concentration dosed (33.7%, 
35.2% and 38.8%, respectively). A marginal decrease, 
followed by an increase in 16:0 was found in the same 
range (15.2%, 15.4% and 20.3%, respectively), compared 
to controls (16.7%). 18:0 levels ranged from 3.4% to 
6.5% (8.6% in controls), while between 0.5% and 2.6% 
24:0 was found (none in controls). 16:lw9 was decreased 
with 20 and 40mg/l (1.1% each), but parallel to controls 
(5.9%) with 60mg/l (5.7%). However, all PUFA levels 
dropped as the p-00 concentrations dosed increased, 
especially that of 22:4w6 (35.1%, 28.8% and 23.6%, 
respectively vs 35.3% in controls).
16:0 incorporation increased from 19.3% to 17.3% and 
25.0% when erythrocytes were dosed with 20, 40 or 60mg/l 
p-SSO, respectively (16.7% in controls). 18:0 levels 
also increased with 20 and 40mg/l p-SSO (9.4% to 12.2%, 
respectively), but levels paralleled controls (8.6%)
with 60mg/l (8.7%). 24:0 was absent in controls, while 
0.8% to 1.5% was detected in dosed cells. 18:lu9 levels 
dropped slightly from 22.5% to 20.0% and 20.4%, 
respectively with increasing p-SS0 concentrations dosed, 
and only 15.3% was detected in controls. On the other 
hand, 16:lu9 levels decreased to below control levels 
(5.9%) with 20, 40 and 60mg/l p-SSO (0.9%, 2.0% and 
4.9%, respectively). 18:2w6 incorporation amounted to 
10.5% with 20mg/l p-SS0, but dropped slightly to 5.9% 
and 6.2% with 40 and 60mg/l p-SS0, respectively, 
although these percentages were higher than in controls 
(3.9%). Other PUFA levels, however, were not increased.
16:0 levels increased significantly with 20 or 60mg/l 
p-L0 incubation (21.7% and 31.6%, respectively), but 
paralleled control levels (16.7%) with 40mg/l (16.9%). 
18:0 percentages were greater than control levels (8.6%) 
with all concentrations dosed, but decreased as greater 
amounts of p-L0 were dosed (14.1%, 10.0% and 9.3%, 
respectively). 24:0 was absent in controls, but up to 
2.2% was detected in dosed cultures. Ulith 20 or 40mg/l 
p-LO supplementation, 0.6% and 1.1% 18:3w3 was detected, 
respectively, while 18:3w3 levels increased to 2.6% with 
60mg/l, compared to 0.3% for controls. Relative 18:2w6 
levels increased with p-LO concentration dosed (2.0%, 
2.7% and 3.0%, respectively), but were nevertheless 
below control levels (3.9%). Both 22:4w6 and 20:4w3 
percentages approximated to controls (35.3% and 6.0%,
respectively) with 20 and 40mg/l p-LO, but were 
decreased with 60mg/l (26.3% and 2.2%, respectively). 
22:5u6 levels were 4.5% with 40mg/l, but <0.5% with 20 
or 60mg/l p-LO, compared to 3.9% in controls.
A marked increase in 18:2w6 incorporation was observed 
when erythrocytes were dosed with 20, 40 or 60mg/l p-EP0 
(9.4%, 18.8% and 27.7%, respectively, 3.9% in controls). 
18:3w6 was absent in control erythrocytes, but small 
amounts were incorporated when p-EPO dosage increased 
(0%, 0.4% and 1.2%, respectively). There was a marked 
fall in 22:4w6 levels with increased concentration dosed 
(39.5%, 6.9% and 5.4%, respectively, 35.3% in controls), 
with increased 16:0, 18:0 and 18:lu9 levels, compared to 
controls (16.7%, 8.6% and 15.3%, respectively).
The amount of 16:0 incorporated into erythrocytes with 
20 and 40mg/l p-FO was 33.3% and 26.0%, respectively, 
but only 18.7% with 60mg/l, paralleling control amounts 
(16.7%). 18:0 levels were reduced from 8.6% in controls 
to 4.9%, 2.6% and 1.3% with 20, 40 and 60mg/l p-FO, 
respectively. There was, however, a marked increase in 
16:lw9 incorporation (18.8%, 32.2%, 32.0%, respectively 
vs 5.9% in controls), and 18:lw9 levels increased 
similarly (18.9%, 21.8% and 21.9%, respectively vs 15.3% 
in controls). The increase in 18:2w6 was more linear 
(5.1%, 8.2% and 10.5%, respectively, 3.9% in controls). 
22:4u6 proportions were reduced by at least 2 fold 
(15.5%) with 20mg/l p-FO, compared to controls (35.3%),
while considerably lower amounts were found with 40 and 
60mg/l (2.9% and 4.9%, respectively). 0.3% 20:5w3 was 
detected in control cells, but 0.7%, 3.3% and 7.0% when 
20, 40 or 60mg/l p-F0 were dosed, respectively. 22:5u3 
and 22:6w3 were absent from controls, and only trace 
amounts were detected in dosed cells (<0.5%).
3.1.4 Effects of pseudo-Oils on Lipid Peroxide
Format i on.
Lipoperoxide production was measured in rat erythrocytes 
dosed with p-oils and their respective spent media, and 
this compared to controls. Results are shown in Table 
3.1.4.1. as nmoles MDA/106 cells, but in the case of the 
spent media, this represents the nmoles of MDA in the 
volume of medium from which lxlO6 cells were obtained.
No 1ipoperoxides were detected in control erythrocytes. 
Those p-oils which predominantly contained FA's of one 
double bond or less, viz. p~CO, p-MO and p-00, did not 
exhibit a significant change in lipid peroxide formation 
relative to controls. With incubation of 60mg/l p-00, 
however, 1.4 nmoles MDA/10® cells was detected. p—Oils 
containing significant amounts of PUFA's induced greater 
amounts of cellular lipid peroxides, which increased 
markedly with the p-oil concentration dosed, and was 
greatest for erythrocytes incubated with 60mg/l p-FO or 
p-EPO (41.2 and 33.8nmoles MDA/106 cells, respectively).
Lipoperoxides were absent from spent medium in which 
control erythrocytes had been maintained, and in spent 
medium dosed with 20, 40 or 60mg/l p-CO, p-MO or p-00. 
However, spent media from cells dosed with 40 or 60mg/l 
PUFA-rich p-oils generally contained lipoperoxides, and 
the highest amounts measured were with 60mg/l p-EPO and 
p—SSO (41.4 and 43.5nmoles MDA/106 cells, respectively).
Lipid peroxide formation by rat erythrocyte cultures
incubated with p-oils. expressed as nmoles MDA/10& cells.
pseudo­
Oil
CELLS
(mg/1) 0 20 40 60
Control -
CO - - 0.1
MO 0.1 0.1 0.2
00 0.1 0.1 1.4
SSO 2.8 1.9 10.8
L0 0.1 0.6 3.1
EPO 6.9 12.2 33.8
F0 1.7 7.8 41.2
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - -
SSO - 0.9 43.5
L0 - 2.9 -
EPO - 25.5 41.4
F0 0.6 - 16.1
3.1.5 Discussion.
Supplementation of rat erythrocytes with p-oils induced 
hemolysis in every instance (Figs. 3.1.1.1-3.1.1.8.). 
However, the extent of cytotoxicity induced was 
relatable to p-oil PUFA composition (Table 2.3.3.2.), as 
hemolysis was greatest with p-oils rich in PUFA's 
(p-SSO, p-LO, p-EPO and p-FO), and less extensive with 
p-00 and p-MO which contained smaller amounts of PUFA's. 
Furthermore, the stabilisation of erythrocyte membranes 
with dosage of low and intermediate p-CO concentrations 
correlated with the lack of PUFA's in this p-oil. Uhen 
large amounts of p~CO were dosed, the incorporation of 
saturated FA's into erythrocyte membranes may have 
caused rigidification, and this possibly explains the 
hemolysis induced. The similar effects induced overall 
with p-SSO or p-EPO dosage probably relates to the large 
amount of 18:2u6 (about 70%) in these p-oils, while the 
small amount of 18:3w6 (about 9%) in p-EPO only may 
account for the slightly greater cytotoxicity of p-EPO. 
As the concentration of 18:3u3 in p-LO was similar to 
that of 18:2u6 in p-SSO and p-EPO, the significantly 
lower amount of p—L0 than p—SSO or p—EPO required to 
reduce cell viabililty to 50% of controls suggests that 
18:3w3 is more cytotoxic than 18:2u6, and that such 
relates to differences in the number and position of 
double bonds in these C18 FA's. p-FO induced similar 
effects to p-EPO and p-SSO, despite a different FA
composition, suggesting that synergism and/or antagonism 
between p-oil FA's probably also played a role in the 
modulation of erythrocyte viability.
Supplementation of cultures with p-oils induced changes 
in erythrocyte total protein concentrations (Table 
3.1.2.1.) which largely mirrored the changes reported 
in cell viability (Figs. 3.1.1.1-3.1.1.8.). Hemoglobin 
comprises at least 9 5 k of total erythrocyte protein 
(Geigy 1984), thus cell lysis and subsequent loss of 
hemoglobin would be consistent with the marked reduction 
in erythrocyte protein reported with hemolytic p-oil 
concentrat ions.
The effects induced with p-oil supplemenation were 
consistent with reports indicating that FA's modify 
erythrocyte morphology, their ability to change shape 
and to resist hemolysis (Rao et al 1979, Csordas et al 
1984, Cartwright et al 1985 and German et al 1985). 
Csordas et al (1984) investigated the effect of C18 
unsaturated FA's on erythrocyte osmotic resistance, 
and showed that 18:lw9, 18:2u6 and 18:3u3 induced 
hemolysis with concentrations from 0.03 to 80mg/l. With 
3~8mg/l FA, however, 18:lu9 protected erythrocytes from 
rupture, 18:2w6 was much less effective, but 18:3u3 was 
hardly protective at all. These findings correlated with 
those from our study. Firstly, p-oils rich in 18:lw9 
(p-00), 18:2w6 (p-SSO and p-EPO), or 18:3w3 (p-LO)
induced extensive hemolysis overall. Secondly, with 
10mg/l p-oil, p-00 induced no hemolysis, p-SSO and p-EPO 
induced approximately 40% hemolysis, while p-LO induced 
about 95% hemolysis. Ue additionally showed that 10 and 
20mg/l p-MO were protective against hemolysis, although 
20 to 60mg/l p-CO was most effective. Protection against 
hemolysis thus seems to relate directly to the degree of 
p-oil saturation, while cytotoxicity relates to the 
presence of PUFA's.
Numerous workers have investigated the manipulation of 
erythrocyte FA profiles. Monsen et al (1962) showed that 
varing the nature of dietary fat caused changes in the 
18:lu9 and 18:2u)6 content of rat erythrocyte PGL's. 
Rats fed safflower oil had twice as much 18:2u6 in 
erythrocyte PGL's than did animals fed coconut oil, 
whereas the PGL/s of the latter group had twice as much 
18:lw9. 20:4u>6 levels were unchanged, however, although 
others reported an accumulation of 20:4u6 relative to 
18:2w6 in a ratio of at least 5:1 in erythrocytes of 
rats fed a source of 18:2w6 (Mohrhauer et al 1963e). On 
the other hand, Uatson (1963) found that feeding rats an 
EFA-deficient diet resulted in erythrocytes deficient 
both in 18:2w6 and 20:4u6, with increased membrane 
permeability, although cell morphology was unaltered. 
Latter work, however, proved that PUFA-deficiency in 
rats caused a concommitant decrease in erythrocyte PUFA 
content, and that EFA—deficiency had pronounced effects
on erythrocyte morphology (Rao et al 1979). Ehrstrom et 
al (1981) showed that erythrocyte membranes exhibited 
increased osmotic sensitivity when rats were fed a low 
EFA content diet. These dietary changes, however, did 
not alter membrane fluidity, whereas cod liver oil or 
oils rich in 20:5w3 and 22:6u3 increased both the 
degree of unsaturation of erythrocyte PGL's and cell 
deformabi1ity (Popp-Snijers et al 1984, 1986a, 1986b, 
Cartwright et al 1985 and German et al 1985).
Ue found about 4% total EFA's in control erythrocytes 
(Table 3.1.3.1.), compared to approximately 12% reported 
by Horrobin et al (1984c) in rat erythrocyte PGL's. In 
the light of the work reviewed above, the morphological 
changes reported in 3.1.1 for some erythrocytes after 
the 48 hour incubation period may therefore relate to 
EFA-deficiency and resulting changes in membrane 
permeability. Rat erythrocytes incorporated dosed p-oi1 
FA's (Table 3.1.3.1.), probably into the PGL fraction. 
The overall erythrocyte FA profile was significantly 
altered compared to controls by both the amount and 
nature of FA's supplied (Table 3.1.3.1.), thus it seems 
likely that membrane fluidity, permeability and/or 
osmotic sensitivity were altered, and contributed to 
the effects induced in Figs. 3.1.1.2-3.1.1.8.
The data in Table 3.1.3.1. confirmed the lack of 
desaturase and elongase activity in rat erythrocytes 
(Lehninger 1982). These cells in vivo are therefore
dependent on dietary intake and/or on other tissues 
capable of desaturation as a source of PUFA's to 
maintain membrane fluidity.
The absence of 1ipoperoxides in control erythrocytes 
(Table 3.1.4.1.), despite the detection of approximate 1y 
75°4 unsaturated FA's in control cells (Table 3.1.3.1.) 
and the capability for non-enzymic lipid peroxidation in 
erythrocytes (Lehninger 1982), suggested that cellular 
FA's were not susceptible to peroxidation. Such may have 
occurred if erythrocyte unsaturated FA's were components 
of complex lipids such as membrane PGL's, if the rate of 
PGL turnover and therefore also the rate of FA uptake 
and release were slow, and/or if the erythrocytes 
contained sufficient vitamin E to prevent oxidation of 
FFA s. Evidence of increased lipid peroxidation has 
indeed been reported in erythrocytes membranes derived 
from vitamin E-deficient rats (Barker et al 1975). On 
the other hand, the lack of 1ipoperoxides in spent 
control medium reflected the large amounts of saturated 
FA's in growth medium (Table 2.3.3.3.).
The absence of significant 1ipoperoxides in erythrocytes 
and the corresponding spent medium of cultures dosed 
with p—CO or p-MO was consistent with the presence of 
only small amounts of unsaturated FA's in these p-oils 
(Table 2.3.3.2.). On the other hand, detection of small 
amounts of cellular 1ipoperoxides with p-00 or p-LO
dosage, despite the large amounts of 18:lw9 and 18:3w3 
present, respectively, suggested that incorporated p-oil 
FA's were possibly components of complex membrane lipids 
such as PGL's, and thus not so readily accessible to 
oxidation. The lack of significant 1ipoperoxides in the 
corresponding spent culture medium, despite significant 
hemolysis, supports this. The large amounts of cellular 
1ipoperoxides reported with p-SSO, p-EPO or p-FO dosage 
were consistent with the susceptibility and availability 
of free PUFA's to oxidation, and this has been shown to 
increase with deficiencies in erythrocyte vitamin E 
(Lubin et al 1982). The 1ipoperoxides formed with p-SSO 
dosage probably reflect oxidation of the large amount 
of 18:2u6 present in this p-oil (approximately 70%). 
p-SSO and p-EPO exhibited similar FA compositions and 
induced similar changes in cell viability, thus the 
significantly greater lipid peroxide amounts generated 
overall with p-EPO supplementation probably relates to 
the presence of about 9% 18:3w6 in p-EPO only. Rat 
erythrocytes were shown to incorporate exogenous FA's 
(Table 3.1.3.1.), thus the lipid peroxides in the 
corresponding spent medium of cultures dosed with PUFA- 
rich p-oils probably related to the release of cellular 
1ipoperoxides as a direct result of hemolysis.
PUFA-rich p-oils induced large amounts of 1ipoperoxides 
and were responsible for the most extensive destruction 
of erythrocytes, while both lipoperoxide production and
hemolysis were less pronounced with more saturated 
p-oils (Figs. 3.1.1.1-3.1.1.8. and Table 3.1.4.1.). 
Reports that 1ipoperoxides have been implicated in 
hemoglobin and membrane damage, and that 1ipoperoxide- 
induced membrane protein cross-1 inking affects rat 
erythrocyte deformabi1ity (Chio et al 1969, Mead 1976, 
Tappel 1980, Trotta et al 1982, MacDonald et al 1983b, 
Frankel 1984 and Sakai et al 1990) support lipid 
peroxide involvement in the modulation of p-oi1-induced
hemolysis.
3.2 THE EFFECTS OF PSEUDO-OILS ON RAT
LYMPHOCYTES.
3.2.1 Effects of pseudo-Qils on Cell Viability.
Rat lymphocyte cultures were free of erythrocyte or 
platelet contamination. Microscopic examination of 
control lymphocytes before, during and after each 
experiment showed no morphological changes at any time, 
and p-oil dosed lymphocytes were morphologically similar 
to controls.
The effect of albumin on rat lymphocyte viability was 
investigated with final medium concentrations ranging 
from 0 to 250mg/l. The results indicated that albumin 
alone had no significant effect on cell viability with 
any concentration (Fig. 3.2.1.1.). Hence, the effects 
observed with p-oil supplementation were induced by the 
exogenous FA's and not the albumin used as FA carrier.
Lymphocytes do not normally divide in culture without 
appropriate mitogen stimulation, and did not require 
trypsinisation, thus no 24 hour post-trypsinisation 
recovery period was needed. Lymphocytes were dosed 
immediately subsequent to plating, thus the seeding 
concentration was the cytostatic number.
The results obtained from the incubation of lymphocytes 
with p-oils are shown in Figs. 3.2.1.2-3.2.1.8. All
The results are expressed as mean percent (%) cell 
viabi1itytstandard error of the mean (s.e.m.), where 'n' 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.2.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 3.2.1.2-3.2.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 3.2.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to 50% of the controls.
F i g .  3 . 2  ♦ 1 . 1
A1bumin 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100,0 3.2 12
25 99.2 6.3 12
50 103.2 CM• 12
75 102.8 5.1 12
100 100.1 5.2 12
125 99.7 5.4 12
150 96.6 5.3 12
175 100.9 5.8 12
200 95.5 5.6 12
225 97.6 3.8 12
250 95.5 4.6 12
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 5.0 6
10 86.4 4.1 6
20 90.2 2.7 6
30 83.8 4.4 6
40 60.7 6.3 6
50 38.1 4.7 6
60 27.1 3.6 6
70 22.5 2.4 6
80 17.6 3.8 6
90 12.9 2.4 6
100 10.6 1.8 6
pseudo-Oi1 
Concentration 
< mg/1 )
Mean ±s.e.m. n
0 100.0 5.8 6
10 124.0 1.6 6
20 92.7 4.5 6
30 59.0 4.1 6
40 45.9 3.1 6
50 23.4 2.9 6
60 12.9 1.2 6
70 11.4 2.0 6
80 7.7 1.1 6
90 8.8 in•H 6
100 4.9 2.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.5 6
10 102.2 3.6 6
20 148.8 5.1 6
30 99.6 4.9 6
40 116.2 3.4 6
50 96.4 4.9 6
60 48.5 4.2 6
70 14.0 3.2 6
80 2.6 (SI• 6
90 0.0 o•o 6
100 o • o 0.0 6
pseudo-Oi1 
Concentration 
< mg/1 )
Mean ±s.e.m. n
0 100.0 5.1 6
10 77.5 4.2 6
20 80.1 6.0 6
30 86.6 6.0 6
40 68.6 5.7 6
50 73.5 5.2 6
60 67.8 5.0 6
70 43.3 4.1 6
80 21.2 3.7 6
90 11.4 2.1 6
100 1.6 1.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ± s .e.m. n
0 100.0 3.6 6
10 98.8 5.8 6
20 90.0 4.5 6
30 65.9 5.1 6
40 34.5 3.3 6
50 30.5 2.2 6
60 36.8 2.6 6
70 32.9 1.9 6
80 31.4 2.1 6
90 31.2 1.5 6
100 24.9 2.4 6
pseudo-Oi1 
Concentration 
< mg/1)
Mean ±s.e.m. n
0 100.0 5.4 6
10 71.7 5.5 6
20 45.0 5.0 6
30 34.5 2.6 6
40 22.7 3.2 6
50 20.9 2.3 6
60 21.0 3.2 6
70 16.5 5.6 6
80 10.4 3.0 6
90 8.7 1.9 6
100 8.7 3.5 6
The percentage viability of rat lymphocyteg incubated
with p-FO.
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m.' n
0 100.0 4.0 6
10 78.7 3.9 6
20 76.8 4.9 6
30 85.7 5.3 6
40 51.4 2.8 6
50 26.2 2.8 6
60 23.5 2.5 6
70 21.1 1.8 6
80 20.0 5.3 6
90 10.5 2.4 6
100 11.4 1.1 6
A1bumin 
icentrat ion 
(mg/1)
Mean ±s.e.m . n
0 100.0 7.1 6
100 53.6 4.3 6
125 53.8 5.4 6
150 50.2 5.6 6
175 53.0 6.3 6
200 50.7 4.4 6
p-oils induced concentration dependent cytotoxicity, but 
it was unclear whether PUFA-rich p-oils exhibited 
greater cytotoxic potential than monounsaturated, or 
saturated, FA-rich p-oils.
Only p-CO concentrations greater than 30mg/l caused 
marked concentration dependent inhibition of lymphocyte 
viability (Fig. 3.2.1.2.). On the other hand, 10mg/l 
p-MO increased cell viability to 124.0%, followed by 
rapid concentration dependent cytotoxicity in the range 
20 to 60mg/1 (Fig. 3.2.I.3.).* ID50 values for cells 
dosed with p-CO or p-MO were approximately 45 and 
38mg/l, respectively, with 10.6% and 4.9% viability 
found with 100mg/l p-CO or p-MO, respectively.
p-00 supplementation induced the most dramatic changes 
in lymphocyte viability (Fig. 3.2.1.4.). Relative cell 
viability was greater than, or equal to, controls with 
concentrations up to 50mg/l, and stimulated to a maximum 
of 148.8% with 20mg/l p-00, and to 116.2% with 40mg/l 
p-00. Cytostasis was induced with 50mg/l p-00, and 
concentration dependent cytotoxicity with greater 
amounts dosed. Approximately 59mg/l p-00 reduced cell 
viability to 50% of controls (ID5 0), and no viable 
lymphocytes were present with 90 or 100mg/l p-00.
A gradual inhibitory response was induced with p-SS0 
dosage up to 60mg/l, with lymphocyte viability reduced 
to 67.8% (Fig. 3.2.1.5.). Cytotoxicity became more
pronounced with greater concentrations dosed, and only 
11.4% and 1.6% of lymphocytes were viable with 90 and 
100mg/l p-SSO, respectively. p-SSO dosed lymphocytes 
nevertheless exhibited the highest ID50 (about 67mg/l). 
On the other hand, 10mg/l p-LO induced cytostasis, and 
concentrations from 20 to 40mg/l were considerably more 
cytotoxic than was p-SSO in the same range (Fig.
3.2.1.6.). The ID50 uas approximately 36mg/l p-LO, and 
cell viability was reduced to 34.5% with 40mg/l p-LO. 
Thereafter, a plateau effect was noted, with viability 
only marginally influenced with further concentration 
increases (30.5% to 36.8% viability over the range 40 to 
90mg/l). About 25% of lymphocytes were viable with 
100mg/l p-LO, and this was at least double that found 
with any other p-oil dosed at this concentration.
Low concentrations of p-EPO were very cytotoxic, and 
only 18mg/l p-EPO was required to reduce the viable cell 
count to 50% of controls (Fig. 3.2.1.7.). This was the
lowest ID50 obtained with rat lymphocytes. The toxicity 
induced with p-FO was less pronounced than with p-EP0 
dosage, and lymphocyte viability was reduced to 50% with 
approximately 40mg/l p-FO (Fig. 3.2.1.8). The cytotoxic 
potential of both p—EPO and p—FO increased slowly with 
concentrations greater than 50mg/l, and viability was 
about 10% with 100mg/l p-oil.
To exclude the possibility that any of the effects 
induced with p—oil dosage were influenced by the amount
of albumin bound to the FA^s, lymphocytes were incubated 
with p-SSO to correspond with its ID50 (about 67mg/l>. 
Five points were chosen around which to wary the albumin 
concentration keeping the p-SSO concentration fixed, 
viz. two points above, two points below, and the ID50 of 
p-SSO, The appropriate amount of albumin was added to 
these cultures to give the desired concentrations. The 
results are shown in Fig. 3.2.1.9., and indicated that 
the amount of p-SSO dosed reduced lymphocyte viability 
to approximately 50% of controls, and that such was not 
influenced by the amount of albumin present as FA 
carrier. Hence, synergistic effects of albumin could be 
excluded, and the effects induced with the p-oils were 
solely due to the exogenous FA^s.
Subsequent to these studies, rat lymphocytes were plated 
and dosed appropriate 1y with 0, 20, 40 or 60mg p-oil/1 
culture medium in sufficient amounts for all qualitative 
and quantitative analyses to be carried out. Upon 
harvesting, cell viabilities relative to controls were 
compared to those in Figs. 3.2.1.1-3.2.1.8., and were 
found not to be statistically different. All further 
biochemical assays were performed on these samples.
3.2.2 Effects of pseudo-Oils on Total Protein.
Total lymphocyte protein was determined for each of the 
p-oil concentrations dosed* and the data shown in Table 
3.2.2.1. as jug total protein/106 cells seeded.
Control rat lymphocytes contained 6.5jug protein/106 
cells seeded, while levels in dosed lymphocytes ranged 
from 5.2 to 97.3Aig protein/106 cells seeded. All dosed 
cells, except those supplemented with 20mg/l p-EPO or 
p-SSO, exhibited total protein concentrations greater 
than controls.
Protein concentrations increased progressively with the 
amount of p-oil dosed. The saturated p-oils, p-CO and 
especially p-MO, induced the greatest overall increases 
in protein, particularly with a concentration of 60mg/l. 
Dosage with any PUFA-rich p-oil generally induced the 
smallest overall increment in protein, while that with 
p-00 supplementation was intermediary between the two 
extremes. With dosage of 60mg/l p-oil, the overall 
capability to enhance lymphocyte protein was in the 
order p-MO > p-CO > p-00 > p-SSO > p-EPO > p-FO > p-LO.
The protein content of rat lymphocytes. expressed as jug 
total protein/106 cells seeded.
pseudo­
Oil
(mg/1)
CELLS
0
1l
20 1
11
40 60
Control 6.5
11
ili
CO
i
ii.3 :i 15.8 36.7
MO
i
ii.9 :i 50.8 97.3
00
i
15.3 ! 1 16.7 29.5
SSO
l
5 . 7 :
1
10.5 20.2
L0
1
8.8 ! 1 8.4 11.2
EPO
1
5 . 2 :
1
7.8 19.3
F0
1
13.8 :
11
14.2 18.2
3.2.3 Effects of pseudo-Qils on the Fatty Acid
Spectrum of Rat Lymphocytes.
The FA spectra of rat lymphocytes dosed with 0, 20, 40 
or 60mg/l of each p-oil are shown in Table 3.2.3.1. 
Control lymphocytes exhibited a FA spectrum in which one 
FA, 22:4w6, was present at 52.8%. FA's which contributed 
>5.0% to the spectrum included 16:0 (11.7%), 18:0
(7.2%), 18:lu9 (5.5%), 22:5u6 (5.5%) and 20:4u3 (6.0%).
Dosed cells contained varying amounts of these FA's.
The FA spectra showed that the major p-oil FA components 
dosed were incorporated. In general, 16:0, 18:lu9 and 
18:2to6 levels were greater in dosed lymphocytes than in 
controls, more 16:lw9 was found in control lymphocytes, 
while 18:0 levels were more variable. 18:2w6 
desaturation and elongation products were generally 
decreased in dosed cells, as were the long chain more 
unsaturated products of 18:3w3.
16:0 proportions increased from 11.7% in controls, to 
24.3%, 45.1% and 48.6% with supplementation of 20, 40 
or 60mg/l p-CO, respectively. 18:lw9 levels increased
similarly (15.2%, 15.3% and 16.4%, respectively vs 5.5% 
in controls), but the increment in 18:0 was only 
slight (8.3% to 8.7% vs 7.2% in controls). In contrast, 
22:4w6, 22:5w6, 18:4w3 and 20:4uj3 percentages decreased 
significantly compared to controls (52.8%, 5.5%, 3.8% 
and 6.0%, respectively).
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n‘ is 
the number of experiments. "Cp-OilU" refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of rat lymphocytes.
FATTY ACID 
SPECTRUM
CONTROLS 
(n=3)
Cp-co:
(mg/l)
20 ! 40 ! 60
Cp-m o :
(mg/l)
20 ! 40 ! 60
Cp-OOD 
(mg/1)
20 ! 40 ! 60
Cp-sson
(mg/l)
20 ! 40 ! 60
Cp-l o:
(mg/l)
20 ! 40 ! 60
Cp-EPOH 
(mg/l)
20 ! 40 ! 60 20
Zp -FOI 
(mg/l)
! 40 ! 60
s
A
16:0 11.7+0.55 24.3 45.1 48.6 21.3 32.8 33.9 14.6 16.7 15.6 10.7 23.4 16.7 16.4 25.6 23.7 9.4 26.0 21.2 24.6 30.7 23.6
T
u
18:0 7.2±0.00 8.3 8.5 8.7 7.8 18.1 10.1 5.0 1.5 1.3 9.3 9.0 6.0 5.5 7.8 5.6 12.9 10.1 7.5 6.0 3.9 2.4
R
A
20:0 0.1±0.00 - 0.2 - - - - 2.9 - - - - - - - - - - - 2.7 - -
T
c
22:0 0.7±0.00 0.7 0.1 0.1 0.3 0.1 0.1 - - - 0.1 - - 0.4 - - - 0.1 0.1 - - -u
S. 24:0 0.8 — 0.4 — — “ - - 0.4 0.7 0.6 - 0.5 - - 1.6 0.5 - - -
u9
M
16:1 1.5±0.00 - 0.3 1.1 - - 3.0 2.7 - 0.5 1.0 0.2 0.1 0.6 1.5 0.1 0.2 0.2 0.9 13.6 25.9 33.6
0
N
18:1 5.5±0.10 15.2 15.3 16.4 23.0 26.6 24.7 37.9 71.6 73.4 10.5 34.0 33.1 23.1 34.0 27.9 12.2 21.4 18.9 12.7 23.3 23.7
0
S.
24:1 — — — — 0.1 - - - - - - - - - - - - - -
18:2 2.1±0.00 1.7 1.3 1.0 6.7 6.7 4.8 2.2 4.1 4.6 7.7 20.0 37.0 3.2 7.6 11.5 14.2 31.3 42.4 1.5 7.2 8.1
u6
18:3 - - - - - - - - - - - - - - - - - 0.9 1.6 - - -
p
20:2 — — — — — - 1.2 1.7 1.4 - - - - 0.2 - - - - - 0.9 0.8
01 20:3 0.4±0.05
- - 0.1 - - 0.1 2.7 - - - - - - - 0.1 - - - 2.0 0.2 0.1
Y 
q.
20:4 1.1±0.00 - 0.2 0.2 0.4 0.7 0.4 - - - - 0.2 0.1 - 0.2 0.1 - 0.3 0.1 - 0.2 0.1
22:4 52.8±0.65 40.2 23.1 21,. 0 34.7 11.3 20.6 23.2 2.9 2.4 53.4 8.4 5.2 41.1 10.6 8.7 41.5 4.4 5.7 27.0 4.2 4.3
22:5 5.5±0.65 0.3 1.0 — — 0.4 — — 0.2 — - 0.5 - 0.3 0.6 - 0.4 1.8 - 0.7 0.1 -
18:3 0.3+0.06 0.3 0.2 0.2 1.0 0.5 0.3 - 0.2 0.2 - 0.3 0.1 1.0 8.2 20.9 - 0.2 - 0.3 0.4 0.5
u3 18:4 3.8±0.15 0.9 1.2 0.3 0.4 1.0 0.3 4.4 0.5 0.2 0.5 1.3 0.2 0.7 1.2 0.3 4.2 0.9 0.1 4.0 0.5 0.1
p
Q
20:4 6.0+0.55 7.4 3.8 2.3 4.1 1.8 1.1 3.1 0.7 0.2 6.3 1.4 0.6 7.5 1.5 0.7 5.3 1.0 0.5 2.8 0.5 0.5
L
Y
20:5 1.0±0.00 0.2 - - 0.7 - 0.1 0.1 - 0.6 - 0.4 0.4 0.2 - - - 1.6 1.7 2.1
S. 22:5 — “ — — — — — — — — — - - — - - - - - - 0.1 -
22:6 — — — — 0.1 — *— — — — 0.2 — 0.1 0.2 — — 0.5 0.5 0.2 0.1
Ulhen lymphocytes were dosed with 0, 20, 40 or 60mg/l 
p-MO, 16:0 incorporation increased from 11.7% to 21.3%, 
32.8% and 33.9%, and 18:0 increased from 7.2% to 7.8%,
18.1 % and 10.1%, respectively. A considerable increase 
in 18:lu9 was also found (from 5.5% to 23.0%, 26.6% and 
24.7%, respectively), but 16:1uj9 increased only with 
60mg/l (3.0% vs 1.5% in controls). 18:2u6 incorporation 
increased from 2.1% in controls to between 4.8% and 
6.7% over the range dosed, but 20:4w6 and particularly 
22:4w6 levels were decreased compared to controls (1.1% 
and 52.8%, respectively).
37.9% 18:lu9 was found with dosage of 20mg/l p-00, and 
this amount almost doubled to 71.6% and 73.4% with 40 
and 60mg/l p-00, respectively, compared to only 5.5% in 
controls. 16:0 levels increased only marginally over the 
range dosed (14.6%, 16.7% and 15.6%, respectively vs 
11.7% in controls), 18:0 proportions were reduced from 
5.0% to 1.3% (7.2% in controls), while 2.9% 20:0 and 
2.7% 16:lw9 were detected with 20mg/l p-00 (0.1% and 
1.5% in controls, respectively). 18:2w6 percentages with 
20mg/l p-00 were similar to controls (2.2% and 2.1%, 
respectively), but levels increased about two fold with 
40 and 60mg/l. 20:2w6 levels ranged from 1.2% to 1.7% in 
dosed cells, but this FA was absent from controls, while 
2.7% 20:3u6 was detected with 20mg/l p-00 (0.4% in 
controls). Less than half the control level (52.8%) of 
22:4u6 was found with supplementation of 20mg/l p—00
(23.2%), and this decreased further to 2.9% and 2.4% 
with 40 and 60mg/l p-00, respectively.
16:0 levels were parallel to controls with 20mg/l p-SSO, 
but increased with dosage of 40 or 60mg/l p-SSO (11.7%, 
10.7%, 23.4% and 16.7%, respectively). 18:0 percentages 
were not significantly different with 20 or 40mg/l (9.3% 
and 9.0 %, respectively), while only 6.0% was shown with 
60mg/l (7.2% in controls). 18:lu9 levels increased about 
2 fold with 20mg/l p-SSO compared to controls (10.5% a^d 
5.5%, respectively), and this increased to at least six 
fold with 40 and 60mg/l (34.0% and 33.1%, respectively). 
18:2w6 incorporation into lymphocytes dosed with 20, 40 
or 60mg/l p-SSO increased from 7.7% to 20.0% and 37.0%, 
respectively (2.1% in controls), but other w6, and all 
w3, PUFA levels were parallel to, or significantly lower 
than, controls.
16:0 and 18:lu9 percentages ranged from 16.4% to 25.6% 
and 23.1% to 34.0%, respectively with p-LO dosage (11.7% 
and 5.5% in controls, respectively), while 18:0 levels 
were parallel to controls (1.5%) or decreased. 18:2u6 
incorporation increased from 3.2% to 7.6% and 11.5% with 
20, 40 and 60mg/l p-LO, respectively (2.1% in controls), 
but other w6 PUFA levels were decreased. The amount of 
18:3u3 incorporated into lymphocytes dosed with 20mg/l 
p-LO was 1.0%, but increased significantly to 8.2% with 
with 40mg/l and 20.9% with 60mg/l (0.3% in controls).
18:4w3 percentages ranged from 0.3% to 1.2% (3.8% in 
controls), and 7.5% 20:4u3 was detected with 20mg/l p-LO 
(6 .0 %  in controls), but no significant increases in 
other w3 PUFA's were found.
\
16:0 proportions changed from 11.7% to 9.4%, 26.0% and 
21.2% with 0, 20, 40 or 60mg/l p-EPO dosage, compared to 
7.2%, 12.9%, 10.1% and 7.5% 18:0, respectively. 1.6% 
24:0 was found with 40mg/l p-EPO (0% in controls), while 
18:lw9 levels ranged from 12.2% to 21.4% (5.5% in 
controls). 18:2u6 incorporation increased significantly 
to 14.2%, 31.3% and 42.4% with 20, 40 or 60mg/l p-EPO, 
respectively (2.1% in controls). No 18:3w6 was found in 
control lymphocytes, but 0.9% and 1.6% were detected 
with 40 and 60mg/l, respectively. However, other w6 PUFA 
levels were significantly decreased, and no significant 
increase in U)3 PUFA's were found.
Uhen lymphocytes were dosed with 20, 40 or 60mg/l p-FO, 
the amount of 16:0 incorporated ranged between 2 to 3 
fold that of controls (11.7%), 18:0 levels decreased 
from 6.0% to 2.4%, respectively (7.2% in controls), and 
2.7% 20:0 was detected with 20mg/l (0.1% in controls). 
16:lu9 incorporation was concentration dependent (1.5%, 
13.6%, 25.9% and 33.6% with 0, 20, 40 and 60mg/l p—FO, 
respectively), as was 18:lw9 uptake (5.5%, 12.7%, 23.3% 
and 23.7%, respectively). 18:2u6 was increased only with 
40 and 60mg/l p-FO (7.2% and 8.1%, respectively vs 2.1% 
in controls), a significant amount of 20:3w6 was
detected with 20mg/l p-FO (2.0% vs 0.4% in controls), 
but no increases in 20:4w6 or 22:4u6 were found. Dosed 
lymphocytes incorporated 20:5u3 in p-FO (1.6%, 1.7% and 
2.1%, respectively vs 1.0% in controls), but only trace 
amounts (*0.5%) of 22:5w3 and 22:6w3 were detected.
3.2.4 Effects of Pseudo-Oils on Lipid Peroxide
Formation.
Results obtained from the measurement of lipid peroxides 
both in rat lymphocytes and their respective spent media 
are shown in Table 3.2.4.1. The values are reported as 
nmoles MDA/106 cells, but in the case of spent growth 
media, this represents the nmoles of MDA in the volume 
of medium from which lxlO6 cells were obtained.
Lipoperoxide concentrations for dosed lymphocytes ranged 
from a low of 1.2nmoles MDA/106 cells (with 20mg/l p-MO 
or p-EPO) to a high of 102.6nmoles MDA/106 cells (with 
60mg/l p-LO), compared to 0.4nmoles MDA/106 control 
lymphocytes. Lipid peroxide amounts increased in every 
instance with increments in p-oil concentration dosed, 
and the greatest increase was detected with u3 PUFA 
rich-p-oils (5.0, 26.1 and 102.6nmoles MDA/106 cells 
with p-LO, and 7.3, 12.7 and 65.2nmoles MDA/106 cells 
with p-FO, respectively). On the other hand, lymphocytes 
supplemented with 20, 40 or 60mg/l p-MO or p-EPO induced 
the smallest concentration dependent increase in lipid 
peroxides, although the amounts generated were similar 
(1.2, 3.0 and 8.3nmoles MDA/106 cells, and 1.2, 5.1 and 
8.4nmoles MDA/106 cells, respectively). Lipid peroxide 
production with p-CO, p-SSO or p-00 dosage was 
intermediate between the two extremes, ranging from 2.9 
to 18.2nmoles MDA/106 cells.
Lipid peroxide formation by rat lymphocyte cultures 
incubated with p-oils. expressed as nmoles MDA/106 rp>11»=;.
pseudo- 
Oi 1
CELLS
(mg/1 ) 0 20 40 60
Control 0.4
CO 2.9 11.1 15.3
MO 1.2 3.0 8.3
00 2.8 11.2 18.2
SSO 4.4 9.9 12.4
L0 5.0 26.1 102.6
EPO 1.2 5.1 8.4
F0 7.3 12.7 65.2
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - -
SSO - - -
L0 - 31.5 102.7
EPO - - -
FO - - 10.4
Only spent medium derived from cultures incubated with 
w3 PUFA-rich p-oils contained lipid peroxides. Medium 
derived from cultures incubated with p-FO contained 
fewer 1ipoperoxides than the lymphocytes themselves, 
with significant amounts measured in spent medium only 
with 60mg/l p—FO (10.4-nmoles MDA/10^ cells). As with the 
cells, the greatest amounts of medium 1ipoperoxides were 
found with 40 or 60mg/l p-LO dosage (31.5 and 102.7 
nmoles MDA/106 cells, respectively), which correlated 
with cellular levels.
3.2.5 Discussion.
No reference has been found in the literature with 
regard to the influence of exogenous FA's on normal rat 
lymphocyte viability in culture. However, investigation, 
of the effects of exogenous FA's on mitogen-induced DNA 
synthesis and cell activation in the modulation of mouse 
T and B lymphocyte proliferation showed that saturated 
FA's alone were more potent inhibitors of these 
processes than unsaturated FA's, and that the 
simultaneous addition of equimolar amounts of a 
saturated and an unsaturated FA abrogated the inhibitory 
effect of the former (Tsang et al 1977 and Buttke 1984). 
The finding that mitogen-activated B cells were much 
less susceptible to inhibition by FFA's than T cells 
(Buttke 1984) implied differential sensitivity of 
lymphocytes to the effects of FFA's. This was clear from 
comparison with our data. p-Oil supplementation affected 
rat lymphocyte viability (Figs. 3.2.1.2-3.2.1.8.), but 
it was unclear whether PUFA-rich p-oils exhibited 
greater cytotoxic potential than monoenoic or saturated 
FA-rich p-oils, since the effects induced were p-oil- 
specific rather than dependent on the degree of p-oil 
unsaturation. This implied that the modulation of rat 
lymphocyte viability related both to the nature (type) 
and proportion of saturated, monoenoic and/or polyenoic 
FA s dosed (Table 2.3.3.2.). p—EPO was most, and p—SSO 
least, cytotoxic, despite similar FA compositions,
implying involvement of both major and minor p-oil FA 
components, and possibly also p-oil FA synergism and/or 
antagonism, in the effects induced. Comparison of cell 
viability with p-EPO, p-SSO or p-LO dosage with the 
respective p-oil FA profiles indicated that GLA was a 
more effective cytotoxic agent than ALA, and both GLA 
and ALA exhibited greater cytotoxic potential than LA. 
This illustrated that both FA chain length and the 
number and position of double bonds present were 
involved in the modulation of rat lymphocyte viability.
Lymphocytes do not normally divide in culture without 
appropriate mitogenic stimulation, thus increased cell 
viability only with supplementation of 10mg/l p-MO, or 
20 or 40mg/l p-00, indicated FA involvement in the 
stimulation of rat lymphocyte proliferation at low 
concentrations. This, together with the finding of Dubin 
et al (1965) that an optimum concehtration of only 
0.07mg/l LA effectively promoted macrophage growth in 
culture, suggests that p-oil concentrations below 10mg/l 
may also effectively stimulate rat lymphocyte 
proliferation.
The data in Table 3.2.3.1. confirmed the ability of rat 
lymphocytes to incorporate exogenous FA's (Tsang et al 
197?, Stubbs et al 1980 and Conroy et al 1986). A 
mechanism by which p—oils affected lymphocyte viability 
may therefore relate to differential uptake of p—oi1
FA's and alterations in membrane fluidity. Studies have 
indeed shown that modification of rat diets either with 
olive oil or fish oil altered lymphocyte membrane 
fluidity, with the fish oil diet more effective in 
increasing the unsaturation index of the membrane than 
olive oil (Conroy et al 1986). p-Oil dosed lymphocyte FA 
compositions were modified compared to controls, thus it 
was likely that overall membrane fluidity was altered 
and this involved in the viability changes reported in 
Figs. 3.2.1.2~3.2.1.8. Supplementation with optimal 
proportions of saturated and unsaturated p-oil FA's at 
low concentrations may have allowed the cells to 
maintain a degree of membrane fluidity compatable with 
viability, whereas addition of large amounts of highly 
saturated or unsaturated p-oils may have led to 
pronounced changes in membrane fluidity such that 
lymphocyte viability could not continue. However, it 
was unlikely that eicosanoids were directly involved in 
the modulation of lymphocyte viability with p-oil dosage 
since this mechanism could not explain the effects of 
p-oils rich in saturated or monoenoic FA's, which can 
not be metabolised by this route. Even EFA-rich p-oils 
could not act as sources of eicosanoid precursors 
since the data in Table 3.2.3.1. indicated that rat 
lymphocytes exhibited no significant capability for PUFA 
desaturation (J6D, J5D and J4D) or elongation. Others 
have similarly shown that neither C14C3-18:2u6 nor 
C3H3-20:4w6 were further metabolised by these enzymic
pathways in rat leukocytes, despite considerable and 
rapid uptake into lipid pools, and suggested that the 
desaturase cascade was a minor route for FA metabolism 
in these cells (Brenner et al 1966, Mead et al 1976, 
Kanau et al 1977 and Cunnane et al 1984).
Detection of small, but significant, increases in 20:3u6 
levels with p-00 or p-FO dosage, which contained small 
amounts of 20:2w6 (Table 2.3.3.2.), implied possible AQD 
capability. This may reflect an attempt by the cells to 
maintain membrane PUFA levels by activating J8D when A6Zi 
expression is suppressed/inhibited. However, it appeared 
that this mechanism was unable to sufficiently maintain 
lymphocyte PUFA levels since J8D substrate availability 
was limited by the inability to elongate 18:2w6 
incorporated with p-oil supplementation.
Zevallos et al (1989) showed that when rat lymphocytes 
were incubated with either CiaCT-18:0 or C 14C0-18: 2u6, 
in the presence of either diheptadecanoy1 phosphatidyl - 
choline or dioleylphosphatidylcholine, the fluidity of 
all membranes, including those of the microsomes, 
increased. Such membrane fluidisation was associated 
with depressed conversi on of 18:0 to 18:lu9, and 18:2u6 
to 18:3w6 via A9D and A 6D, respectively. The data in 
Table 3.2.3.1. showed that p-oil incorporation altered 
rat lymphocyte FA profiles. This may have altered the 
physical state (fluidity) of microsomal membranes and
depressed desaturase activity. Such may have contributed 
to absence of significant desaturase/elongase activity 
reported, and in particular, may explain the lack of 
PDFA formation from 18:2w6 or 18:3u3 incorporated with 
p-SSO, p-EPO or p-LO incubation (Table 3.2.3.1.). 18:lu9 
levels were significantly increased with p-oil dosage, 
but such probably reflects decreased PDFA levels and the 
fact that all p-oils contained 18:lu9 in amounts ranging 
from about 5% to 70% (Table 2.3.3.2.), rather than 
18ilu9 formation from 16:0, 16:lu9 and/or 18:0. It was 
unlikely, however, that the desaturase and elongase 
activity reported related to p-oil induced cytotoxicity 
since no significant evidence for such enzyme capability 
was found even when p-oils induced little or no 
toxicity.
Rode et al (1982) found between 4.5 and 6.0jug total 
protein/106 control lymphocytes, and this was in close 
agreement with the data reported in Table 3.2.2.1. The 
results presented also indicated that rat lymphocyte 
protein synthesis was significantly stimulated in a 
concentration dependent manner with increased p-oil 
concentration dosed (Table 3.2.2.1.), despite the 
inverse correlation with cell viability (Figs. 3.2.1.2­
3.2.1.8.). p-Oils were thus potent agents for enhancing 
rat lymphocyte protein synthesis, and the extent to 
which such was stimulated was relatable to p-oil FA 
composition (Table 2.3.3.2.). The finding that saturated
FA-rich p-oils were generally most, and PUFA-rich p-oils 
least, effective in enhancing protein synthesis implied 
that the ability to modulate rat lymphocyte protein 
production related partly to p-oil unsaturation. This, 
did not explain why p-MO, for example, induced more 
protein than p-CO, although it was possible that such 
differences related to the mediation of synergistic or 
antagonistic effects between p-oil FA's.
Increased lymphocyte protein synthesis may reflect 
promotion of lymphocyte activation, enhanced protein 
synthesis in different cell components, as was shown 
by Rode et al (1982) in concanavalin A stimulated 
lymphocytes, increased enzyme synthesis to metabolise 
incorporated p-oil FA's, and/or enhanced biosynthesis of 
proteins required to maintain the integrity of cell 
membranes damaged directly with p-oil dosage, or 
indirectly by 1ipoperoxide formation (Table 3.2.4.1.). 
However, it was unlikely that increased protein 
synthesis related to enhanced desaturase or elongase 
expression in light of the data reported in Table
3.2.3.1.
The data presented in Table 3.2.4.1. was consistent with 
intact cellular enzymic and/or non-enzymic mechanisms 
for the production of 1ipoperoxides. Large amounts of 
PUFA's were detected in control lymphocytes (Table
3.2.3.1.), thus the small amounts of 1ipoperoxides 
measured may reflect cellular anti-oxidant and enzymic
mechanisms of protection against free radical attack. It 
was also possible that cellular PUFA's were present as 
components of complex lipids, eg. membrane PGL's, which 
would therefore not be so readily accessible to 
oxidation. On the other hand, saturation of the cellular 
anti-oxidant mechanisms and/or increased cellular FA 
availability may have occurred with incorporation of 
supplemented p-oils, and the 1ipoperoxides measured thus 
reflected the p-oil concentration dosed, p-oil FA 
composition (Table 2.3.3.2.) and FA susceptibility to 
oxidation. Measurement of the largest amounts of 
cellular and medium 1ipoperoxides with p-LO or p-FO 
dosage correlated with the significant w3 PUFA levels in 
these p-oils. The significantly greater amount of ALA in 
p-LO relative to EPA in p-FO (approximately 63% and 18%, 
respectively) was consistent with the greatest lipid 
peroxide levels measured, both in the cells and spent 
medium, despite the greater susceptibility of EPA to 
oxidation. Rat lymphocytes were shown to incorporate 
p-oil FA's (Table 3.2.3.1.), thus the medium lipid 
peroxides measured with p-LO or p-FO dosage probably 
reflect cellular 1ipoperoxides released upon cell lysis, 
and/or released cellular FA's oxidised extrace 11u 1 ar 1 y 
by released cellular peroxidising enzymes.
Mosconi et al (1988) reported that superoxide production 
by white blood cells increased significantly when rat 
diets were supplemented with fish oil compared to olive
oil, and this correlated with the findings in Table
3.2.4.1. The significantly lower amounts of cellular 
1ipoperoxides measured with p-MO, p-00, p-SSO or p-EPO, 
compared to p-LO or p-FO, suggested that more substrates 
for peroxidation were lipid bound and stable with 
incubation of the former group, despite all these p-oils 
containing significant amounts of unsaturated FA's. This 
finding was consistent with the absence of 1ipoperoxides 
in the corresponding spent medium with p-MO, p-00, p-SSO 
or p-EPO dosage, despite the mediation of cell lysis. 
The cellular lipid peroxides formed with p-SSO or p-EPO 
incubation possibly related to oxidation of incorporated 
LA or other cellular FA's. Both p-oils exhibited similar 
FA compositions, thus the greater lipoperoxide amounts 
induced with p-SSO suggested enhanced PGL cycling, which 
would have increased the rate of FA incorporation, 
release and pool of FFA's available for peroxidation. 
Alterations in PGL turnover could also have been 
consistent with the greater amounts of lipid peroxides 
measured with dosage of p-CO or p-00 than p-MO or p-EPO.
Current evidence suggests that lipid peroxides affect 
normal cell metabolism and cause membrane damage (Ohio 
et al 1969, Mead 1976, Tappel 1980, Gavino et al 1981c, 
Morisaki et al 1982b and Frankel 1984), thus it was 
possible that such compounds were involved in the 
modulation of cytotoxicity induced with p-oil dosage. 
This may explain the inverse relationship between
lipid peroxide levels (Table 3.2.4.1.) and lymphocyte 
viability (Figs. 3.2.1.2—3.2.1.8.) with increased p-oil 
dosage. However, the finding that the greatest lipid 
peroxide levels did not correlate with the greatest 
cytotoxicity implied that these compounds were only 
partly involved in the modulation of rat lymphocyte 
viability. The data presented rather suggested that both 
1ipoperoxides and alterations in membrane fluidity were 
involved in the effects induced.
3.3 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM RAT AORTIC ENDOTHELIUM.
3.3.1 Effects of pseudo-Oils on Cell Viability.
No morphological changes were observed between control 
cells before, during or after each experiment, and p-oil 
dosed cells were morphologically similar to controls, 
although cytoplasmic droplets were observed with p-oil 
incubation at high concentrations in some instances.
Investigation of the effects of 0 to 250mg albumin/1 
growth medium showed no significant changes in rat 
aortic endothelial cell viability (Fig. 3.3.1.1.), nor 
were any synergistic effects evident. The effects 
induced with p-oil dosage were thus a result of the 
mixture of exogenous FA's and not the albumin used as FA 
carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period 
was 10.2xl04/ml. This equated to approximately 89% of 
the final control cel 1 number at the end of the 48 hour 
incubation period and represented the cytostatic number. 
Only p-oil concentrations limiting cell viability to 
significantly below 89% were considered cytotoxic.
Figs. 3•3.1.2—3.3.1.8. show the results obtained from 
the incubation of rat endothelial cells with p-oils.
Legend to Figs. 3.3.1.1-3.3.1.9.
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where "n" 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.3.1.1. shows the mean percent cell 
viabiWty versus the albumin concentration (mg/1), and 
Figs. 3.3.1.2-3.3.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 3.3.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to 50% of the controls.
AT bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 5.3 12
25 103.4 5.5 12
50 96.5 3.0 12
75 98.0 3.4 12
100 97.7 2.3 12
125 102.8 Hin 12
150 97.1 3.7 12
175 95.9 3.3 12
200 94.9 2.6 12
225 95.5 2.8 12
250 96.0 4.4 12
pseuso-Oi 1 
Concentration 
(mg/1>
Mean ±s.e.m . n
0 100.0 5.4 6
10 100.5 2.1 6
20 108.4 3.6 6
30 95.6 2.7 6
40 95.3 4.1 6
50 95.0 3.5 6
60 80.3 4.4 6
70 81.2 4.6 6
80 69.0 1.8 6
90 65.6 2.7 6
100 51.2 4.3 6
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pseuso-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 2.3 6
10 96.0 2.0 6
20 97.0 2.3 6
30 90.9 2.6 6
40 96.3 1.0 6
50 89.9 2.4 6
60 82.8 2.3 6
70 82.5 2.8 6
80 75.4 2.3 6
90 72.1 2.1 6
100 68.7 1.5 6
pseuso-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.3 6
10 101.2 3.5 6
20 99.6 2.9 6
30 103.2 3.2 6
40 102.0 2.7 6
50 97.2 2.9 6
60 88.5 2.4 6
70 70.8 2.2 6
80 72.3 2.8 6
90 36.8 3.2 6
100 13.4 2.0 6
Fig. 3 ♦3 .1 .5 .
pseuso-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 3.6 6
10 99.2 3.7 6
20 96.1 6.8 6
30 102.0 5.7 6
40 115.4 2.3 6
50 106.7 4.5 6
60 99.8 4.4 6
70 89.5 3.6 6
80 88.3 3.3 6
90 - 92.6 6.3 6
100 86.4 4.0 6
pseuso-Oi1 
Concentration 
(m g / 1 )
Mean ±s.e.m . n
0 100.0 CO • 00 6
10 101.0 3.5 6
20 107.5 3.8 6
30 102.0 3.3 6
40 98.0 3.5 6
50 97.5 4.2 6
60 96.0 4.0 6
70 79.1 3.5 6
80 64.7 2.6 6
90 42.8 3.2 6
100 20.9 3.2 6
pseuso-Oi1 
Concentration 
< m g / 1 )
Mean ±s.e.m . n
0 100.0 5.5 6
10 102.8 inCO 6
20 93.9 4.0 6
30 92.1 3.7 6
40 87.7 4.2 6
50 82.1 00 6
60 91.5 4.6 6
70 75.9 3.3 6
80 83.5 5.1 6
90 77.5 4.0 6
100 75.6 in 6
pseuso-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.1 6
10 100.9 4.2 6
20 96.4 3.0 6
30 103.3 3.6 6
40 105.4 3.1 6
50 97.9 2.5 6
60 94.3 5.1 6
70 92.5 4.2 6
80 94.9 4.0 6
90 82.2 3.4 6
100 83.4 3.3 6
The percentage viability of cells derived 
aortic endothelium incubated uiith albumin at 
of P-00.
from rat 
the IDen
Albumin - Mean ±s.e.m. n
Concentration
< mg/1)
0 100.0 4.1 6
125 53.4 2.5 12
150 51.7 5.1 12
175 47.7 4.5 12
200 52.2 3.1 12
225 46.4 2.2 12
Certain concentrations of some p-oils stimulated cell 
proliferation, and all p-oils limited cell viability to 
varying extents, but only p-CO, p-00 and p-LO induced 
significant cytotoxicity.
Dosage with 20mg/l p-CO stimulated cell proliferation to 
108.4%, whereas p-MO did not cause any significant rise 
in cell viability with any concentration supplemented 
(Figs. 3.3.1.2. and 3.3.1.3., respectively). Both p-oils 
induced cytostasis in the range 50 to 60mg/l and cyto­
toxicity with greater concentrations, although p-CO was 
slightly more effective than p-MO. Cell viability was 
reduced to 51.2% and 68.7% with 100mg/l p-CO and p-MO, 
respectively, thus ID50 values could not be calculated.
No significant change in cell viability occurred with 
dosage of up to 50mg/l p-00 or 60mg/l p-LO, although 
20mg/l p-LO stimulated cell proliferation to a maximum 
of 107.5% (Figs. 3.3.1.4. and 3.3.1.6., respectively). 
These p-oils induced the greatest cytotoxicity with 
concentrations greater than 60mg/l, and reduced cel 1 
viability almost linearly to 13.4% and 20.9% with 
100mg/l p-oil, respectively. ID50 values for p-00 and 
p-LO were alike (about 86mg/l and 87mg/l, respectively), 
and this supported the similar effects these p-oils 
induced.
p-SSO dosage induced the greatest growth stimulatory and 
least limiting effects (Fig. 3.3.1.5.). Incubation with
10 or 20mg/l p-SSO had little effect on cell viability, 
but such was stimulated in the range 20 to 60mg/l p-SSO 
to a maximum of 115.4% with 40mg/l, and limited to 
approximate the cytostatic number (about 89%) with 
concentrations greater than 60mg/l p-SSO.
10mg/l p-EPO had little effect on cell viability, but 
concentrations of 20 to 60mg/l p-EPO were slightly 
growth limiting or cytostatic (Fig. 3.3.1.7.). Cell 
viability was not significantly altered with p-FO dosage 
up to 80mg/l, but was marginally stimulated to 105.4% 
with 40mg/l p-FO (Fig. 3.3.1.8.). Both p-oils, however, 
induced little cytotoxicity as relative cell viability 
was only slightly lower than the cytostatic number 
with 100mg/l p-oil (75.6% and 83.4%, respectively).
Cells were incubated with p-00 to correspond with its
ID50 (about 86mg/l) and dosed with varying amounts of 
albumin to exclude the possibility that the effects
induced with p-oil dosage were influenced by the amount 
of albumin bound to the FA's. Five points were chosen 
around which to vary the albumin concentration, keeping 
the p—oi1 concentration fixed, viz. two points above, 
two points below, and the ID5o Df p-00. The appropriate 
amount of albumin was added to these cultures to give 
the desired concentrations. The results are shown in 
Fig. 3.3.1.9., and indicated that the concentration of 
p-00 supplemented reduced cell viability to about 50% of 
controls, and that such was not significantly influenced
by different albumin concentrations. Exclusion of the 
synergistic involvement of albumin therefore implied 
that the effects induced with the p-oils were attributed 
solely to the exogenous FA's.
Rat aortic endothelial cells were subsequently plated 
and dosed appropriate!y with 0, 20, 40 or 60mg p-oil/1 
culture medium in sufficient amounts for all qualitative 
and quantitative analyses to be performed. Cell 
viabilities were assessed upon harvesting, and found not 
to be statistically different from those in Figs.
3.3.1.1-3.3.1.8. All further biochemical assays were 
performed on these samples.
3.3.2 Effects of pseudo-Oils on Total Protein.
The results obtained from the determination of total 
protein in control and dosed cells are shown in Table 
3.3.2.1. as jug total protein/10& cells seeded.
181.1jug protein was measured per 106 control cells 
seeded, while cells incubated with 60mg/l p-CO exhibited 
the lowest protein levels (174.2jug/106 cells seeded). 
All other dosed cells contained more protein than 
controls, and the highest amount measured was 254.7jug 
protein/106 cells seeded (with 40mg/l p-SSO).
p-Oil dosage induced concentration dependent changes in 
cellular protein. Total protein concentrations increased 
in direct correlation with the amount of p-00 dosed, but 
were generally inversely related to the p-CO, p-MO, p-LO 
or p-EPO concentration supplemented. Uith p-SSO or p-FO 
incubation, however, the highest protein concentrations 
measured were with a concentration of 40mg/l.
The protein content of cells derived from rat aortic 
endothelium. expressed as jug total protein/106 rp1 Is 
seeded.
pseudo­
Oil
CELLS
(mg/1) 0 20 40 60
Control 181.1
CO 212.3 188.1 174.2
MO 195.0 195.5 188.5
00 198.4 215.7 226.1
SSO 201.5 254.7 201.9
L0 227.9 195.0 187.5
EPO 201.9 195.4 194.2
F0 184.6 227.9 219.3
3.3.3 Effects of Pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Rat Aortic 
Endothelium.
Table 3.3.3.1. shows the FA spectra of rat aortic 
endothelial cells incubated with 0, 20, 40 or 60mg/l of 
each p-oi1.
Control cells exhibited a FA spectrum in which no one FA 
was present in amounts greater than 20.5% (for 16:0). 
Other FA's contributing *5.0% to the total control 
spectrum included 18:0 (19.4%), 16:lw9 (6.1%), 18:lw9
(15.0%) and 22:4w6 (13.5%). The remaining 25.5% was made 
up of small amounts (<5.0%) of 18:2u6, 18:3w6, 18:3w3, 
18:4w3, 20:3u6, 20:4w6, 20:4w3, 20:5cj3, 22:5w6, 22:5w3
and 22:6w3. The above FA's were detected in varying 
amounts in the dosed cells.
In general, 16:0 levels were variable, and 18:lw9 levels 
similar, between control and dosed cells, while 16:lw9 
and 18:0 percentages were higher in control cells. Dosed 
cells contained at least twice as much 18:2u6 than 
controls, w6 PDFA levels were variable depending on the 
p-oil and concentration supplemented, while small but 
significant increases in 22:5w3 and 22:6u3 were detected 
in dosed cel Is.
16:0 levels were increased with dosage of 20mg/l p-CO 
(27.5%), but parallel to controls (20.5%) with 40mg/l
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n" is 
the number of experiments. 'Cp-OilD* refers to the
pseudo-oil concentration used.
The fatty acid spectrum of cells derived from rat aortic
endothelium»
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p-CO (19.9%), and decreased with 60mg/l p-CO (16.7%). 
16:lu9 levels decreased considerably with 40 and 60mg/l 
(1.5% and 1.4%, respectively vs 6.1% in controls), while 
notable increases in 18:0, 20:0 and 18:lu9 occurred with 
60mg/l (26.1%, 2.5% and 24.2% vs 19.4%, 0% and 15.0% in 
controls, respectively). Dosed cells contained 4.7% to 
11.6% 18:2w6 and 0.6% to 2.2% 18:3w3 (2.8% and 0.2% in 
controls, respectively), and the greatest increase in 
22:4w6, 22:5cj6, 22:5u3 and 22:6w3 occurred with 40mg/l 
P-CO (19.7%, 2.3%, 3.3% and 5.3% vs 13.5%, 0.9%, 1.2% 
and 1.7% in controls, respectively).
p-MO dosage induced an overall increase in 16:0 levels 
(20.2% to 26.1% vs 20.5% in controls), a decrease in 
16:lu9 and 18:0 (4.1% to 4.7% and 13.7% to 16.3% vs 6.1% 
and 19.4% in controls, respectively), but little change 
in 18:lu9 (14.7% to 18.9% vs 15.0% in controls). 18:2u6 
incorporation increased significantly from 8.2% to 9.2% 
and 10.8% with 20, 40 and 60mg/l p-M0, respectively 
(2.8% in controls). 20:4w6 was only increased with 
40mg/l (6.0% vs 4.1% in controls), although 18.9% and 
16.3% 22:4io6 was found with 20 and 40mg/l , respectively 
(13.5% in controls). Small but significant increases in 
22:5u3 (2.0% to 2.6%) and 22:6u3 (2.9% to 3.4%) were 
also found (1.2% and 1.7% in controls, respectively).
Supplementation with 20, 40 or 60mg/l p-00 resulted in 
concentration dependent 18:lu9 incorporation (21.5%, 
29.5% and 35.1%, respectively vs 15.0% in controls),
followed by a concommitant decrease in both 16:lu9 
(6.0 %, 5•6% and 3.8%, respectively vs 6.1% in controls) 
and 18:0 (11.5%, 10.7% and 10.3%, respectively vs 19.4% 
in controls), but little overall change in 16:0 levels 
(23.4%, 17.8% and 21.6%, respectively vs 20.5% in 
controls). Neither 18:3w6, 20:3w6 nor 20:4w6 levels were 
increased, despite 18:2w6 and 20:2U)6 incorporation, 
although 18.0% 22:4w6 and 1.3% 22:5w6 were detected 
with 20 and 40mg/l p-00 (13.5% and 0.9% in controls, 
respectively). Dosed cells also contained slightly 
elevated proportions of 22:5u3 and 22:6w3, especially 
with 40mg/l (2.4% and 3.4% vs 1.2% and 1.7% in controls, 
respective!y).
p-SSO supplementation had little effect on 18:lw9, but 
decreased overall 16:0, 16:lu9 and 18:0, levels (15.0%, 
20.5%, 6.1% and 19.4% in controls, respectively). 
2.8%, 19.4%, 21.6% and 19.0% 18:2w6 were found with 
dosage of 0, 20, 40 or 60mg/l p-SSO, with small amounts 
of 20:2u6 detected over the entire range dosed (0.5% to 
1.5% vs 0% in controls). 18:3w6 was increased only with 
dosage of 20mg/l p-SSO (1.7% vs 0.8% in controls), and 
20:3w6 and 20:4w6 were decreased over the entire range 
dosed. However, 20.4% and 15.0% 22:4w6 were found with 
20 and 40mg/l, respectively, and 1.5% 22:5u6 with 40mg/l 
(13.5% and 0.9% in controls, respectively). Increases in 
22:5u3 and 22:6w3 were also detected, especially with 
40mg/l (2.3% and 3.3% vs 1.2% and 1.7% in controls,
respectively).
The results obtained for cells dosed with 20, 40 or 
60mg/l p-LO indicated concentration dependent 18:3w3 
incorporation (3.8%, 8.4% and 11.4%, respectively vs 
0.2% in controls). 18:4u3 increased significantly only 
with 60mg/l (7.3% vs 3.9% in controls), although 22:5w3 
and 22:6u3 were enhanced slightly with 20mg/l, and 
approximately two fold with 40mg/l, compared to controls 
(1.2% and 1.7%, respectively). 16:0 levels dropped from 
27.3% to 18.3% and 6.5%, and 18:0 increased from 13.9% 
to 15.8% and 28.0% with 20, 40 and 60mg/l p-LO (20.5% 
and 19.4% in controls, respectively). 6.9% 16:lw9 was 
found with 20mg/l, but this decreased to 1.0% and 0.7% 
with 40 and 60mg/l, respectively (6.1% in controls), and 
18:lw9 levels increased significantly only when 60mg/l 
p-L0 was dosed (22.5% vs 15.0% in controls). 18:2w6 
percentages ranged from 10.5% to 15.6% (2.8% in 
controls), with 1.2% 18:3u6 detected with 20mg/l (0.8% 
in controls), and 5.1% 20:4w6 with 40mg/l (controls 
4.1%). There was, however, a concentration dependent 
decrease in 22:4u6 from 13.5% in controls to 0.7% with 
60mg/l, although 1.4% 22:5u6 was detected with 40mg/l 
(0.9% in controls).
16:0 amounts ranged from 16.3% to 27.7% with p-EP0 
incubation (20.5% in controls), while overall 16:lw9, 
18:0 and 18:lu9 levels were slightly decreased (6.1%,
19.4% and 15.0% in controls, respectively). 18:2w6 
incorporation was marked (13.4%, 20.1% and 19.4% with 
20, 40 and 60mg/l p-EPO, respectively vs 2.8% in 
controls), with up to 1.0% 20:2u6 detected (0% in 
controls). With the exception of 2.7% 22:5w6 with 
40mg/l p-EPO (0.9% in controls), u6 PDFA levels were 
parallel to controls, or decreased, although up to 2.2% 
22:5w3 and 2.9% 22:6u3 were detected (1.2% and 1.7% in 
controls, respectively).
Incubation with 20mg/l p-FO resulted in significant 16:0 
incorporation (29.4%), while 18:0 percentages were 
slightly decreased over the entire range dosed, in 
relation to controls (20.5% and 19.4%, respectively). 
18:lw9 levels were parallel to controls (15.0%), with 
7.8% to 9.8% 16: lw9 and 7.6% to 8.2%. 18:2w6 detected 
(6.1% and 2.8% in controls, respectively). Uith the 
exception of 1.6% 22:5u6 with 40mg/l p-EPO (0.9% in 
controls), w6 series PDFA levels were parallel to 
controls, or decreased. 1.6%, 3.8% and 3.7% 20:5w3 were 
detected with 20, 40 and 60mg/l p-FO, respectively (3.3% 
in controls), although 22:5w3 levels were significantly, 
and 22:6w3 slightly, increased compared to controls 
(1.2% and 1.7%, respectively).
3.3.4 Effects of pseudo-Oils on Lipid Peroxide
Format i on.
Table 3.3.4.1. shows the 1ipoperoxides measured in the 
cultured cells and their respective growth media. The 
values are shown as nmoles MDA/106 cells, but in the 
case of the spent incubation media, this reflects the 
nmoles of MDA in the volume of medium from which lxlO6 
cells were obtained.
Lipid peroxide formation in dosed cells ranged from 0.7 
to 2.7nmoles MDA/106 cells (with 20mg/l p-FO and 60mg/l 
P-L0, respectively) compared to 0.7nmoles MDA/106 
controls cells. Lipid peroxide formation increased in an 
overal1 concentration dependent manner with increased 
amount of p-oil dosed. Cells incubated with 20mg/l p-oil 
generally induced <1.0nmole MDA/106 cells, while amounts 
ranged from 1.1 to 2.3 and 1.1 to 2.7nmoles MDA/106 
cells with supplementation of 40 or 60mg/l p-oil,
respectively. No clear relationship between lipid 
peroxidation and degree of p—oil unsaturation was 
evident, although cells incubated with 40 or 60mg/l p-LO 
generated the largest 1ipoperoxide amounts at these 
concentrations (2.3 and 2.7nmoles MDA/106 cells,
respectively). Lipid peroxides were, however, absent 
from all spent media.
Lipoperoxide formation by rat aortic endothelial cultures 
incubated with p-oils. expressed as nmoles MDA/10S cells.
pseudo­
Oil
CELLS
(mg/1) 0 20 40 60
Control 0.7
CO 1.1 1.8 1.7
MO 0.9 1.1 1.4
00 1.3 00•rH 1.9
SSO 0.9 1.3 1.1
L0 0.9 2.3 2.7
EPO 0.9 1.1 1.7
F0 0.7 1.1 1.8
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - -
SSO - - -
L0 - - -
EPO - - -
FO - - ' -
3.3.5 Discussion.
No reference has been found in the 1iterature in which 
the effects of FA's on the growth of rat aortic 
endothelial cells has been found. This study showed that 
p-oil supplementation affected rat aortic endothelial 
cell viability (Figs. 3.3.1.2-3.3.1.8. ). However, it was 
unclear whether PUFA-rich p-oils generally exhibited 
greater growth stimulatory or cytotoxic potential than 
monoenoic or saturated FA-rich p-oils as the effects 
induced were not consistent with the degree of p-oil 
unsaturation. This may relate to differences in p-oil FA 
composition (Table 2.3.3.2.) and to FA's in the p-oils 
acting synergistica11y or antagonistically with each 
other to modulate the effects induced. Such may explain 
why p-oils of similar FA composition (p-EPO and p-SSO) 
induced different effects. The large amount of LA in 
p-EPO and p-SSO (about 70%) probably accounted for the 
effects these p-oils induced, although the greater 
capability for growth limitation and inability to 
stimulate cell proliferation significantly with p-EPO 
dosage may have related to the presence of about 9% GLA 
in p-EPO only. These findings implied LA involvement in 
the stimulation of cell proliferation and that GLA was a 
more potent growth inhibitory agent than LA. The large 
proportion of ALA in p—L0 and 0A in p—00 (approximately 
63% and 71%, respecti vel y) probably accounted largely 
for the extensive toxicity these p-oils induced with
high concentrations dosed, unlike both p-EPO and p-SSO. 
These moieties therefore appeared considerably more 
cytotoxic than LA, and such could reflect differences in 
the number and position of double bonds in these C18 
FA's.
Rat aortic endothelial cells incorporated the exogenous 
FA's dosed (Table 3.3.3.1.), thus the p-oils may have 
induced their effects by alterations in membrane 
fluidity as there is substancial evidence to suggest 
that dietary supplementation with FA's induces changes 
both in membrane physical properties and membrane- 
associated cell functions and (King et al 1971, Ginsberg 
et al 1981, Simon et al 1982 and Stubbs et al 1984). 
Incubation with large amounts of p-00 or p-LO may have 
increased the membrane unsaturation index to such an 
extent that cell viability could not continue. In 
contrast, the large complement of saturated FA's 
(approximately 95?£) and absence of PUFA's in p-CO could 
have inhibited cell viability with high concentrations
by shifting membrane fluidity to a less stable state by
increasing its rigidification. Such may explain the
greater inhibition of cell viabi1ity with high
concentrations of p-CO than p-MO, p-SSO, p-EPO or p-FO. 
On the other hand, the finding that p-FO had little 
overall effect on cell viability may relate to its more 
even balance of saturated, monoenoic and polyenoic FA's.
The cel lular protein concentrations reported with p-oil 
dosage (Table 3.3.2.1.) generally paralleled the changes 
observed in cell viability (Figs. 3.3.1.2-3.3.1.8.). The 
highest protein concentration was for cells dosed with 
40mg/l p-SSO, which corresponded to the greatest cell 
viability increase. This may have represented increased 
cell number, but with constant or increased protein per 
cell. The latter possibility seemed more likely as 
enhanced protein levels were measured even when cell 
proliferation was parallel to controls, or limited, with 
p-oil supplementation. The finding that dosed cells 
contained more protein than controls when cell viability 
was not significantly impaired indicated that p-oil 
FA's stimulated protein synthesis, possibly when the 
requirement for lipid metabolising enzymes increased. On 
the other hand, decreased protein only with 60mg/l p-CO 
dosage could have represented decreased cell numbers 
either with constant or decreased protein per cell.
Endothelial cells play a central role in eicosanoid, and 
especially prostacyclin, production, and therefore in 
vascular homeostasis (Moncada et al 1976a). Thus, the 
ability to desaturate FA's to generate eicosanoid 
precursors is of prime importance. The data in Table
3.3.3.1. indicated that cultured rat endothelium has the 
capability to desaturate and elongate PUFA's. Evidence 
for J6D, J5D, J4D and elongase expression were found 
with both u3 and u6 series PUFA's with p-oil dosage. The
finding that J6D and J5D product levels were generally 
lower, and that J4D substrates and products were higher, 
in dosed cells than in controls implied that the initial 
reaction steps in the desaturase cascade occurred 
rapidly. J4D product formation was more limited with 
w6 than u3 PUFA substrates, and this confirmed the 
preference for U)3 desaturase substrates (eg. Brenner 
1974 and Kanau et al 1977). The formation of 22:5w3 and 
22:6u3 even with p-oils which did not contain w3 PUFA's 
implied that such p-oils enhanced desaturation and 
elongation of cellular u3 PUFA's, and such may reflect a 
mechanism to restore membrane fluidity altered with 
exogenous FA incorporation.
Hornstra et al (1981) showed the endothelium of the rat 
to be very specific in the way in which it metabolises 
long chain polyenoic FA's. These workers found that rat 
aorta endothelium PGL 20:4u6 levels were low when fed 
diets rich in 18:2u)6, implying inability of these cells 
to express the rate limiting enzyme, J6D. Low 20*4w6 
levels were also found with dosage of p-oils rich in 
18:2u6 (p-EPO or p-SSO) in our study (Table 3.3.3.1.). 
However, increased 22:4u6 detected with 20mg/l p-SSO, 
and enhanced 22:5w6 levels with 40mg/l p-SSO and p-EPO 
were indeed consistent with at least some expression of 
desaturase cascade enzymes. Hornstra et al (1981) did 
not comment on the levels of these moieties, and 
decreased 20:4u6 may merely have reflected further
metabolism to 22:4w6 and/or 22:5u)6. Hornstra et al 
(1981) also found low 20:4u6 levels when fish oil was 
fed, but 20:5w3 and 22:6u3 increased up to 4.0^ in the 
vessel walls. Their findings supported the data in Table
3.3.3.1. with p-FO dosage, although the increments we 
showed in 20:5u3 and 22: 6io3 were not as great. On the 
other hand, 22:5w3 levels increased by up to 6.8^ with 
p-FO dosage, and 22:5w6 increased almost 2 fold with 
40mg/l p-FO. The data from both studies were nonetheless 
consistent with elongase and J4D expression.
Decreased 16:0 and increased 18:0 levels when rat 
aortic endothelial cells were incubated with 60mg/l p-CO 
or p-LO suggested that 16:0 was elongated, and the 
concommitant increase in 18:lu9 indicated the potential 
for A9D expression (Table 3.3.3.1.). 16:lw9 elongation 
could possibly be excluded as contributing to the 
enhancement of 18:lu)9 since the incorporation of 16:lu)9 
with p-FO supplementation did not produce a concommitant 
increase in 18:lw9. Both 18:3u3 and 18:2w6 competitively 
inhibit desaturation of 18:lw9 (Brenner et al 1966, 
1969, Brenner 1977, 1982 and Holman 1986b). Relative EFA 
percentages were enhanced with p-oil incubation (Table
3.3.3.1. ), and such probably explains the lack of 20:3w9 
formation despite significant 18:lu9 incorporation with 
p-00 supplementation, significant 18:lu9 formation with 
60mg/l p-CO or p-LO dosage, and the capability of these 
cells to express A6D and J5D.
Supplementation with 20, 40 or 60mg/l p-oil induced no 
significant growth limitation or cytotoxicity (Figs.
3.3.1.2-3.3.1.8.), thus it was unlikely that such 
limited the extent of desaturase cascade enzyme 
activity reported (Table 3.3.3.1.). It was more likely 
that the relative amounts of cellular FA's, both of 
the same and different series, modulated desaturase 
expression by competitive interactions which have been 
well documented (eg. Garcia et al 1956, Brenner et al 
1966, Brenner 1974, Ul1 man et al 1971, de Schriver et 
al 1982 and Nassar 1986). w3 PUFA^s were desaturated and 
elongated to a greater extent than w6 PUFA's (Table
3.3.3.1.), thus it was possible that the w3 PDFA's 
formed suppressed, or inhibited, u6 PUFA metabolism, 
depending on the overall w3/w6 PUFA balance in the cell. 
On the other hand, incubation of cells with saturated 
FA-rich p-oils (p-CO or p-MO) could have induced a 
relative EFA/PDFA deficiency, and such may have enhanced 
desaturase cascade enzyme expression in an attempt to 
restore membrane PUFA levels.
The results presented in Table 3.3.4.1. indicated that 
rat aortic endothelial cells exhibit intact enzymic 
and/or non-enzymic mechanisms for the production of 
1ipoperoxides. Control cell lipid peroxides reflected 
oxidation of endogenous unsaturated FA's, whereas 
increased lipid peroxide production in dosed cells 
reflected oxidation of incorporated exogenous (p-oil)
unsaturated FA's. The finding that lipid peroxide
generation increased overall as greater amounts of p-oil
/
were supplemented was consistent with saturation of the 
protective mechanisms against fi%ee radical production, 
eg. glutathione peroxidase, and therefore increased 
FA availability for oxidation. However, the similar 
lipid peroxide amounts formed with incubation of p-CO 
or p-MO compared to p-00, p-SSO, p-EPO or p-FO, despite 
differences in p-oil FA composition and unsaturation 
(Table 2.3.3.2.), suggested that the substrates for 
1ipoperoxidation in the latter group were not so readily 
accessible to oxidation, possibly because they were 
present as components of complex membrane lipids. The 
absence of 1ipoperoxides in the spent medium of al1 
dosed cultures indeed supported p-oil FA incorporation. 
It was also possible that incubation with p-CO or p-MO 
increased, or that p-00, p-SSO, p-EPO or p-FO decreased, 
the rate of PGL turnover and therefore the size of the 
FFA pool. The above mechanisms could also explain the 
greatest cellular 1ipoperoxide amounts measured with 40 
or 60mg/l p-LO supplementation, which probably related 
to the large amount of ALA in p-LO (about 63%) and its 
susceptibility to oxidation.
Measurement of relatively low 1ipoperoxide levels in 
dosed cells and their absence in all spent media (Table
3.3.4.1.) correlated with the lack of significant 
cytotoxicity induced with dosage of up to 60mg/l p-oil
(Figs. 3.3.1.2-3.3.1.8.). This suggested 1ipoperoxide 
involvement in the modulation of cell proliferation* 
although no correlation with cytotoxicity could be 
established. Lipoperoxide amounts greater than those 
reported with dosage of 60mg/l p-oil should, however, 
not be overlooked as a possible mechanism involved in
the modulation of cytotoxic i ty. Overa11 * it seems 1ikely
that the modulation of rat aortic endothelial cel 1
viability relates both to 1ipoperoxides and alterations
in membrane fluidity.
3.4 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM RAT SKELETAL MUSCLE.
3.4.1 Effects of pseudo-Oils on Cell Viability.
Cells were examined microscopically before, during and 
after each experiment, and at no time were changes seen 
in the morphology of control or p-oil dosed cells, 
except for cytoplasmic droplets observed with p-oil 
incubation at high concentrations in some instances.
Final medium albumin concentrations ranging from
0 to 250mg/l induced no significant effect on cell 
viability (Fig. 3.4.1.1.). The effects induced with the 
p-oils dosed were therefore a result of the exogenous 
FA's and not the albumin used as FA carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period 
was 10.6xl04/ml. This equated to about 76% of the final 
control cel 1 number at the end of the 48 hour incubation 
period, and represented the cytostatic number. Only 
p-oil concentrations limiting cell viability to
significantly below 76% were considered cytotoxic.
The results of the incubation of cells with p-oils are 
depicted in Figs. 3.4.1.2-3.4.1.8. Cell proliferation 
was enhanced only with certain concentrations of p-SSO, 
P“EP0 or p-LO, all p-oils exhibited growth limiting
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where 'n* 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.4.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 3.4.1.2-3.4.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 3.4.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to 50% of the controls.
A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 5.4 12
25 102.3 4.2 12
50 100.7 4.2 12
75 98.9 4.2 12
100 103.6 4.6 12
125 96.7 in 12
150 97.9 6.2 12
175 101.4 4.4 12
200 99.1 2.3 12
225 98.1 4.5 12
250 100.8 3.7 12
pseudo-Oi1 
Concentration 
(m g / 1 )
Mean ±s.e.m . n
0 100.0 2.8 6
10 100.2 Is-in 6
20 92.2 2.4 6
30 83.6 3.0 6
40 87.6 4.7 6
50 88.4 4.4 6
60 73.7 4.0 6
70 53.5 3.3 6
80 45.4 2.3 6
90 38.0 3.2 6
100 CO o h-* CD 6
Fig. 3 ♦ 4.1 ♦ 3.
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 1.9 6
10 102.7 2.2 6
20 102.1 2.1 6
30 100.0 2.8 6
40 94.2 2.5 6
50 97.6 2.4 6
60 95.4 2.7 6
70 97.3 2.9 6
80 90.6 2.7 6
90 77.2 1.5 6
100 74.8 2.7 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 1.1 6
10 99.8 2.7 6
20 96.8 1.4 6
30 98.0 1.8 6
40 99.8 1.7 6
50 99.8 1.2 6
60 92.6 in• 6
70 84.7 2.0 6
80 89.6 3.1 6
90 83.5 2.3 6
100 79.0 3.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.1 6
10 116.9 3.9 6
20 106.7 3.7 6
30 99.8 2.6 6
40 107.2 4.3 6
50 102.8 5.3 6
60 96.4 5.2 6
70 88.3 4.2 6
80 91.0 6.2 6
90 75.1 2.8 6
100 94.3 4.8 6
pseudo-Oi1 
Concentration 
< m g / 1 )
Mean ±s.e.m . n
0 100.0 2.8 6
10 99.6 2.7 6
20 95.0 3.4 6
30 94.6 5.2 6
40 99.3 4.2 6
50 98.4 4.0 6
60 106.1 1.6 6
70 90.9 1.2 6
80 89.6 1.7 6
90 79.7 2.6 6
100 61.4 3.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.7 6
10 107.9 2.3 6
20 105.1 3.8 6
30 90.7 3.2 6
40 83.6 3.3 6
50 74.5 3.4 6
60 29.9 2.5 6
70 3.0 1.1 6
80 0.2 0.2 6
90 o•o o•o 6
100 0.0 oo 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.2 6
10 84.0 3.1 6
20 77.9 3.3 6
30 79.3 4.3 6
40 79.5 3.5 6
50 75.9 2.6 6
60 74.2 3.2 6
70 60.8 3.1 6
80 60.8 3.4 6
90 56.2 2.5 6
100 25.0 2.3 6
A1bumin 
Concentration 
< mg/1)
Mean ±s.e.m. n
0 100.0 2.9 6
100 55.5 5.6 6
125 52.1 4.4 6
137.5 50.0 3.7 6
150 52.3 3.6 6
175 50.5 4.4 6
potential dependent on the concentration dosed, while 
significant cytotoxicity was induced only with p-CO, 
p-FO or p-EPO incubation.
10mg/l p-CO had little effect on cell proliferation, but 
greater amounts dosed induced an overall concentration 
dependent reduction in cell viability (Fig. 3.4.1.2.). 
Cytostasis was induced with 60mg/l p-CO, while 50% of 
cells remained viable with about 75mg/l p-CO (IDso), ancj 
30.4% with 100mg/l p-CO.
Cell proliteration approximated to controls with dosage 
of up to 80mg/l p-MO or 60mg/l p-00 (Figs. 3.4.1.3. and
3.4.1.4., respectively). Greater amounts incubated were 
growth limiting, and 74.8% and 79.0% of cells remained 
viable with 100mg/l p-MO or p-00, respectively, which 
approximated to the cytostatic number (about 76%). Cell 
viability was stimulated to 116.9% with 10mg/l p-SSO, 
ranged from 99.8% to 106.7% with concentrations between 
10 and 60mg/l p-SSO, and was 1imited with greater 
amounts dosed to a minimum of 75.1% with 90mg/l p-SS0 
(Fig. 3.4.1.5.). No cytotoxicity was induced with p-M0,
P-00 or p-SSO dosage, thus ID50 values could not be 
calculated.
Cell viability ranged from 94.6% to 106.1% with dosage 
of up to 60mg/l p—L0, but was reduced in a concentration 
dependent manner to 79.7% with 90mg/l p-L0 (Fig.
3.4.1.6.). Despite cytotoxicity with 100mg/l p-L0, no
ID50 value could be calculated as cell viability was 
61.4*.
The cell viability changes induced with p-EPO incubation 
followed a sigmoidal relationship (Fig. 3.4.1.7.). Cell 
proliferation increased to 107.9* and 105.1* with 10 and 
20mg/l p-EPO, respectively, was progressively reduced to 
equate the cytostatic number (about 76*) with 50mg/l 
p-EPO, and was markedly inhibited with greater amounts 
dosed. p-EPO was the most cytotoxic p~oil dosed since a 
concentration of about 55mg/l reduced cell viability to
50* of controls (ID^o), and practically all cells took 
up Trypan blue with concentrations of 70mg/l or greater.
Cell viability was effectively limited to 84.0* with 
10mg/l p-F0 (Fig. 3.4.1.8.), and ranged from 74.2* to 
79.5* when amounts of 20 to 60mg/l p-F0 were incubated 
( cytostasis). Supplementation with higher concentrations 
induced cytotoxicity. Cell viability was reduced by half 
with about 92mg/l p-F0 (ID5 0), and by three quarters 
with 100mg/l p-F0.
To exclude the possibility that any of the effects 
observed with p-oil dosage were influenced by the amount 
of albumin bound to the FA's, cells were incubated with 
a fixed amount of p-oil (55mg/l p-EP0, ID5o) and dosed 
with varying amounts of albumin. Five points were chosen 
around which to vary the albumin concentration, keeping 
the p-oil concentration fixed, viz. two points above,
two p o i n t s  bol ow^ and th© IDcn _.p c d h  t u  • *.=»° or p-hru. I he appropriate
amount of albumin was added to these cultures to give 
the desired concentrations. The results shown in Fig. 
3.4.1.9. indicated that the concentration of p-EPO dosed 
reduced cell viability to approximately 50% of controls, 
and that such was not influenced by different albumin 
concentrations. Exclusion of the synergistic involvement 
of albumin indicated that the effects induced with the 
p-oils could be attributed solely to the exogenous FA's.
Rat skeletal muscle cells were subsequently plated and 
dosed appropriately with 0, 20, 40 or 60mg p-oil/1
culture medium in sufficient quantities for all the 
quantitative and qualitative analyses to be carried out. 
Upon harvesting, cell viabilities relative to controls 
were compared and found not to be statistically 
different from those obtained in Figs. 3.4.1.1-3.4.1.8., 
thus al1 further biochemical assays were performed on 
these samples.
3.4.2 Effects of pseudo—Oils on Total Protein.
The protein concentrations for cells supplemented with 
0, 20, 40 or 60mg/l p-oil are shown in Table 3.4.2.1. 
as jug total protein/106 cells seeded.
Cells dosed with 60mg/l p-EPO contained only 362.4jug 
protein/106 cells seeded compared to 401.7jug protein/106 
control cells seeded. All other dosed cells, however, 
contained significantly more protein than controls, with 
amounts ranging from 451.4 to a maximum of 607.4^9 
protein/106 cells seeded (with 60mg/l p-FO and 20mg/l 
P-EP0, respectively). The changes reported in cellular 
protein were p-oil concentration dependent. Total 
protein levels increased in direct correlation with the 
amount of p-LO incubated, but were generally inversely 
related to the p-MO, p-SSO, p-EPO or p-FO concentration 
supplemented. Uith p-CO or p-00 dosage, however, the 
highest protein amounts measured were with a 
concentration of 40mg/l.
The protein content of cells derived from rat skeletal 
muscle, expressed as up total protein/10s cells seeded.
pseudo­
Oil
CELLS
(mg/1 ) 0 20 40 60
Contro1 401.7
CO 524.2 537.7 498.0
MO 551.1 537.9 537.9
00 499.7 597.7 504.4
SSO 602.5 569.8 481.4
L0 516.8 548.7 600.1
EPO 607.4 501.5 362.4
F0 563.5 499.7 451.4
3.4.3 Effects of pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Rat 
Skeletal Muscle.
Table 3.4.3.1. shows the FA spectra of rat skeletal 
muscle cells incubated with 0, 20, 40 or 60mg/l of each 
of the p-oils. The greatest amount of any single FA in 
control cells was 22.7% 22:4w6, but significant levels 
of 16:0 (17.8%), 18:0 (13.7%), 18:lu9 (13.7%) and 20:4u6 
(9.5%) were also found. Varying amounts of these FA's 
were found in the dosed cells.
16:0 and 16:lto9 percentages in dosed cells generally 
approximated to controls, or were decreased, while the 
converse was true for 18:0, 18:lw9 and 18:2w6. w6 PDFA 
levels were raised only with certain concentrations of 
some p-oils, although no increments in 22:5u6 were 
found. Dosed cells generally contained 18:4u)3 amounts 
parallel to, or greater than, controls, but 20:4w3, 
20:5w3, 22:5w3 and 22:6w3 were again increased only with 
certain concentrations of some p-oils.
15.1%, 16.8% and 24.0% 16:0 was found when cells were
dosed with 20, 40 or 60mg/l p-CO, respectively (17.8% in 
controls), although 16:lw9 was decreased (0.6% to 2.3% 
vs 3.9% in controls). 18:0 and 18:lu9 levels, in 
contrast, were significantly increased with 20mg/l p-CO 
(32.4% and 22.4%, respectively vs 13.7% in each 
control), but approximated to controls with 40 or
All values are tabulated as relative percent total 
Control values are reported as mean±s.e.m., where ‘ 
the number of experiments. 'Lp-0il3" refers to 
pseudo-oil concentration used.
area. 
n' is 
the
The fatty acid spectrum of cel la derived from rat 
skeletal muscle.
FATTY ACID 
SPECTRUM
m
CONTROLS 
(n=3 )
Cp -c o :
(mg/1)
20 : 40 : 60
Cp -m o :
(mg/l )
20 ! 40 ! 60
Cp-0 0 3  
(mg/1)
20 ! 40 ! 60
Cp-SSOU 
(mg/1)
20 ! 40 ! 60
Cp-LOH 
(mg/1)
20 ! 40 ! 60
Cp -e p o :
(mg/1)
20 ! 40 ! 60 20
Cp -f o :
(mg/1)
! 40 ! 60
s
A
16 :0 1 7.8±0 .05 1 5 .1 1 6 .8 24 .0 13 .3 15 .6 2 5 .4 16 .0 19 .4 1 2 .3 1 0 .4 18 .7 7 .9 1 6 .6 2 0 .5 2 2 .4 3 . 6 18 .6 4 .1 10 .6 1 7 .7 4 . 8
T
u
. 18 :0 1 3.7±0 .10 3 2 . 4 1 3 .9 16 .8 12 .0 16 .1 16 .2 12 .8 11 .9 2 4 .1 1 3 .6 1 2 .2 2 5 .8 2 0 . 7 13 .6 10 .6 13 .3 13 .1 12 .8 13 .0 13 .8 2 9 .9
R
A
2 0 :0 0 .3±0 .00 - 0 . 3 - - 0 . 4 0 . 3 - 0 . 4 - - 0 .1 - - 0 . 2 ‘ - - 0 . 2 - - 0 .1 -
T
F
2 2 :0 0 .2±0 .05 - 0 . 2 0 .1 0 . 1 0 . 1 0 . 1 - 0 . 1 - - 0 .1 - - 0 .1 _ - - - - 0 . 2 -
s . 2 4 : 0 0 .3±0 .00 — 0 . 6 — — 0 . 2 — - 0 . 1 - - - - - - - - 0 .1 - - 0 .1 -
u9
M
16 :1 3 .9±0 .25 0 . 6 1 . 6 2 . 3 1 . 2 0 . 8 5 . 9 1 .0 1 .4 1 . 1 0 . 4 1.1 0 . 8 0 . 7 1 .9 2 . 8 0 . 3 2 . 4 0 . 2 2 .1 4 .1 0 . 9
0
N
18 :1 1 3.7±0 .20 2 2 . 4 1 2 .3 14 .8 13 .0 13 .3 15 .5 23 .1 2 7 .5 2 8 . 3 3 0 . 4 15 .5 24 .7 18 .3 15 .4 18 .5 3 1 . 7 14 .1 30 .0 26 .1 12 .6 2 3 .8
0
S .
2 4 :1 — — — — — — — “ — — — — — — — — — - -
1 8 :2 3 .8±0 .10 3 . 6 3 . 2 3 .6 5 . 3 4 . 9 5 .1 5 . 5 6 . 0 1 8 .2 2 4 . 7 9 .0 26 .8 5 . 4 4 .0 7 . 2 3 2 .1 6 . 9 3 2 .7 17 .9 3 . 6 2 4 .2
u6
1 8 :3 - * «■_ - - - - - 0 . 2 - - - - - 0 .1 - - - - - - 0 . 1 -
P
2 0 : 2 — - - - — — - 0 . 4 1 .0 2 . 0 - 0 . 2 - - - - - 0 . 1 - 0 . 2 0 . 1 -
0
l
2 0 : 3 1 .610 .10 0 . 9 1 . 7 2 .1 1 . 2 1 .7 1 .4 1 .4 1 . 4 1 . 9 2 . 5 1 .7 0 . 2 1.5 1.4 - 2.2 1.5 0.2 3.3 2.4 1.9
Y 
S .
20:4 9 .511 .00 7.1 11.7 12.2 10.4 11.7 9.5 9.3 8.9 2.8 3.2 7.6 1.7 8.2 7.1 7.8 2.9 5.6 2.3 4.3 10.7 2.4
22:4 2 2 .7±1 .40 10.9 26.4 10.3 32.7 21.9 13.8 18.8 9.6 2.3 4.9 22.0 3.1 16.1 24.5 17.2 3.5 26.0 2.2 3.2 15.9 1.9
22:5 2.810.00 0.4 1.8 0.3 0.5 2.5 — 0.8 2.5 0.4 0.4 2.7 0.2 1.9 1.4 1.4 0.3 2.2 0.3 0.4 2.3 0 . 1
18:3 0.510.05 - 0.4 0.5 0.4 0.4 0.4 0.6 0.8 3.0 - 0.2 - 1.4 1.5 6.0 - 0.5 - 0.7 0.4 -
u3 18:4 1 .H 0 .3 0 1.1 1.9 1.0 0.7 3.2 0.5 0.7 1.6 2.2 6.3 1.6 7.3 0.8 2.4 2.5 7.7 2.3 12.7 12.5 2.3 7.5
P
n
20:4 3 .310 .00 2.1 1.5 2.5 4.9 3.2 1 . 8 3.3 2.3 0.2 1.9 3.5 0.8 3.0 3.0 1.6 1.8 3.6 2.3 1.4 2.3 0.6
L
V
S.
20:5 0 .410 .10 0.2 1.7 3.0 0.2 0.2 0.3 0.2 0.2 0 . 1 - 0.2 - 0.2 0 . 1 - - 0.4 - 1 .0 2.3 0.7
22:5 2 .H 0 .1 0 1.7 3.2 3.2 2.2 2.8 2.3 3.2 2.6 0.5 0.7 2.0 0.3 3.3 1*.6 1.2 0.4 1.4 0 . 1 2.8 6.9 1.1
22:6 2 .H 0 . 1 0 1.6 0.9 3.3 1.9 0.9 1.9 2.7 2.3 0.6 0.6 1.7 0.2 1.9 1.2 0.8 0.3 1 .0 0 . 1 0.6 2.1 0.3
60mg/l p-CO. No significant changes in 18:2u6 or 18:3w3 
percentages were observed, but small increases in some 
PDFA's were found with incubation of 40 or 60mg/l p-CO. 
The most significant increases were for 22:4w6 (26.4% 
with 40mg/l vs 22.7% in controls) and 20:5w3 (1.7% and 
3.0% with 40 and 60mg/l, respectively vs 0.4% in 
controls), with smaller increments shown for 20:3w6, 
20:4u6, 18:4w3, 22:5w3 and 22:6u3.
Both 16:0 and 16:lw9 percentages were decreased with 
dosage of 20 or 40mg/l p-M0, but increased with 60mg/l 
p—MO (13.3%, 15.6% and 25.4%, and 1.2%, 0.8% and 5.9% vs 
17.8% and 3.9% in controls, respectively). 18:0 and 
18:lw9 levels ranged from lows of 12.0% and 13.0% with 
20mg/l p-MO, to highs of 16.2% and 15.5% with 60mg/l 
p-MO, respectively (13.7% in each control), while 4.9% 
to 5.3% 18:2w6 was found (3.8% in controls). Only 10.4%, 
11.7% and 9.5% 20:4w6 were detected with 20, 40 and 
60mg/l p-MO, respectively (9.5% in controls), although 
the elongation product, 22:4w6, was significantly raised 
with 20mg/l (32.7% vs 22.7% in controls). However, no 
increase in 22:5w6 was found in dosed cells (2.8% in 
controls). u3 PUFA's were absent in p-MO, yet 18:4w3 
and 22:5w3 were increased in cells dosed with 40mg/l 
p—MO (3.2% and 2.8% vs 1.1% and 2.1% in controls, 
respectively), while 20:4w3 was increased with 20mg/l 
p-MO (4.9% vs 3.3% in controls).
Concentration dependent 18:lw9 incorporation occurred 
with 20, 40 or 60mg/l p-00 incubation (23.1%, 27.5% and 
28.3%, respectively vs 13.7% in controls). 16:0, 16:lw9 
and 18:0 levels were generally lower than controls 
(17.8%, 3.9% and 13.7%, respectively), although 18:0 was 
significantly increased with 60mg/l p-00 (24.1%). 
Concentration dependent increases in 18:2u6 and 20:2w6 
were observed (5.5% to 18.2% and 0.4% to 2.0% vs 3.8% 
and 0% in controls, respectively), but w6 PDFA levels 
were parallel to controls, or significantly decreased. 
On the other hand, small increases in 18:3w3, 18:4w3, 
22:5w3 and 22:6w3 were found with p-00 incubation.
p-SSO dosage decreased overall 16:0 and 16:lu9 levels, 
significantly increased 18:0 only with 60mg/l (25.8% vs 
13.7% in controls), and raised 18:lu9 levels with all 
concentrations dosed (15.5% to 30.4% vs 13.7% controls). 
24.7% and 26.8% 18:2u6 were detected with 20 and 60mg/l 
p-SSO, respectively, but only 9.0% with 40mg/l (3.8% in 
controls). 18:3u6 was absent both in control and p-SS0 
dosed cells, 2.5% 20:3w6 was found with 20mg/l p-SS0 
(1.6% in controls), but no increases in 20:4u6, 22:4w6 
or 22:5w6 were detected. Surprisingly, 18:4u3 amounts 
were increased with p-SS0 incubation (1.6% to 7.3% vs 
1.1% in controls), but this did not induce significant 
increments in 20:4u3, 22:5u3 or 22:6w6.
16:0 levels increased to 16.6%, 20.5% and 22.4% with
20, 40 or 60mg/l p-|_0 incubation, respectively (17.8% in 
controls), while 18:0 decreased from 20.7% to 13.6% and 
10.6%, respectively (13.7% in controls). 16:lw9 amounts 
were decreased (0.7% to 2.8% vs 3.9% in controls), while 
18:lu9 percentages increased slightly (15.4% to 18.5% vs 
13.7% in controls). 4.0% to 7.2% 18:2u)6 was found (3.8% 
in controls), but w6 PDFA levels were not significantly 
increased. Cellular 18:3u3 amounts increased to 1.4%, 
1.5% and 6.0% with addition of 20, 40 or 60mg/l p-LO, 
respectively (0.5% in controls). Furthermore, increased 
levels of 18:4w3 were detected with 40 and 60mg/l p-LO 
(2.4% and 2.5%, respectively vs 1.1% in controls), and 
22:5w3 with 20mg/l p-L0 (3.3% vs 2.1% in controls), but 
no increment in 22*6w3 was found.
Supplementation with 20 or 60mg/l p-EPO caused a marked 
decrease in 16:0 (3.6% and 4.1%, respectively vs 17.8% 
in controls), but a significant increase in 18:lu9 
(31.7% and 30.0%, respectively vs 13.7% in controls). 
P-EP0 had little effect on 18:0 levels, induced a 
reduction in 16:lu9, and increased 18:2u6 levels nearly 
2 fold with 40mg/l and 10 fold with 20 and 60mg/l (6.9%, 
32.1% and 32.7%, respectively vs 3.8% in controls). 
18:3w6 was absent in control and dosed cells, but 2.2% 
20:3w6 was found with 20mg/l p-EPO (1.6% in controls) 
and 26.0% 22:4w6 with 40mg/l p—EPO (22.7% in controls). 
18:4u3 amounts were significantly increased over the 
range dosed (2.3% to 12.7% vs 1.1% in controls), yet the
levels of its products were not significantly raised.
16:0 and 16:lw9 levels were parallel to controls (17.8% 
and 3.9%, respectively), or significantly decreased, 
with p-FO incubation, whereas marked increases in 18:0 
were found with 60mg/l p-FO (29.9% vs 13.7% in controls) 
and 18:lu9 with 20 and 60mg/l p-FO (26.1% and 23.8% vs 
13.7% in controls). Significant increments in 18:2u6 and 
20:3w6 were detected with p-FO dosage, yet overall 
20:4u6, 22:4u6 and 22:5w6 percentages were decreased. 
22:6u3 levels were not increased, despite raised amounts 
of 22:5u3 found with 20 and 40mg/l p-FO (2.8% and 6.9%, 
respectively vs 2.1% in controls), and 18:4w3 and 20:5w3 
detected with all p-FO concentrations supplemented (2.3% 
to 12.5% and 0.7% to 2.3% vs 1.1% and 0.4% in controls,
respective!y).
3.4.4 Effects of pseudo-Oils on Lipid Peroxide
Formation.
The results obtained from the quantitation of lipid 
peroxides in rat skeletal muscle cultures are shown in 
Table 3.4.4.1., expressed as nmoles MDA/106 cells. In 
the case of spent incubation media, however, this 
represents the nmoles of MDA in the volume of medium 
from which lxlO6 cel Is were derived.
Lipid peroxide concentrations in dosed cells ranged 
from 0.1 to 8.0nmoles MDA/106 cells (with 20mg/l p—CO 
and 60mg/l p~EP0, respectively), compared to 0.Inmoles 
MDA/106 control cells. The 1ipoperoxide amounts measured 
both in the cells and spent medium varied with the p-oil 
supplemented, and generally increased in a concentration 
dependent manner. Cultures dosed with p-CO, p-MO or p-00 
induced 0.1 to 0.8nmoles MDA/106 cells, and a maximum of 
0.6nmoles MDA/106 cells was measured in the spent medium 
with p-MO (none in control medium). Surprisingly, cells 
supplemented with 20, 40 or 60mg/l p-L0 contained only 
0.2nmoles MDA/106 cells, although corresponding spent 
media lipid peroxides were the largest amounts measured 
(0.7, 2.1 and 3.9nmoles MDA/106 cells, respectively).
Similarly, p-FO induced only 0.2 to 0.6nmoles MDA/106 
cells, but 0.1, 0.5 and 1.4nmoles MDA/106 cells in the 
corresponding spent media, respectively. Only 0.3 and 
0.4nmoles MDA/106 cells were measured with incubation of
Table 3.&.A.1
Lipoperoxide formation by rat skeletal muscle cultures 
incubated uiith p~oils. expressed as nmoles MDA/106 cells.
pseudo­
Oil
CELLS
< m g / 1) 0 20 40 60
Control 0.1
CO 0.1 0.2 0.8
MO 0.2 0.3 0.4
00 0.5 0.7 0.6
SSO 0.3 0.4 7.7
L0 0.2 0.2 * 0.2
EPO 1.8 1.9 8.0
F0 0.2 0.2 0.6
pseudo- SPENT INCUBATION MEDIUM
Oil
( m g / 1 ) 0 20 40 60
Control -
CO - - -
MO 0.6 0.4 -
00 - - -
SSO - - -
L0 0.7 2.1 3.9
EPO - - -
F0 0.1 0.5 1.4
20 or 40mg/l p-SSO, respectively, compared to 7.7nmoles 
MDA/10^ cel Is with 60mg/l p—SSO, whereas p—EPO induced 
the largest cellular lipid peroxide amounts measured at 
any concentration (1.8, 1.9 and 8.0nmoles MDA/10& cells 
with 20, 40 or 60mg/l, respectively). However, neither 
p-SSO nor p-EPO induced any lipid peroxides in the 
corresponding spent media.
3.4.5 D i sc us s i on .
The effects of FA's on the growth of rat skeletal muscle 
have not been found in the literature, and this is the 
first report describing the modulation of such cell 
growth in culture with supplementation of exogenous FA 
mixtures mimicking the composition of dietary oils. The 
data reported in Figs. 3.4.1.2-3.4.1.8. showed that rat 
skeletal muscle cell viability was affected with p-oil 
supplementation. The effects induced, however, were 
not consistent with the degree of p-oil unsaturation, 
and it was unclear whether the potential to modulate 
cell pro 1iferation was greater with p-oils rich in 
polyunsaturated, monounsaturated or saturated FA^s. The 
p-oi1-specific effects induced rather appeared to relate 
to the unique FA composition of each p-oil (Table
2.3.3.2.), although the possibility also exists that 
certain effects could have been enhanced or deminished 
by the mediation of synergistic or antagonistic effects 
between FA's within any p-oil. The FA spectra of p-00, 
p-SSO and p-LO suggested that the effects induced with 
dosage of each p-oil related to the large amount of OA, 
LA or ALA present, respectively, and that these C18 FA's 
exhibited little, or no, growth inhibitory capability at 
the concentrations dosed. The FA composition of p-EPO 
was similar to that of p-SSO, although the mediation of 
significantly more growth limitation and cytotoxicity
with p~EPO dosage was consistent with the presence of 
approximately 9% GLA in p—EPO only. It was apparent from 
the above, therefore, that GLA exhibited greater growth 
limiting and cytotoxic ability than LA, ALA and OA. This 
may relate to the presence of a double bond at the 
ul2-position in GLA, and the fact that this moiety is a 
PDFA. Such may also explain the marked cytotoxicity 
induced with high concentrations of p-FO, which 
contained 18% EPA. Indeed, the finding that pronounced 
growth inhibition was induced with supplementation of 
p-EPO or p-FO, but not with p-MO, p-00, p-SSO or p-LO 
which contained insignificant PDFA amounts, implicated 
PDFA involvement in the modulation of cytotoxicity. On 
the other hand, the finding that cell viability was 
stimulated with certain concentrations of p-SSO, p-EPO 
or p-LO only, rich either in LA or ALA, implied EFA 
involvement in the enhancement of cell pro 1iferation.
Evidence to support exogenous FA incorporation was found 
with p-oil supplementation (Table 3.4.3.1.), hence the 
changes reported in cell viability could relate to 
differential uptake of p-oil FA's, alterations in 
membrane unsaturation and fluidity. It was possible 
that the abundance of saturated FA's (about 95%) in p-CO 
inhibited cell viability at high concentrations by
increasing membrane rigidification, whereas addition of 
large amounts of p—EPO or p—FO elevated the unsaturation 
index of the membrane sufficiently to induce cell death.
Modifications of the membrane PGL FA composition may 
desatabilise the membrane and induce changes in the 
activity of membrane-bound enzymes (Stubbs et al 1984 
and Spector et al 1985). A possible mechanism whereby 
these p-oils induced cell death may therefore relate to 
uncoupling of calcium ATPase activity and altered 
calcium transport. At this stage, however, the effects 
of FA's on sarcoplasmic reticulum calcium ATPase are 
unclear (Hidalgo et al 1982, East et al 1984, Almeida et 
al 1986, Hidalgo 1987, Infante 1987 and Stubbs et al
1990). On the other hand, maintenance of basal membrane 
fluidity may explain why p-MO, p-00, p-SSO and p-LO were 
not significantly cytotoxic. During periods demanding 
extra energy, skeletal muscle TAG stores are mobilised, 
releasing FFA's which this tissue can utilise as an 
energy source (Lehninger 1982). Skeletal muscle may 
therefore be well equipped to tolerate high FFA 
concentrations, and this could also partly explain the 
findings that many p-oils had little effect on cell 
viability, stimulated cell proliteration, or were merely 
growth limiting.
The changes in cellular protein concentrations reported 
with p-oil supplementation (Table 3.4.2.1.) reflected 
the changes induced in cell viability (Figs. 3.4.1.2­
3.4.1.8.). Enhanced cellular protein amounts with 20 and 
40mg/l p—SSO, 20mg/l p-EPO and 60mg/l p—L0 correlated 
with increased cell viabilities at these concentrations,
but it was apparent that increments in cell number alone 
could not justify the marked protein increases. This 
implied FA involvement in the stimulation of rat 
skeletal muscle protein synthesis, particularly since 
protein concentrations were significantly increased even 
when p-oils induced growth limitation and cytostasis. 
The extent to which protein synthesis was stimulated 
varied with dosage of identical amounts of different 
p-oils, even when such yielded similar cell numbers. 
This suggested that the capability to enhance protein 
synthesis varied with FA, and was probably relatable 
to FA structure and concentration in any p-oi1. The 
enhancement of protein synthesis with p-oil dosage may, 
nevertheless, reflect the extremely high metabolic 
activity of skeletal muscle in vivo (Lehninger 1982) and 
a mechanism whereby the cells enhanced the production of 
lipid metabolising enzymes in an attempt to metabolise 
the exogenous FA^s incorporated with p-oil incubation. 
On the other hand, the reduction of cellular protein 
concentations only with 60mg/l p~EP0 correlated with the 
marked cytotoxicity this p-oil induced, and reflected 
decreased cell numbers either with constant or decreased 
protein per cel 1 .
Comparison of control cell FA spectra with those 
from p-oil-dosed cells indicated the potential 
tured cells derived from rat skeletal muscle to
derived 
of cul- 
express
desaturase and elongase enzymes (Table 3.4.3.1.). The
capability for 16:0 desaturation and elongation, and 
18:0 desaturation to 18:lu9 via J9D, were suggested. 
However, it was apparent that delta-6-desaturation of 
18:lw9 was competitively inhibited by 18:2w6 and/or 
18:3u3 since evidence for J6D and subsequent elongase 
activities were found with both w3 and w6 series PUFA's 
as substrates. PDFA product formation was clearly more 
limited with w9 than w6, and U)6 than w3, series FA's, 
and this confirmed the established substrate preference 
(Brenner 1974, Mead et al 1976 and Kanau et al 1977). 
Increased 18:4w3 levels in cells supplemented with 
p-oils deficient in 18:3w3 was consistent with delta-6- 
desaturation of endogenous 18:3w3 and/or extramicrosomal 
retroconversion of 20:4w3. The significant increase in 
20:5u3 amounts with p-CO dosage implied J5D capability, 
and the finding that J5D expression was more restricted 
with supplementation of PUFA-rich p-oils supported the 
formation of 18:4u3 by retroconversion of 20:4u)3. Gavino 
et al (1981b) similarly showed limited conversion of 
20:3w6 to 20:4u6 via J5D in rodent smooth muscle cell 
cultures, which elongated 20:4u6, but did not desaturate 
22:4w6. The present study demonstrated elongation both 
of 20:4ui6 and 20:5w3, but the formation of small amounts 
of 22:6w3 only with p-CO or p-00 incubation reflected 
1imited/suppressed J4D activity. This explained the 
accumulation of the J4D substrates, 22:4w6 and 22:5w3, 
particularly with dosage of p-MO or p-FO, respectively.
Desaturation is regulated by competitive interactions 
between FA's of the same and different families (eg. 
Garcia et al 1965, Brenner et al 1966, Ullman et al 
1971, de Schriver et al 1982 and Nassar et al 1986), and 
this partly determined the pattern of desaturation and 
elongation reported in Table 3.4-.3.1. with p-oil dosage. 
Studies have also shown that dietary FA/s alter the 
lipid composition of microsomal membranes and that such 
is involved in the modulation of desaturase enzyme 
activity (Nervi et al 1968, Kurata et al 1980, Garda 
et al 1984, 1985 and Garg et al 1988a, 1988b, 1988c). 
Detection of increased PDFA levels with p-CO incubation, 
which contained about 95% saturated FA's and no PUFA's, 
implied enhanced desaturase cascade enzyme expression 
and subsequent desaturation and elongation of endogenous 
PUFA's. This reflected an attempt to re-establish 
membrane fluidity altered with uptake of exogenous 
saturated FA's. On the other hand, PDFA formation with 
dosage of PUFA-rich p-oils was consistent with the 
availability of desaturase cascade enzyme substrates. 
However, once optimal PUFA levels were established 
to maintain normal membrane fluidity and cellular 
functions, it was likely that desaturase cascade enzyme 
expression was suppressed by negative feedback reactions 
which have been well documented (Garcia et al 1965, 
Brenner et al 1966, Brenner 1974, Ullman et al 1971, de 
Schriver et al 1982 and Nassar 1986). Such probably
explains why long chain polyenoic FA levels were not 
markedly raised with dosage of PUFA-rich p-oils, despite 
incorporation of such moieties. The potential of these 
cells to desaturate and elongate FA's nevertheless 
reflects a mechanism to maintain its own FA levels.
Detection of large proportions of unsaturated FA's in 
control cells (Table 3.4.3.1.), but only small amounts 
of lipid peroxides (Table 3.4.4.1.) implied chemical and 
enzymic mechanisms of protection against free radical 
attack, eg. vitamin E and/or superoxide dismutase. It 
was also possible that most cellular unsaturated FA's in 
control cells were present as components of complex 
lipids, eg. membrane PGL's, which would therefore not be 
so readily accessible to oxidation. Increased lipid 
peroxide measurement in dosed cells, however, could have 
reflected saturation of the cellular anti-oxidant 
mechanisms induced with exogenous unsaturated FA uptake 
and/or increased cellular unsaturated FA availability. 
The lipid peroxides detected in dosed cells were 
nevertheless consistent with intact cellular enzymic 
and/or non—enzymic mechanisms for their generation, and 
reflected the p-oil concentration incubated, p-oil FA 
composition (Table 2.3.3.2.), and FA availability and 
susceptibility to oxidation.
The small increment in cellular 1ipoperoxides detected 
with p-CO or p-MO dosage (Table 3.4.4.1.) correlated 
with the large concentration of saturated FA's these
p—oils contained (Table 2.3.3.2.). Howeuer, quantitation 
of small cellular 1ipoperoxide amounts also with p-00, 
p-LO or p-FO incubation, despite these p-oils containing 
significant leuels of unsaturated FA's, implied that the 
substrates for peroxidation were lipid bound and stable. 
Furthermore, the finding that overal1 1ipid peroxide 
leuels were lowest in the cells and greatest in the 
spent medium with p—LO supplementation in the absence of 
cytotoxicity (Fig. 3.4.1.6.) suggested that the cellular 
lipid peroxides formed with incorporation of this p-oil 
were transfered into the incubation medium through the 
intact plasma membrane. This correlated with studies 
which haue implicated 1ipid peroxides in increasing 
membrane permeability (Chio et al 1969, Mead 1976, 
Tappel 1980, Gauino et al 1981c, Morisaki et al 1982b 
and Frankel 1984). This may also explain why cellular 
lipid peroxide leuels were greater in the spent medium 
than in the cells with p-FO supplementation. It was 
also possible that these medium 1ipoperoxides reflected 
released cellular FFA's which were oxidised extra- 
cel lularly by released cellular peroxidising enzymes. 
Neuerthe1 ess, measurement of the largest medium lipid 
peroxide amounts with p-LO or p-FO dosage correlated 
with the significant w3 PUFA leuels in these p-oils. The 
significantly greater concentration of ALA in p-LO than 
EPA in p—FO (approximately 63% and 18%, respectiuely) 
was consistent with the greatest medium 1ipoperoxide
levels measured, despite the greater susceptibility of 
EPA to oxidation.
The cellular lipid peroxides formed with p-SSO or p-EPO 
supplementation (Table 3.4.4.1.) probably related mainly 
to oxidation of incorporated free LA. Both p-oils 
exhibited similar FA compositions (Table 2.3.3.2.), but 
the presence of about 9 ’4 GLA in p-EPO only probably 
explains the greater lipid peroxides amounts induced 
overall with this p-oil. Morisaki et al (1984) have 
indeed shown that GLA generates large quantities of 
1ipoperoxides in rodent smooth muscle cell cultures, and 
that such could induce cytotoxicity. The greatest 
cellular 1ipoperoxide levels quantitated with dosage of 
60mg/l p-EPO correlated with the most extensive growth 
inhibition induced at this p-oil concentration (Fig.
3.4.1.7.), and suggested lipid peroxide involvement in 
the mediation of cytotoxicity. This supported current 
evidence which implicates that 1ipoperoxides affect 
normal cell metabolism and cause membrane damage (Ohio 
et al 1969, Mead 1976, Tappel 1980, Gavino et al 1981c, 
Morisaki et al 1982b and Frankel 1984). Demonstration 
of cell lysis and the absence of 1ipoperoxides in the 
spent medium with p-EPO supplementation implied that the 
cytotoxicity induced arose partly as a result of 
oxidation of membrane FA^s. Lipoperoxides were also 
absent in the spent medium with p—SSO incubation, and 
similar amounts of cellular lipid peroxides were
quantitated with 60mg/l p—EPO or p—SSO supplementation, 
yet cell viability was not significantly limited with 
this amount of p-SSO (Figs. 3.4.1.5. and 3.4.1.7.). 
These findings suggested that a critical lipid peroxide 
concentration may have to be attained before 1ipid 
peroxides become membrane damaging and detrimental to
f
cel 1 survival, dependant on the overal1 state of 
cellular equilibrium. On the other hand, it may indicate 
that 1ipoperoxides are less involved in FA mediated 
cytotoxicity than postulated, and that changes in 
membrane fluidity are equally or more important. The 
absence of significant amounts of unsaturated FA's in 
p-CO would indeed imply that the reduction of cell 
viability this p-oil induced related to alterations in 
membrane fluidity rather than 1ipoperoxide production. 
However, the finding that the low concentrations of 
cellular 1ipoperoxides measured with p-MO, p-00, p-|_0 or 
p-FO dosage (Table 3.4.4.1.) correlated with the absence 
of cytotoxicity (Figs, 3.4.1.3., 3.4.1.4., 3.4.1.6. and
3.4.1.7., respectively), indicated the possiblity that 
1ipoperoxides were partly involved in the modulation of 
cel 1 viabi1ity.
3.5 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM RAT BRAIN.
3.5.1 Effects of Pseudo-Oils on Cell Viability.
Cells isolated from rat cerebral cortex were largely 
astrocytic, and microscopic examination of control and 
p-oil dosed cells before, during and after each 
experiment showed no morphological changes at any time, 
except for cytoplasmic droplets observed with p-oil 
incubation at high concentrations in some instances.
Final medium albumin concentrations ranging from 0 to 
250mg/l had no significant effect on cell viability 
(Fig. 3.5.1.1.), nor were any synergistic effects 
evident. Thus, the cell viability changes induced with 
the p-oils were a result of the exogenous FA's, and not 
the albumin used as FA carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period 
was 12.8xlOa/ml, This equated to approximately 62% of 
the final control cel 1 number at the end of the 48 hour 
incubation period and represented the cytostatic number. 
Only p-oil concentrations limiting cell viability to 
significantly below 62% were thus considered cytotoxic.
Figs. 3.5.1.2—3.5.1.8. depict the data derived following 
incubation of rat brain cells with p-oils. Certain
Legend to Figs. 3.5.1♦1-3.5.1.9.
The results are expressed as mean percent cell
viabi1ityistandard error of the mean (s.e.m.), where *n* 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.5.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 3.5.1.2-3.5.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 3.5.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to of the controls.
A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.8 12
25 96.8 5.4 12
50 102.5 3.3 12
75 102.9 4.3 12
100 104.9 2.7 12
125 102.9 3.2 12
150 103.5 5.2 12
175 102.8 4.4 12
200 101.5 5.0 12
225 102.9 3.1 12
250 99.0 2.9 12
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.2 6
10 104.4 2.6 6
20 105.8 ' 1.6 6
30 97.1 1.9 6
40 91.8 3.0 6
50 82.0 00H 6
60 67.9 1.3 6
70 55.8 1.6 6
80 42.4 1.9 6
90 28.4 in•H 6
100 15.8 1.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 1.7 6
10 91.3 3.5 6
20 83.1 2.6 6
30 69.6 6.3 6
40 56.8 5.1 6
50 43.5 2.5 6
60 32.3 2.4 6
70 15.3 2.4 6
80 15.4 4.6 6
90 18.0 2.8 6
100 12.5 00 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.9 6
10 90.9 00•*3 6
20 94.8 4.9 6
30
l
100.4 00•in 6
40 107.3 4.5 6
50 86.2 5.7 6
60 70.4 3.7 6
70 64.9 3.0 6
80 38.2 4.1 6
90 10.8 2.4 6
100 0.0 0.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 2.4 6
10 96.7 2.3 6
20 95.0 2.0 6
30 98.0 1.9 6
40 93.5 3.1 6
50 95.2 2.8 6
60 95.2 2.4 6
70 78.3 5.3 6
80 70.8 3.0 6
90 60.1 2.4 6
100 34.5 1.3 6
pseudo-Oi1 
Concentration 
( m g / 1 )
Mean ±s.e.m . n
0 100.0 1.8 6
10 99.2 2.8 6
20 99.1 2.6 6
30 99.5 2.3 6
40 90.9 2.4 6
50 87.5 2.7 6
60 86.8 2.3 6
70 80.6 3.4 6
80 70.3 1.4 6
90 64.5 2.2 6
100 54.3 1.4 6
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pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 3.8 6
10 100.2 2.9 6
20 102.1 2.7 6
30 101.3 3.0 6
40 109.2 2.5 6
50 96.3 2.3 6
60 89.0 2.1 6
70 73.1 2.7 6
80 52.1 2.9 6
90 11.9 0.9 6
100 1.0 0.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean -3.e.m. n
0 100.0 00• 6
10 109.1 3.4 6
20 99.0 3.1 6
30 88.0 2.5 6
40 89.8 2.7 6
50 64.8 2.3 6
60 52.6 5.5 6
70 45.1 2.1 6
80 10.5 3.3 6
90 o♦o o • o 6
100 o • o oo 6
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A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 4.5 6
100 56.6 3.1 6
125 54.6 5.7 6
150 55.3 3.6 6
175 46.1 4.8 6
200 45.8 4.0 6
concentrations of p-CO, p-00, p-EPO and p-FO stimulated 
cell proliferation slightly, whereas all p-oils limited 
and inhibited cell growth. The magnitude of the effects 
induced, however, varied with the nature of the p-oil 
and concentration dosed.
Cell proliferation was stimulated to a maximum of 105.8% 
with 20mg/l p-CO and to 107.3% with 40mg/l p-00 (Figs.
3.5.1.2. and 3.5.1.4., respectively). Incubation with 
greater amounts of p-CO or p-00 limited cell viability 
in a concentration dependent manner, while amounts 
greater than 70mg/l p-CO or p-00 induced cytotoxicity 
and reduced the viable cell yield, almost linearly, to 
15.8% and 0% with 100mg/l p-CO and p-00, respectively.
The ID50 for both p-oils was approximately 75mg/l, which 
reflected the similar effects these p-oils induced.
Dosage with up to 70mg/l p-MO reduced cell viability in 
an approximately linear concentration dependent manner 
(Fig. 3.5.1.3.). p-MO was the most effective p-oil to 
impair cell proliferation as cytotoxicity was induced 
with amounts greater than 30mg/l p-MO, and 50% of cells 
were killed with only 45mg/l p-MO ( ID50 ) .  The cytotoxic 
effect of p-MO plateaued with concentrations of 70mg/l 
to 100mg/l as cell viability ranged from 12.5% to 18.0%.
Cell proliferation was not significantly influenced with 
supplementation of up to 60mg/l p-SS0 or 30mg/l p-L0 
(Figs. 3.5.1.5. and 3.5.1.6., respectively). Higher
concentrations limited cell growth almost linearly, but 
cytotoxicity was induced only with amounts greater than 
80mg/l p-SSO and 90mg/l p-LO. Half the cells were viable
with about 94mg/l p-SSO (ID5 0 ), compared to 34.5% with 
100mg/l p-SSO. More than half the cells, however, were 
still viable with 100mg/l p-LO (54.3%), thus no ID50 
could be calculated. This was the least cytotoxic p-oil.
Supplementation with up to 30mg/l p-EPO had little 
effect on cell viability and increased cell numbers were 
found with 40mg/l p—EPO (109.2%), whereas proliferative 
effects were induced only with 10mg/l p-FO (109.1%) 
(Figs. 3.5.1.7. and 3.5.1.8., respectively). These were 
the greatest increments in cell proliferation found. 
Concentrations greater than 50mg/l p-EPO and 20mg/l p-FO 
induced growth limitation, but amounts greater than 
70mg/l p-EPO and 50mg/l p-FO were cytotoxic. Calculation
of ID50 values showed that p-EPO was less cytotoxic than 
p-FO (approximately 81mg/l and 65mg/l, respectively),
and practically all cells took up the Typan blue with 
100mg/l p-EPO and 90mg/l p-FO.
To exclude the possibility that any of the effects 
induced with p-oil dosage were influenced by the amount 
of albumin bound to the FA's, cells were incubated with 
a fixed amount of p-00 corresponding to its ID50 (about 
75mg/l). Five points were selected around which to vary 
the albumin concentration, viz. two points above, two 
points below, and the ID5Q of p_00, and the appropriate
amount of albumin added to these cultures to give the 
desired concentrations. The results are depicted in Fig.
3.5.1.9., and indicated that the amount of p-00 dosed 
reduced cell viability to approximately 50% of controls, 
and that such was not influenced by the concentration of 
albumin present as FA carrier. Hence, synergistic 
effects of albumin could be excluded, and the effects 
induced with the p-oils could be attributed solely to 
the exogenous FA's.
Subsequent to these studies, cells derived from rat 
brain were plated and dosed appropriatel y with 0, 20, 
40 or 60mg p-oil/1 culture medium in sufficient amounts 
to permit all the quantitative and qualitative analyses 
to be performed. Upon harvesting, cell viabilities 
relative to controls were compared and found to be 
statistically similar to those in Figs. 3.5.1.1-3.5.1.8. 
A11 further biochemical assays were thus performed on 
these samples.
3.5.2 Effects of pseudo-Qils on Total Protein.
Table 3.5.2.1. shows the total protein concentrations 
of cells incubated with 0, 20, 40 or 60mg/l p-oil, 
expressed as jug total protein/106 cells seeded.
455.5^9 protein/106 control cells seeded was detected, 
whereas dosed cells contained protein amounts ranging 
from 198.7 to 500.5M9/106 cells seeded (with 60mg/l 
p-MO and 20mg/l p-EPO, respectively). Cells supplemented 
with 20mg/l p-oil (except p-00) exhibited the highest 
protein concentrations quantitated over the range dosed 
(422.1 to 500.5Aig/106 cells seeded), which approximated 
to control amounts. Cellular protein levels were related 
inversely to the p-oil concentration dosed, although 
slightly more protein was found in cells incubated with 
40mg/l than with 20mg/l p-00 (478.2 vs 461.5,ug/106 cells 
seeded). Cells dosed with 40mg/l p-00 or p-EP0 exhibited 
enhanced protein levels, whereas significantly reduced 
protein concentrations were found in all cells incubated 
with 60mg/l p-oil, compared to controls.
The protein content of cells derived from rat brain. 
expressed as jug total protein/10s cells seeded.
pseudo­
Oil
CELLS
(mg/1) 0 20 40 60
Control 455.5
CO 471.9 351.2 297.9
MO 451.5 254.9 198.7
00 461.5 478.2 309.7
SSO 450.5 428.1 397.7
L0 474.9 409.9 387.1
EPO 500.5 496.5 409.9
F0 422.1 400.8 223.2
3.5.3 Effects of Pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Rat Brain.
Table 3.5.3.1. lists the FA profiles of cells incubated 
with 0, 20, 40 or 60mg/l p-oil. The greatest percentage 
of any single FA detected in control cells was 18:lw9 
(25.9%). FA s comprising >5.0% of the total spectrum 
in control cells included 16:0 (20.5%), 18:0 (18.6%), 
18:2u6 (5.4%) and 22:4u6 (6.4%).
p-Oil dosed cells contained 16:0 and 18:lu9 percentages 
parallel to, or greater than, those in control cells, 
whereas 16:lw9 proportions were generally, and 18:0 
levels were always, lower in dosed cells. 18:2w6, 
18:3u6, 20:4u6, 18:3u3 and 20:5w3 percentages were
generally only comparable to, or higher than, control 
amounts if the p-oils dosed contained these moieties, 
and the levels of most other polyenoic FA's were 
parallel to, or lower than, control levels.
Incubation with 20, 40 or 60mg/l p-CO increased 16:0 
levels to 27.9%, 29.0% and 41.8%, respectively (20.5% in 
controls), while 16:lw9 and 18:lw9 amounts ranged from 
1.0 to 5.5% and 23.8% to 29.6%, relative to 3.8% and 
25.9% in controls, respectively. 18:0 and 18:2w6 levels 
were both decreased (12.9% to 13.2% and 2.8% to 4.6% vs 
18.6% and 5.4% in controls, respectively), although up 
to 4.7% 20:4u6 and 8.6% 22:4w6 were found (3.5% and 6.4% 
in controls, respectively).
A11 ya1ues 
Control val 
the number 
pseudo-o i1
are tabulated as relative percent total 
ues are reported as mean±s.e.m., where ' 
of experiments. 'Cp-OilD' refers to 
concentration used.
area. 
n " is 
the
The fatty acid spectrum of cells derived from rat brain -
FATTY ACID 
SPECTRUM
( y . )
CONTROLS 
(n=3)
Cp-COH 
(mg/1) " 
20 ! 40 ! 60
Cp-MOI] 
(mg/1)
20 ! 40 ! 60
Cp-003 
(mg/1)
20 40 ! 60
Cp-SSOD 
(mg/1)
20 ! 40 ! 60
Cp-lo:
(mg/1)
20 : 40 :
|
60
Cp-EPOD 
(mg/1)
20 ! 40 ! 60 20
Cp-FOIl 
(mg/1 )
! 40 ! 60
s
A
16:0 20.5±0.50 27 i 9 29.0 41.8 22.8 23.1 30.7 17.7 19.3 17.9 23.1 25.8 17.8 19.0 32.3! 22.9 16.8 26.9 22.1 19.5 41.1 33.5
T 11 18:0 18.610.30 13.2 12.9 13.0 11.9 12.1 18.0 7.3 6.2 3.4 11.3 13.5 16.8 10.6 15.3! 7.9 9.5 14.6 11.8 9.1 10.2 6.1
R
A
20:0 1.210.05 - 0.2 0.1 - - 0.1 - - - - - - - - I
l
- - - - 0.1 0.1
T
c
22:0 - - - 0.1 - - - - - - - - - - - ! I - - - - - -
S. 24:0 0.310.05 - 0.3 - - - 0.1 - - - 0.2 - - 0.1!
| - 0.2 0.2 - 0.1 -
u9
M
16:1 3.810.10 5.5 3.1 1.0 1.7 1.9 3.5 1.8 0.7 1.1 4.4 4.0 1.1 1.5 1.7! 2.7 1.5 1.2 2.7 12.4 13.3 20.5
0
N
0
S.
18:1 25.910.55 29.6 28.1 23.8 32.3 31.4 26.7 48.5 58.6 66.3 26.8 28.8 31.0 28.0 24.4! 30.1 21.1 21.6 22.9 26.0 20.7 23.6
24:1 — - - — — — — - - - - - - - - ! - - - - - - -
18:2 5.410.00 4.6 3.6 2.8 10.4 13.0 7.8 9.2 6.4 6.0 21.2 18.2 27.1 10.0 5.5! 11.1 31.7 23.2 32.4 9.1 4.3 6.6
u6
18:3 - ' 0 4 - 0.2 0.1 - - 0.1 - - 0.1 - - 0.1 0.1! 0.2 0.5 0.7 2.2 0.1 - -
p 20:2 1.910.05 0.2 0.3
“ 0.3 0.3 0.3 1.0 2.5 1.5 0.9 0.2 0.3 0.3 0.3! 0.1 1.1 0.2 - 0.4 0.6 0.5
0
1
20:3 1.810.05 1.3 1.2 0.9 1.3 1.0 0.5 0.9 0.3 0.2 1.0 0.6 0.3 0.9 0.7! 0.5 3.9 0.8 0.4 1.0 0.5 0.4
Y
c
20:4 3.510.10 4.7 3.9 2.7 5.5 5.6 2.8 2.7 0.6 0.6 2.5 1.4 0.8 4.6 1.7! 1.4 3.2 1.4 1.1 3.4 0.9 1.0
22:4 6.410.05 5.0 7.6 8.6: 5.8 5.4 6.5 5.5 3.1 1.7 4.2 3.6 2.6 6.8 5.8! 3.1 5.6 4.2 1.5 6.1 3.6 3.5
22:5 1.210.10 0.1 1.0 0.1 — 0.3 — — 0.5 — 0.1 0.6 0.1 — 0.6! - 0.7 0.1 0.1 0.4 0.1
18:3 0.910.00 0.9 0.7 0.6 1.1 0.8 0.6 0.9 0.3 0.2 0.6 0.5 0.2 12.7 7.2! 18.0 0.4 0.4 0.8 0.9 0.6 0.5
u3 18:4 0.910.05 0.2 0.9 0.2 0.2 0.4 0.2 0.1 0.3 0.1 0.2 0.6 0.2 0.1 0.5! 0.1 0.1 0.6 0.2 0.2 0.4 0.2
Pn 20:4 1.810.10 0.4 1.6 0.9 0.2 0.3 0.7 0.4 0.3 0.1 0.1 0.7 0.7 0.6 0.7! 0.3 0.3 0.9 0.1 0.8 0.6 0.6
LV 20:5 0.410.00 0.5 0.9 0.4 1.0 0.6 0.2 0.2 0.1
- 0.1 0.1 - 0.8 0.2! 0.4 0.3 0.3 0.1 3.8 1.1 1.6
S. 22:5 3.010.30 2.9 2.5 1.7 2.8 1.9 0.9 1.9 0.5 0.5 1.9 1.1 0.6 2.2 -1.4! 0.9 2.0 1.2 0.8 4.7 1.0 0.7
22:6 2.510.30 2.9 2.4 1.4 2.8 2.1 0.7 1.8 0.4 0.3 1.7 0.6 0.4 1.9 1.0! 0.7 2.0 0.9 0.6 2.5 0.6 0.6
Cells dosed with 20, 40 or 60mg/l p—MO contained 22.8%, 
23.1% and 30.7% 16:0, respectively (controls 20.5%), but 
decreased amounts of 16:lu9 (1.7% to 3.5% vs 3.8% in 
controls). 18:0 was decreased with 20 and 40mg/l p-M0 
(11.9% and 12.1%, respectively) and parallel to controls 
with 60mg/l p—MO (18.0%), while 18:lw9 levels were 
greatest with 20 and 40mg/l p-MO (32.3% and 31.4%, 
respectively), and comparable to controls with 60mg/l 
p-M0 (26.7%). 18:2w6 uptake increased significantly over 
the range dosed (7.8% to 13.0% vs 5.4% in controls), and 
5.5%, 5.6% and 2.8% 20:4u6 was detected with 20, 40 and 
60mg/l p-MO, respectively (3.5% in controls), yet other 
PDFA levels were not significantly increased.
A marked increase in 18:lu9 proportions was found with 
20, 40 or 60mg/l p-00 supplementation (48.5%, 58.6% and 
66.3%, respectively vs 25.9% in controls). 16:0 levels 
were slightly decreased, but 16:1cj9 and 18:0 amounts 
were considerably reduced, compared to controls (20.5%, 
3.8% and 18.6%, respectively). 6.0% to 9.2% 18:2w6 was 
found (5.4% in control), with 2.5% 20:2w6 detected with 
40mg/l p-00 (1.9% in controls), but other PUFA levels 
were not significantly raised.
16:0 percentages were 23.1% and 25.8% with 20 and 40mg/l 
p-SSO, respectively, but only 17.8% with 60mg/l p-SS0 
(20.5% in controls). 16:lw9 levels were slightly raised 
when incubated with 20mg/l p-SSO (4.4%), decreased with
60mg/l p-SSO ( 1 , 1 % ) , and parallel to controls (3.8%) 
with 40mg/l p-SSO (4.0%). Decreased amounts of 18:0 were 
found (11.3% to 16.8% us 18.6% in controls), but 18:lw9 
leuels were increased (26.8% to 31.0% us 25.9% in 
controls). Despite marked 18:2u6 incorporation (5.4%, 
21.2%, 18.2% and 27.1% with 0, 20, 40 and 60mg/l p-SSO, 
respectiue1y), no significant increases in PDFA's were 
detected, and all w3 PUFA leuels were decreased.
16:0, 16:lu9, 18:0 and 18:lu9 percentages were parallel 
to controls or decreased with p-LO dosage, although 
increased 16:0 and 18:lu9 were found with 40 and 60mg/l 
p-LO, respectiuely (32.3% and 30.1% us 20.5% and 25.9% 
in controls, respectiuely). 18:2u6 leuels increased only' 
with 20 and 60mg/l p-LO (10.0% and 11.1%, respectiuely 
us 5.4% in controls), and 20:4w6 was slightly increased 
with 20mg/l p-L0 (4.6% us 3.5% in controls). Incubation 
with p-L0 raised cellular 18:3u3 percentages markedly 
(7.2% to 18.0% us 0.9% in controls), yet U)3 PDFA amounts 
were not significant increased.
The leuels of the saturated and monoenoic FA's reported 
in Table 3.5.3.1. were parallel to controls or decreased 
with p-EP0 supplementation, although increased 16:0 was 
detected with 40mg/l p-EP0 (26.9% us 20.5% in controls).
A marked eleuation in cellular 18:2w6 occurred with all 
p-EPO concentrations dosed (23.2% to 32.4% us 5.4% in 
controls), and 0.5%, 0.7% and 2.2% 18:3u6 were detected 
with 20, 40 and 60mg/l p-EPO, respectiuely (no 18:3w6 in
controls). 2 0 :3u6 levels increased approximately 2 fold 
with 20mg/l p-EPO (3.9% vs 1.8% in controls), but all 
other u6 and U)3 PUFA percentages were decreased relative 
to controls.
Incubation with 20mg/l p—FO induced no significant 
change in 16j0 levels (19.5% vs 20.5% in controls), but 
amounts were dramatically raised with 40 and 60mg/l p-FO 
(41.1% and 33.5%, respectively). 16:lw9 levels increased 
from 3.8% in controls to 12.4%, 13.3% and 20.5% with 
20, 40 or 60mg/l p-FO, respectively, while 18:0 amounts 
were decreased with all concentrations dosed (6 .1% to 
10.2% vs 18.6% in controls), and 18:lu9 percentages were 
generally parallel to control levels (25.9%). 18:2w6 
proportions ranged from 4.3% to 9.1% (5.4% in controls), 
and no significant increases were found for any other 106 
PUFA's. Significantly increased 20:5u3 amounts were 
detected with 20, 40 and 60mg/l p-FO (3.8%, 1 .1% and 
1.6%, respectively vs 0.4% in controls), but with the 
exception of 4.7% 22:5w3 detected with 20mg/l p-FO (3.0% 
in controls), no increases in other u3 PUFA's were
observed.
3.5.4 Effects of pseudo-Oils on Lipid Peroxide
Format i on.
Table 3.5.4.1. shows the 1ipoperoxides measured in rat 
brain cells and their respective growth media following 
incubation with 0, 20, 40 or 60mg/l p-oil. The values 
are shown as nmoles MDA/106 celIs, but in the case of 
the spent media, this represents the nmoles of MDA in 
the volume of medium from which 106 cells were obtained.
0.4nmoles MDA/106 control cells was measured, while the 
amounts detected for dosed cells ranged from a low of 
0.5nmoles MDA/106 cells (with 20mg/l p-EPO) to a high of 
2.7nmoles MDA/106 cells (with 60mg/l p-MO). The cellular 
1ipoperoxide amounts measured varied with the p-oil 
dosed and generally increased in a p-oil concentration 
dependent manner, but showed no correlation overall with 
the degree of p-oil unsaturation. Cells dosed with p-EPO 
contained only 0.5 to 0.8nmoles MDA/106 cells, whereas 
0.9, 1.6 and l.Onmole MDA/106 cells were detected with 
20, 40 and 60mg/l p-SSO, and 0.7, 0.7 and 1.3nmoles MDA 
per 106 cells quantitated with p-LO, respectively. In 
comparison, cells incubated with 20, 40 or 60mg/l p-CO 
or p-00 contained 0.7, 1.1 and 1.8 or 0.8, 1.1 and 2.0 
nmoles MDA/lxlO6 cells, respectively, and p-MO induced 
0.6, 0.9 and 2.7nmoles MDA/lxlO6 cel Is. However, p—FO 
generated the largest cellular lipid peroxide amounts 
overall across the range dosed (1.4, 1.4 and 2.4nmoles
Lipoperoxide formation by rat brain cultures incubated 
with p-oils. expressed as nmoles MDA/105 cells.
pseudo­
Oil
CELLS
(mg/1 ) 0 20 40 60
Control 0.4
CO 0.7 1.1 1.8
MO 0.6 0.9 2.7
00 0.8 1.1 2.0
SSO 0.9 1.6 1.0
L0 0.7 0.7 1.3
EPO 0.5 0.6 0.8
F0 1.4 1.4 2.4
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - 2.7
MO - - 4.8
00 - - 3.4
SSO - - 3.3
L0 - 1.0 4.9
EPO - 1.8 7.8
F0 - 2.9 12.3
MDA/106 cells, respectively).
Lipoperoxides were absent both in spent control medium, 
and in the spent media derived from cultures dosed with 
20mg/l p-oil. Further, only p~L0, p-EPO and p-FO induced 
medium lipoperoxides when 40mg/l p-oil was incubated 
(1.0, 1.8 and 2.9nmoles MDA/lxlO6 cells, respectively). 
On the other hand, lipoperoxides were measured in all 
spent media derived from cultures supplemented with 
60mg/l p-oil (2.7 to 12.3nmoles MDA/106 cells). Unlike 
the cells, however, the lowest concentrations of lipid 
peroxides in the spent media occurred with p-CO dosage, 
whereas 1arger MDA concentrations were quantitated with 
p-00 or p-SSO, followed by p-MO, p-LO, p-EPO or p-FO 
incubation, respectively.
3.5.5 D i scussi on.
This study showed that supplementation of primary 
cultures of normal rat brain with p-oils affected the 
viability of these cells (Figs. 3.5.1.2-3.5.1.8.), and 
that the p-oi1-specific cell viability changes induced 
reflected the unique FA profile each p-oil exhibited 
(Table 2.3.3.2.). The FA compositions of p-00, p-SSO and 
p-LO suggested that the effects induced with incubation 
of each p-oil were largely attributable to the high 
concentrations of 18:lw9 (71%), 18:2w6 (70%) or 18:3w3 
(63%) present, respectively. Since the capability to 
kill cultured rat brain cells increased markedly in the 
order p-LO, p-SSO and p-00, it seemed possible that OA 
was the most, and ALA the least, cytotoxic of these 
moieties, and that such related inversely to the number 
of double bonds in these C18 FA's. This, however, was in 
direct contrast with a previous study in our 1aboratory
which showed LD50 values of about 55, 50 and 35mg/l for 
rat brain primary cultures incubated with 18:lw9, 18:2w6 
or 18:3w3, respectively (Girao 1988). 18:3w3 and 18:3u6 
were equally cytotoxic, whereas comparison of the FA 
profiles of p-EPO, p-LO, p-SSO and p-00 with the cell 
viability changes these p-oils induced suggested that 
18:3u6 exhibited greater cytotoxic capability than 
18:3u3, 18:2u6 and 18:lu9. Girao (1988) found that 18:0 
induced cytotoxicity in the range 60 to 100mg/l and 
cytostasis overall in the range 0 to 60mg/l, although
amounts of 1, 25, 35 and 45mg/l 18:0 increased growth by 
6% to 12"4. Low concentrations of p-CO, p-00, p-EPO and 
p-FO enhanced cell proliferation similarly by between 5% 
and 10^ (Figs. 3.5.1.2., 3.5.1.4., 3.5.1.7., 3.5.1.8., 
respectively), but this was not found when individual 
C18 unsaturated FA's (18:lu9, 18:2w6, 18:3u6 or 18:3u3) 
were supplemented (Girao 1988). Others found that 
addition of 18:2w6, 18:3w3, 20:4u6 or 22:6u3 at seeding
I
time to cultured fetal mouse brain cells increased 
L3HH-thymidine incorporation into DNA, stimulated cell 
pro1iferation with optimal concentrations of 1.0mg/l FA, 
and were toxic with higher amounts (Bourre et al 1983). 
The finding that optimum cell growth was achieved with 
p-oil concentrations of 20mg/l p-CO, 40mg/l p-00, 40mg/l 
p-EPO or 10mg/l p-FO, and cytotoxicity was induced only 
with significantly higher amounts of these compounds, 
clearly demonstrated that p-oils were less growth 
inhibitory than individual FA's.
The quantitative and qualitative differences described 
above with supplementation of individual FA's or p-oils 
were not surprising, but in fact supported the mediation 
of synergistic or antagonistic effects between FA's 
within a p—oil which may have enhanced or diminished the 
effects caused by individual FA's. This may indeed 
explain the different effects which p-SSO and p-EPO 
induced, despite the similar FA compositions these 
p-oils exhibited. Furthermore, this phenomenon more than
likely occurs in vivo when organisms consume FA mixtures 
as dietary oils, thus the modulation of cell viability 
reported with p-oil dosage probably reflects closer to 
the Veal world' than studies using individual FA's.
Uptake of FA's by rat brain in vivo has been reported 
by Cook (1978a, 1978b, 1980). FA's must be in their 
activated state before being incorporated, and this 
requires plasma membrane acyl CoA synthetase, which has 
been demonstrated in rat brain synaptosomal plasma 
membranes in our 1aboratory (Davidson 1986). Thus, the 
potential exists within the brain to incorporate 
exogenous FA's, and there is no evidence that such is 
lost when cells are maintained in culture. Numerous 
studies have in fact shown rat brain cells in culture to 
be capable of exogenous FA incorporation. Yavin et al 
(1974) demonstrated that the rate of 12:0, 14:0, 16:0, 
18:0, 18:lw9, 18:2w6 and 18:3w3 uptake into cultured 
cells derived from rat cerebral tissue was greatest with 
18:0 and decreased progressively with decreasing chain 
length, although no clear relationship was evident 
between uptake and degree of FA unsaturation. These 
cells have been reported to incorporate the above FA's 
into TAG's, PGL's and glycerolipids, although such 
moieties could also remain in the free form (Menkes 1972 
and Yavin et al 1974). On the other hand, addition of 
18:2u6, 18:3u3, 20:4w6 or 22:6uj3 at seeding time to 
cultured fetal mouse brain cells resulted in these
FA's being incorporated predominantly into the PGL 
fraction (Bourre et al 1983). The site(s) of p-oil FA 
uptake were not investigated in the present study, but 
the data in Table 3.5.3.1. nevertheless supported the 
capability of cultured rat brain cells to incorporate 
exogenous FA's to varying extents. Hence, it was likely 
that membrane fluidity changes occurred. Brain membrane 
lipids have been reported to be highly unsaturated and 
conservative in nature (Crawford et al 1971), and any 
alteration in membrane stability induced with p-oil 
incubation may consequently have caused cell death. The 
cytotoxicity reported with p-CO and p-MO could well have 
related to a marked decrease in the unsaturation index 
of brain membrane lipids when these saturated FA-rich 
p-oils were dosed. This mechanism alone, however, could 
not fully explain why p-MO was more growth inhibitory 
than p-CO, despite the more saturated nature of the 
latter. The inclusion in p-MO of the PDFA and 
endoperoxide substrate, 20:4u6, may be an explanation. 
Indeed, considerably more cytotoxicity was induced with 
incubation of p-00, p-EPO or p-FO which also contained 
EFA desaturation and/or elongation products, than with 
p-SSO or p-LO which were EFA-rich and PDFA-deficient. In 
fact, the finding that p-FO was significantly more 
growth inhibitory than p-EPO correlated with the 
presence of almost 20* PDFA's in p-FO, compared to 10* 
in p-EPO. These moieties may have altered membrane
stability, either directly or indirectly, to such an 
extent that cell viability could not continue.
The cellular protein concentrations reported with p-oil 
dosage (Table 3.5.2.1.) generally paralleled the changes 
observed in cell viability (Figs. 3.5.1.2-3.5.1.8.). The 
slight increments in cellular protein levels found with 
20mg/l p—CO, 40mg/l p—00 or 40mg/l p-EPO supplementation 
primarily reflected increased cell numbers with constant 
or slightly elevated protein per cell. Comparison of 
cellular protein concentrations with cell viability 
indicated that 20mg/l p—L0 or p—EPO enhanced protein 
synthesis slightly, whereas such was suppressed with 
20mg/l p-FO, 40 or 60mg/l p-SSO. On the other hand, the 
finding that dosed cells contained less protein than 
controls when cell viability was impaired correlated 
with decreased cell numbers with constant or decreased 
protein per cell; the latter may relate to the low 
turnover of proteins known to exist in the brain 
(Lehninger 1982). When Vignikin et al (1989) incubated 
primary cultures of newborn rat glial cells with single 
FA's at 30mg/l, they found that oleic acid induced a 
greater protein increment over a two week period 
than cells treated with linoleic, alpha~linolenic or 
especially arachidonic acid. This correlated with the
mean protein concentrations reported in Table 3.5.2.1. 
for cells supplemented with 20 or 40mg/l p-00, p-SSO, 
p-LO or p-MO, respectively, but the finding that such
largely reflected changes in cell viability extended the 
work of Vignikin et al (1989).
The results obtained from the analysis of FA's in 
control and p-oil dosed cells (Table 3.5.3.1.) were 
consistent with an overall lack or suppression both of 
desaturase and elongase expression in cultured rat 
brain. However, slightly increased levels of some PDFA's 
with dosage of certain p-oils supported the potential 
for limited desaturase cascade enzyme activity. 18:3w3 
incorporated with p-LO supplementation was not further 
metabolised, and such was consistent with impaired A6D 
expression. 18:2u6 incorporated with p-SSO incubation 
was also not converted to PDFA's, thus 20:3w6 formation 
with 20mg/l p-EPO incubation probably related only to 
elongation of incorporated 18:3w6. The lack of further 
20:3u6 metabolism with p-EPO supplementation, however, 
was consistent with impaired J5D expression. Slightly 
increased 20:4u6 and/or 20:5w3 levels when certain 
concentrations of p-CO, p-MO or p-LO were supplemented 
reflected limited J5D expression or extramicrosoma1 
retroconversion of cellular 22 : d u 6 and 22:5w3, 
respectively. No evidence for elongation of 20:4w6 
incorporated with p-MO dosage was found, although 22:5u3 
formation with 20mg/l p—FO supplementation supported 
elongation of incorporated 20:5u3. However, the lack of 
significant increments in 22:5w6 or 22:6w3 with p-oil 
dosage indicated impaired A dD capability.
Literature reports on the capability of rat brain cells 
to desaturate and elongate FAs are contradictory. 
Menkes (1972) showed the capability of such cells in 
lipid-free culture medium to desaturate and elongate 
both C14Cn-16:0 and C14C3—18:0 prior to incorporation 
into cellular lipids. The potential for 16:0 and 18:0 
desaturation were also indicated in the present study, 
but neither these moieties nor their immediate 
desaturation products were further elongated (Table 
3.5.3.1.). A possible explanation for the latter finding 
came out of the work of Yavin et al (1974) who found 
that incorporated FA's underwent elongation in cultured 
rat brain cells and that such was maximal for 12:0 and 
decreased with increased FA chain length. The same group 
demonstrated that these cells were also able to 
synthesise 20:4w6 from 18:2u6 and convert 18:3uj3 and 
20:5u3 to 22:6u3 (Yavin et al 1974, 1975). Similar 
results were reported by Dhopeshwarkar et al (1971), 
Sinclair et al (1972) and Anding et al (1986) in 
neonatal and adult rat brain in vivo. Cook et al (1978a) 
found that developing rat brain had the capacity to 
desaturate both 18:0 and EFA^s, but J6D activity clearly 
appeared a rate limiting step in suckling rats, and its 
activity was hardly above background in the adult. 
Hassam et al (1975) showed that when suckling rats were 
orally fed radiolabel1ed 18:2w6 or 18:3w6, most 18:2w6 
activity remained unchanged, while 18:3w6 radioactivity
had been incorporated into 20:3w6 and 20:4w6, in brain 
lipids. Sinclair (1975b) also reported that desaturation 
of 18:2u6 was very slow after birth in rat brain. The 
present study used newborn rat pups, hence this may 
partly account for the relatively low desaturase cascade 
enzyme activity reported overall (Table 3.5.3.1.). It 
was unlikely, however, that such activity was suppressed 
primarily as a result of the growth limitation or cyto­
toxicity induced with p-oil dosage, since the capability 
for PDFA formation was 1imited/impaired even when p-oils 
had little effect on, or stimulated, cell viability. 
Desaturase cascade enzyme suppression may rather be a 
characteristic of this cel 1 type in vitro under the 
present culture conditions. Our results, nevertheless, 
supported the finding of Novelot et al (1986) that the 
liver is implicated in desaturating and elongating FA's 
in vivo, and packaging such moieties for transport to 
the brain.
MDA measurement in rat brain cultures both in the 
absence and presence of dosed p-oils (Table 3.5.4.1.) 
supported the a b i l i t y  of these cells to oxidise FFA's, 
as others have shown (Pitas et al 1987). This reflected 
intact cellular enzymic and/or non—enzymic mechanisms 
for lipoperoxide generation when the lines of protection 
against FA oxidation were saturated, impaired or absent. 
Control cel 1 1ipid peroxides implied oxidation of 
endogenous unsaturated FA's released during PGL
turnover, whereas the enhanced lipoperoxide amounts 
measured in dosed cultures were consistent with 
oxidation of unsaturated p-oil FA's.
The abundance of saturated FA's in new incubation medium 
(Table 2.3.3.3.) and the ability of these cells to 
incorporate exogenous FA's (Table 3.5.3.1.) supported 
the likelyhood that most peroxides found in the spent 
media of dosed cultures originated intracel1ularly. 
Such were released as a result of cell death with 60mg/l 
p-MO or p-FO dosage, whereas the ability of cellular 
1ipoperoxides to alter membrane permeability (Mead 1976, 
Tappel 1980 and Frankel 1984) implied their leakage 
through the plasma membrane of intact cells with 
incubation of p-oils which did not induce cytotoxicity 
at the concentrations studied. Cellular FA's and 
peroxidising enzymes could also have been released into 
the culture medium in the above processes, thus the 
possiblity that enzymic and/or spontaneous FA oxidation 
occurred extrace 11u1ar1y, and contributed to the lipid 
peroxides measured in the spent medium, can not be 
ignored. Such may explain the greater lipoperoxide 
amounts shown in the spent medium of cultures dosed 
with 40mg/l p-LO, p-EPO, p—FO, or 60mg/l p—oil, than in 
the cells themselves.
The finding that lipoperoxide generation increased 
overall with the amount of p—oil supplemented (Table 
3.5.4.1.) reflected increased FA availability for
oxidation. However, the numerical differences in the 
1ipoperoxide amounts reported with p-oil supplementation 
at a particular concentration reflected the different 
p-oil FA compositions (Table 2.3.3.2.). This related not 
only to the amount of unsaturated FA's present in any 
p-oil, but also to their susceptibility to oxidation, 
dependent on the number and position of double bonds in 
a FA. The susceptibility of 20:5w3 to oxidation may 
indeed explain why cultures dosed with p-FO exhibited 
the largest lipid peroxide amounts measured overall. The 
greater cellular 1ipoperoxide concentrations found with 
dosage of p-CO than with p-LO or p-EPO, for example, 
was surprising considering the significantly greater 
unsaturated FA content of the latter p-oils. This 
suggested that the substrates for 1ipoperoxidation in 
the p~LO and p-EPO were not so readily accessible to 
oxidation, possibly because they were present as 
components of complex membrane lipids. It may also 
reflect a slower rate of PGL turnover and therefore FA 
release into the cellular pool from membrane lipids with 
p-LO and p-EPO. Alternatively, low cellular 1ipoperoxide 
levels may reflect their release into the culture 
medium. This supported the higher lipid peroxide amounts 
found in the spent medium with p-EPO, compared to in the 
cells with p-SSO, dosage; these 1ipoperoxides probably 
related mainly to oxidation of free 18:2w6. p-EPO and 
p-SSO both exhibited similar FA compositions, thus the 
greater total 1ipoperoxide amounts induced with the
former may reflect the presence of about 9X 18:3w6 in 
P“EPO only. This PDFA merely requires chain elongation 
to be usable as a substrate for enzymatic peroxidation, 
whereas 18:2w6 requires desaturation first. The lipid 
peroxides formed with p—MO or p—FO supplementation could 
similarly have related partly to the -utilisation of 
exogenous 20:4u6 and 20:5co3, respectively as direct 
endoperoxide substrates.
The observation that the cell viability changes reported 
in Figs. 3.5.1.2_3.5.1.8. with p-oil incubation were 
generally inversely related to the MDA amounts produced 
(Table 3.5.4.1.) suggested 1ipoperoxide involvement in 
the modulation of cell proliferation. Support for this 
was the fact that 60mg/l p-MO induced the greatest 
increase in cellular 1ipoperoxide amounts and the most 
pronounced cytotoxicity. However, the finding that the 
greatest 1ipoperoxide levels in the spent incubation 
media did not correlate with the greatest cytotoxicity 
indicated that the modulation of cell viability also 
related to other mechanisms, such as alterations in 
membrane fluidity. Indeed, the lack of significant 
ability to desaturate or elongate FA's overall implied 
that these cells were largely unable to redress membrane 
lipid FA composition and fluidity altered with exogenous 
FA incorporation, and that such was involved in the 
modulation of growth limitation and inhibition reported 
in Figs. 3.5.1.2-3.5.1.8.
3.6 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM RAT LUNG.
3.6.1 Effects of pseudo-Qils on Cell Viability.
Microscopic examination of control cells before, during 
and after each experiment showed no morphological 
changes at any time, and p-oil supplemented cells were 
morphologically similar to controls, although cyto­
plasmic droplets were observed with p-oil incubation at 
high concentrations in some instances.
The results depicted in Fig. 3.6.1.1. showed that final 
medium albumin concentrations ranging from 0 to 250mg/l 
had no significant effect on rat lung cell viability. 
The effects induced with the supplemented p-oils were 
therefore a result of the exogenous FA's and not the 
albumin used as FA carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period 
was 13.Ixl04/ml. This equated to about 60% of the final 
control cel 1 number at the end of the 48 hour incubation 
period, and represented the cytostatic number. Only 
p—oi1 amounts reducing cell viability to significantly 
below 60^ were therefore considered growth inhibitory.
The results of the incubation of cells with p-oils are 
shown in Figs. 3.6.1.2—3.6.1.8. Overall, cell viability
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where 'n* 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.6.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 3.6.1.2-3.6.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig, 3.6.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to 50% of the controls.
Fig. 3.6 .1.1
A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.6 12
25 103.2 4.0 12
50 101.1 5.3 12
75 100.0 4.9 12
100 104.7 5.5 12
125 103.3 3.8 12
150 104.5 3.9 12
175 102.1 3.1 12
200 104.7 4.2 12
225 100.9 2.3 12
250 103.7 5.1 12
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 1.7 6
10 100.0 2.5 6
20 97.8 2.3 6
30 94.2 2.9 6
40 95.6 2.9 6
50 85.4 2.5 6
60 87.3 2.7 6
70 67.2 2.2 6
80 54.3 1.2 6
90 44.3 1.6 6
100 43.3 1.5 6
pseudo-Oi1 
Concentration 
< mg/1)
Mean ±s.e.m. n
0 100.0 4.3 6
10 84.0 4.1 6
20 89.3 2.5 6
30 75.7 1.4 6
40 74.7 4.7 6
50 69.6 4.0 6
60 70.4 2.9 6
70 61.4 4.7 6
80 61.1 2.9 6
90 58.3 1.1 6
100 60.6 1.4 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±3.e.m. n
0 100.0 3.8 6
10 102.2 3.9 6
20 103.8 00• 6
30 103.4 5.6 6
40 96.3 2.4 6
50 86.8 7.4 6
60 81.1 4.7 6
70 68.5 2.4 6
80 74.6 5.6 6
90 35.9 2.9 6
100 00•o 0.5 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean — s • © • m ♦ n
0 100.0 3.8 6
10 101.8 4.4 6
20 102.4 2.8 6
30 94.6 4.1 6
40 93.7 3.4 6
50 87.1 4.2 6
60 86.5 4.0 6
70 80.7 4.7 6
80 86.7 5.9 6
90 72.9 4.7 6
100 in 2.4 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 1.5 6
10 99.8 1.5 6
oCM 89.4 2.2 6
30 86.3 2.1 6
40 87.1 1.3 6
50 86.1 2.0 6
60 83.5 2.2 6
70 63.0 1.9 6
80 80.8 2.9 6
90 62.1 3.0 6
100 62.6 2.5 6
pseudo-Oi1 
Concentration 
< mg/1)
Mean ±s.e.m. n
0 100.0 1.9 6
10 101.4 1.5 6
20 99.5 1.8 6
30 105.1 2.8 6
40 110.4 2.7 6
50 104.2 00•H 6
60 105.0 1.9 6
70 101.1 2.2 6
80 101.2 1.3 6
90 96.6 1.6 6
100 97.7 1.7 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.1 6
10 111.0 4.7 6
20 109.6 CM« 6
30 98.3 4.3 6
40 104.4 5.8 6
50 98.5 3.9 6
60 •o00 3.6 6
70 87.9 5.8 6
80 75.4 4.1 6
90 69.8 4.3 6
100 26.2 4.6 6
A1bumin 
Concentration 
C mg/1 )
Mean ts.e.m. n
0 100.0 1.6 6
175 49.1 2.8 6
200 *300<sf 2.1 6
212 51.6 3.2 6
225 50.5 4.6 6
250 52.6 2.7 6
was stimulated only with low amounts of p-EPO and p-FO, 
all p-oils besides p—EPO limited cell proliferation to a 
greater or lesser extent, and cytotoxicity was induced 
only with high concentrations of p-CO, p-FO and p-00.
p-CO concentrations up to 40mg/l had little effect on 
cell viability, whereas 50 to 70mg/l p-CO limited cell 
pro1iferation, and greater amounts were cytotoxic (Fig.
3.6.1.2.). Half the cells were viable with 85mg/l p-CO
(ID5 0 ) and 43.3% with 100mg/l p-CO. On the other hand, 
p-MO induced concentration dependent growth 1 imitation
with amounts up to 60mg/l, and cytostasis with 70 to 
100mg/l p-MO (Fig. 3.6.1.3.), therefore no ID50 could be 
calcu1ated.
Concentrations up to 40mg/l p-00 induced no significant 
change in cell viability, but 50 to 80mg/l p-00 limited 
cell proliferation to a minimum of 68.5% with 70mg/l 
p-00 (Fig. 3.6.1.4.). 50% of cells were killed with
about 86mg/l p-00 (IDso), but higher amounts induced the 
greatest cytotoxicity observed and practically all cells 
took up Trypan blue with 100mg/l p-00.
Dosage with up to 30mg/l p-SSO had little effect on cell 
proliferation, but greater amounts progressively limited 
the viable cell yield in an overall concentration 
dependent manner to 72.9% and 74.5% with 90 and 100mg/l 
p-SSO, respectively (Fig. 3.6.1.5.). Cell proliferation 
with 10mg/l p-LO mirrored controls, but ranged from
83.5% to 89.4% with 20 to 60mg/l p-LO (Fig. 3.6.1.6.). 
Higher p-LO concentrations induced cytostasis and were 
therefore slightly more growth limiting than p-SSO, 
although 80.8% viability occurred with 80mg/l p-LO.
30 to 60mg/l p-EPO stimulated cell proliferation to a 
maximum of 110.4% with 40mg/l, but other concentrations 
had little effect on cell viability, and no growth 
limitation was observed (Fig. 3.6.1.7.).
10 and 20mg/l p-FO enhanced cell proliferation to 111.0% 
and 109.6%, respectively, 30 to 50mg/l p-F0 had little 
effect on cell viability, and higher amounts limited 
cell growth to a minimum of 69.8% with 90mg/l p-F0 (Fig.
3.6.1.8.). Half the cells were viable with 95mg/l p-F0 
(ID5 0 ), but only 26.2% with 100mg/l p-FO.
Rat lung cells were incubated with an amount of p-00
corresponding to its ID50 (approximately 86mg/l), and 
dosed with varying albumin concentrations to exclude the 
possibility that any effects induced with p-oil dosage 
were influenced by the amount of albumin bound to the 
FA's. F ive points were chosen around which to vary the 
albumin concentration, keeping the p-oil concentration 
fixed, viz. two points above, two points below, and the
ID50 of p-00. The results are depicted in Fig. 3.6.1.9., 
and indicated that the p—00 concentration incubated
reduced cell viability to approximately 50% of controls, 
and that such was not significantly influenced by
different albumin concentrations. Exclusion of the 
synergistic involvement of albumin thus implied that the 
effects reported in Figs. 3.6.1.2-3.6.1.8. were solely 
attributed to the exogenous FA's.
Cells were subsequently plated and dosed appropriately 
with 0, 20, 40 or 60mg p-oil/1 culture medium in amounts 
sufficient to permit all quantitative and qualitative 
analyses to be carried out. Cell viabilities relative to 
controls were compared upon harvesting and found to be 
statistically similar to those in Figs. 3.6.1.1-3.6.1.8. 
Hence, all further biochemical assays were performed on 
these samples.
3.6.2 Effects of Pseudo-Oils on Total Protein.
The results derived from the quantitation of total 
protein in control and p-oil dosed cells are shown in 
Table 3.6.2.1.
176.5 jig protein/106 control cells seeded was measured, 
while concentrations in dosed cells ranged from 158.5 to 
a maximum of 247.5jug protein/10& cells seeded (obtained 
with 60mg/l p-MO and 20mg/l p-00, respectively). Cells 
contained protein amounts equal to, or greater than, 
controls when 20mg/l p-oil (except p-EPO) or 40mg/l 
p-oil were dosed (176.9 to 247.9jug/106 cells seeded), 
while concentrations were increased with 60mg/l p-EPO or 
P-00 (209.5 and 199. ljig/10& cells seeded, respectively), 
parallel to controls with 60mg/l p-SSO (176.8jug/106 
cells seeded) and slightly decreased with 60mg/l p-CO, 
p-MO, p-LO or p-FO (158.5 to 165.6jug/106 cells seeded). 
The changes induced in total cellular protein were p-oil 
concentration dependent as protein levels increased in 
direct correlation with the amount of p-EPO dosed, but 
were inversely related to the p-CO, p-MO or p-LO 
concentration supplemented. With p-SSO or p-FO dosage, 
however, the highest protein levels measured were with a 
concentration of 40mg/l, but the reverse was true with
p-00 supplementation.
The protein content of cells derived from rat lung. 
expressed as jug total protein/lO5 r^llg seeded.
11
! pseudo­
! Oil
i
CELLS !1i1l
! (mg/l) 1 1
0 20 40
11
60 :ii11
! Control 1 176.5
iiiit1
: coi 189.0 184.4 163.2 : 1
: moi 187.1 182.0 158.5 :
: ooi 247.9 186.7 199.1 : 1
! SSO 1 204.0 213.9
1
176.8 :
: loi 186.7 176.9
1
160.0 : 1
! EPO 1 167.9 203.5
1
209.5 !
: foii
182.0 187.7
1
165.6 !11
3.6.3 Effects of pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Rat Lung.
The FA spectra of cells incubated with 20, 40 or 60mg/l 
p-oil are shown in Table 3.6.3.1. in relation to undosed 
cells. The greatest proportion of any FA in controls was 
16:0 (23.4%), but FA's contributing at least 5.0% to the 
total spectrum in controls included 18:0 (18.4%), 18:lw9 
(15.9%), 20:4u6 (11.8%) and 22:4w6 (9.0%). Significant 
proportions of these moieties were also detected in 
dosed cel Is.
In general, dosed cells contained 16:0 and 18:lu9 
proportions parallel to controls, but decreased 18:0 and 
more varied 16:lw9 percentages. 18:2w6, 20:2w6, 18:3u6, 
22:4w6, 18:3w3 and 20:4w3 levels were generally equal 
to, or greater than, controls, and 18:4u3 amounts were 
consistently increased with 40mg/l p-oil. The relative 
percentages of 20:5w3 and 22:5w3 were more variable, but 
22:5u6 and 22:6w3 levels were generally lower in dosed 
c e l  I s .
16:0 percentages were parallel to controls (23.4%) with 
P—CO incubation, 16:lu9 was slightly increased with 20 
and 40mg/l p-CO and decreased with 60mg/l p-CO (4.1%, 
4.2% and 2.4%, respectively vs 3.5% in controls), while 
18:0 levels were marginally reduced (15.8%, 15.2% and 
13.8%, respectively vs 18.4% in controls). p-CO had no 
marked effect on 18:lu9 and 18:2w6 levels, but 20:4w6
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where *n* is 
the number of experiments. ’Up-Oil 3’ refers to the
pseudo-oil concentration used.
The fatty acid spectrum of cells derived from rat lung,
FATTY ACID 
SPECTRUM 
C 4)
CONTROLS
(n=3)
Cp-COD 
(mg/1)
20 ! 40 ! 60
Cp-MOD 
(mg/1)
20 1 40 ! 60
Cp-OOD 
(mg/1)
20 ! 40 ! 60
Cp-sso:
(mg/1)
20 : 40 : 60
Cp-LOD 
(mg/1)
20 ! 40 ! 60
Cp-EPOD 
(mg/1 )
20 ! 40 ! 60 20
Zp-FOl 
(mg/1)
! 40 ! 60
S
A
16:0 23.4±0.15 23.8 20.9 25.1 23.1 20.3 27.1 18.3 20.3 22.2 23.4 18.7 12.5 24.6 19.6 26.5 22.4
11
18.9!26.8l 26.8 20.4 23.2
Tu 18:0 18.4±0.30 15.8 15.2 13.8 13.0 15.4 16.5 12.9 12.4 11.3 19.6 14.6 25.2 15.9 15.6 14.1 16.6 15.8!15.2 19.2 14.6 10.7
R
A
20:0 0.1±0.00 - 0.1 - - - - - - - - 0.2 3.2 - - - -
1_ • _ 1 - 0.1 -
T
E
22:0 - 0.2 - 0.3 - 0.1 0.1 0.1 - - 0.1 - - 0.1 0.1 0.2 -
1
0.1! 0.11 - 0.1 0.1
S. 24:0 0.2±0.00 — 0.7 — — — - — — — — 0.2 - - 0.6 - 0.8! -1111
- 0.7 -
w9
M
16:1 3.5±0.05 4.1 4.2 2.4 11.2 2.9 - 0.9 1.0 3.8 4.6 3.0 1.1 6.6 1.4 4.6 4.9
11
1.4! 4.8 1 6.8 5.9 8.3
0
N
18:1 15.9±0.10 16.0 14.8 18.0 17.8 17.8 21.6 24.8 31.2 35.6 18.5 14.3 22.7 14.9 14.8 18.2 14.4
1
12.7!16.4 17.8 14.9 15.7
0
s.
24:1 — - — — — - - - - - - - - - -
1_ 111111
- - -
18:2 4.0±0.10 5.2 3.7 6.3 7.3 7.7 9.3 8.0 7.4 8.7 14.1 15.4 20.3 7.5 8.1 9.1 16.3
1
19.3!15.3 1 7.4 5.8 7.5
u6
18:3 - ^Q.7 - 0.7 0.5 - 0.8 0.6 - 0.6 1.8 0.1 - 0.7 - 1.0 - - ! 1.111
0.6 - 0.4
p
20:2 — - — “ — — 0.1 0.3 1.1 0.9 0.2 0.9 1.2 - - - - 0.8! 0.1 1 - 0.3 0.3
0
1
20:3 2.0±0.00 1.7 2.0 1.7 1.3 1.4 1.0 1.5 1.3 1.0 1.0 1.8 0.7 1.3 2.1 1.2 2.4
1
5.2! 1.7 1 0.9 1.5 1.1
Y
S.
20:4 11.8±0.20 8.2 9.7 7.3 6.8 8.6 6.2 8.5 6 • 6 3.9 5.0 6.5 2.0 5.3 7.3 4.5 6.7 5.7! 3.7 5.2 6.7 3.8
22:4 9.0±0.65 14.7 12.3 13.0 10.9' 13.6 9.4 13.4 9.8 4.9 4.3 12.0 2.7 12.9 12.8 9.3 8.2 6.1! 9.5 1 7.8 10.2 10.5
22:5 1.3±0.10 0.2 1.5 0.2 0.2 1.5 0.2 0.1 0.8 — 0.4 1.0 0.2 0.1 1.4 0.2: 0.8
1
0.8! 0.1111
. J  . .
0.2 0.8 0.1
18:3 0.5±0.05 0.8 0.6 1.0 0.7 0.6 1.0 1.2 1.0 1.3 1.3 0.6 4.0 2.2 4.9 6.2 -
11
0.5! 0.91 0.5 0.5 0.7
u3 18:4 0.5±0.00 0.3 1.9 0.5 0.3 2.2 0.3 0.3 1.3 0.2 0.3 1.0 1.2 0.3 1.9 0.3 1.7! 0.2 1 0.3 1.4 0.4
P
0
L
V
20:4 0.7+0.00 1.0 1.0 1.7 1.4 0.7 1.3 1.1 0.4 0.6 0.1 1.0 0.4 1.4 0.7 1.4 0.3
l
0.8! 1.0 1 0.6 1.0 1.9
20:5 1.2±0.05 1.3 2.7 1.0 0.9 1.4 0.5 1.6 0.2 0.8 0.5 1.3 0.2 0.9 1.9 0.4 0.1
1
1.1! 0.3 1 1.2 4.5 5.3i
S. 22:5 3.1+0.15 2.6 3 . 7 2 . 9 2 .1 2 . 6 2 .1 2 . 8 2 . 4 1 . 8 2 . 2 3 .4 1 .2 2 . 4 3.2 1 .5 2 . 9 3.8! 1.3 1 2 .9 7 .8 7 .5
22 :6 4 . 3 ± 0 . 2 0 3 . 5 5 .1 4 . 2 2 . 5 3 . 3 2 . 5 3 . 8 3 .0 2 . 4 2 . 6 4 . 3 1 .4 3 . 1 3 . 9 1 .5 4 .0 4 . 7 !  1 .4t1
l
1 .9 3 .0 2 . 7
percentages were at least 2.0% lower than controls 
(11.8%), whereas 22:4u6 levels were 3.0% to 6.0% greater 
than controls (9.0%). However, no significant increase 
in 22:5u6 was found. 18:4u>3, 20:5u3, 22:5u3 and 22:6w3 
amounts increased only with 40mg/l p-CO (1.9%, 2.7%, 
3.7% and 5.1% vs 0.5%, 1.2%, 3.1% and 4.3% in controls, 
respectively), but 20:4w3 was increased slightly with 
all concentrations (1.0% to 1.7% vs 0.7% in controls).
20.3% to 27.1% 16:0 was detected with p-MO dosage (23.4% 
in controls), whereas 16:lu9 levels were significantly 
increased with 20mg/l p-M0, but decreased with 40 and 
60mg/l p-M0 (11.2%, 2.9% and 0%, respectively vs 3.5% in 
controls). p-M0 induced a slight decrease in 18:0 (13.0% 
to 16.5% vs 18.4% in controls), but an increase in 
18:lw9 (17.8% to 21.6% vs 15.9% in controls) and 18:2w6 
(7.3% to 9.3% vs 4.0% in controls), percentages. 20:4u6 
levels were lower than controls (11.8%), and a greater 
proportion of its elongation product, 22:4cj6, was found 
(up to 13.6% vs 9.0% in controls), but 22:5w6 levels 
were parallel to controls (1.3%) or decreased. The only 
u3 PUFA's that were significantly increased were 18:4u3 
(2.2% with 40mg/l p-M0 vs 0.5% in controls) and 20:4u3 
(1.4% and 1.3% with 20 and 60mg/l p—MO, respectively vs 
0.7% in controls).
18:lu9 levels increased significantly with dosage of 20, 
40 or 60mg/l p-00 (24.8%, 31.2% and 35.6%, respect i ve1y
vs 15.9% in controls), whereas 16:0, 18:0 and 16:lw9 
proportions were parallel to controls (23.4%, 18.4% and 
3.5%, respectively), or decreased. Raised percentages of 
18:2w6 (7.4% to 8.7% vs 4.0% in controls) and 20:2u6 
(0.3% to 1.1% vs 0% in controls) were found, but 20:4w6 
levels were lower than controls (11.8%). However, 22:4w6 
was significantly raised with 20mg/l p-00 (13.4% vs 9.0% 
in controls), yet 22:5w6 levels were significantly lower 
than controls (1.3%). 18:3w3 increased at least 2 fold 
with p-00 dosage (1.0% to 1.3% vs 0.5% in controls), and 
40mg/l p-00 raised 18:4w3 percentages (1.3% vs 0.5% in 
controls), but other u3 FA levels were only marginally 
raised, or decreased.
16:0 and 16:lw9 percentages decreased inversely with the 
amount of p-SSO dosed (23.4% to 12.5% and 4.6% to 1.1% 
vs 23.4% and 3.5% in controls, respectively), but 18:0, 
20:0 and 18:lw9 proportions increased significanty with 
60mg/l p-SSO (25.2%, 3.2% and 22.7% vs 18.4%, 0.1% and 
15.9% in controls, respectively). p-SSO supplementation 
raised cellular 18:2w6 amounts (14.1% to 20.3% vs 4.0% 
in controls), and induced small increments in 18:3u6, 
22:4u6 and 20:2w6 with concentrations of 20, 40 and 
60mg/l, respectively (1.8%, 12.0% and 1.2% vs 0%, 9.0% 
and 0% in controls, respectively). Up to 4.0% 18:3w3 and 
1.2% 18:4u3 were detected (0.5% each in controls), but 
other w3 PUFA levels were parallel to controls, or 
decreased.
Cells dosed with p-LO exhibited 16:0 and 18:lu9 levels 
similar to controls (23.4% and 15.9%, respectively), 
marginally decreased 18:0 (14.1% to 15.9% vs 18.4% in 
controls), and varied 16:lw9 amounts (1.4% to 6.6% vs 
3.5% in controls). A concentration dependent increase in 
18:2u6 incorporation (7.5% to 9.1% vs 4.0% in controls), 
and up to 1.0% 18:3u6 (none in controls), were detected, 
and 22:4u6 was increased with 20 and 40mg/l p-L0 (12.9% 
and 12.8%, respectively vs 9.0% in controls). 18:3w3 
incorporation increased from 0.5% in controls to 2.2%, 
4.9% and 6.2% when 20, 40 or 60mg/l p-L0 were added to 
cultures, respectively. Increased 18:4w3 and 20:5w3 were 
detected with 40mg/l p-LO (1.9% each vs 0.5% and 1.2% in 
controls, respectively) and 20:4w3 with 20 and 60mg/l 
p-LO (1.4% vs 0.7% in controls), yet 22:5u3 and 22:6u3 
levels were parallel to controls, or reduced.
p-EPO dosage had no pronounced effect on cellular 16:0 
and 18:lw9 levels, but decreased 18:0 marginally (15.2% 
to 16.6% vs 18.4% in controls), and had a more variable 
effect on 16:lu9 (1.4% to 6.6% vs 3.5% in controls). 
18:2u6 increased from 4.0% in controls to 16.3%, 19.3% 
and 15.3% with 20, 40 and 60mg/l p—EPO, respectively, 
and 1.1% 18:3w6 was detected with 60mg/l p-EPO, but none 
in controls, with 20 or 40mg/l p-EPO. 20:3w6 increased 
significantly with dosage of 40mg/l p-EPO (5.2% vs 2.0% 
in controls), but no such changes were shown for other 
w6 PUFA s. With the exception of slight increments in
18:4to3, 22: 5w3 and 22:6u3 detected with 40mg/l p-EPO, u)3 
FA levels were either parallel to controls or decreased.
16:0 and 18:lu9 levels were not markedly altered with 
P-F0 incubation, whereas 18:0 was decreased overall, and 
16:lw9 significantly increased (5.9* to 8.3* vs 3.5* in 
controls). 5.8* to 7.5* 18:2u6 was detected (4.0* in
controls), and up to 10.5* 22:4u6 (9.0* in controls), 
but 22:5u6 levels were decreased. A maximum of 1.4* 
18:4u3 was detected with 40mg/l p-FO and 1.9* 20:4u3 
60mg/l p-FO (0.5* and 0.7* in controls, respectively), 
whereas 20:5u3 was significantly increased both with 40 
and 60mg/l p-F0 (4.5* and 5.3*, respectively vs 1.2* in 
controls). 22:5w3 increased by at least two fold with 40 
and 60mg/l p-FO (7.8* and 7.5*, respectively vs 3.1* in 
controls), yet 22:6u3 was decreased (1.9* to 3.0* vs 
4.3* in controIs).
3.6.4 Incorporation of Radiolabel1ed C18 Fatty
Acids into Cells Derived from Rat Lung.
The radioactivity recovered from cultures incubated with 
2/jCi of each of the radiol abel 1 ed C18 FA's is shown in 
Table 3.6.4.1.
The total counts recovered in the spent incubation media 
ranged from 2.4 to 3.0xl0scpm, with only 0.5 to 0.8x10s 
cpm recovered from the pooled buffers after washing the 
cells; this accounted for non-specific binding. For 
both CiaCT-18:lu9 and C14CD-18'3u3, the equivalent of 
4.3x10s cpm were dosed to the incubation medium. Total 
recovery of radiolabel from cultures dosed with these 
FA's was approximately 84% and 91%, respectively. For 
CiaCD-18;2co6 the equivalent of 4.8xl0scpm were dosed to 
the incubation medium, and total recovery of this radio­
isotope from the cultures was about 96%. The total 
amount of each of these radioisotopes incorporated into 
the cells was approximately 13% for CiaCJ-18*lw9, 15%
for C14C:-18:2w6, and 7% for C1aCD-18:3w3.
The percentage conversion of each of the incorporated 
radiolabel1ed C18 FA's above to w9, w6 or u3 series 
products after 48 hours incubation with rat lung 
fibroblasts is shown in Table 3.6.4.2. As A 6D represents 
the first enzyme in the desaturase cascade, total 
activity of this enzyme is reflected by the sum of all 
subsequent desaturase and elongase products.
The radioactivity (cpid) recovered from rat lung cultures 
incubated uiith radio!abel1ed C18 fatty acids. expressed as 
mean (is.e.m.). n=3.
SPENT
MEDIA
(M)
POOLED
WASHINGS
(W)
TOTAL
(M+U)
CELLS TOTAL
xl0&
Total 18:1 counts dosed to incubation medium = 4.3 x 106
2350600
(±26420)
664370
(±14630)
3014970 548552
(±1989)
3.6
Total 18:2 counts dosed to incubation medium = 4.8 x 106
3043260
(±18423)
784740
(±7191)
3828000 734574
(±1176)
4.6
Total 18:3 counts dosed to incubation medium = 4.3 x 106
3044360
(±36020)
521690
(±5265)
3566050 304473
(±1779)
3.9
The counts detected for the radiolabel1ed fatty ac i ds
dosed and their resultino metabolites formed after
incubation with cells deriwed from rat lung, expressed
as a Percentage of the total counts recowered upon GLC
analysis.
u9
MONOS.
C14C >  
18:lu9
u6
POLYS.
C14CD-
18:2u6
w3
POLYS.
c14co-
18:3u3
18:1 12.7 18:2 4.8 18:3 3.4
20:1 34.5 18:3 17.2 18:4 22.8
22:1 37.9 20:2 24.2 20:3 14.7
24:1 15.0 20:3 25.5 20:4 18.7
20:4 14.7 20:5 19.0
22:4 7.2 22:5 11.1
22:5 6.5 22:6 10.3
TOTAL
CPM 1107
TOTAL
CPM 1865
TOTAL
CPM 804
12.7% of the total CiaCJ—18Jlu9 counts derived upon GLA 
analysis (1107cpm) remained as 18:lu9, whereas 34.5%, 
37.9% and 15.0% were elongated to 20:1uj9, 22:lu9 and 
24:lu9, respectively.
Only 4.8-^  of the total C 1 “^CO-IS J 2u6-der i ved counts 
measured (1865cpm) remained unchanged, whereas 17.2% was 
shown to be 18j3u6. 24.2% and 25.5% of the total counts 
were found as 20J2w6 and 20t3w6, respectively, compared 
to 14.7% 20:4u6. Furthermore, 7.2% and 6.5% 22:4u6 and 
22:5w6 were detected, respectively.
Only 3.4% of total counts (804cpm) remained as 18:3w3, 
and 14.7% was found as the immediate elongation product, 
20:3u3. 22.8% 18:4w3 was detected, compared to 18.7% 
20 : 4u3 and 19.0% 20:5u3. 11.1% of total C iaC0-18: 3to3- 
derived counts were shown to be 22:5w3 and 10.3% 22:6w3, 
and these percentages were 1arger than those found for 
corresponding products in the w6 series.
3.6.5 Effects of pseudo-Qils on Lipid Peroxide 
Formation.
Table 3.6.5.1. shows the 1ipoperoxides quantitated in 
dosed rat lung fibroblasts and their respective spent 
incubation media, compared to controls. The results are 
expressed as nmoles MDA/106 cel Is, but in the case of 
the spent media this represents the nmoles of MDA in the 
volume of medium from which 1x10s cells were obtained.
Spent medium derived from cultures supplemented with 
60mg/l p-SSO, 60mg/l p-FO, 40mg/l p-LO, or p-60mg/l p-LO 
contained 0.3, 0.6, 0.1 and 3.7nmoles MDA/106 cells, 
respectively, but MDA was absent from all other spent 
media. However, control and all dosed cells formed MDA. 
1.Inmoles MDA/106 control cells was measured, whereas 
concentrations in dosed cells ranged from a low of 1.0 
nmole MDA/106 cells (with 20mg/l p-SSO and p~EP0) to a 
maximum of 10.8nmoles MDA/106 cells (with 60mg/l p-EPO). 
Cellular 1ipoperoxide amounts varied with the p-oil 
supplemented, but increased in an overall concentration 
dependent manner. p-00 and p-SSO produced the smallest 
cellular 1ipoperoxide amounts overall, ranging from 
1.0 to 1.3nmo1es MDA/106 cells, whereas p-CO and p-M0 
generated 1.4 to 2.1nmoles MDA/106 cells. Cells dosed 
with 20mg/l p-L0, p-EPO or p-FO contained no more MDA 
than controls, but p-LO and p-FO generated more MDA 
than p-EPO with a concentration of 40mg/l (1.9, 2.1 and
Lipoperoxide formation by rat lung cultures incubated 
uiith p-oils. expressed as nmoles MDA/10& cells.
pseudo­
Oil
CELLS
(mg/1) 0 20 40 60
Contro1 1.1
CO 1.4 1.4 1.5
MO 1.6 1.7 2.1
00 1.2 1.2 1.3
SSO 1.0 1.1 1.3
L0 1.1 1.9 7.2
EPO 1.0 1.2 10.8
F0 , 1.1 2.1 2.6
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - -
SSO - - 0.3
L0 - 0.1 3.7
EPO - - -
FO - - 0.6
1.2nmoles MDA/10& cells, respectively). p-EPO, however, 
induced the greatest cellular 1ipoperoxide amounts with 
a concentration of 60mg/l, followed by p-LO and p-FO 
(10.8, 7.2 and 2.6 nmoles MDA/10^1 cells, respectively).
The Eicosanoid Profile of Cells Derived 
from Rat Lung.
Table 3.6.6.1. shows the eicosanoids positively detected 
in control and dosed rat lung fibroblasts. All data is 
presented as a percentage of the total area quantitated, 
but an indication of the actual amount found is given 
for controls in ’( )" as pmoles total eicosanoids/106 
cel Is.
Total eicosanoid production by control cells amounted to 
727.6pmo1es/10e cells, of which 22.0% correlated with 
the retention times of the prostanoid standards used. 
This fraction was shown to be composed of 11.9% PGE,
9
1.6% PGI2, 3 , o -4 TXB2 , 4.2% PGF& and 1.3% PGE2. Varying 
proportions of these prostanoids were found in dosed
cells, but neither control nor dosed cells formed PGD2*— •
The percentage of total prostanoids detected in dosed 
cells ranged from 15.8% (with 40mg/l p-MO) to a maximum 
of 28.5% (with both 60mg/l p-MO and p-LO), compared to 
22.0% in controls, but no consistent correlation was 
evident between total eicosanoid percentages and p-oil 
concentration. p-Oil supplementation, however, altered 
the production of individual prostanoids in these cells.
r u i 2 levels were lower in dosed cells than in controls 
(0.3% to 1.0% vs 1.6%, respectively), and no particular
p-oil concentration consistently induced greater PGI2 
percentages than any other concentration. Cellular TXB2
Values are tabulated as relative percent of the 
area detected, and as pmoles total eicosanoi 
control cel Is.
tota 1 
ds/106
The profile of the eicosanoids detected in extracts of 
cells derived from rat lung.
pseudo­
Oil
(mg/1)
EICOSANOIDS ( X )
!TOTAL pgi2 TXBz PGFot(1+2) PGE2 PGEi PGD2
CONTROL ! 22.0 1.6 3.0 4.2 1.3 11.9
(727.6)
20 : 25.4 0.9 14.6 8.5 1.2 0.2
o o o : 23.6 0.8 4.3 6.6 - 11.9 -
60 : 24.3 0.5 14.9 7.4 1.2 0.3 -
20 : 24.9 0.7 14.9 7.9 1.2 0.2 _
MO 40 : 15.8 1.0 3.2 4.2 - 7.4 -
60 : 28.5 0.3 17.4 8.7 1.8 0.3 -
20 ; 2 1 .0 0.7 11.0 8.1 1.1 0.1 _
00 40 : 26.i 1.0 4.3 4.4 - 16.4 -
60 : 26.5 0.3 14.9 9.7 1.1 0.5 -
20 : 26.6 0.3 15.5 9.1 1.5 0.2 —
SS0 40 : 24.8 0.9 4.3 3.4 - 16.2 -
60 : 27.5 0.4 15.9 8.0 2.1 1.1 -
20 : 22.2 0.7 11.8 8.0 1.5 0.2 —
LO 40 ! 18.1 0.7 3.7 4.3 - 9.4 -
60 : 28.5 0.5 16.1 9.2 2.1 0.6 -
20 : 24.i 0.5 13.1 8.8 0.8 0.9 —
EP0 40 : 2o.i 0.7 5.1 3.1 - 11.2 -
60 : 26.9 0.4 15.0 7.9 1.4 2.2 —
20 : 28.3 0.9 17.0 8.7 1.5 0.2 —
F0 40 : 19 .1 0.8 4.0 1.7 - 12.6 -
60 : 20.7 0.8 12.3 5.7 1.2 0.7 —
percentages were comparable to controls (3.0%) with 
40mg/l p~oi1 (3.2% to 5.1%), but were increased between 
3 and 6 fold with 20 and 60mg/l p-oil (11.0% to 17.4%).
ur0c production was also enhanced with dosage of 20mg/l 
(7.9% to 9.1%) or 60mg/l (5.7% to 9.7%) p-oil, but more
variable with 40mg/l p-oil (1.7% to 6.6%), compared to 
controls (4.2%). Incubation with 20 or 60mg/l p-oil had 
no profound effect on PGE2 ] e w e ] s (0.8% to 2.1% vs 1.3% 
incontrols), but such was inhibited with 40mg/l p-oil.
PGEi percentages, in contrast, were comparable in cells 
dosed with 0 or 40mg/l p-oil (11.9% vs 7.4% to 16.2%), 
and markedly decreased both with 60mg/l (0.3% to 2.2%) 
and 20mg/l (0.1% and 0.9%) p-oil.
3.6.7 D i scuss i on.
It was apparent from lack of literature that very little 
is known regarding the effects of exogenous FA's on 
normal rat lung fibroblast growth. The present study
indicated that p-oil supplementation affected the
*
viability of such cells (Figs. 3 .6.1.2-3.6.1.8.), and 
that this was dependent both on the p-oil concentration 
dosed and p-oil FA composition (Table 2.3.3.2.). The 
mediation of cytotoxicity only with p-00, p-FO or p-CO 
dosage at concentrations greater than 80mg/l may relate 
partly to the relatively low population doubling time 
these cells exhibited (Table 2.3.1.1.). Furthermore, the 
ability of cultured rat lung fibroblasts to withstand 
large amounts of PUFA-rich p-oils without being killed 
may relate to the finding that this tissue has been 
implicated as the primary site for eicosanoid synthesis 
(Mathe' et al 1977, Hyman et al 1978 and Harper et al 
1984), the precursors of which are PUFA's.
OA, LA or ALA comprised about 71%, 70% and 63% of all 
FA s in p-00, p-SSO and p-LO, respectively, thus it was 
likely that the cell viability changes induced with 
incubation of either p-oil related largely to these C18 
FA's. Such moieties were all J6D substrates, but the 
variation in the number and position of their double 
bonds could explain the mediation of cytotoxicity with 
high p-00 concentrations, but not with p-SSO or p-LO.
The similar extent of growth limitation induced overall 
with p-SSO or p-LO dosage, however, implied that ALA and 
LA modulated similar effects in these cells, which may 
relate to the fact that both moieties are EFA's and 
exhibit a double bond at the u6 position, unlike OA. 
On the other hand, the similar FA compositions of p-SSO 
and p-EPO suggested that the inability to limit cell 
viability with dosage of up to 100mg/l p-EPO related to 
the presence of 9 4 GLA only in this p-oil. Such may be 
important for optimal rat lung fibroblast proliferation, 
or may suppress the growth limiting capability of other 
FA constituents in p-EPO, particularly LA. The finding 
that the greatest enhancement of cell viability occurred 
with incubation of p-oils containing significant PDFA 
amounts ( 9 4 GLA in p-EPO and 1 8 4 EPA in p-FO) indeed 
implied involvement of these moieties in the modulation 
of rat lung fibroblast proliferation. Synergistic and 
antagonistic interations between FA's in any p-oil 
should, however, not be overlooked as mediators of the 
growth responses induced. This may explain why cell 
viability did not always relate inversely to the p-oil 
concentration dosed and why p-oils of similar FA 
composition induced different effects.
The data in Table 3.6.3.1. supported the ability of rat 
lung fibroblasts to incorporate exogenous FA's, which 
modified dosed cell FA compositions to a greater or 
lesser extent compared to controls. There is substancial
evidence to indicate that dietary FA supplementation 
induces changes in membrane physical properties (eg. 
King et al 1971, Ginsberg et al 1981, Simon et al 1982, 
Stubbs et al 1984 and Spector et al 1985). A possible 
mechanism whereby p-oils were involved in the reduction 
of cell viability reported may therefore relate to 
differential uptake of exogenous FA's and alterations 
in membrane fluidity, dependent on p-oil FA composition. 
Furthermore, incubation with low p—oil concentrations 
could have allowed the cells to maintain a similar 
degree of membrane fluidity to controls, whereas 1arger 
p-oil amounts could have led to more pronounced changes 
in the membrane unsaturation index such that cell 
viability was limited or inhibited.
The finding that the cellular protein concentrations 
reported with .p-oil supplementation (Table 3.6.2.1.) did 
not always correlate with the cell viability changes 
induced (Figs. 3.6.1.2-3.6.1.8.) implied FA involvement 
in the modulation of protein synthesis. Increased 
protein levels when cell viability was parallel to 
controls or limited indeed indicated that protein 
synthesis was stimulated, ' whereas the finding that 
decreased cell numbers alone could not justify the 
lowest amount of protein measured with 60mg/l p-MO 
implied suppression of protein synthesis. Since the 
modulation of protein synthesis varied in magnitude with 
dosage of identical amounts of different p-oils, even
when such yielded similar cell numbers, it was suggested 
that the capability to enhance or suppress protein 
synthesis varied with FA, and was relatable to FA 
structure and concentration in any p-oil. Absolute 
changes in cellular protein with p-oil dosage may 
nevertheless relate to alterations in the production of 
structural membrane proteins and/or enzymes involved in 
FA metabolism.
The lung has been implicated as the primary site for 
eicosanoid synthesis (Mathe et al 1977, Hyman et al 1978 
and Harper et al 1984), thus its ability to desaturate 
and elongate FA^s to provide eicosanoid precursors is of 
major importance. Comparison of control cell FA spectra 
with those derived from p-oil dosed cells indicated the 
capability of cultured rat lung fibroblasts to express 
desaturase and elongase enzymes (Table 3.6.3.1.). The 
raised 16:lu9 levels found in dosed cells implied 16:0 
desaturation, and the possibility for 16:lu9 elongation 
also existed. In addition, the significantly decreased 
16:0 and increased 18:0, 20:0 and 18:lw9 levels detected 
with 60mg/l p-SSO dosage supported the capability for 
elongase and A9D expression. Comparison of w3 PUFA 
desaturase cascade substrates and products indicated 
J6D, subsequent elongase and J5D expression. 18:3w6 and 
20:3w6 formation with 20mg/l p-SSO and 40mg/l p-EPO, 
respectively supported J6D and elongase capability. 
Further, raised 22:4u6 levels in dosed cells suggested
rapid 20:3u6 desaturation and 20:4u6 elongation, and 
this could reflect a requirement for higher PDFA's to 
maintain membrane fluidity. 22:4u6 accumulation may also 
reflect a lack of significant 22:5u6 formation via J4D. 
Slightly increased 22:6w3 levels with supplementation of 
40mg/l p-CO suggested the capability to express J4D, 
although 22j6u3 levels lower than controls with p-FO 
dosage implied suppression of J4D expression, despite 
substrate availability. It has been suggested that 
22:5u3 is the storage form of 20:5u3 in rat lung 
(Swanson et al 1987). This could explain the preference 
to form 22:4u6 and 22:5u3 rather than 22:5u6 and 22:6w3, 
especially since the former moieties can undergo extra­
microsomal retroconversion and further desaturation, 
thus giving the cells greater flexibility to utilise 
these PUFA's efficiently to form the products required, 
particularly for 2- and 3-series eicosanoid synthesis. 
Overal1, the potential to express desaturase cascade 
enzymes implied that rat lung fibroblasts could control 
membrane fluidity, and this may explain why cytotoxicity 
was induced only with p-CO, p-00 and p-FO concentrations 
greater than 80mg/l.
Desaturation with individual radiolabel1ed C18 FA's was 
assessed to establish whether the pattern of p-oi1 
desaturation reported in Table 3.6.3.1. was modulated 
with FA mixtures. 24:lw9 detection when cultures were 
dosed with C14C3-18:lw9 was consistent with elongase
expression, although no evidence to suggest £14CT-18:lu9 
desaturation was found (Table 3.6.4.2.). This probably 
reflects the inhibition of 18:lu9 desaturation by EFA's, 
which has been well documented (Brenner et al 1966, 
1969, Brenner 1977 and Holman 1986b). On the other hand, 
the pattern of radioactivity derived from cultures 
incubated with either £14CH-18:3w3 or £iaC3-18:2u6 was 
consistent with significant A6D and subsequent elongase 
activity (Table 3.6.4.2.), and the significant amounts 
of £14C3-18J3u3 and £14CT-18:2w6 directly elongated to 
20:3u)3 and 20:2w6, respectively could have served as EFA 
storage products for retroconversion. Conversion of 
about 40* £14CD-18:3w3 and 28* £14CD-18:2w6 to post-J5D 
PUFA's supported J5D expression. 20:5u3 and 20:4u6 
elongation was shown, but J4D activity was more 
limited. The finding that desaturase capability was 
greatest with EFA substrates and progressively decreased 
as more unsaturated PDFA's were formed nevertheless 
comfirmed the rate 1imiting nature of J6D in the cascade 
(Castuma et al 1972, Brenner 1974 and de Gomez Dumm et 
al 1976). Furthermore, the greater proportion of £14CT- 
18:3u3 converted to PDFA's than £14C3-18:2w6 supported 
the established preference for u)3, rather than w6, 
series PUFA substrates for desaturation (Brenner et al 
1966, Mead et al 1976 and Kanau et al 1977). This was 
consistent with the direct elongation of more £14CD- 
18:2u6 to 20 :2u6 than £ 14CI!-18:3u3 to 20:3u3 (Table
3.6.4.2.).
Comparison of the data in Tables 3.6.3.1. and 3.6.4.2. 
clearly indicated that the capability for desaturation 
and elongation were more'limited with p-oil than with 
indiuidual C18 FA incubation. Competitive interactions 
between p-oil FA^s could well have suppressed desaturase 
cascade enzyme expression, particularly since the
competitive nature of FA's for such enzymes have been 
wel1 documented both in vivo and in vitro (Brenner et al 
1966, Mohrhauer et al 1963a, Ullman et al 1971, de
Schriver et al 1982, Holman 1986a, 1986b, 'Nassar et al 
1986 and Cook et al 1987). Cells in vivo are exposed to 
FA mixtures rather than to individual FA's, ' hence the 
desaturase cascade enzyme capability reported with 
individual FA dosage may not necessarily reflect the 
situation in the "real world". On the other hand, p-oil 
FA composition mimicked that of dietary oils, thus 
enzyme expression reported with p-oil dosage probably 
reflects the capability of rat lung fibroblasts to 
desaturate and elongate dietary oils in vivo.
The cellular 1ipoperoxides measured both in the presence 
and absence of p-oil supplementation (Table 3.6.5.1.) 
supported enzymic and/or non-enzymic mechanisms for' 
their production in rat lung fiboblasts. Control cellsi
contained unsaturated FA's that were potential oxidation 
substrates (Table 3.6.3.1.), hence the lipid peroxides 
measured in such were not surprising. Control cell 
lipid peroxides could reflect the lack of sufficient
alpha-tocopherol to limit FA oxidation, or inefficient 
mechanisms to remove different species of activated 
oxygen that promote 1ipoperoxidation, such as catalase, 
peroxidase and superoxide dismutase (Lands et al 1971, 
Smith et al 1972, Tappel 1972, 1980 and Pryor 1976). The 
greater lipid peroxide amounts reported in certain 
dosed cultures than in controls implied oxidation of 
unsaturated p—oil FA/s, and the numerical differences 
in lipoperoxide concentrations reported between dosed 
cultures reflected the different p-oil FA compositions 
(Table 2.3.3.2.). This related not only to the amount 
of unsaturated FA's present in any p-oil, but also to 
their susceptibility oxidation, which in turn related to 
the number and position of double bonds in a FA.
It was apparent that the small cellular lipoperoxide 
amounts formed with 60mg/l p—SSO incubation related 
largely to oxidation of free LA, but the greatest 
cellular lipoperoxide amounts induced with 60mg/l p-EPO 
incubation probably also reflected oxidation of GLA 
incorporated only with p-EPO dosage, as both p-oils 
otherwise exhibited similar FA compositions. It followed 
from comparison of the amount of C18 trienoic FA's 
present in p-EPO and p-LO (about 9% GLA and 63% ALA, 
respectively) with the lipid peroxides these p-oils 
induced that GLA was more susceptible to oxidation than 
ALA. This could relate to the easier production of 
endoperoxides from GLA than ALA because the former
merely requires chain elongation to be usable as an 
endoperoxide substrate, while ALA requires elongation 
and two desaturations first. On the other hand, the 
fact that incubation for 48 hours with 60mg/l p-EPO or 
p-LO induced markedly more 1ipoperoxides than p-FO, 
despite the presence of 18% EPA in the latter, may 
relate to FA availability for oxidation. The finding 
that 1ipoperoxide amounts approximated to controls with* 
supplementation of certain unsaturated FA-rich p-oils 
(20mg/l p-LO, 20mg/l p-FO, 20 and 40mg/l p-EPO, and all 
concentrations of p-00 and p-SSO) indeed implied that 
the incorporated exogenous FA's were largely components 
of complex membrane lipids, and therefore not so readily 
accessible to oxidation. In fact, the ability of rat 
lung to peroxidise lipids in vitro has been shown to 
correlate with the presence of PUFA's in the TAG 
fraction (Kehrer et al 1978), It was also possible that 
dosage with different p-oils altered the rate of PGL 
turnover and thus the release of FA's from membrane 
lipids into the cellular pool. Such may explain the 
slightly greater cellular 1ipoperoxide amounts formed 
with supplementation of p-CO or p-MO than with certain 
more unsaturated FA-rich p-oils.
The significantly greater amounts of cellular than spent 
medium lipid peroxides (Table 3.6.5.1.) supported the 
ability of these cells to incorporate exogenous FA's 
(Table 3.6.3.1.). Hence it was unlikely that the lipid
peroxides measured in the spent medium of dosed cultures 
were formed primarily as a result of auto-oxidation 
of unincorporated p-oil FA's, particularly since these 
moieties were albumin-bound. The absence of cytotoxicity 
with dosage of 60mg/l p-oil (Figs. 3.6.1.2-3.6.1.8.) and 
the known ability of 1ipoperoxides to increase membrane 
permeability (Chio et al 1969 and Frankel 1984) rather 
suggested that the spent medium 1ipoperoxides originated 
intrace11u1ar1y via passage through the plasma membrane. 
Cellular FFA's and 1ipoperoxidation enzymes could also 
have been released in this process, thus the possiblity 
that spontaneous and/or enzymic FFA oxidation occurred 
extrace 11u1ar1y can not be ignored as contributing to 
the spent medium lipid peroxides reported.
Growth inhibition was not induced with supplementation 
of 20, 40 or 60mg/l p-oil (Figs. 3.6.1.2-3.6.1.8.), thus 
no correlation between lipid peroxide formation (Table
3.6.5.1.) and cytotoxicity could be established. Lipid 
peroxides should, however, not be overlooked as a 
possible mechanism involved in the modulation of 
cytotoxicity with dosage of higher p-oil concentrations. 
It was nevertheless apparent that if lipid peroxides 
were directly involved in the inhibition of rat lung 
fibroblast proliferation, the concentrations required 
would have to be considerably greater than those 
reported. On the other hand, the inverse relationship 
generally found between rat lung cell viability and MDA
concentrations with p-oil incubation suggested lipid 
peroxide involvement in the modulation of growth 
limitation. However, the fact that the greatest cellular 
1ipoperoxide concentrations induced with 60mg/l p-EPO 
correlated with the absence of growth limitation implied 
that the modulation of cell viability also related to 
other mechanisms, such as alterations in membrane 
fluidity. As the lung is continuously exposed to high 
oxygen levels in vivo, this tissue may be particularly 
resistant both to the formation and effects of 1ipid 
peroxides. The extent of 1ipoperoxidation in rat lung 
microsomes has indeed been shown to be considerably 
lower .than in liver microsomes, and this was relatable 
to its markedly greater vitamin E content and affinity 
for the vitamin (Krishnamurthy et al 1963, Gallo-Torres 
et al 1971, Kelleher et al 1972, Kornbrust et al 1980 
and Sevanian et al 1982).
Total eicosanoid production accounted for 66% of all 
cellular 1ipoperoxides measured in control cells (Tables
3.6.5.1. and 3.6.6.1.), and this supported studies which 
have shown the lung to be an important site for 
eicosanoid production (Mathe et al 1977, Hyman et al 
1978 and Harper et al 1984). In the presence of 
exogenous AA, Pace-Asciak et al (1977) found that the 
primary eicosanoids formed by rat lung homogenates were
6 keto PGF1q. f followed by TXB2, whereas such exhibited 
relatively little capacity to produce PGE2 f PC Fz^ and
PGt-*2. Others reported some PGE2 , PGFiot and PGF2oc, but no 
PGD2 , formation in this tissue (Moore 1985). Under the 
conditions used in the present study, control rat lung
fibroblasts similarly produced no PGD2 and small amounts
of PGE2 f PGI2 , TXB2 and PGFoc, although marked PGEi 
formation was additionally shown (Table 3.6.6.1.). The
preferential synthesis of PGEi may be the reSult of
increased PGHi_pGEl iSOmerase expression or relative 
decreases in the biosynthesis of other prostanoids. 
However, the finding that dosage with 20 or 60mg/l p-oil 
markedly enhanced TXB2 and pGFo( > and suppressed PGEi , 
production implied modulation of eicosanoid synthesis, 
probably at the level of the synthetase enzymes. Changes 
in the proportions PGI2 and PGE2 were also found with 
p-oil dosage, although total eicosanoid production was 
not markedly altered compared to controls (Table
3.6.6.1.). Others showed that eicosanoid synthesis
(6 keto PGF1&t TXB2 and PGE2) was not altered in 
this tissue when olive oil enriched diets were fed 
compared to controls (fed a lard enriched diet), despite 
displacement of AA with 0A in membrane lipids (Lokesh et 
al 1988). Menhaden oil also displaced AA with u3 PUFA's, 
although eicosanoid synthesis was decreased (Lokesh et 
al 1985). This implied that different FA components of 
these oils mediated eicosanoid production in a specific 
manner. It was apparent, however, that the modulation of 
eicosanoid production in our study did not relate 
primarily to incorporation of exogenous FA^s per se.
since no clear differences in total or individual 
eicosanoid production was found between cells dosed with 
identical amounts of different p-oils, either containing 
or devoid of eicosanoid precursors. The production of 
the prostanoids reported was also not related to the 
degree of p-oil unsaturation (Table 2.3.3.2.) or the 
ability of these cells to form eicosanoid precursors 
with p-oil supplementation (Table 3.6.3.1.).
The inability to induce marked differences in the levels 
of the eicosanoids reported with dosage of the same 
concentration of different p-oils suggested utilisation 
of endogenous rather than exogenous PUFA precursors for 
eicosanoid production. The enhanced prostanoid levels 
reported in Table 3.6.6.1. could indeed relate to the 
presence of 20:3u6 and particularly 20:4u6 in undosed 
cells (Table 3.6.3.1.), which are usable by this tissue 
for prostanoid synthesis (Lokesh et al 1985). The 
eicosanoids detected nevertheless implied that the 
cyclooxygenase pathway was functional in these cells, 
although the exact mechanism by which prostanoid 
production was modulated with p-oil dosage was unclear. 
The possibility exists that incubation with different 
p-oil concentrations influenced eicosanoid precursor 
availability, or modulated various enzymic steps in the 
prostanoid biosynthetic pathway either by activating, 
suppressing or inhibiting their activity under the 
culture conditions used.
Eicosanoid profiles (Table 3.6.6.1.) did not correlate 
in any way with the changes reported in cell viability 
(Figs. 3.6.1.2-3.6.1.8.), total cellular protein (Table
3.6.2.1.), desaturation capability (Table 3.6.3.1.), or 
lipid peroxide production (Table 3.6.5.1.) with p-oi1 
dosage. This implied that although p-oil supplementation 
influenced the overall production of the eicosanoids 
detected, or the balance between individual prostanoid 
groups, these endogenously synthesised eicosanoids were 
probably not directly involved in the modulation of the 
effects demonstrated with p-oil dosage. Indeed, this 
mechanism could not explain the effects of p-oils rich 
in saturated or monoenoic FA's, which can not be 
metabolised by this route. Membrane fluidity changes and 
1ipoperoxides were proposed as alternative mechanisms.
3.7 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM RAT SKIN.
3.7.1 Effects of Pseudo-Oils on Cell Viability.
Microscopic examination of rat skin fibroblasts before, 
during and after each experiment showed no morphological 
changes in control or dosed cells, although cytoplasmic 
droplets were observed with p-oil supplementation at 
high concentrations in some instances.
Final medium albumin concentrations ranging from 0 to 
250mg/l had no significant effect on the viability of 
these cells (Fig. 3.7.1.1.). The effects observed with 
p-oil dosage were therefore a result of the exogenous 
FA's and not the albumin used as FA carrier.
The number of control cells, seeded at 10xl04/ml, at the 
end of the 24 hour post-trypsinisation recovery period 
was 10.8xl04/m1. This equated to approximately 72% of 
the final control cel 1 number at the end of the 48 hour 
incubation period and represented the cytostatic number. 
Only p-oil concentrations reducing cell viability to 
significantly below the cytostatic number were hence 
considered cytotoxic.
Figs. 3.7.1.2-3.7.1.8. show the data obtained from the 
incubation of cells with p-oils. Cell proliteration was 
significantly enhanced only with low concentrations of
The results are expressed as mean percent (%) cell 
viabi1ity±standard error of the mean (s.e.m.), where ’n‘ 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.7.1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 3.7.1.2-3.7.1.8. depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 3.7.1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount of pseudo-oil which limits cell 
viability to 50% of the controls.
A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 1.8 12
*25 96.2 3.2 12
50 101.1 3.2 12
75 97.9 1.1 12
100 101.4 3.5 12
125 96.6 2.4 12
150 97.5 2.3 12
175 97.2 3.1 12
200 96.4 3.0 12
225 98.4 3.2 12
250 96.3 5.4 12
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m . n
0 100.0 5.6 6
10 94.9 2.8 6
20 90.3 4.5 6
30 94.2 1.1 6
40 86.5 5.5 6
50 69.4 4.6 6
60 63.8 6.1 6
70 53.1 4.4 6
80 49.0 2.4 6
90 40.3 2.3 6
100 30.9 3.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean — s ♦ © ♦ m ♦ n
0 100.0 3.2 6
10 103.3 2.7 6
20 96.2 1.8 6
30 100.3 1.9 6
40
*
93.8 2.4 6
50 80.0 1.7 6
60 77.8 2.0 6
70 70.5 2.0 6
80 69.7 2.1 6
90 68.8 2.0 6
100 69.7 1.8 6
MO.
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m. n
0 100.0 3.8 6
10 110.6 2.9 6
20 100.4 2.0 6
30 101.8 4.7 6
40 112.4 2.7 6
50 101.9 3.1 6
60 101.4 5.0 6
70 76.9 3.0 6
80 56.9 3.4 6
90 4.8 00•o 6
100 o•o o • o 6
pseudo-Oi1 
Concentration 
(mg/1 )
Mean ±s.e.m . n
0 100.0 1.1 6
10 100.7 2.0 6
20 103.4 2.3 6
30 98.8 2.2 6
40 99.0 1.8 6
50 95.8 1.8 6
60 97.6 2.2 6
70 83.9 2.4 6
80 61.6 3.1 6
90 39.1 1.9 6
100 14.9 1.2 6
pseudo-Oi 1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.4 6
10 103.9 4.9 6
20 102.7 3.9 6
30 88.2 4.4 6
40 86.0 2.9 6
50 74.0 4.7 6
60 29.4 5.0 6
70 9.2 1.9 6
80 2.1 1.0 6
90 0.5 0.3 6
100 0.3 0.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.7 6
10 95.9 2.1 6
20 96.3 6.0 6
30 97.6 2.8 6
40 98.9 2.7 6
50 74.3 4.6 6
60 38.9 4.3 6
70 8.9 1.1 6
80 0.9 0.6 6
90 0.0 0.0 6
100 0.0 0.0 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 • CO 6
10 114.8 2.5 6
20 94.1 2.5 6
30 84.5 2.9 6
40 79.4 3.4 6
50 78.7 4.0 6
60 68.9 3.4 6
70 56.0 2.3 6
80 35.5 2.5 6
90 0.0 0.0 6
100 0.0 o•o 6
A1bumin 
Concentration 
< mg/1)
Mean ±s.e.m . n
0 100.0 3.7 6
125 47.9 2.5 6
150 53.5 1.4 6
175 47.1 3.5 6
200 52.8 1.1 6
225 54.0 3.7 6
p-00 or p-FO, whereas all p-oils limited, and with the 
exception of p-MO all p-oils inhibited, cell viability 
to a greater or lesser extent, dependent on the p-oil 
and concentration supplemented.
Dosage with increasing amounts of p-CO reduced cell 
viability in an overall concentration dependent manner 
(Fig. 3.7.1.2.). Cytostasis was induced with 50mg/l 
p-CO, whereas half the cells were viable with 76mg/l 
p-CO (ID5 0 ) and 30.9% with 100mg/l p-CO.
Enrichment of the culture medium with up to 30mg/l p-MO 
had little effect upon cell viability, but such was 
progressively reduced to 77.8^ with 60mg/l p-MO (Fig.
3.7.1.3.). Cell viability plateaued and ranged from 
68.8% to 70.5?£ with dosage of 70 to 100mg/l p-MO. This 
approximated to the cytostatic number, thus no ID50 
could be calculated.
Cell viability was similar to controls with dosage of up 
to 60mg/l p-00 or p-SSO (Figs. 3.7.1.4. and 3.7.1.5., 
respectively), although pro 1iferation was stimulated to 
110.6 ‘4 with 10mg/l p-00 and 112.4^ with 40mg/l p-00. 
Growth limitation occurred with 70mg/l p-00 or p-SSO, 
but greater amounts were increasingly cytotoxic. Both 
p-00 and p-SSO exhibited comparable ID50 values (about 
82 and 85mg/l, respectively), but no viable cells were 
found when cultures were enriched with 100mg/l p-00, 
compared to 14.9/J with 100mg/l p-SSO.
Dosage with up to 20mg/l p-LO or 40mg/l p-EPO had 
little significant effect on cell viability, but growth 
was limited to a point of cytostasis with 50mg/l p-LO or 
P-EPO (Figs. 3.7.1.6. and 3.7.1.7., respectively). These 
were the most effective p-oils to inhibit rat skin 
fibroblast proliferation, and this correlated with the
lowest ID50 values calculated (about 55mg/l for p-LO and 
57mg/l p-EPO). More than 90% of the cells took up Trypan 
blue with 70mg/l p-LO or p-EPO, and this increased to 
practically 100% with concentrations of 90 or 100mg/l.
Cell pro 1iferation was enhanced to a maximum of 114.8% 
with 10mg/l p-FO, and was progressive!y limited with 
concentrations of 20 to 50mg/l p-FO such that cytostasis 
occurred with 60mg/l p-F0 and cytotoxicity with higher 
amounts (Fig. 3.7.1.8.). Half the cells were viable with 
approximately 73mg/l P-F0 (ID50) compared to 35.5% with 
80mg/l p-FO, but 100% cell death was observed with 
90mg/l and 100mg/l p-F0.
To eliminate the possibility that any of the effects 
induced with p-oil dosage were influenced by the amount 
of albumin bound to the FA^s, these cells were incubated 
with a fixed amount of p-FO corresponding with its ID50 
(approximately 73mg/l) and dosed with varying amounts of 
albumin. Five concentrations were chosen around which to 
vary the amount of albumin, viz. two points above, two 
points below and the ID50 Qf p_F0. The results shown in
Fig. 3.7.1.9. indicated that the amount of p-FO dosed 
reduced cell viability to approximately 50% of controls, 
and that such was not affected by the amount of albumin 
used as FA carrier. Synergistic effects of albumin could 
hence be excluded, and any effects induced by the p-oils 
could be attributed solely to the exogenous FA's.
Fig. 3.7.1.10. depicts the growth of cells obtained from 
rat skin in culture medium supplemented with 10% serum 
derived from its own species compared to commercially 
available fetal calf serum (FCS) in order to establish 
whether FCS modulated cell growth in any way. These 
cells grew from 10.0 to 13.1xl04 over a 72 hour period 
when culture medium was supplemented with 10% FCS. 
Plating efficiency was low in the presence of 10% rat 
serum (RS), however, resulting in an initial decrease in 
the number of viable cells at 24 hours to 7.0xl04, The 
cells grew in a linear manner over the next 48 hours, 
although only 8.2xl04 viable cells were found at the end 
of the incubation period. Thus, the routine use of 10% 
FCS did not limit cell growth compared to 10% RS, and 
promotion of growth limitation and cytotoxicity were 
attributed solely to the exogenous FA's incorporated.
Rat skin fibroblasts were subsequently 
appropriately with 0, 20, 40 or 60mg 
medium in sufficient amounts for all 
qualitative analyses to be carried out. 
cel 1 numbers were compared and found to
plated and dosed 
p-oil/1 culture 
quantitative and 
Upon harvesting, 
be statistically
The results are expressed as mean cell number±standard 
error of the mean (s.e.m.), where "n" is the number of 
experiments. The cell numbers given are xl04/ml growth 
medium. Fig. 3.7.1.10. shows mean cell numbers versus 
the incubation period (hours).
The growth of cells derived from rat skin in DMEM 
containing 10% foetal calf serum compared with 10% adult 
rat serum.
Incubation Mean ±s.e.m. n
Time Cel 1 Number
(hrs) (xlO^/ml)
Foetal calf 
serum:
24 10.8 0.3 9
48 12.7 0.2 9
72 13.1 0.4 9
Adult rat 
serum:
24 7.0 0.2 9
48 7.7 0.3 9
72 8.2 0.3 9
similar to those obtained in Figs. 3.7.1.1-3.7.1.8. A1 
biochemical assays were thus performed on these samples
3.7.2 Effects of pseudo-Qils on Total Protein.
Table 3.7.2.1. shows total protein content of rat skin 
fibroblasts at each of the 3 p-oil concentrations dosed 
compared with controls, expressed as jug total protein 
per 106 cells seeded.
Control fibroblasts exhibited 374.7jug total protein/106 
cells seeded, whereas p-oil dosed fibroblasts contained
269.4 to 579.6jug protein/106 cells seeded (obtained with 
60mg/l p-LO and 40mg/l p-00, respectively). Protein
levels were higher than controls in every instance with
incubation of 20mg/l p-oil (392.2 to 473.6jug protein/106 
cells seeded). This was also true with dosage of 40mg/l 
p-oil (436.1 to 579.6jug protein per 10s cells seeded),
although cells exhibited less protein than controls
with addition of 40mg/l p-CO (327.4jugprotein/106 cells 
seeded). Enhanced protein levels were found with 60mg/l 
p-00 supplementation (445.4jug protein/106 cells seeded), 
but amounts were decreased with incubation of other 
p-oils at this concentration (269.4 to 366.8,ug protein 
per 106 cells seeded). Cellular protein levels decreased 
inversely with the amount of p-CO, p-SSO, p-LO or p-FO 
supplemented, whereas the greatest and lowest amounts 
measured with p-MO, p-00 or p-EPO dosage occurred with a 
concentration of 40 and 60mg/l, respectively.
The spent incubation media derived from these cultures 
were also analysed for total protein. The values for all
The protein content of cells derived from rat skin, 
expressed as jug total protein/106 cells seeded.
pseudo­
Oil
CELLS
(mg/1) 0 20 40 60
Control 374.7
CO 392.2 327.4 305.9
MO 422.5 449.3 366.8
00 471.2 579.6 445.4
SSO 444.9 436.1 361.4
L0 473.6 466.3 269.4
EPO 436.1 468.2 348.4
F0 458.1 440.5 366.9
samples uere summed, and a mean protein concentration of 
46.8±0.35mg/106 cells seeded obtained (n=22), However, 
statistical comparison of individual samples by analysis 
of variance showed no significant differences in the 
spent media protein levels between control and dosed 
cultures (F=136.5, p=0,001).
3.7.3 Effects of pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Rat Skin.
Table 3.7.3.1. lists the FA spectra of cells incubated 
with 0, 20, 40 or 60mg/l p-oil.
Control cells exhibited a FA spectrum in which 18:0 
comprised 19.1?: of all FA's detected. 16:0, 18:lw9, 
20:4cj6 and 22:4w6 contributed 18.3?:, 16.5?:, 13.3?: and 
9.9?: to the total spectrum, respectively, while other 
FA's contributed less than 5?: each to the total.
Dosed cells generally contained variable proportions of 
16:0, less 18:0 and 16:lw9, and more 18:lw9 and 18:2w6, 
than control cells. 20:4u6 and 22:5u6 percentages were 
decreased in dosed cells, although 22:4w6 was markedly 
increased with supplementation of 20mg/l p-oil. Dosed 
cells generally contained less 18:4u3 and 20:4u3 than 
controls, while the relative amounts of 18:3w3, 20:5w3, 
22:5u3 and 22:6u3 were more variable.
Dosage with 20mg/l p-CO had little effect on 16:0 levels 
(17.3?: vs 18.3?: in controls, respectively), but this was 
increased with 40 and 60mg/l p-C0 (25.9?: and 27.7?:, 
respectively). Similar changes occurred in 18:lw9 levels 
(16.5?:, 15.1?:, 19.3?: and 23.3?: with 0, 20, 40 and 60mg/l 
p-C0, respectively), while 18:0 and 16:lu9 proportions 
were decreased compared to controls (19.1?: and 4.2?:, 
respectively). p-CO had little effect on 18:2w6 levels
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where "n" is 
the number of experiments. "Cp-OilD‘ refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cells derived from rat skin.
FATTY ACID  
SPECTRUM
m
CONTROLS 
(n = 3)
Cp-COD 
(m g/1)
20 ! 40 ! 60
Cp-MOT 
(mg/1 )
20 ! 40 ! 60
Cp-000 
(m g/1)
20 40 1 60
Cp-SSOO 
(m g/1)
20 ! 40 ! 60 20
Cp-LO] 
(m g/1) 
! 40 : 60
Cp-EPOD 
(m g/1)
20 ! 40 ! 60
Cp-FOII 
I (mg/1 )
' 20 ! 40 ! 60
s
A
1 6 :0 1 8 .3 ±0 .00 17 . 3 2 5 . 9 2 7 . 7 17 .0 20.8 2 4 . 3 1 4 . 6 15 .9 12.0 19 .2 1 6 . 5 9 . 5 1 4 . 2 1 6 .7 !21.2 2 0 . 9 16 .5 1 4 . 7 : 15.4 19 .0 15 .0
T
u
18 :0 1 9 .1 ±0 . 0 5 12.0 13 .7 1 6 . 7 1 4 . 3 13 .4 16 . 6 8.6 7 .1 15 .2 11.6 11.0 2 1 . 7 12.1 1 6 . 1 : 9 . 9 1 1 . 5 10.1 1 6 . 2 111.7 12.2 1 9 . 7
R
A
20:0 0 .4 10 .0 0 - 0.2 - - 0.2 - - - - - - - - 0 .1! - - - - 1 __ 0.1 -
T
F
22:0 0 . 2 1 0 . 0 0 0 . 4 0.2 0.2 0.2 0.2 0.1 0.1 0.2 - 0.2 - 0.1 0.2 0 .1! 0.1 - - 0 . 3 i 0.1 0.1
s. 2 4 : 0 0 .3 10 .0 0 0 . 7 0.8 0.2 — 0,8 — 0 . 3 0.1 - 0.1 0.1 - - - ! - 0.2 1.0 - 1 __
i
0 . 3 -
w9
M
16 :1 4 .2 10 .1 0 2 . 3 2 . 7 3 . 9 0.8 1.2 2.0 1.1 1 .4 1.6 4 .0 1.1 1.1 1.1 0 .8! 3 . 5 4 . 3 1 . 7 2.2 1 5 . 4 11.1 11.0
0
N
18:1 1 6 .5 10 .1 0 15 .1 1 9 .3 2 3 . 3 1 5 .6 19 .0 2 8 . 5 3 0 . 9 4 1 . 8 55.1 13 .6 18 .2 2 2 . 5 14.1 1 6 .8 !16 .1 9 . 8 1 2 . 5 1 7 . 9 15 .9 18 .7 22.6
0
S .
24 :1 — — — — — — — - - - - - - - - ! - - - -
1
- -
18:2 3.210.00 3.2 3.4 2.7 6.2 7.8 8.2 6.4 8.0 5.8 15.3 25.9 36.3 8.0 9.2! 11.2 1 5 . 2 23.1 28.9 5.3 6.8 15.8
u6
18:3 *s _ - 0.1 - - - - - - - - - - - ! 0.1 0.1 0.1 3.1 - - -
p
20:2 O .H O .O O - - — — 0.3 0.1 1.0 1.5 1.6 1.2 1.8 0.6 - 0.3! - 0.8 1.1 1.2 0.1 0.5 0.3
0
|_
20:3 1.610.05 1.4 1.4 1.1 1.5 1.6 0.9 1.1 1.1 0.4 1.2 1.4 0.5 1.1 1.1! 0.7 3.5 3.8 2.4 1.1 1.0 0.4
Y
S.
20:4 13.310.05 11.1 10.1 6.5 13.2 11.8 7.5 8.3 5.7 2.2 6.9 6.3 1.8 10.8 8.9! 5 .1 7.4 4.8 2.5 8.7 6.4 2.5
22:4 9.910.35 26.6 11.3 9.1 ?21.1 14.3 6.3 20.3 10.0 3.0 20.4 10.7 3.4 26.0 11.5! 8.0 20.0 17.2 4.2 23.6 8.0 2.8
22:5 1.810.03 — 1.3 0.3 0.2 — 0.8 — 0.1 0.9 0.1 - 1.3! 0.1 0.2 1.6 0.1 0.1 1.1 0.1
18:3 0.310.00 0.4 0.6 0.4 0.7 0.6 0.4 1.1 1.2 0.5 0.4 0.5 0.1 4.0 9.1! 19 .5 0.2 0.3 2.4 0.4 0.5 0.3
u3 18:4 1.610.05 0.3 1.7 0.8 0.5 1.1 0.3 0.2 0.8 0.3 0.3 0.9 0.3 0.2 2.1! 0.2 0.2 1.1 1.2 0.3 1.2 0.5
P
n
20:4 4.310.05 1.7 2.0 2.6 2.3 2.3 1.4 1.2 1.8 1.2 1.6 1.6 1.2 1.5 2.9! 1.5 1.9 3.1 1.2 2.1 1.4 1.5w
L
V
20:5 0.710.00 1.4 1.2 1.0 0.4 0.5 0.2 0.2 0.2 - 0.2 0.3 - 2.0 0.5! 0.3 0.1 0.3 0.1 2.3 4.1 4.1
S. 22:5 3.110.03 2.9 2.7 1.7 3.2 2.5 1.4 2.4 1.8 0.5 2.0 2.1 0.5 2.5 2* 0! 1.1 2.0 1.4 0.6 6.1 6.8 2.7
22:6 1.210.10 3.1 1.7 2.3 3.2 1.4 1.6 2.4 0.9 0.7 1.9 0.6 0.6 2.3 0.6! 1.4 1.7 0.5 0.8 1.6 0.8 0.8
(2.7% to 3.2% vs 3.2% in controls)* but decreased 20:4u6 
amounts from 11.1% to 10.1% and 6.5% with 20, 40 and 
60mg/l, respectively (13.3% in controls). Significantly 
increased 22:4u6 was found with 20mg/l p-CO (26.6% vs 
9.9% in controls), but this did not raise 22:5w6 levels. 
On the other hand, increased 20:5w3 and 22:6w3 reflected 
decreased 18:4w3, 20:4u3 and 22:4u3 proportions.
Decreased 18:0 and 16:lu9 levels were found when cells 
were incubated with p-MO, but 16:0 and 18:lu9 increased 
significantly with 60mg/l p-M0 (24.3% and 28.5% vs 18.3% 
and 16.5% in controls, respectively). 18:2u6 increased 
from 6.2% to 7.8% and 8.2% with 20, 40 and 60mg/l p-M0, 
respectively (3.2% in controls), and 20:4u6 decreased 
from 13.2% to 11.8% and 7.5%, respectively (13.3% in 
controls), whereas the elongation product, 22:4w6, was 
markedly increased with 20mg/l p-MO (21.1% vs 9.9% in 
controls). u)3 PDFA levels were parallel to controls or 
decreased, although 22:6u3 was significantly increased 
with 20mg/l p-MO (3.2% vs 1.2% in controls).
The percentages of 18:lw9 detected in cells dosed with 
0, 20, 40 or 60mg/l p-00 increased from 16.5% to 30.9%, 
41.8% and 55.1%, respectively, whereas 16:0, 16:lu9 and 
18:0 levels were decreased. Significant increments in 
18:2w6 (5.8% to 8.0% vs 3.2% in controls) and 20:2u6 
(1.0% to 1.6% vs 0.1% in controls) were detected, but 
20:3u6 and 20:4w6 were decreased. However, 22:4u6 
increased about two fold with 20mg/l p-00 (20.3% vs 9.9%
in controls). With the exception of a two fold increase 
in 22:6io3 with 20mg/l p-00 (2.4%), u3 PDFA levels were 
reduced with p- 0 0 dosage.
16:0, 16:lu9, 18:0 and 18:lw9 percentages were either 
parallel to controls or decreased in cells dosed with 
p-SSO, although 18:lw9 was increased with 60mg/l p-SSO 
(22.5% vs 16.5% in controls). The provision of p-SSO 
resulted in concentration dependent 18:2w6 incorporation 
from 3.2% in controls to 15.3%, 25.9% and 36.3% with 
concentrations of 20, 40 or 60mg/l, respectively. 20:2u6 
levels were raised (0 .6% to 1 .8% vs 0 .1% in controls), 
and 22:4lj6 increased approximately two fold with 20mg/l 
p-SSO (20.4% vs 9.9% in controls), but other 106 PDFA 
levels were parallel to controls or decreased. With the 
exception of a slight increase in 22:6u3 with 20mg/l 
p-SSO (1.9% vs 1.2% in controls), u3 PDFA levels were 
also decreased.
p-LO generally had little effect on cellular 16:0 and 
18:lu9 levels, but lowered the amount of 16:lw9 and 
18:0. 18:2u6 increased from 3.2% in controls to 8.0%, 
9.2% and 11.2% with 20, 40 and 60mg/l p-L0, respectively 
and 26.0% 22:4w6 was detected with 20mg/l p-LO (9.9% in 
controls). Other w6 PDFA levels, however, approximated 
to controls or were decreased. The percentage of 18:3w3 
increased from 4.0% to 9.1% and 19.5% when 20, 40 or 
60mg/l p—LO was incubated with the cells, respectively
(0.3% in controls). 18:4w3 was enhanced with 40mg/l p-LO 
(2.1% os 1.6% in controls), 20:5u3 with 20mg/l p-LO 
(2.0% os 0.7% in controls) and 22:6u3 with 20mg/l p-LO 
(2.3% os 1.2% in controls), while other concentrations 
of p-LO had little effect on, or lowered w3 PDFA leoels.
16:0, 16:lu9, 18:0 and 18:lu9 leoels were parallel to 
controls or decreased in cells incubated with p-EPO, but 
18:2u6 increased markedly (15.2%, 23.1% and 28.9% with 
20, 40 or 60mg/l, respectioely os 3.2% in controls). 
18:3u6 was absent from controls, but up to 3.1% was 
found in dosed cells. Significant increments in 20:2w6 
(0.8% to 1.2% os 0.1% in controls) and 20:3w6 (2.4% to 
3.8% os 1.6% in controls) were found, but 20:4w6 leoels 
decreased from 13.3% to 7.4%, 4.8% and 2.5% with 0, 20, 
40 and 60mg/l p-EPO, respectioely. 22:4u6 percentages 
were significantly raised both with 20 and 40mg/l p-EPO 
(20.0% and 17.2%, respectioely os 9.9% in controls), but 
this did not induce an increase in 22:5w6. Incubation 
of cells with 20mg/l p-EPO caused a slight increase in 
22:6w3 (1.7% os 1.2% in controls), but other w3 PDFA 
leoels were parallel to controls or decreased.
Cells supplemented with p-FO exhibited 16:0 and 18:0 
percentages either approximating to controls (18.3% and 
19.1%, respectioely) or decreased, raised 16:lu9 leoels 
(5.4% with 20mg/l, 11.1% with 40mg/l and 11.0% with 
60mg/l, respectioely os 4.2% in controls), and increased 
18:lu9 with 40 and 60mg/l p-FO (18.7% and 22.6% os 16.5%
in controls). 18:2u)6 increased significantly from 5.3% 
with 20mg/l p-FO to a maximum of 15.8% with 60mg/l p-FO 
(3.2% in controls), and 22:4u6 increased more than two 
fold with 20mg/l p-FO (23.6% vs 9.9% in controls), but 
no increment in 22:5u6 was detected. 20:5w3 percentages 
increased with p-FO dosage (2.3% with 20mg/l and 4.1% 
each with 40 and 60mg/l vs 0.7% in controls), and its 
elongation product, 22:5u3, increased approximately two 
fold with 20 and 40mg/l (6.1% and 6.8%, respectively vs 
3.1% in controls). Yet, 22:6w3 was only slightly raised 
with 20mg/l p-FO (1.6% vs 1.2% in controls).
The FA spectra of the spent growth medium removed from 
each of the above cultures is shown in Table 3.7.3.2. 
The medium in which control cells had been grown 
contained 96.6% 14:0, 2.0% 17:0 and less than 0.5% each 
of 16:0, 16:lu9, 18:0, 18:lw9 and 22:4u6. Spent media 
obtained from cultures dosed with p-oils similarly 
contained at least 96% 14:0 and 0.4% to 2.7% 17:0, but 
only trace amounts of the major FA components present in 
the p-oils remained in the medium following the 48 hour 
incubation period.
3.7.4 Incorporation of Radiolabel1ed C18 Fatty
Acids into Cells Derived from Rat Skin.
Table 3.7.4.1. shows the radioactivity recovered from
I
cultures incubated with 2,uCi C14CH-18: lu9, C 14CD-18 : 2u6 
or :14C2-18:3u3.
Total counts recovered from the spent incubation media 
ranged from 2.0 to 2.8xl06cpm. Only 0.3 to 0.5xl06cpm 
were recovered from the pooled buffers after washing the 
cells, and this accounted for non-specific.binding. For 
both CiaC2-18:lu9 and C14C0-18J3u3 the equivalent of 
4.3xl06cpm were dosed to cultures, and total recovery of 
each was approximately 77% and 84%, respectively. For 
C14C3-18:2w6 the equivalent of 4.8xl06cpm were dosed to 
the incubation medium, and the total recovery of this 
radioisotope amounted to about 88%. However, the total 
amount of each of these radioisotopes incorporated into 
the cells approximated to 22% for C14CD-18J 1(*)9, 23% for 
1I14C:-18:2w6 and 10% for C 14CII-18:3u3.
Table 3.7.4.2. shows the percentage of each incorporated 
radiol abel 1 ed C18 FA converted to w9, u6 or u3 series 
products after incubation with rat skin fibroblasts.
15.5% of the total L 185lw9 counts derived upon 
GLC analysis (1151cpm) remained unchanged, while the 
proportions of 20:lu9, 22:lw9 and 24:lw9 detected were 
35.3%, 39.1% and 10.2%, respectively.
The fatty acid spectrum of the spent culture medium of
cells derived from rat akin.
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The radioactivity (cpro) recovered from rat skin cultures 
incubated with radio! abel 1 ed C18 fatty acids. expressed as 
mean (±s.e.m.). n=3.
SPENT
MEDIA
(M)
POOLED
WASHINGS
(U)
TOTAL
(M+U)
CELLS TOTAL
xlO6
Total 18:1 counts dosed to incubation medium = 4.3 x 106
1946880
(±15780)
421260
(±3240)
2368140 959907
(±5226)
3.3
Total 18:2 counts dosed to incubation medium = 4.8 x 106
2524200
(±22620)
528840
(±2520)
3053040 1121016
(±3027)
4.2
Total 18:3 counts dosed to incubation medium = 4.3 x 10s
2831960
(±11900)
344100
(±5040)
3176060 407862
(±3507)
3.6
The counts detected for the radiolabel1ed fatty acids 
dosed and their resulting metabolites formed after 
incubation with cells derived from rat skin. expressed 
as a percentage of the total counts recovered upon GLC 
analysis.
cj9
MONOS.
LiaC0- 
18:lu9
u6
POLYS.
L i a C l -
18:2u6
u3
POLYS.
C14CD-
18:3u3
18:1 15.5 18:2 6.7 18:3 7.0
20 :1 35.3 18:3 16.1 18:4 17.1
22:1 39.1 20 :2 16.7 20:3 16.8
24:1 10 .2 20:3 18.3 20:4 12.2
20:4 23.2 20:5 23.2
22:4 10.9 22:5 10 .6
22:5 8 . 2 2 2 :6 13.1
TOTAL
CPM 1151
TOTAL
CPM 2689
TOTAL
CPM 1011
On the other hand, only 6 ,7 *4 of the total C14CH-18: 2u6- 
derived counts measured (2689cpm) remained unchanged. 
16.7% and 16.1 *4 of total counts recovered were found 
as 20:2u6 and 18:3w6, respectively, compared to 18.3% 
20:3w6, 23.2% 20:4u6, 10.9% 22:4u6 and 8.2% 22:5w6.
The total counts derived following GLC analysis of cells 
incubated with C14C3-18:3u3 were lOllcpm, of which only 
7.0% was detected for 18:3w3. The percentage for 18:4w3 
(17.1%) was comparable with that of 18:3cj6 (16.1%), as 
were those for the immediate elongation products of 
18:3w3 and 18:2u6 (16.8% 20:3w3 and 16.7% 20:2u6). 12.2% 
20:4u3 was detected, while the levels of the subsequent 
products of desaturation and elongation (23.2% 20:5w3 
and 10.6% 22:5u3) were almost identical to those found 
for corresponding products in the w6 series. However, a 
1arger proportion of total C14C3-18:3w3-derived counts 
were shown as 22:6w3 (13.1%) than for the corresponding 
J4D product in the u6 series (8.2% for 22:5u6).
J6D represents the first enzyme in the desaturase enzyme 
cascade, thus total activity of this enzyme is reflected 
by the sum of all subsequent desaturase and elongase
products.
3.7.5 Effects of pseudo-Oils on Lipid Peroxide
Format i on.
The 1ipoperoxides quantified in dosed cells and their 
respective growth media are presented in Table 3.7.5.1. 
in relation to controls. Values are reported as nmoles 
MDA/105 cells, but in the case of the spent incubation 
media this represents the nmoles of MDA in the volume 
of medium from which lxlO5 cells were derived.
Medium derived from cultures incubated with 60mg/l p-LO 
or p-FO for 48 hours contained 1.0 and 0.9nmoles MDA/105 
cells, respectively, but MDA was absent from all other 
spent media. On the other hand, MDA was measured both in 
control and all dosed cells. The MDA amounts quantitated 
in dosed rat skin fibroblasts ranged from 0 .1 to 2 .6  
nmoles MDA/105 cells (with 20mg/l p-MO or 60mg/l p-FO 
incubation, respectively), compared to 0.2nmoles MDA/105 
control cells. Little 1ipoperoxide formation occurred 
when cells were dosed with 20, 40 or 60mg/l p-CO, p-MO, 
p-00 or even p-SSO since only 0.1 to 0.4nmoles MDA/105 
cells were measured. Cells supplemented with 20mg/l 
p-LO, p-EPO or p-FO induced similar 1ipoperoxide amounts 
(0.4 to 0.5nmoles MDA/105 cells), but p—EPO formed more 
1ipoperoxides than p-LO or p-FO at quantities of 40mg/l. 
(1.3, 0.4 and 0.5nmoles MDA/105 cells, respectively).
However, p-F0 induced the greatest quantity of cellular 
1ipoperoxides with a concentration of 60mg/l, followed
Lipoperoxide formation by rat skin cultures incubated 
uiith p-oils. expressed as nmoles MDA/106 r ells.
pseudo- 
Oi 1
CELLS
(mg/1) 0 20 40 60
Contro1 0 . 2
CO 0 . 2 0 . 2 0.4
MO 0 .1 0.4 0 . 2
00 0 . 2 0 . 2 0.4
SSO 0 . 2 0 . 2 0 . 2
L0 0.4 0.4 0.7
EPO 0.5 1.3 2 .1
F0 0.4 0.5 2 . 6
pseudo- SPENT INCUBATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - -
SSO - - -
L0 - - 1.0
EPO - - -
F0 - - 0.9
by p-EPO and p-LO (2.6, 2.1 and 0.7nmoles MDA/106 cells, 
respective 1y).
3.7.6 The Eicosanoid Profile of Cells Derived
from Rat Skin.
The eicosanoids positively detected in control and dosed 
rat skin fibroblasts are presented in Table 3.7.6.1. as 
a percentage of the total area found. However, an 
indication of the total eicosanoid amounts quantitated 
is given for controls in ’( )’, expressed as pmoles/10s
c e l  I s .
Total eicosanoid formation amounted to 165.7pmoles/106 
control cells, of which 15.4% could be positively 
identified with the prostanoid standards available. 
Approximately half of this was TXB2 (7 .3*) and Qne third
PGF* (5.2%), compared to 1.3% PGI2 , 1.0% PGE2 and 0.6% 
PGEi# Varying proportions of these prostanoids were 
also found in dosed cells, whereas PGD2 was no-t produced 
by control, or dosed, rat skin fibroblasts.
Total percentages for the prostanoids detected in dosed 
cells varied significantly with p-oil concentration as 
such approximated to controls (15.4%) with 40mg/l p-oil 
(9.5% to 15.1%), but were significantly increased both 
with 20mg/l (22.9% to 29.4%) and 60mg/l (24.1% to 33.7%) 
p-oil. These differences were reflected by appropriate 
changes in the amount of individual prostanoids. PGI2 
levels generally approximated to controls (1 .3%) with 
supplementation of 40mg/l p-oil, but none was detected 
with 20 or 60mg/l p-oil. Cellular TXB2 percentages were
Values are tabulated as relative percent of the total 
area detected, and as pmoles total eicosanoids/106 
control cel Is.
The profile of the eicosanoids detected in extracts of 
cells deriued from rat skin.
pseudo­
Oil
(mg/1)
EICOSANOIDS m
TOTAL (VI 
1—1 CD CL TXB2 (l+2<5 PGE2 PGEi PGD2
CONTROL 15.4 1.3 7.3 5.2 1.0 0 . 6 _
(165.7)
20 29.0 - 17.5 9.3 1.9 CO•o —
CO 40 13.9 0.9 6 . 2 6.5 0.3 - -
60 33.7 — 18.2 15.2 0.3 - -
20 22.9 — i3;o 8.4 1.5 — —
MO 40 15.1 0 . 6 5.5 8 . 8 0 . 2 - -
60 33.4 — 2 0 .6 12.5 0.3 — -
20 27.5 — 16.6 8 . 8 1.7 0.4 —
00 40 13.0 o • 00 6 . 8 5.1 0.3 - -
60 29.2 — 18.0 11.1 0 .1 — -
20 23.7 — 13.3 8.9 1 .2 0.3 —
SSO 40 11 .2 0.4 7.4 3.1 0.3 - -
60 24.1 — 13.4 10.0 0 .1 0 . 6 —
20 24.3 — 14.9 7.8 1.4 0 . 2 —
LO 40 9.7 1.9 4.5 3.1 0 . 2 - -
60 24.5 13.5 10.4 0 .1 0.5 -
20 27.6 — 16.9 9.1 1.4 0 . 2 —
EP0 40 14.8 1.0 8 . 8 4.4 0 . 6 - -
60 27.2 — 16.3 10.3 0 .1 in•o —
20 29.4 — 17.7 9.9 1.5 CO*o —
FO 40 9.5 0.9 5.3 3.1 0 . 2 - -
60 33.2 — 20.3 12.3 0 . 6 “ —
comparable to controls (7.3%) with 40mg/l p-oil dosage 
(4,5% to 8 .8%), but these increased 2 to 3 fold 
with incubation of 20 or 60mg/l p-oil (13.0% to 20.6%).
Control PGFq, proportions (5.2%) were also parallel to 
those found in cells supplemented with 40mg/l p-oil 
(3.1% to 8 .8%), but levels increased slightly with 
20mg/l p-oil (7.8% to 9.9%) and 2 to 3 fold with 60mg/l 
p-oil (10.0% to 15.2%). Incubation with 20mg/l p-oil
enhanced PGE2 production only slightly (1 .2% to 1 .9% 
vs 1.0% in controls), but decreased PGE2 levels were 
detected with 40. and 60mg/l p-oil (0.1% to 0.6%). p-Oil 
supplementation, however, had little effect on PGEi 
production as trace amounts (£0 .6%) of this compound
were found both in control and dosed cells.
3.7.7 D i scuss i on.
Supplementation of cultured rat skin fibroblasts with 
p-oils affected the viability of such cells. The finding 
that the p-oils used exhibited varying abilities to 
modulate cell pro 1iferation reflected the different FA 
compositions of these compounds (Table 2.3.3.2.). The 
greater potential to inhibit cell viability with high 
concentrations of p-00, p-SSO, p-LO, p-EPO and p-FO than 
with p-CO and p-MO (Figs. 3.7.1.2-3.7.1.8.) implied that 
monoenoic and polyenoic FA^s were more effective growth 
inhibitory agents than saturated FA's. The greater 
cytotoxic potential of p-EPO compared to p-SSO could 
relate to the presence of approximately 9% GLA in the 
former only as both p-oils contained similar proportions 
of other FA's. It seemed possible therefore, that 
induction of the greatest degree of cytotoxicity with 
p-EPO or p-LO supplementation related to the GLA and ALA 
concentrations in these p-oils, respectively, especially 
since both p-oils contained similar complements of 
saturated and monounsaturated FA's. However, in the 
light of the similar effects these p-oils induced, and 
the fact that the proportion of GLA in p-EPO was much 
lower than ALA in p-LO (9% vs 63%), it was apparent that 
GLA exhibited greater growth inhibitory potential than 
ALA. This probably relates to the different double bond 
positions in these C18 trienoic FA^s. It should be borne 
in mind, however, that synergistic or antagonistic
interactions between different p-oil FA's could also 
have played a role in the modulation of cell viability. 
This phenomenon may explain the enhanced cell growth 
induced only when certain concentrations of p-00 or p-FO 
were dosed, and why cell viability changes did not 
always correlate linearly with the amount of p-oil 
supp1emented.
The finding that only trace amounts of the major FA 
components present in the p-oils remained in the spent 
medium following the 48 hour incubation period (Table
3.7.3.2. ) indicated the capability of these cells to 
incorporate exogenous FA^s, even in the presence of high 
14:0 levels derived from 90% DMEM+10% FCS itself (Table
2.3.3.3. ). Support for p-oil FA uptake from the culture 
medium was also shown in Table 3.7.3.1. Modifications of 
the membrane PGL FA composition have been reported to
■ induce changes in membrane physical properties (Stubbs 
et al 1984 and Spector et al 1985). A mechanism whereby 
p-oils affected cell viability may therefore relate to 
differential exogenous FA uptake and alterations in 
membrane stability, dependent on p-oil FA composition 
and concentration dosed. Pronounced shifts in membrane 
fluidity would indeed support the limitation and 
inhibition of cell proliferation shown when large 
quantities of saturated or unsaturated FA-rich p-oils 
were fed (Figs. 3.7.1.2-3.7.1.8.).
p-Oil supplementation induced concentration changes in 
total cellular protein (Table 3.7.2.1.) which did not 
always parallel the changes found in cell viability 
(Figs. 3.7.1.2-3.7.1.8.). In fact, cell numbers could 
not justify the marked protein increase found with 
40mg/l p-00 dosage, nor the increased cellular protein 
measured when p-oil dosage induced little effect on, or 
limited, cell viability. This, however, indicated p-oil 
FA involvement in the stimulation of protein synthesis, 
which may reflect enhanced protein turnover or enzyme 
expression to metabolise the incorporated p-oil FA's. 
Numerical differences in the protein concentrations 
measured when supplementation with identical amounts of 
different p-oils yielded similar cell numbers suggested 
that the ability to modulate protein synthesis related 
to differences in FA structure and probably also to FA 
synergism and antagonism. On the other hand, the protein 
amounts quantified in the spent medium of dosed cells 
were not statistically different from controls (section 
3.7.2), thus it was unlikely that medium protein itself 
contributed significantly to the cellular protein 
changes demonstrated (Table 3.7.2.1.).
Cultured rat skin fibroblasts had little capability to 
desaturate or elongate 16:0 when incubated with p-oils, 
although decreased 18:0 and enhanced 18:lu9 levels in 
dosed cells suggested the potential for A9D expression 
(Table 3.7.3.1.). The fact that all p-oils contained
18:Iw9 (Table 2.3.3.2.)» however, could have contributed 
to the enhancement of cellular 18:lu9 levels, although 
16:lw9 elongation could possibly be excluded in this 
regard since 16:lu9 incorporated with p-FO dosage did 
not produce a concommitant increase in 18:lw9. The lack 
of 18:lw9 desaturation or elongation may nevertheless 
relate to competitive inhibition by PUFA's (Brenner et 
al 1966, 1969, Brenner 1977 and Holman 1986a, 1986b).
Cultured rat skin fibroblasts exhibited the potential to 
desaturate and chain elongate PUFA's in the presence of 
p-oil supplementation (Table 3.7.3.1.). No significant 
18:3w6 production from 18:2u6 was apparent with p-oil 
dosage, although elevated 20:3w6 levels with incubation 
of p-EPO, providing 18:3u6, suggested that delta-6- 
desaturation of 18:2w6 was slow, probably due to the 
rate limiting nature of this enzyme (eg. Stoffel 1961, 
Holloway 1963, Marcel et al 1968, Brenner 1971, 1974, 
1977, 1982 and de Gomez Dumm et al 1976). Detection of 
small amounts of 20:2u6 supported the capability for 
limited 18:2w6 elongation, while decreased 20:3u6/20:4u6 
and increments in 22:4u6 levels, particularly with 
20mg/l p-oil dosage, suggested J5-desaturation of 20:3u6 
and rapid subsequent elongation. However, the inability 
to form 22:5u6 via J4D was consistent with 22:4u6 
accumulation. The finding that the immediate products of 
desaturation were lower than those following elongation 
supported documentation implicating the desaturases as
the rate limiting steps in the desaturase enzyme cascade 
(eg. Stoffel 1961, Holloway 1963, Marcel et al 1968 and 
Brenner 1971, 1977, 1982). A similar pattern of slow A 6 -  
and J5-desaturation was found with w3 PUFA substrates. 
Despite 22:5w3 formation by elongation of 20:5w3 
incorporated with p-FO dosage, only a small increase in 
22:6w3 production occurred via J4D with 20mg/l p-FO, 
suggesting suppressed expression of this enzyme, 
possibly because ' membrane unsaturation index was 
increased. Detection of low levels of long chain more 
unsaturated PDFA's when PUFA-rich p-oils were dosed 
could indeed relate to the known inhibitory effect of 
such moieties on desaturase enzymes, particlarly when 
product levels are sufficient for maintaining cell 
functions and membrane fluidity (eg. Garcia et al 1965, 
Brenner et al 1966, 1967, Brenner 1971 and Sprecher 
1981). On the other hand, the greatest increase in 
relative 22:6w3 percentages found when saturated or 
monoenoic FA-rich p-oils were dosed implied an increased 
need for highly unsaturated PDFA's to re-establish 
membrane fluidity altered with exogenous FA uptake, for 
example. However, increased detection of higher PDFA 
levels with p-CO, p-MO or p-00 dosage suggested enhanced 
desaturation and/or elongation of endogenous PUFA's as 
these p-oils contained relatively little, or no, PUFA's. 
The degree of FA unsaturation attained in the cells with 
P“oil dosage was therefore a factor involved in control
of desaturase cascade enzyme expression, particularly 
since modifications of the membrane PGL FA composition 
have been shown to induce changes in the activity of 
membrane bound enzymes (eg. Brenner et al 1965a, 1965b, 
1966, 1967, 1969, Stubbs et al 1984 and Spector et al
1985). This could explain why the capability for 
desaturation and elongation were generally greatest with 
addition of low p-oil concentrations, despite increased 
cellular uptake of major p-oil FA components with the 
amount dosed (Table 3.7.3.1.).
To assess whether the pattern of p-oil desaturation 
described above was modulated by the presence of FA 
mixtures, p-oil desaturation was compared with that of 
individual radiolabel1ed C18 FA's. Only the pathway for 
elongation was shown with C14CD-18:lw9 dosage, whereas 
the pattern of radioactivity derived from cells enriched 
with either CiaC0-18:3u3 or C14C0-18: 2uj6 was consistent 
with both desaturation and elongation of these moieties 
(Table 3.7.4.2.). Conversion of approximately 76% of 
incorporated C14C3-18:3u3 or Z14CH-18:2u6 to PDFA's 
supported A6D expression, and the formation of 20:3u3 
and 20:2to6 by elongation could have served as storage 
substrates for retroconversion or further desaturation. 
Conversion of about 47% of incorporated C14CD-18:3u3 and 
42% C14CD-18:2u6 to post-J5D FA's was evidence for J5D 
activity, but J4D expression was more limited. Chapkin 
et al (1984) demonstrated a lack of conversion of 18:2u6
to 1 8 : 3u6 and 2 0 J3u6 to 2 0 J4w6 in isolated microsomes of 
rat epidermis, even when different amounts of 18:2w6 or 
2 0 : 3u6 were fed as A6D or J5D substrates, respectively. 
They suggested that 2 0 : 4u6 in rat skin was synthesised 
elsewhere, presumably the liver, and transported to the 
skin. Others reported that A6D and A5D activities were 
suppressed in the skin of EFA-deficient rats only, and 
that significant A6D and J5D expression occurred in the 
skin when the diet of normal rats was supplemented with 
18:2w6 (Lowe et al 1 9 7 8 ) .  The variations in desaturase 
activity described above may relate to different 
experimental designs, but could also reflect the ability 
of this tissue to selectively regulate PDFA production.
J
The finding that desaturase cascade enzyme expression 
was more limited with p-oil compared to individual FA 
supplementation (Tables 3.7.3.1. and 3.7.4.2.) supported 
the mediation of competitive interactions between p-oil 
FA's for these enzymes. However, as organisms consume 
mixtures rather than individual FA's in the diet, the 
desaturase capability shown with p-oils probably relates 
closer to the situation in vivo than that shown with 
single FA's.
MDA quantitation showed that rat skin fibroblasts 
exhibited the capability to produce 1ipoperoxides (Table
3.7.5.1.). This could occur either enzymatically or by 
auto-oxidation of free monoenoic and/or polyenoic FA's. 
Measurement of relatively low MDA concentrations in
control and most dosed fibroblasts, however, indicated 
efficient intrace 1 1u1ar mechanisms of protection against 
free radical formation. Indeed, it is recognised that 
aerobic organs are protected from oxygen toxicity by an 
array of defence systems, including preventative anti-t
oxidants such as vitamin E, and anti-oxidant enzymes 
such as peroxidase, superoxide dismutase and catalase 
which remove different species of activated oxygen that 
promote 1ipoperoxidation (Lands et al 1971, Smith et al 
1972, Tappel 1972, 1980 and Pryor 1976). Alternatively, 
FA oxidation could have been suppressed by limited 
substrate availability. If FA's were present within the 
membranes as components of complex lipids they would not 
have been so readily accessible to oxidation, although 
the rate of PGL turnover could have influenced the 
release of FA's from membrane lipids into the cellular 
pool. These factors probably accounted for the greater 
cellular lipoperoxide amounts p-EPO induced compared to 
p-SSO, despite the similar FA compositions of these 
p-oils, although such could also relate to the presence 
of 18:3w3 in p-EPO only (Table 2.3.3.2.) and the greater 
capability to form 20:3u6 with p-EPO incubation (Table
3.7.3.1.). This could also explain the greater amounts 
of total 1ipoperoxides generated with p-EPO than p-LO 
supplementation (despite 63% 18:3u)3 in p-LO and only 9% 
18:3w6 in p-EPO), which probably related to the easier 
production of endoperoxides from 18:3w6 and 20:3w6 than
from 18:3w3. The suppression/inhibition of microsomal PG 
biosynthesis or oxygenase activity by io3 series PUFA's 
(Morisaki et al 1982b) could probably be excluded in 
this regard since dosage with 60mg/l p-FO induced the 
greatest cellular lipid peroxide amounts measured, which 
was probably largely attributable to the susceptibility 
of 20 : 5to3 to oxidation.
Lipoperoxides have been implicated in the disruption of 
biological membranes (Mead et al 1976, Tappel et al 1980 
and Frankel 1984), thus the small MDA amounts found in 
the spent medium of cultures dosed with 60mg/l p-FO or 
p~L0 may have arisen from the release of cellular lipid 
peroxides through the membrane of intact cells or as a 
result of cell lysis. This could also have resulted in 
the escape of cellular FFA's and enzymes responsible for 
peroxidation into the medium, thus extracel1ular auto­
oxidation should not be overlooked as a contributor to 
these medium 1ipoperoxide levels. On the other hand, the 
absence of MDA from al1 other spent media supported 
cellular uptake of dosed p-oil FA's.
Low cellular 1ipoperoxide levels generally correlated 
with high cell yields, whereas the significant increases 
in cellular and/or medium lipoperoxides levels found 
only with p-LO, p-EPO or p-FO dosage (Table 3.7.5.1.) 
correlated inversely with cell viability (Figs. 3.7.1.6­
3.7.1.8.). It was apparent, however, that lipoperoxides 
were only partly responsible for the modulation of cell
viability since the greatest cytotoxicity induced with 
60mg/l p-LO or p-EPO did not correlate with the highest 
cellular 1ipoperoxide amounts found. Skin in vivo is 
continuously exposed to oxygen in air, thus this tissue 
may be particularly resistant both to the generation and 
effects of 1ipoperoxides, and the changes induced in 
cell viability with p-oil dosage probably involved other 
mechanisms, such as alterations in membrane stability.
The finding that total eicosanoid formation by control 
rat skin fibroblasts comprised 83% of all 1ipoperoxides 
quantified (Tables 3.7.5.1. and 3.7.6.1.) was not 
surprising considering endogenous 20:4u6 levels and the 
capability of these cells to form 1-, 2- and 3-series 
eicosanoid precursors via desaturation and elongation 
(Tables 3.7.3.1. and 3.7.4.2.). The observation that the 
prostanoids studied comprised a fraction of the molar 
amount quantitated indicated that these cells were 
largely invloved in the production of other eicosanoids, 
but nevertheless supported functional cyclooxygenase 
activity in rat skin fibroblasts. Under the experimental 
conditions employed, the enzymic pathways for TXB2 an(j
synthesis were greatly favoured over those involved 
in PGI2, P6E2 and PGEl production, and it was possible 
that PGH2_pG02 isomerase was inhibited rather than 
absent as PGD2 formation has been reported in rat skin
in vivo (Ujihara et al 1988)
Loue et al (1978) showed that 18:2u)6 supplementation of 
the diet of normal mice resulted in at least a two fold 
increase ' in cutaneous PGE and PGF levels compared to 
controls, but had little effect in EFA-deficienc y. p-Oil 
supplementation also influenced the ability of rat skin 
fibroblasts to produce the prostanoids studied (Table
3.7.6 .1 .), but this was not related to the degree of 
p-oil unsaturation, the ability of the p-oils to provide 
direct eicosanoid precursors (Table 2.3.3.2.), or the 
capability of the cells to form eicosanoid precursors 
via the desaturase cascade (Table 3.7.3.1.). Indeed, the 
detection of increased levels of the 1-series eicosanoid 
precursor, 20:3w6, only when cells were dosed with p-EPO 
induced no marked effect upon eicosanoid production
compared to other p-oils at identical concentrations. 
Even p-LO and p-FO yielded prostanoid profiles similar 
to those derived from cells incubated with corresponding 
amounts of other p-oils, despite the known inhibitory 
actions of 18j3u3 and 20:5u3 on 20:4w6 metabolism
via cyclooxygenase and therefore 2-series prostanoid 
production (Lands et al 1971, 1973, Dyerberg et al
1978, Culp et al 1979, Hwang et al 1980, Hamazaki et al 
1982, Marshall et al 1982 and Nassar et al 1987). 
The lack of significant differences in PGI2 , TXB2 PGFa
and PGEi levels found with dosage of different 
p—oils at the same concentration implied that exogenous
the eicosanoids studied, thus enhancement of prostanoid 
production related to utilisation of membrane 20:3w6 and 
20:4u6, uhich were detected in rat skin fibroblasts 
(Table 3.7.3.1.). However, the finding that 40mg/l p-oil 
had little effect on or suppressed prostanoid formation, 
whereas 20 and 60mg/l p-oi1 significantly stimulated 
eicosanoid production primarily by enhancing TXB2 ancj
rur& synthesis, implied p-oil concentration involvement 
in prostanoid synthesis. This could have influenced
eicosanoid precursor availability, or modulated the 
expression of enzymes involved in the formation of the 
prostanoids studied, particularly at the PGH level.
Numerous studies have implicated PG involvement in the 
modulation of cell division in skin when such compounds 
were provided exogenously (Ziboh et al 1972, Bern et al 
1974, Lupulescu 1976, Lowe et al 1977 and McCullough 
et al 1978). PGE compounds in particular, have been 
associated with increased epidermal proliferation i n 
vivo (Lowe et al 1977), and similar results have been 
obtained in culture (Bern et al 1974). Others, however, 
found that the rate of epidermal proliferation increased 
5 fold over controls in EFA-deficient rats with impaired
synthesis, and that topical PGE2 application daily 
for one week restored the slower, normal rate of growth
(Ziboh et al 1972 and McCullough et al 1978). 'The 
present study, in contrast, could not establish any 
correlation between the eicosanoid profiles (Table
3.7.6.1.) and cell viability changes (Figs. 3.7.1.2­
3.7.1.8.) induced with p-oil supplementation, and this 
implied that the endogenously synthesised prostanoids 
studied were not directly involved in the modulation 
of cell proliferation, despite alterations in overall 
prostanoid production or the balance between individual 
prostanoid groups. The involvement of 1ipoperoxides and 
alterations in membrane physical properties were 
proposed as likely mechanisms.
3.8 THE EFFECTS OF PSEUDO-OILS ON CELLS
DERIVED FROM RAT ADIPOSE TISSUE.
3.8.1 Effects of pseudo-Oils on Cell Viability.
No morphological changes were found between control 
cells before, during and after each experiment, and 
dosed cells were morphologically similar to controls, 
except for cytoplasmic droplets observed with p-oil 
incubation at high concentrations in some instances.
The data depicted in Fig. 3.8 .1.1. showed that final 
medium albumin concentrations ranging from 0 to 250mg/l 
induced no significant changes in cell viability. This 
excluded the possibility that albumin as FA carrier had 
any effect on cell viability, hence the effects induced 
with the p-oils were a result of the exogenous FA^s.
1 1.4xl0a control cells/ml culture medium were found at 
the end of the 24 hour post-trypsinisation recovery 
period. This equated to 70% of the final control cell 
number at the end of the 48 hour p-oil incubation period 
and represented the cytostatic number. Growth inhibition 
was therefore induced only with p-oil concentrations 
which reduced cell viability to significantly below 70%.
The cell viability changes induced following incubation 
with 0 to 100mg/l p-oil for 48 hours are shown in Figs.
3.8 .1.2-3.8 .1.8 . All p-oils enhanced cell pro!iferation
The results are expressed as mean percent (^ ) cell 
viabi1ity±standard error of the mean (s.e.m,), where "n‘ 
is the number of experiments. The concentrations given 
are as mg albumin or pseudo-oil per litre of growth 
medium. Fig. 3.8 .1.1. shows the mean percent cell 
viability versus the albumin concentration (mg/1), and 
Figs. 3.8 .1.2~3.8 .1.8 . depict the mean percent cell 
viability versus the pseudo-oil concentration (mg/1). 
Fig. 3.8 .1.9. shows the mean percent cell viability 
versus the albumin concentration (mg/1) for cells dosed 
with the amount' of pseudo-oil which limits cell 
viability to of the controls.
A1bumin 
Concentration 
(mg/1 ).
Mean ±s.e.m. n
0 100 .0 2.3 12
25 1 0 2 .8 2 .0 12
50 100.7 2 .6 12
75 10 1 .6 2 .1 12
100 99.3 2 .0 12
125 101.1 2 .1 12
150 99.8 3.1 12
175 99.9 3.6 12
200 100.3 2 .8 12
225 98.8 3.7 12
250 98.1 2 .1 12
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100 .0 3.6 6
10 108.8 5.6 6
20 93.4 4.5 6
30 99.5 5.5 6
40 96.0 3.9 6
50 84.8 3.6 6
60 74.4 2 .6 6
70 63.0 1 .8 6
80 73.3 5.1 6
90 61.5 3.4 6
100 64.4 3.3 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 10 0 .0 5.1 6
10 108.6 4.2 6
20 95.1 5.7 6
30 88.3 4.9 6
40 8 6 .0 5.9 6
50 84.8 2 .1 6
60 80.5 5.0 6
70 80.9 3.8 6
80 80.3 5.3 6
90 82.3 2 .0 6
100 76.9 2.7 6
pseudo-Oi1 
Concentration 
(mg/1)
Mean is.e.m. n
0 100 .0 2.7 6
10 110.1 5.2 6
20 10 2 .2 6.4 6
30 114.1 6 .1 6
40 97.8 1.9 6
50 93.4 3.2 6
60 85.1 4.3 6
70 87.0 2.7 6
80 85.1 7.0 6
90 75.9 3.4 6
100 21.9 2 .1 6
The percentage viability of cells derived from
adipose tissue incubated uiith p-SSO.
pseudo-Oi1 
Concentration 
(mg/1)
Mean — s • © ♦ m« n
0 100 .0 1 .6 6
10 104.7 4.7 6
20 98.9 4.3 6
30 107.0 3.6 6
40 105.4 2 .2 6
50 90.4 2 .2 6
60 1 0 2 .8 3.7 6
70 93.7 2.5 6
80 92.2 4.7 6
90 97.0 3.6 6
100 87.0 3.6 6
rat
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100 .0 4.0 6
10 104.0 5.2 6
20 120.5 3.9 6
30 120.3 4.0 6
40 99.9 4.0 6
50 100.9 2.4 6
60 99.8 5.1 6
70 89.1 5.8 6
80 64.4 5.4 6
90 51.8 4.4 6
100 42.0 3.6 6
rat
The percentage viability of cells derived from
adipose tissue incubated with p-EPO.
pseudo-Oi1 
Concentration 
( m g/1)
Mean ±s. e . m. n
0 100 .0 5.6 6
10 108.1 2 .6 6
20 97.8 4.3 6
30 100.5 4.8 6
40 103.3 4.6 6
50 80.9 5.4 6
60 71.2 5.4 6
70 53.9 1.9 6
80 35.2 1.9 6
90 4.7 1 .2 6
100 0.3 0.3 6
rat
pseudo-Oi1 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100 .0 2 .8 6
10 107.8 7.1 6
20 91.7 4.3 6
30 92.2 3.7 6
40 97.5 4.5 6
50 102.4 4.4 6
60 88.5 4.8 6
70 79.1 3.5 6
80 81.9 5.6 6
90 72.6 4.4 6
100 75.2 5.0 6
rat
A1bumin 
Concentration 
(mg/1)
Mean ±s.e.m. n
0 100.0 3.2 6
125 45.0 4.5 6
150 49.3 2.4 6
175 52.0 4.1 6
200 51.0 3.1 6
225 54.1 3.1 6
slightly with low concentrations and limited growth to 
*
a greater or lesser extent with higher amounts dosed, 
although p-EPO, p-LO and p-00 were cytotoxic at high 
concentrations.
p-CO enhanced cell viability to 108.8% with 10mg/l, had 
little effect with 20 to 40mg/l, and limited growth to 
84.8% with 50mg/l (Fig. 3.8.1.2.). Cell viability ranged 
from 61.5% to 74.4% with 60 to 100mg/l p-CO, relative to 
the cytostatic number of 70%, thus cytotoxicity was not
marked and no ID50 was found. Cell proliferation was 
also stimulated with 10mg/l p-MO to 108.6%, and growth 
limitation increased progressively with higher amounts 
dosed to a minimum of 76.9% with 100mg/l p-M0 (Fig.
3.8.1.3.), thus no ID50 could be calculated either.
Cell proliferation increased to 110.1% and 114.1% with 
10 and 30mg/l p-00, respectively, but approximated to 
controls with 20 and 40mg/l p-00 (Fig. 3.8.1.4.). Higher 
concentrations progressively limited cell growth to 
85.1% with 60mg/l and 75.9% with 90mg/l p-00, whereas 
50% of cells were viable with 95mg/l p-00 (IDso), but 
only 21.9% with 100mg/l p-00.
Incubation with 10 to 90mg/l p-SSO had little effect on 
cell pro 1iferation, although such was increased to 
107.0% and 105.4% with 30 and 40mg/l p—SS0, respectively 
(Fig. 3»8.1.5.). This was the least effective p—oil to 
impair cell growth as 87.0% viability occurred even with
100mg/l p-SSO.
p-LO stimulated cell proliferation by 20% with 20 and 
30mg/l and had little effect with 40 to 60mg/l, but 
limited growth to 89.1% with 70mg/l (Fig. 3.8.1.6.). 
p-LO induced cytotoxicity with concentrations of 80mg/l, 
or more, and half the cells were viable with 92mg/l p-LO
(ID5 0 ), compared to 42% with 100mg/l p-LO.
Cell viability was 108.1% with 10mg/l p-EPO, but in line 
with controls following 20 to 40mg/l p-EPO dosage (Fig. 
3.8.1.7.). Cell proliferation was limited to 80.9% with 
50mg/l p-EPO and parallel to the cytostatic number with 
60mg/l p-EPO, but higher amounts induced concentration 
dependent cytotoxicity such that half the cells were 
killed with 73mg/l p-EPO (ID50) and practically all with 
90 and 100mg/l p-EPO. This was the most effective p-oi1 
to impair the pro 1iferation of these cells.
Cell viability remained within 10% of controls with 
dosage of up to 50mg/l p-FO, and was merely limited with 
higher concentrations to a minimum of 72.6% with 90mg/l 
p-F0 (Fig. 3.8.1.8.). p-FO thus induced similar effects 
to p-MO (Fig. 3.8.1.3.) and p-SSO (Fig. 3.8.1.5.).
Cells were incubated with a fixed amount of p-EPO to 
correspond with its ID50 (70mg/l) and supplemented with 
varying amounts of albumin to eliminate the possibility 
that any effects induced with p-oil dosage were related 
to the amount of albumin used as FA carrier. The albumin
concentration was varied at 2 points above and below the
IDso of p-EPO, and the results obtained following the 48 
hour incubation period are depicted in Fig. 3.8.1.9.
This indicated that the concentration of p-EPO dosed 
reduced cell viability to about 50% of controls, and 
that such was not significantly influenced by different 
albumin concentrations. Exclusion of the synergistic 
involvement of albumin therefore implied that the 
effects induced with the p-oils were attributed solely 
to the exogenous FA's.
Subsequent to these studies, cells derived from rat 
adipose tissue were plated and dosed appropriately with 
0, 20, 40 or 60mg p-oil/1 culture medium in sufficient 
amounts to permitt all quantitative and qualitative 
analyses to be carried out. Upon harvesting, cell yields 
were compared and found to be statistically similar to 
those in Figs. 3.8.1.1-3.8.1.8. All further biochemical 
assays were thus performed on these samples.
3.8.2 Effects of pseudo-Qils on Total Protein.
The total protein concentrations determined for cells 
supplemented with 0, 20, 40 or 60mg/l p-oil are shown in 
Table 3.8.2.1. as ,ug total protein/106 cells seeded.
134.7jjg total protein per 106 control cel Is seeded was 
quantitated, whereas concentrations in dosed cells were 
increased and ranged from 142.8 to 205.5jug protein/106 
cells seeded (found with 60mg/l p-EPO and 20mg/l p-LO, 
respectively). Cellular protein concentrations decreased 
over the range dosed in the presence of p-CO, p-SSO or 
p-LO, but increased with the amount of p-MO added. On 
the other hand, more cellular protein was measured with 
40mg/l than with 20 or 60mg/l p-EPO and p-FO, but the 
converse was found with p-00.
The protein content of cells derived from rat adipose 
tissue, expressed as jug total protein/10s r^11s seeded.
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3.8.3 Effects of Pseudo-Oils on the Fatty Acid
Spectrum of Cells Derived From Rat 
Adipose Tissue.
The FA spectra for cells incubated with 20, 40 or 60mg/l 
p-oil are shown in Table 3.8.3.1. in relation to undosed 
cells. The greatest proportion of any single FA in the 
controls was 18:lw9 (23.4%), but similar percentages 
were found for 16:0 (22.3%) and 18:0 (21.8%). Other FA's 
contributing >5.0% to the total spectrum in control 
cells included 18.*2u6 (9.0%) and 22:4w6 (5.8%). Varying 
amounts of these moieties were present in dosed cells.
In general, dosed cells contained less 18:0 and 18:lw9, 
variable proportions of 16:0 and 16:lu9, and more 18:2w6 
and 18:3u6, compared to controls. w6 PDFA levels were 
generally parallel to controls or increased in dosed 
cells, although 22:5u6 was decreased. 18:3w3 and 20:4u3 
levels were decreased, but 20:5u3, 22:5u3 and 22:6w3 
amounts were generally increased in dosed cells.
16:0 levels increased from 22.3% and 21.4% to 28.1% and 
31.6% when cells were supplemented with 0, 20, 40 and 
60mg/l p-CO, respectively. On the other hand, 16:lw9 was 
significantly raised only with 40mg/l p-CO (4.0% vs 1.5% 
in controls), while 18:0 and 18:lw9 levels were parallel 
to controls or decreased. Dosed cells contained less 
18:2u6 than controls (9.0%), but 20:4w6 was increased at 
least 2 fold (3.6% to 5.3% vs 1.6% in controls). 22:4u6
All values are tabulated as relative percent total area. 
Control values are reported as mean±s.e.m., where 'n' is
i
the number of experiments. "Cp-OilH' refers to the 
pseudo-oil concentration used.
The fatty acid spectrum of cells derived from rat
adipose tissue.
FATTY ACID 
SPECTRUM 
(*)
CONTROLS 
(n=3)
Cp-C03 
(mg/1)
20 ! 40 ! 60
Cp-m o:
(mg/1)
20 ! 40 60
Cp-003 
(mg/1)
20 1 40 1 60
Cp-SS03 
(mg/1)
20 1 40 1 60
Cp-L0D 
(mg/1)
20 1 40 1 60
Cp-EPOH 
(mg/1)
20 1 40 1 60
: Cp-f o:
(mg/1 )
1 20 1 40 1 60
S
A
16:0 22.3±0.55 21.4 28.1 31.6 19.3
11
21.9123.2 1 17.7 16.0 19.1 17.5 17.6 19.8 26.1 14.3 23.6 11.0 24.4 23.5 18.5 20.6 21.2
T
u
18:0 21.8±0.00 15.7 15.7 18.7 15.6 18.1115.1l 10.8 13.6 6.7 14.6 17.2 10.8 15.4 13.9 11.6 21.6 20.9 11.7 13.8 11.2 8.1
R
A
20:0 0.8±0.05 - - - -
l— 1 1 "" 1 - - - - - - - 0.2 0.1 - 1.0 - - - -
T
E
22:0 0.2±0.00 0.2 0.6 0.1 0.1
1
1.01 0.1 - - - - - - 0.1 1.8 - - 0.1 0.1 - 0.1 0.1
S. 24:0 0.3±0.03 — 0.5 0.1 0.1
1
0.61 0.4
!ii
- - - - 0.2 0.3 - 0.2 - - 0.3 0.4 - - -
u)9
M
16:1 1.5±0.05 0.9 4.0 1.8 0.5
ii
0.41 2.21 0.7 0.4 2.3 0.4 0.7 2.7 4.1 3.1
1
3.8 0.4 0.7 0.9 4.6 11.7 15.9
0
N
18:1 23.4±0.75 20.7 18.1 25.3 20.0 19.1123.41 31.6 42.2 48.8 19.4 19.1 19.7 15.8 17.1 18.3 22.3 21.3 18.8 19.6 17.4 18.1
0
S.
24:1 — 0.7 — — —
1
~ ! ■” i iii
— - - - - - - - - - - i - -
18:2 9.0±0.85 8.4 3.4 5.6 13.0
ii
10.3114.31 11.1 11.8 11.6 24.7 26.7 31.6 11.1 11.9 11.7 31.1 20.7 33.7 11.5I 7.8 9.2
u6
18:3 - O’. 9 0.6 0.3 0.9
1
0.21 0.9j 0.6 - 0.4 1.8 - 1.1 0.7 1.4 0.9 4.6 0.9 1.6
i
' 1.4i 0.2 0.3
p 20:2 1.4±0.05
- 3.9 - — 3.71 0.3 0.9 3.7 1.7 0.9 2.0 1.3 - 1.7 - 0.5 0.5 - - 0.9 0.5
0
1
20:3 1.0±0.05 1.9 2.3 1.3 1.6 2.71 1.4l 1.4 0.6 0.7 1.2 1.4 1.0 1.0 1.9 0.9 4.1 1.0 0.4 1.2 1.4 0.9
Y
S.
20:4 1.610.05 5.3 4.0 3.6 5.0
l
4.6! 5.6 1 3.5 1.5 1.7 2.7 2.3 1.9 3.7 3.2 2.7 1.6 1.5 0.6 3.5 2.7 2.3
22:4 5.810.90 10.5 7.7 4.1 10.8
1
7.2! 5.5 1 11.4 4.0 2.1 8.0 4.3 5.0 8.4 6.6 7.4 1.0 4.4 6.5 8.5 5.4 4.9
22:5 2.010.05 0.2 1.9 0.2 0.2
1
1.51 0.2
!ii
0.1 0.6 0.1 0.3 1.1 0.1 0.1 1.7 0.1 0.1 0.7 - 0.2 1.0 0.1
18:3 0.210.00 1.0 0.4 0.6 1.1
!
0.31 0.9l 1.3 0.6 1.2 1.8 0.5 1.1 5.1 10.7 15.7 - 0.2 0.4 1.4 0.5 0.7
u3 18:4 2.910.20 0.4 - 0.6 0.7 0.21 0.2 l 0.3 1.0 0.1 0.4 1.5 0.2 0.3 1.5 0.2 0.1 0.9 0.2 0.3 0.2 0.3
P
o
20:4 3.010.15 2.2 2.2 0.5 1.9
1
1.91 0.7l 1.0 1.5 0.1 1.1 1.5 0.4 1.8 2.6 0.6 - 0.5 0.3 0.7 1.7 1.2
L
Y
20:5 0.410.00 1.3 1.4 0.7 1.5
1
1.21 0.61 1.4 0.2 0.4 0.3 0.4 0.4 1.6 0.6 0.3 0.2 - - 4.3 5.8 9.5
S. 22:5 1.110.00 3.9 2.3 2.2 3.6 2.41 2.3 2 . 9 1.0 1.4 2.5 1.8 1.4 2.3 4*3 1 .1 0.8 0.3 0.5 7.7 9.1 4.9
22:6 1.310.10 4.6 3.0 2.8 4.1 2.9.' 2.7111l
3.2 1.3 1.6 2.5 1 .9 1.4 2.6 1.5 1.0 0.6 0.2 0.4 3.0 2.3 2.1
percentages were raised with 20 and 40mg/l p-CO (10.5% 
and 7.7%, respectively vs 5.8% in controls), yet 22:5w6 
levels were parallel to controls (2.0%) or decreased. 
p-CO induced a marked reduction in 18:4w3 (0% to 0.6% vs 
2.9% in controls), but 20:5w3, 22:5w3 and 22:6w3 levels 
increased 2 fold or more in relation to controls (0.4%, 
1.1% and 1.3%, respectively).
P~M0 dosage had little effect on 16:0 and 18:lu9 levels, 
but reduced 18:0 and 16:lu9 amounts, although the latter 
was slightly raised with 60mg/l p-MO (2.2% vs 1.5% in 
controls). Up to 14.3% 18:2u6 and 2.7% 20:3w6 were found 
(9.0% and 1.0% in controls, respectively), 20:4w6 levels 
ranged from 4.6% to 5.6% (1.6% in controls), and 22:4w6 
was increased almost 2 fold with 20mg/l (10.8% vs 5.8% 
in controls), yet 22:5w6 amounts were decreased. p-MO 
induced a marked reduction in 18:4u3 and 20:4w3, but up 
to 1.5% 20:5w3, 3.6% 22:5w3 and 4.1% 22:6u3 were found 
(0.4%, 1.1% and 1.3% in controls, respectively).
A concentration ' dependent increase in cellular 18:lu9 
occurred with dosage of 0, 20, 40 or 60mg/l p-00 (23.4% 
to 31.6%, 42.2% and 48.8%, respectively), but 16:0 and 
18:0 levels were decreased and increased 16:lu9 was 
found only with 60mg/l p-00 (2.3% vs 1.5% in controls).
p-00 had little effect on 18:2u6 levels, but 20:2w6 was 
increased with 40mg/l (3.7% vs 1.4% in controls). 20:4u6 
and 22:4u6 increased about 2 fold with 20mg/l p-00 (3.5%
and 11.4% vs 1.6% and 5.8% in controls, respectively), 
but no increase in 22:5w6 was found. 18:4u3 and 20:4w3 
amounts were decreased with all concentrations, but 
20:5w3, 22:5w3 and 22:6u3 were significantly increased 
only with 20mg/l p-00 (1.4%, 2.9% and 3.2% vs 0.4%, 1.1% 
and 1.3% in controls, respectively).
p-SSO supplementation decreased cellular 16:0, 18:0 and 
18:lw9 amounts, and 16:lu9 was significantly increased 
only with 60mg/l p-SSO (2.7% vs 1.5% in controls). 
18:2u6 percentages increased from 9.0% to 24.7%, 26.7% 
and 31.6% with 0, 20, 40 and 60mg/l p-SSO, respectively, 
and up to 1.8% 18:3w6 was found (none in controls). 
20:3w6 levels were parallel to controls (1.0%), but 
20:4w6 amounts were increased (1.9% to 2.7% vs 1.6% in 
controls). 22:4u6 levels were increased only with 20mg/l 
p-SSO (8.0% vs 5.8% in controls), and decreased 22:5w6 
was found. p-SSO decreased cellular 18:4w3 and 20:4w3 
amounts, but 22:5w3 and 22:6u3 were increased about two 
fold with 20mg/l p-SSO (2.5% each vs 1.1% and 1.3% in 
controls, respectively).
16:0 levels ranged from 14.3% to 26.1% with p-L0 dosage 
(22.3% in controls), 22:0 increased significantly with 
40mg/l p-LO (1.8% vs 0.2% in controls), 16:lw9 increased 
at least two fold (1.5% in controls), whereas 18:lw9 and 
18:0 percentages were decreased. p-L0 had little effect 
on 18:2u6 levels, 20:4u6 and 22:4w6 were increased (2.7% 
to 3.7% and 6.6% to 8.4% vs 1.6% and 5.8% in controls,
respectively), although 22:5u)6 was decreased. 18:3w3 
percentages increased from 0.2% to 5.1 %, 10.7% and 15.7% 
with 0, 20, 40 or 60mg/l p-LO dosage, respectively, yet 
decreased 18:4u3 and 20:4u3 were found. Increments were, 
however, detected for 20:5w3 with 20mg/l p-LO Cl. 6?S vs 
0.4% in controls), 22:5u3 with 20 and 40mg/l p-L0 (2.3% 
and 4.3%, respectively vs 1.1% in controls) and 22:6w3 
with 20mg/l p-L0 (2.6% vs 1.3% in controls).
16:0, 16:lw9, 18:0 and 18:lw9 percentages approximated 
to controls or were decreased with p-EP0 incubation, but 
18:2w6 proportions were greatly increased (31.1%, 20.7% 
and 33.7% with 20, 40 and 60mg/l, respectively vs 9.0% 
in controls). Cells contained 0%, 4.6%, 0.9% and 1.6% 
18:3w6 with 0, 20, 40 and 60mg/l p-EP0, respectively, 
and 4.1% 20:3u6 was detected with 20mg/l p-EP0 (1.0% in 
controls). 20:4uj6 levels, however, were not increased, 
and the percentage of 22:4w6 was raised only with 60mg/l 
p-EPO (6.5% vs 5.8% in controls). On the other hand, w3 
PDFA levels were parallel to controls or decreased.
p-F0 incubation increased cellular 16:lu9 levels to 4.6% 
with 20mg/l, 11.7% with 40mg/l and 15.9% with 60mg/l 
(1.5% in controls), reduced 18:0 percentages from 21.8% 
in controls to 13.8%, 11.2% and 8.1%, respectively, but 
had no marked effect on 16:0, 18:lu9 and 18:2w6. Raised 
amounts of 20:4u6 were found with 20, 40 and 60mg/l p-F0 
(3.5%, 2.7% and 2.3%, respectively vs 1.6% in controls),
3nd 22:4w6 with 20mg/l p—FO (8.5% vs 5.8% in controls)* 
but 22:5u6 percentages were decreased. Dosage with 20, 
40 or 60mg/l p-FO greatly increased the levels of 20:5w3 
(4.3%, 5.8% and 9.5%, respectively vs 0.4% in controls), 
and 22:5w3 (7.7%, 9.1% and 4.9%, respectively vs 1.1% in 
controls), but the increment in 22:6w3 was smaller 
(3.0%, 2.3% and 2.1%, respectively vs 1.3% in controls).
3.8.4 Incorporation of Radiolabel1ed C18 Fatty
Acids into Cells Derived from Rat Adipose 
T i ssue.
The radioactivity recovered from cultures incubated with 
2*iCi F14C3-18: lw9, FiaC3-18:2u6 or F14CI1-18: 3w3 is shown 
in Table 3.8.4.1.
For both F14C3-18:lu9 and F14C3-18:3w3 the equivalent 
of 4.3xl06cpm were dosed to the cultures, and total 
recovery approximated to 77% and 91%, respectively. For 
F14C3-18: 2u)6 the equivalent of 4.8xl06cpm were dosed to 
the growth medium, and the total recovery of this radio­
isotope after 48 hours incubation amounted to 85%. The 
counts recovered from the spent incubation media ragged 
from 1.8 to 2.8xl06cpm, whereas only 0.4 to 0.5xl06cpm 
were recovered from the pooled buffers after washing the 
cells, which accounted for non-specific binding. The 
amount of each of these radioisotopes incorporated into 
the cells themselves equated to 22% for FiaC3-18:lw9, 
29% for F14C3-18:2w6 and 14% for FiaC3-18:3u3.
The percentage conversion of incorporated FlaCH-18:lw9, 
F14C3 —1812w6 and F1^ CD — 18*3u3 to u9, w6 and w3 series 
products, respectively after 48 hours incubation with 
cells derived from rat adipose tissue are shown in Table
3.8.4.2.
29.9% of the total F iaC3-18 J lio9 counts derived upon GLC
The radioactivity (cpm) recovered from rat adipose cultures 
incubated with radiolabel1ed C18 fatty acids, expressed as 
mean (±s.e.m.), n=3♦
SPENT
MEDIA
(M)
POOLED
WASHINGS
(U)
TOTAL
(M+U)
CELLS TOTAL
xl-06
Total 18:1 counts dosed to incubation medium = 4.3 x 10s
1838100
(±10480)
528000
(±7440)
2366100 938754
(±771)
3.3
Total 18:2 counts dosed to incubation medium = 4.8 x 10s
2235400
(±14720)
508380
(±4020)
2743780 1368009
(±5787)
4.1
Total 18:3 counts dosed to incubation medium = 4.3 x 10s
2841400
(±11940)
419400
(±3360)
3260800 613707
(±2496)
3.9
The counts detected for the radiolabelled fatty acids 
dosed and their resulting metabolites formed after 
incubation uiith cells derived from rat adipose tissue, 
expressed as a percentage of the total counts recovered 
upon GLC analysis.
u9
MONOS.
C14CD- 
18:lw9
u6
POLYS.
C14C3-
18:2u6
w3
POLYS.
C14C3- 
18:3u3
18:1 29.9 18:2 2.8 18:3 6.7
20:1 28.1 18:3 18.3 18:4 26.9
22:1 30.4 20:2 17.6 20:3 11.4
24:1 11.7 20:3 16.3 20:4 11.4
20:4 20.3 20:5 21.1
22:4 12.8 22:5 8.2
22:5 11.9 22:6 14.2
TOTAL
CPM 1237
TOTAL
CPM 2745
TOTAL
CPM 1485
analysis (1237cpm) were unchanged. Similar percentages 
were detected for 20:lw9 (28.1%) and 22:lw9 (30.4%), but 
only 11.7% was found as 24:lw9.
Only 2.8% of the total C14CD~18J2u6-derived counts 
detected following GLC (2745cpm) remained unaltered, 
whereas 18.3% was found as 18:3u6 and 17.6% as 20:2u6. 
20:3u6 and 20:4w6 accounted for 16.3% and 20.3% of the 
total, respectively, compared to 12.8% 22:4u6 and 11.9% 
22:5w6.
1485cpm were derived upon GLC analysis of cells dosed 
with C14CD-18:3u3, of which only 6.7% remained as 18:3w3 
and 11.4% found for its immediate elongation product, 
20:3u3. The percentage for 18:4u3 (26.9%) was almost 10% 
higher than that of the corresponding w6 series product, 
18:3w6 (18.3%), while 11.4% 20:4w3 was found. 21.1% of 
the total counts were shown to be 20:5w3 compared to 
8.2% 22J5u3, and the level of the subsequent product of 
delta-4-desaturation was similar to that found for the 
corresponding product in the w6 series (14.2% 22:6w3 vs 
11.9% 22:5w6).
46D is the first and rate limiting enzyme in the 
desaturase cascade, thus total activity of this enzyme 
is reflected by the sum of all subsequent desaturase and
elongase products.
3.8.5 Effects of pseudo-Oils on Lipid Peroxide 
Format ion.
Table 3.8.5.1. shows the MDA concentrations measured in 
cells dosed with 0, 20, 40 or 60mg/l p-oil, as well as 
their respective growth media. The data is expressed as 
nmoles MDA/106 cells, but in the case of the spent media 
this represents the nmoles of MDA in the volume of 
medium from which lxlO6 cells were obtained.
0.5nmoles MDA/106 control cells were quantified, while 
concentrations in dosed cells ranged from 0.6 to 4.2 
nmoles MDA/106 cells. MDA generation varied with p-oil, 
but generally increased with the concentration of p-oil 
supplemented. Cells incubated with 20, 40 or 60mg/l p-00 
induced the lowest MDA amounts overall (0.6, 0.6 and 0.9 
nmoles MDA/106 cells, respectively), concentrations were 
similar with p-C0, p-M0 or p-FO supplementation (0.8 to 
1.5nmoles MDA/106 cells), whi-le PUFA-rich p-oils induced 
the largest MDA amounts. Cellular levels increased from 
0.6 to 0.8 and 4.2nmoles MDA/106 cel Is in the presence 
of 20, 40 or 60mg/l p-L0 compared to 1.1, 1.1, 2.Inmoles 
MDA/106 cells with p-SSO and 1.6, 1.6, 2.2nmoles MDA/106 
cells with p-EPO, respectively. Medium derived from 
cultures incubated with 60mg/l p-EP0 contained 2.Inmoles 
MDA/106 cells, but none was found in other spent media.
Lippperoxide formation by rat adipose cultures incubated 
uiith p-oils. expressed as nmoles MDA/106 rells.
pseudo­
Oil
(mg/1)
CELLS
0 20 40 60
Control 0.5
CO 0.9 1.3 1.3
MO 1.0 1.2 in♦
00 0.6 0.6 0.9
SSO 1.1 1.1 2.1
L0 0.6 00•o 4.2
EPO 1.6 1.6 2.2
F0 CO•o 1.2 1.5
pseudo- SPENT INCIJRATION MEDIUM
Oil
(mg/1) 0 20 40 60
Control -
CO - - -
MO - - -
00 - - -
SSO - - -
L0 - - -
EPO - - 2.1
F0 - - -
3.8.6 The Eicosanoid Profile of Cells Derived
from Rat Adipose Tissue.
Table 3.8.6.1. shows the eicosanoids detected positively 
in control and dosed cells. All data is presented as a 
percentage of the total area found, but an indication of 
the total eicosanoid amounts quantified is given for 
controls in ’( )", expressed as pmoles total eicosanoids
per 106 cells.
Total eicosanoid production by control cells amounted to 
215.9Pmoles/10s cells, of which 35.9* correlated with 
the retention times of the prostanoid standards used. 
This was composed of 16.6* PGFa> g.2* TXB2 , 7.7* PGE2
and 3.4* PGI2 , and no PGD2 was shown in control cells.
Varying proportions of these prostanoids were found in
dosed cells, but neither control nor dosed cells formed
PGEi 1 *
The percentage of total prostanoids detected in dosed 
cells varied significantly with p-oil concentration, as 
such was decreased with supplementation of 60mg/l p-oil 
(20.9* to 26.7*) and particularly 40mg/l p-oil (11.8* to 
19.7*), but was more variable with 20mg/l p-oil (22.8* 
to 41.4*). Such changes related to alterations in the 
production of individual prostanoids in these cells.
PGI2 levels were increased with dosage of 40mg/l p-oil 
(3.8* to 5.8* vs 3.4* in controls), generally decreased
with 60mg/l p-oil (1.9* to 3.4*), and more variable with
Values are tabulated as relative percent of the total 
area detected» and as pmoles total eicosanoids/106 
control cel Is.
The profile of the eicosanoids detected in extracts of 
cells derived from rat adipose tissue.
! pseudo­
! Oil
EICOSANOIDS m
11111i
! (mg/1 ) TOTAL pgi2 TXBz PGF(v
(1+27 PGE2 PGEi PGD2 ; 1
! CONTROL 35.9 3.4 8.2 16.6 7.7
11
! (215.9) 
! 20 22.8 4.8 11.0 7.0
I111
1
o o t* o 11.8 5.3 3.3 2.2 0.4 - o.6 :
: 60 20.9 2.5 10.3 6.1 2.0 — “ i i
1 20 27.8 3.9 13.1 8.2 2.6 —
i
i
: MO 40 17.2 5.3 5.4 4.0 1.9 - o.6 :
: 60 22.7 2.9 11.2 7.0 1.6 — ii
: 20 36.3 2.5 15.3 18.5 — —
i
iooo
17.8 3.9 6.1 4.6 2.3 - o.9 :
! 60 26.7 2.0 14.6 7.7 2.4 — i
1 20 41.4 3.1 23.0 9.3 6.0 —
i
i
: sso 40 19.6 3.8 6.3 4.5 3.1 - 1 .9 :
: 60 24.3 2.1 12.5 7.8 1.9 -
: 20 29.2 2.6 18.1 7.5 1.0 —
i
— iQO_l 15.5 5.8 4.4 3.6 1.5 - 0 . 2  :
: 60 23.5 1.9 12.8 7.0 1.8 —
: 20 36.4 4.7 17.8 13.0 0.9 —
i
i
! EP0 40 19.7 5.5 7.1 . 4.5 1.8 — 0.8 !
! 60 21.2 3.4 9.1 5.7 3.0 - 1
: 20 30.1 4.1 13.5 8.5 4.0 _
1
™ 1
: FO 40 14.5 5.5 3.1 2.0 3.3 — o.6 :
: 60 22.2 2.3 12.2 6.8 0.9 — iii
20mg/l p-oil (2.5% to 4.8%). TXB? 4. • ,
in relation to controls (8 .2%) with 20mg/l (1 1.0% to 
23.0%) and 60mg/l (9.1% and 14.6%) p—oil, but decreased 
with 40mg/l p—oil (3.1% to 7.1%). p—Oi1 supplementation 
suppressed the production of PGF^, particularly with a 
concentration of 40mg/l (2.0% to 4.6%), although amounts 
were comparable to controls (16.6%) in the presence of 
20mg/l p—00 (18.5%). Dosed cells also formed less PGE2 
than controls (0% to 6.0% us 7.7%), and small amounts of
PGD2 were detected only with incubation of 40mg/l p-oil 
(0 .6% to 1.9% us 0% in controls).
3.8.7 Discussion♦
p-Oil supplementation affected the viability of cultured 
rat adipose cells (Figs. 3.8.1.2-3.8.1.8.). The effects 
induced, however, were not consistent with the degree of 
p-oil unsaturation, hence it could not be established 
whether PUFA-rich p-oils exhibited greater potential to 
modulate cell proliferation than p-oils abundant in 
monounsaturated or saturated F A ' s .  The p-oi1-spec ific 
effects induced could rather be explained in terms of 
p-oil FA composition (Table 2.3.3.2.) and concentration 
dosed, although the possibility also existed that 
effects were enhanced or deminished by p-oil FA's 
operating either in concert with each other, or 
antagonistically. The data supported FA involvement in 
the enhancement of cel 1 proliferation with incubation of 
low p-oil concentrations. However, the finding that cell 
proliferation was stimulated over a wider concentration 
range with incubation of p-00, p-SSO or p-LO than with 
other p-oils implied greater involvement of 18:lw9, 
18:2u6 and 18:3w3, respectively in this process than 
other FA's. This may relate to the chain length of these 
moieties and the fact that 18:lw9, 18:2u6 and 18:3w3 are 
J6D substrates, whereas the different number and 
position of double bonds in these C18 FA's may explain 
why 18:3u3 was a more effective growth promoting agent 
than 18:2u6 and 18tlw9. This indicated that FA structure 
was an important determinant of cell viability. p-SSO
and p-EPO exhibited similar FA compositions with a rich 
supply of 18:2w6 (about 7 0 % ) , thus the cytotoxicity 
induced with p-EPO, but not p-SSO, dosage probably 
related to the presence of 9% 18:3w6 in p-EPO only. This 
implied, therefore, that 18:3u6 was a more potent growth 
inhibitory agent than 18:2u6. The cell death p-LO and 
p-00 induced at high concentrations also indicated that 
18:3u3 and 18:lw9 exhibited greater cytotoxic potential 
than 18:2u6, but it was apparent that these C18 FA's 
were less effective than 18:3w6. On the other hand, it 
seemed that 18:3w3 was more effective than 18:3u6 in 
stimulating cell proliferation. Such effects could have 
related to the presence of a double bond at the 
wl2-position in 18:3u6.
No reference has been found in the 1iterature in which 
the effects of FA^s on rat adipose cell growth has been 
investigated, although the influence of exogenous FA's 
has been studied with rat mammary cells in culture 
(Uicha et al 1979), Mammary tissue is largely modified 
adipose tissue and is thus another cell type specialised 
for handling large amounts of FA's. Like adipose tissue, 
mammary tissue is actively involved in FA biosynthesis 
and is affected by dietary lipids (Lehninger 1982). In 
the presence of de-1ipidised FCS, insulin, progesterone, 
estrogen and prolactin, Uicha et al (1979) showed that 
normal mammary epithelial cell proliferation in culture 
was inhibited with all concentrations of palmitic and
stearic acids tested (0.l-10mg/1), whereas unsaturated 
FFA's induced both stimulatory and inhibitory effects. 
Linoleic and alpha~linolenic acids were most stimulatory 
and resulted in a doubling of the growth rate with 
concentrations of 1.0 and 0.1mg/l, respectively, whereas 
both oleic and arachidonic acids were vastly less 
stimulatory. Linoleic acid could not induce cytotoxicity 
with any concentration dosed (0,l-10mg/l), but this was 
induced with greater than 0.5mg/l arachidonic acid and 
5mg/l oleic and a-linolenic acids (Uicha et al 1979). 
Comparison with our data clearly indicated that the 
effects individual FA's induced were more dramatic than 
with p-oil dosage, and this supported the mediation of 
antagonistic effects between FA's, which probably occurs 
in v i vo when FA mixtures are consumed as dietary oils. 
On the other hand, it was possible that the individual 
FA effects Uicha et al (1979) reported on cell growth 
were mediated by the EFA-deficient culture conditions 
used, or modifications of membrane-bound hormone 
receptors as a result of hormonal supplementation. Uicha 
et al (1979) solubilised the FA's used in ethanol such 
that the final ethanol concentration in the culture 
medium was 1.0%, Our studies, however, have shown this 
concentration to be toxic both to normal and transformed 
cells (Davidson et al 1987a, 1987b, 1988a, 1988b, 
Giangregorio et al 1988b and Girao 1988), thus their 
data should be interpreted with caution. This could also 
explain discrepancies with our data (Figs. 3.8.1.2-
3.8.1.8.), whereas similar trends between the two 
studies may reflect similarities in these lipid storing 
tissues. Both studies nevertheless established that FA's 
played a role in cell growth, and it was possible that 
the response of the cells to the FA's reflected their 
physiological requirements in vivo.
Ue presented evidence which supported the ability of rat 
adipose cells to incorporate the exogenous FA^s dosed 
(Table 3.8.3.1.). It was mechanistically possible, 
therefore, that the p-oil effects on cell growth were 
the result of changes in cell membrane fluidity and/or 
modifications of membrane-bound enzymes, as evidence 
suggests that dietary supplementation with FA's induces 
changes in membrane physical properties and membrane- 
associated cell functions (King et al 1971, Ginsberg et 
al 1981, Simon et al 1982, Spector et al 1985 and Stubbs 
et al 1984). On the other hand, the finding that growth 
inhibition occurred only with p-00, p-LO or p-EPO dosage 
at high concentrations could reflect the ability of 
these cells to tolerate relatively large changes in FA 
concentration as adipose tissue is primarily involved in 
TAG storage and release (Lehninger 1982).
p-Oil dosage caused changes in the content of total 
cellular protein (Table 3.8.2.1.), but this did not 
always parallel the cell viability changes induced 
(Figs. 3.8.1.2-3.8.1.8.). The greatest increase in total 
protein correlated with the greatest stimulation of cell
viability with 20mg/l p—LO dosage. However, as protein 
increased approximately 50% and cell viability increased 
about 20%, compared to controls, increased protein did 
not appear to relate to increased cell numbers alone. In 
fact, increased cellular protein was found even when 
p-oil dosage induced growth limitation. It was apparent, 
therefore, that while total protein quantitation could 
reflect cell growth changes in terms of actual cell 
numbers, p-oil FA's were involved in the stimulation of 
protein synthesis. The finding that the extent of 
protein stimulation varied with dosage of identical 
concentrations of different p-oils, even when such 
yielded similar cell numbers, suggested that FA's of 
different chain lengths and degrees of unsaturation vary 
in their capability to modulate protein synthesis. 
Whether this related to specific FA's in any p-oil, or 
to synergistic effects induced between p-oil FA's, was 
unclear, although a combination of such effects seemed 
most likely. The enhancement of protein biosynthesis 
with p-oil supplementation may, nevertheless, reflect 
the extremely active metabolism of adipose tissue in 
vivo (Lehninger 1982). The involvement of this tissue in 
processes such as FA synthesis, TAG storage and release, 
as well as-its ability to rapidly respond to metabolic
changes/stimuli (Allman et al 1965, Fain et al 1966 and 
Lehninger 1982) suggested that the increased production 
of cellular proteins related to the enhanced expression
of lipid metabolising enzymes, such as lipases and those 
involved in FA synthesis and oxidation.
Comparison of control cell FA spectra with those derived 
from p-oil supplemented cells indicated the ability of 
cultured rat adipose cells to desaturate and elongate 
PUFA's (Table 3.8.3.1.), This correlated with the active 
involvement of adipose tissue in FA biosynthesis in vivo 
(Allman et al 1965, Fain et al 1966 and Lehninger 1982). 
Formation of small I8:3u6 amounts and no increment in 
18:4w3 in dosed cells, even when significant EFA levels 
were present as substrate, supported the rate limiting 
nature of 46D (Stoffel 1961, Holloway 1963, Marcel et al 
1968 and Brenner 1971, 1977, 1982). Slightly increased 
20:2w6 levels indicated the capability for limited 
18:2u6 elongation, whereas increments in 20:3w6 and 
20:4w6 implied rapid 18:3w6 elongation and subsequent 
45-desaturation. On the other hand, the decreased 
18:4w3/20:4w3 and increased 20:5w3 levels found even 
with incubation of p-oils deficient in w3 PUFA's implied 
elongation and 45-desaturation of endogenous 18:4u3. 
22:5w3 and 22:6w3 formation with p-FO dosage supported 
elongation of incorporated 20:5w3 and subsequent ,44- 
desaturation, while production of these moieties also 
with incubation of p-oils deficient in (*)3 PDFA's implied 
elongation and desaturation of endogenous w3 PDFA's. 
However, despite 22:4u6 formation via elongation, this 
moiety was not further desaturated, hence explaining the
accumulation thereof. Such implied greater J4D activity 
with 22:5w3 than 22:4w6, and this supported the greater 
activity of desaturase cascade enzymes with u)3 than w6 
PUFA's (Brenner 1 9 6 6 , Mead et al 1976 and Kanau et al 
1977) and the potential of u3 PDFA's to suppress/inhibit 
co6 PDFA desaturation (eg. Garcia et al 1965 and Sprecher 
1981).
The raised 16:1oj9 levels found in p-oil dosed cells 
(Table 3.8.3.1.) implied 16:0 desaturation, but it was 
apparent that 16:1uj9 elongation was inhibited/suppressed 
since no increment in 18*lw9 was found, despite 16:lw9 
uptake with p-FO incubation. 18:0 desaturation to 18:lw9 
via J9D was not demonstrated with p-oil supplementation 
(Table 3.8.3.1.), although Gellhorn et al (1964) found 
that rat adipose tissue was able to desaturate 18:0. 
Lack of A9D expression in our study, however, could have 
related to PUFA inhibition of the enzyme, which has been 
well documented in the rat (Ullman et al 1971, Mahfouz 
et al 1984, Pugh et al 1984 and Garg et al 1988b). This 
could also explain the lack of 18:lw9 desaturation and 
elongation found, even when large amounts of 18:lw9 were 
incorporated with p-00 dosage (Table 3.8.3.1.).
Dietary—induced alterations in microsomal FA composition 
and competitive interactions between cellular FA's of 
the same and different families modulate desaturase 
cascade enzyme expression (Garcia et al 1965, Brenner et 
al 1966, Nervi et al 1968, Ullman et al 1971, Kurata et
al 1980, de Schriver et al 1982, Garda et al 1984, 1985, 
Nassar et al 1986 and Garg et al 1988a, 1988b, 1988c). 
Such factors therefore contributed to the pattern of 
desaturation and elongation reported in Table 3.8.3.1. 
with p-oil dosage. In vitro studies using microsomes 
isolated from rat liver, known to exhibit desaturase 
activity, indicated that saturated FA's inhibited PUFA 
desaturation (Brenner et al 1966). This, however, did, 
not appear to be the case in cultured adipose cells, as 
detection of increased PDFA levels in cells dosed with 
saturated FA-rich p-oils (p-MO and p-CO in particular) 
implied that a relative EFA/PDFA deficiency enhanced 
desaturase cascade enzyme expression, probably in an 
attempt to restore membrane fluidity. PDFA formation 
with dosage of p-oils abundant in PUFA's was consistent 
with the availability of desaturase cascade enzyme 
substrates, although such moieties could suppress enzyme 
expression by negative feedback reactions once optimal 
PUFA levels were established to maintain normal membrane 
fluidity and cellular functions. This could explain the 
slightly greater cellular 22:6w3 amounts found with 
supplementation of p-CO or p-MO than with other p-oils. 
The amount of FA synthesised in adipocytes has, however, 
been shown to decline with age in the rat (Henderson et 
al 1979 and Gandemer et al 1985), suggesting that PDFA 
availability and lipid deposition in adipose tissue of 
older rats is more dependent on exogenous lipid than on
de now biosynthesis (Etherton et al 1980 and Jamdar et 
al 1986). The ability of these cells to desaturate and 
elongate FA's nevertheless reflected a mechanism to 
control their FA composition, and this could partly 
account for the lack of growth inhibition found with 
most p-oils and concentrations dosed (Figs. 3.8.1.2­
3.8.1.8. ).
The capability of these cells to desaturate and elongate 
individual C18 FA's was assessed to establish whether 
the pattern of p-oil desaturation found (Table 3.8.3.1.) 
was modulated in any way by the presence of FA mixtures.
The pattern of radioactivity derived from cells enriched
/
with CiaC3-18:lu9 was consistent only with elongation>of 
this moiety, but the finding that these cells converted 
80^ of incorporated Z14CD-18 5 2w6 and C 14CU-18: 3u)3 to 
PDFA's indicated 46D expression (Table 3.8.4.2.). A 6D 
activity was also shown in rat mammary tissue microsomes 
by Cunnane et al (1981), although Brenner (1971) found 
that microsomes isolated from epididymal fat of young 
rats exhibited no potential to convert 18:2u6 to 18:3u6. 
This discrepancy may relate to the fact that A6D is 
extremely sensitive and easily inhibited by slight 
changes in the metabolic and physical environments (Cook 
1979 and Brenner 1982), and could have been damaged upon 
microsomal isolation or inhibited by the experimental 
incubation conditions used. Enzyme activity expressed 
in whole cells is nevertheless more realistic and
relevant than microsomal assays since the former more 
closely parallels the situation in the intact organism,( 
C1aCD-18:2u6 and C14CU-18J3u3 elongation to 20:2u6 and 
20:3w3, respectively (Table 3.8.4.2.) supported the 
capability for extramicrosoma1 retroconversion (Stearns 
et al 1967) and/or J8-desaturation. The presence or 
absence of J8D has not been reported in adipocytes, but 
such has been found in rat testes (Albert et al 1977). 
The capability for J8D expression in the present study 
could therefore not be ruled out as a second pathuay for 
20:3u6 and 20:4w3 synthesis. The formation of about 45% 
post-J5D FA's from incorporated C14CT-18:2w6 and C14CD- 
18:3u3 supported J5D expression, whereas the detection 
of 2255u6 and 22:6w3 was consistent with J4D activity 
(Table 3.8.4.2.).
It was evident from comparison of the data in Tables
3.8.3.1. and 3.8.4.2. that desaturase cascade enzyme 
expression was more limited with p-oil than with C14CU- 
18:lu9, C14CII-18:2u6 or C14C3-18:3u3 incubation. This 
implied suppressed enzyme expression as a result of 
competitive interations between p-oil FA's, particularly 
in the light of the competitive nature of FA's for 
such enzymes (Brenner et al 1966, 1967, Mohrhauer et al 
1963a, Ullman et al 1971, de Schriver et al 1982, Holman 
1986a, 1986b, Nassar et al 1986 and Cook et al 1987). 
Desaturase cascade enzyme expression reported with p-oil 
supplementation may nevertheless be a better indication
of such capability in rat adipose tissue in vivo than 
that reflected with individual FA's as cells are exposed 
to mixtures rather than single FA's in the ‘real world*.
The presence of MDA in cultured rat adipose cells (Table
3.8.5.1.) supported the capability for enzymatic and/or 
spontaneous FFA oxidation when the protective mechanisms 
against free radical formation were saturated. Control 
cells contained unsaturated FA's which could have served 
as potential oxidation substrates (Table 3.8.3.1.), and 
the greater MDA amounts found in dosed cells reflected 
oxidation induced by unsaturated p-oil FFA's. Adipocytes 
are largely concerned with TAG storage (Lehninger 1982), 
and it is well known that the FA composition and level 
of dietary fat influence the FA composition of rat 
adipose tissue TAG's (Stein et al 1962, Knittle et al 
1965, Awad 1981, Becker et al 1986 and Lhuillery et al 
1988). Thus, the cellular 1ipoperoxides formed may well 
reflect oxidation of highly unsaturated FFA's in the 
TAG's.
The numerical variations in MDA concentrations between 
dosed cells (Table 3.8.5.1.) reflected the different FA 
compositions of the p-oils (Table 2.3.3.2.). This was a 
function of the amount of unsaturated FA's present in 
any p-oil and also their susceptibility oxidation, which 
related to the number and position of double bonds in a 
FA. It was also possible that supplementation with 
different p-oils altered the rate of PGL turnover in the
cells, which would have influenced FA availability for 
oxidation by affecting FA uptake and release. Indeed, 
FA's would not be so readily accessible to oxidation if 
they were components of the plasma membranes. This could 
explain the lowest cellular 1ipoperoxide amounts formed 
with p-00 dosage, despite significant OA incorporation 
(Table 3.8.3.1.) and a recognised mechanism for oleate 
auto-oxidation (Frankel 1984). The fact that p-CO and 
p-MO contained predominantly saturated FA's and induced 
1arger cellular 1ipoperoxide amounts than p-00, however, 
suggested the availability of endogenous polyenoic FA's 
for oxidation. Lipid peroxide formation with p-FO dosage 
reflected the more even balance of saturated, monoenoic 
and polyenoic FA's present in this p-oil, whereas the 
preference of polyenoic FA substrates for oxidation was 
reflected with p-SSO, p-LO or p-EPO dosage, particularly 
with a concentration of 60mg/l. Formation of more MDA 
with addition of 20 or 40mg/l p-EPO than p-SSO probably 
related to the availability of GLA present in p-EPO 
only, whereas the largest cellular 1ipoperoxide amounts 
formed with 60mg/l p-LO reflected the abundance of ALA 
i n th i s p-o i1 .
The cytostasis induced with dosage of 60mg/l p-EPO and 
the known ability of 1ipoperoxides to increase membrane 
permeability (Ohio et al 1969, Tappel 1975, Mead 1976 
and Frankel 1984) suggested that the spent medium lipid 
peroxides originated intracel1ular1y via passage through
the plasma membrane and/or as a result of extrace 11u1ar 
oxidation of released cellular FFA's. On the other hand, 
the absence of MDA in al1 other spent growth media 
(Table 3.8.5.1.) supported p-oil FA incorporation and 
correlated with the lack of cytotoxicity 20, 40 or 
60mg/l p-oil induced (Figs. 3.8.1.2-3.8.1.8.). As a 
result of the latter finding, it was unclear whether 
1ipoperoxides were directly involved in the modulation 
of cytotoxicity, although this was a possible mechanism 
with dosage of higher p-oil concentrations. The inverse 
correlation generally found between cell viability and 
MDA concentrations with p-CO, p-MO, p-00, p-EPO or p-FO 
dosage was suggestive of 1ipoperoxide involvement in the 
modulation of growth limitation. However, as 60mg/l p-LO 
induced the greatest cellular 1ipoperoxide amounts, but 
no growth limitation, it was proposed that the control 
of cell viability also related to other mechanisms, such 
as membrane fluidity changes.
The finding that total molar eicosanoid formation 
accounted for 43% of the 1ipid peroxides quantitated in 
control cells (Tables 3.8.5.1. and 3.8.6.1.) reflected 
the eicosanoid requirement of these cells and rate of 
biosynthesis under the experimental conditions employed. 
It was possible, however, that endogenous eicosanoid 
production was suppressed/1imited as a result of the 
small 2053w6, 20t4w6 and 20:5u3 proportions found in 
control cells (Table 3.8.3.1.) • as 1-, 2- and 3-series
eicosanoid precursors, respectively. Negrel et al (1981a 
1981b) found that the rate of PGE2 and 6-keto-PGFia 
biosynthesis in mouse epidermal adipocytes was inversely 
related to cell density, and decreased considerably 
after confluence. Hammarstrom (1977) also described this 
phenomenon, which could well explain the total molar 
eicosanoid amount found and the relative proportions to 
which the prostanoids studied contributed to the total 
molarity (Table 3.8.6.1.).
Prostanoid detection supported cyclooxygenase expression 
in these cells, but it was apparent that PGHi-pg^j an(j
PGH2-PGD2 isomerases were inhibited/suppressed since no 
significant PGEi and PGD2 formation was shown in control 
or dosed cells (Table 3.8.6.1.), despite receptors for
such compounds reported in rat adipocytes (Moore 1985). 
Alternatively, it was possible that these PG's were 
degraded at a faster rate than other eicosanoids by 
cytoplasmic enzymes such as 15-hydroxy PG dehydrogenase. 
On the other hand, the finding' that the rate of PGFa 
production was twice as great as that of TXB2 and PGE2 , 
but considerably greater than PGI2> synthesis in control 
cells may have been the result of increased enzyme
expression for PGFi and/or PFG2 formation, or relative 
decreases in the biosynthesis of other prostanoids.
Lipinski et al (1978) similarly found that the in vitro 
production of PGF2q( uas approximately two fold greater 
than PGE2 jn ra-t adipocytes. This supported the findings
of Lambert et al (1976), although earlier studies found
oery low PGF2Q; levels in such cells (Dalton et al 1974). 
Others reported that isolated fat cells do not produce
detectable amounts of TXB2 (Fredhold et al 1976), unlike 
the present study (Table 3.8.6.1.). Possible reasons for 
such discrepancies were diet fed, incubation conditions 
and method of assay.
The eicosanoid profiles obtained from dosed cells (Table
3.8.6.1.) were consistent with the ability of the p-oils 
to modulate prostanoid synthesis. This, however, did not 
correlate in any way with degree of p-oil unsaturation, 
the ability of the p-oils to provide direct eicosanoid 
precursors (Table 2.3.3.2.), or the capability of the 
cells to form eicosanoid precursors via the desaturase 
cascade (Table 3.8.3.1.). Lipinski et al (1978) showed 
that changing the amount of dietary polyunsaturated fat 
altered PG production in rat adipocytes stimulated with
0
norepinephrine in vitro. As the soyabean oil to beef 
tallow (P/S) ratio increased in the diet, so increased
PGF*a and PGE2 formation. However, basal PGE2 production 
was not altered in unstimulated adipocytes, even with
increments in the P/S ratio, and PGF2ot increased only 
slightly. This implied hormonal involvement in the 
modulation of prostanoid biosynthesis, and the absence 
of hormonal supplementation in the present study could 
explain the findings we described. The modulation of 
prostanoid production could only be related to the p-oil
concentration dosed (Table 3.8.6.1.). This could have 
influenced intracel1ular calcium ion availability, which 
has been implicated as an essential factor regulating 
phosholipase activity (Moore 1985), and thus the release 
of FA's from membrane lipids for eicosanoid production. 
This phenomenon could explain why prostanoid synthesis 
was decreased overall with p-oil dosage. It was also 
possible that different p-oil concentrations influenced 
the expression of enzymes involved in the formation of 
the prostanoids studied from PGH to a greater or lesser 
extent and accounted for the alterations found. However, 
the fact that no correlation could be found between the 
eicosanoid profiles (Table 3.8.6.1.) and cell viability 
changes (Figs. 3.8.1.2-3.8.1.8.) induced with p-oil 
dosage was in vitro evidence against the concept that 
the endogenously synthesised prostanoids studied played 
a direct role ■ in the modulation of cell proliferation. 
It was more likely such related to alterations in 
membrane physical properties and the generation of lipid
peroxides.
3.9 General Discussion.
This chapter presented comprehensive data with regard to 
the effect of p-oil supplementation on the viability of 
cultured normal rat cell types, the capability of such 
cells to incorporate, desaturate and elongate FA's, the 
formation of 1ipoperoxides and eicosanoids and possible 
roles these compounds played in the modulation of cell 
viability. Furthermore, the data obtained from the 
parameters investigated permitted valid comparisons to 
be made between different rat cell types under standard 
experimental conditions.
p-Oil supplementation influenced rat cell viability, but 
the effects induced and magnitude thereof varied with 
rat cell type. The finding that cell viability was 
increased when particular p-oils and concentrations were 
dosed to nucleated rat cell types correlated with the 
work of Launay et al (1968, 1969, 1981), who showed that 
LA enrichment of rat diets increased cell numbers and 
the DNA content in liver and adipose tissue. The present 
study demonstrated that both saturated and unsaturated 
FA-rich p-oils exhibited the capability to promote cell 
viability, but such was usually induced with low and/or 
intermediate concentrations in the range dosed. This 
nevertheless implied FA involvement in the modulation of 
proliferation, dependent on rat cell type, p-oil FA 
composition and concentration dosed. Such factors also
determined the capability of the p-oils to reduce cell 
viability. All p-oils were cytotoxic to blood cells, but 
the fact that erythrocytes were more susceptible to the 
inhibitory effects of unsaturated FA-rich p-oils than 
lymphocytes (sections 3.1.1 and 3.2.1) may reflect the 
more limited metabolic capability of erythrocytes due to 
a lack of organelles. p-Oils were nevertheless far more 
effective in killing suspension cultures of blood cells 
than adherent cells, which could have related to the 
ability of the later to divide in culture without prior 
stimulation. Adherent cells exhibited different rates of 
pro 1iferation (Table 2.3.1.1.), thus the growth limiting 
range established with p-oil incubation was broader with 
faster than with slower growing cells. This range should 
always be defined with dividing cells to ensure valid 
expression of the data as it clearly distinguishes 
between p-oil concentrations which induce mere growth 
limitation or cytostasis from those promoting cell 
proliferation or cytotoxicity. In this regard, rat 
endothelium, skeletal muscle, lung and adipose cell 
viabilities were generally limited with p-oil dosage and 
cytotoxicity induced only with high concentrations of 
certain p-oils (sections 3.3.1, 3.4.1, 3.6.1 and 3.8.1, 
respectively), whereas brain and skin cells were more 
susceptible to growth inhibition (sections 3.5.1 and
3.7.1, respectively). Hence, it was clear that the 
threshold for cytotoxicity varied with rat cell type, 
although no clear correlation could be established
between the rate of cell proliteration (Table 2.3.1.1.) 
and extent of growth inhibition induced. The different 
cell viability changes shown with p-oil dosage between 
these rat cell types may well relate to the different 
physiology and functions of such tissues in vivo. 
Extrapolation of cell viability results from one rat 
cell type to another should thus be avoided to ensure 
valid interpretion of data.
Evidence was presented in this chapter which supported 
the ability of rat cells to incorporate exogenous FA's 
to a greater or lesser extent. This modified the overall 
FA composition of the cells, suggesting that a mechanism 
whereby cell viability was reduced, particularly with 
supplementation of high p-oil concentrations, related to 
differential uptake of exogenous FA's and alterations in 
membrane fluidity.
Considerable variations were demonstrated with regard to 
the total protein concentrations of the different rat 
cell types studied (sections 3.1.2, 3.2.2, 3.3.2, 3.4.2,
3.5.2, 3.6.2, 3.7.2 and 3.8.2). Amounts were lowest in 
control lymphocytes and erythrocytes, intermediate in 
adipose, lung and endothelium, and greatest in skin, 
muscle and brain (6.5, 13.0, 134.7, 176.5, 181.1, 374.7,
401.7 and 455.5/jg/10& cells seeded, respectively). The 
fact that control adherent cells contained considerably 
more total protein than control erythrocytes or 
lymphocytes may once again have related to the ability
of the former to replicate under the culture conditions 
employed without prior stimulation. Control cell protein 
levels, however, showed no c1 ear correlation with the 
proliteration rate of these cells (Table 2.3.1.1.), and 
probably reflected the morphological and physiological 
differences of each cell type in vivo. as well as 
variations in the rate of total protein turnover with 
cell type (Lehninger 1982). The protein content of p-oil 
supplemented cells reflected the cell viability changes 
induced, although it was apparent that exogenous FA's 
had the capability to modulate protein synthesis in 
nucleated cells; the magnitude thereof varied with rat 
cell type, p-oil FA composition and concentration dosed. 
The enhancement or suppression of absolute cellular 
protein levels was suggested to relate to alterations in 
membrane protein synthesis and/or enzyme expression 
involved particularly in FA metabolism.
This chapter provided in vitro evidence to support 
the presence or absence of desaturase cascade enzyme 
capability in a range of normal rat cell types exposed 
to exogenous FA's. The lack of desaturase cascade enzyme 
activity was confirmed in erythrocytes (Table 3.1.3.1.) 
(Lehninger 1982), and these cells could thus be regarded 
as non-enzymatic controls within the species. Similarly, 
lymphocytes exhibited no significant A 6D, J5D, J4D or 
elongase activity, but the potential to express J8D was
suggested (Table 3.2.3.1,). Rat brain cells had limited
PUFA elongase, but no significant desaturase, capability 
(Table 3.5.3.1.), whereas skeletal muscle cells showed 
some 46D and A5D capability with PUFA substrates and J4D 
activity was implicated with t*)3 PUFA's (Table 3.4.3.1.). 
On the other hand, A 6D, 45D, 44D and elongase activities 
were found in rat endothelial cells (Table 3.3.3.1.). 
Rat lung and skin fibroblasts showed A 6 D, A5D and 
elongase activities both with w3 and u6 PUFA substrates, 
whereas A dD activity was found only with t*)3 PUFA's and 
this was slightly greater in skin cells (Tables 3.6.3.1. 
and 3.7.3.1.). A6D and A5D were particularly active with 
both u3 and u6 PUFA substrates in rat adipose cells, 
although A dD activity was expressed only with w3 PUFA's 
(Table 3.8.3.1.). These cells, however, exhibited the 
greatest capability for desaturation and elongation in 
relation to the rat cell types studied. A 6D, 45D, A dD 
and elongase expression were also indicated when rat 
lung, skin and adipose cells were incubated with 
C14CD-18:2w6 or C 14CI!-18: 3u3 (Tables 3.6. d . 2., 3.7. d . 2. 
and 3.8.4.2.). Such supported the slightly greater 
capability to form PDFA's with rat adipose, followed by 
skin and lung cells, as shown with p-oil dosage (Tables
3.6.3.1., 3.7.3.1. and 3.8.3.1.), which was consistent 
with the greater incorporati on of C14C3-18:2w6 and 
C14C3-18:3w3 into adipose than skin or lung cells 
(Tables 3.6.4.1., 3.7.4.1. and 3.8.4.1,).
The above findings clearly demonstrated that desaturase
enzyme capability varies between different rat tissues. 
A study in young rats has indeed shown that the 
percentage desaturation of LA to GLA via A6D was 20% 
adrenals, 14% in liver, 6% in testes and 2% each in 
heart, kidney and brain (Brenner 1971). No desaturation 
was detected in lung or epididymal fat (Brenner 1971), 
but this may have related to the fact that desaturation 
was assessed in isolated microsomes, which may not 
necessarily reflect the situation in a genetically 
entire cel 1 . In vivo studies have indeed shown PDFA 
formation from LA in rat adipose tissue, heart, brain 
and liver (Mohrhauer et al 1963a, 1963b, 1963c, 1963d, 
1963e). Little comparative data is available regarding 
the tissue distribution of other desaturases in the rat 
and the relative activities thereof. J5D, J4D and A9D 
activities have nevertheless been reported in several 
rat tissues, including adrenals, testes, liver, adipose, 
heart and brain (Mohrhauer et al 1963a, 1963b, 1963c, 
1963d, 1963e, Gellhorn et al 1964, Brenner et al 1967, 
Bridges et al 1970, Takayasu et al 1970, Ayala et al 
1973, Dannon et al 1975, Anon 1979, Stone et al 1979, 
Blond et al 1981 and Garg et al 1988b, 1988c). On the 
other hand, J8D activity has been found in rat testes 
(Albert et al 1977), but not in liver or brain (Ullman 
et al 1971b, Sprecher et al 1975 and Dhopeshwarkar et al 
1976). There is evidence, however, that desaturase 
activity varies with tissue development as Cook (1978a)
detected limited A6D activity in fetal rat brain, which 
subsequently fell to very low levels 4 weeks after birth 
and was hardly detectable in the adult. In contrast, 
liver levels were very low after birth, but rose sharply 
after weaning (Cook 1978a). It was apparent, therefore, 
that desaturase activity relates both to the type and 
developmental state (age) of a tissue. Such factors 
warrant some consideration in the interpretation of the 
capability of different tissue types to desaturate FA's 
and in the comparison of the desaturase capabilities we 
reported with that of other workers.
The finding that desaturase enzyme capability was more 
limited with p-oil than individual FA dosage in all rat 
cel 1 types studied supported competitive interations 
between p-oil FA's for such enzymes. Numerous studies 
have indeed indicated that desaturation can be modulated 
by FA's in dietary oils (eg. Brenner 1971, de Gomez Dumm 
et al 1983, Kirstein et al 1983, Barzanti et al 1986, 
Mosconi et al 1988, Garg et al 1989, Dang et al 1989). 
j49D, A6D and J5D expressions were enhanced in rat 1iver 
with corn oil, and suppressed with coconut oil, feeding 
(Pugh et al 1984), whereas others showed that hepatic 
49D, A6D and J5D activities were not significantly 
altered by supplementing fat-free rat diets with 10% 
hydrogenated coconut oil, but were depressed with 10^ 
safflower oil (de Schriver et al 1983). When rats were 
fed diets enriched with either hydrogenated beef tallow,
linseed or fish oils, J9D, J6D and J5D activities were 
inhibited by the latter two oils in liver microsomes, 
although the inhibition was greater with fish oil (Garg 
et al 1988a, 1988b, 1988c). Other investigations showed 
that hepatic J6D activity was greatest when rat diets 
were supplemented with linseed rather than safflower oil 
(Lee et al 1988), consistent with the fact that ALA is 
desaturated more efficiently than LA (Jeffcoat et al 
1984). Linseed oil supplemenation of rat diets has also 
been shown to suppress/inhibit w6 PUFA desaturation 
(Brazanti et al 1986), whereas fish oil administration 
decreased both J6D and J5D expression (Kirstein et al 
1983). These studies indicated that the desaturase 
capabilities of the rat cell types we studied related 
to the overall balance of FA's both of the same and 
different series, as well as the cellular demand and/or 
requirement for longer chain more unsaturated FA's. 
Complex mechanisms control FA desaturation (eg. Holman 
1964, Brenner et al 1966, 1967, 1969, Sprecher 1981 and 
de Schriver et al 1982), but maximum enzyme potential 
is genetically determined for every tissue type within a 
species.
The variations we reported in desaturation capability 
between the rat cell types studied may well relate to 
the different physiology of these tissues in vivo. 
However, the fact that desaturase capability was not 
distributed evenly between the rat tissues implied i.n
vivo dependence of some tissues on others for a supply 
of PDFA^s. The fact that desaturase capability varied 
with rat cell type studied nevertheless indicated that 
extrapolations in this regard to other rat cell types 
should be avoided.
Comparative data obtained from the measurement of 1ipid 
peroxides indicated that the capability to produce these 
compounds varied with rat cell type. Lipoperoxides were 
absent from control erythrocytes (section 3.1.4), but 
were formed by all nucleated control cells, although 
relative concentrations were low in skeletal muscle 
and skin (0.1 to 0.2nmoles MDA/106 cells), intermediate 
in lymphocytes, brain, adipose and aortic endothelium 
(0.4 to 0.7nmoles MDA/106 cells), and greatest in lung 
(1.Inmoles MDA/106 cells) (sections 3.4.4, 3.7.5, 3.2.4, 
3.5.4, 3.8.5, 3.3.4 and 3.6.5, respectively). This 
implied that the efficiency of the mechanisms of 
protection against free radical formation and rates of 
FFA oxidation varied between rat tissues. The finding 
that control cell lipid peroxide levels showed no 
clear correlation with the proliferation rates (Table
2.3.1.1.) or total unsaturated FA contents of these 
cells, however, probably reflected the physiological 
differences of each cel 1 type in vivo. as wel1 as 
variations in the rate of PGL turnover with cell type.
Supplementation of cultures with p-oils induced the 
formation of lipoperoxides from exogenous FA's, although
the concentrations varied numerically between rat cell 
types. Lipoperoxide concentrations greater than lOnmoles 
MDA/106 cells were rarely demonstrated in dosed adherent 
cells or their spent incubation media (Tables 3.3.4.1.,
3.4.4.1., 3.5.4.1., 3.6.5.1., 3.7.5.1. and 3.8.5.1.), 
whereas a significantly wider range was found (0 to 103 
nmoles MDA/106 cells) for erythrocyte and lymphocyte 
suspension cultures supplemented with p-oil (Tables
3.1.4.1. and 3.2.4.1.). Cellular lipoperoxide formation 
increased in an overall concentration dependent fashion 
when rat cultures were enriched with increasing amounts 
of p-oil, and this supported exogenous FA incorporation 
from the growth medium. Mouri et al (1984) similarly 
showed that TBARM levels increased in serum and liver 
when rats were fed increasing amounts of a marine oil 
diet containing a total of 15% u3 PUFA's. Kobatake et al 
(1983) demonstrated that serum and liver lipoperoxide 
levels were more elevated in rats fed 5% marine oil 
(containing 75% u3 PUFA's) compared to 5% oleate or 
linoleate supplementation, consistent with the greater 
susceptibility of u3 PUFA's to oxidation. Others showed 
that 1ipid peroxidation decreased by 90% in rat 1 iver 
microsomes when a 16% coconut oil diet was fed for 3 
days, whereas normal lipid peroxidation was subsequently 
restored within 10 days of feeding a 16% safflower oil 
diet (Lokesh et al 1981). They suggested that diets rich 
in saturated fat reduced microsomal 1ipid peroxidation
by decreasing the availability of PUFA's in substrate 
PGL'’s. The findings we presented in this chapter 
indicated that p-oi1-induced 1ipoperoxidation related to 
the amount of unsaturated FA's present in any p-oil 
(Table 2.3.3.2.) and their susceptibility to oxidation. 
This was dependent not only on the number and position 
of double bonds in a FA, but also the availability of 
these moieties. The possibility also existed that 
synergistic or antagonistic interations between p-oil 
FA's influenced 1 ipoperoxide formation to a greater or 
lesser extent.
The absence of 1ipoperoxides in spent control media from 
all rat cultures reflected the abundance of saturated 
FA's present in new incubation medium (Table 2.3.3.3.), 
and the retention of intracel1ular 1ipoperoxides. This 
implied that the p-oiIs induced the spent medium lipid 
peroxides found occasionally in dosed cultures. The 
ability of the rat cell types studied to incorporate 
exogenous FA's and the presence of albumin as p-oil FA 
carrier in the culture medium supported the likelyhood 
that most spent medium lipid peroxides originated intra­
cel lularly, and were released as a direct result of cell 
lysis or via leakage through the plasma membrane. 
Both intracel1ular and extrace 11u1ar 1ipoperoxides could 
nevertheless have induced cellular damage, and the 
involvement of these compounds in the modulation of cell 
viability was proposed.
The desaturation capability of rat lung, skin and 
adipose cells supported the production of DGLA, AA and 
EPA as precursors for 1-, 2- and 3-series eicosanoids, 
which correlated with the ability of these cells to form 
eicosanoids (Tables 3.6.6.1., 3.7.6.1. and 3.8.6.1.). 
Total molar eicosanoid production varied considerably 
between these different rat cell types, however, being 
greatest for control lung fibroblasts, whereas adipose 
and skin cells formed considerably smaller amounts 
(727.6, 215.9 and 165.7pmoles total eicosanoids per 106 
cells, respectively). This correlated with reports 
implicating the lung as a primary site of eicosanoid 
biosynthesis (Mathe et al 1977, Hyman et al 1978 and 
Harper et al 1984). These variations in eicosanoid 
production may relate partly to the different eicosanoid 
requirements of such cells, rather than the ability to 
solely provide eicosanoid precursors via desaturation. 
Low eicosanoid production may also reflect greater FA 
incorporation into the TAG rather than the PGL pool. 
This could explain the lower molar eicosanoid levels 
generated by adipose than lung cells, despite the 
greater capability for desaturation with the former. 
The f inding that the total eicosanoid:1ipoperoxide molar 
ratio's for control skin (Tables 3.7.5.1. and 3.7.6.1.), 
lung (Tables 3.6.5.1. and 3.6.6.1.) and adipose (Tables
3.8.5.1. and 3.8.6.1.) cells ammounted to 83^, 66% and 
43%, respectively, nevertheless implied a greater
preference to synthesise eicosanoids in skin than in 
lung or adipose cells under the experimental conditions 
employed. This probably related to the different 
physiology and requirements of these tissues in vivo.
The finding that control rat lung, skin and adipose 
cells differed in the relative amounts of PGI2> TXB2 ,
, PGE2 and PGEi they produced signified that 
the expression and activity of enzymes involved in
eicosanoid synthesis varied between rat tissues and that 
such was tissue-specific. This supported the work of 
Pace-Asciak et al (1977), who showed considerable tissue
specificity in PGE2, PGF20t, PGD2, TXB2 and 6-keto PGFioc 
production in rat lung, liver, spleen, stomach, kidney 
and heart homogenates in the presence of AA. These 
tissues contained low PGE2, PGF2o< and PGD2 levels, 
although PGE2 uas detected in greater amounts than PGF2c(
or PGD2 ai 1 tissues. 6-keto PGFiot was specifically
formed by stomach, although lung also formed significant
amounts, whereas TXB2 was mostly directed to spleen,
with lesser amounts in lung. We showed that PGEi was
major prostanoid detected in control rat lung cells and
this correlated with the considerably lower levels of
other prostanoids reported (Table 3.6.6.1.). This could
relate to the fact that PGE. • = 1 w r _1 is partly responsible tor
the control of cAMP levels, a potent inhibitor of AA 
release (Feinstein et al 1977 and Minkes et al 1977).
High PGEi would have resulted in high cAMP levels, and
thus decreased AA mobilisation. In contrast, control 
skin and adipose cells produced little, or no, PGEi and 
such could explain the synthesis of 2-series prostanoids 
(Tables 3.7.6.1. and 3.8.6.1.). In the light of this 
phenomenon, it was possible that a greater proportion of
the PGF^ fraction detected was composed of PGF2oc rather 
than PGFia<
P~Oi1 supplementation modulated the production of the 
prostanoids studied by influencing the balance between 
individual prostanoids to a greater or lesser extent 
(Tables 3.6.6.1., 3.7.6.1. and 3.8.6.1., respectively), 
although total prostanoid production was largely 
unaltered in lung fibroblasts, decreased in adipose 
cells and more varied in skin fibroblasts. These 
changes, however, could not be related to variations in 
p-oil FA composition. Lee et al (1988) similarly found 
no significant difference in TXB2 and pGl2 production 
between rats fed safflower or palm oils, despite the 
large difference in P/S ratio. The reason for these 
findings were unclear, but could have related to 
sufficient endogenous PUFA's in the precursor pool to 
produce an adequate level of prostanoids, or the 
relative unavailability of incorporated exogenous FA's 
for the production of these prostanoids. The possibility 
that dosage with different p-oils induced variations in 
other eicosanoid levels, however, could not be excluded. 
The finding that the modulation of prostanoid production
related to the p-oil amount dosed suggested a preference 
for certain p-oil concentrations to selectively modulate 
enzyme activity involved in the synthesis of these 
compounds. However, the fact that rat lung, skin and 
adipose cell prostanoid profiles showed no p-oil 
concentration dependent correlation with cell viability, 
desaturation capability or lipid peroxide production 
implied that the endogenously synthesised prostanoids 
studied were not directly involved in, or responsible 
for, the effects induced with p-oil supplementation. 
Durant et al (1989) showed that exogenous prostanoids
, 6-keto PGF1& and PGE2 ) could alter endogenous PG 
synthesis/release and increase fibroblast proliferation,
whereas endogenous PG^s alone were not involved in the 
control of cell proliferation. This supported the 
findings we presented, particularly with regard to p-oil 
induced cytotoxicity. Ue extended the work of Durant et 
al (1989) by proposing 1ipoperoxides and alterations in 
membrane physical properties as alternative mechanisms 
involved in the modulation of cell proliferation. 
The role of eicosanoids in the regulation of cell 
functions, however, remains undisputed.
In summary, this chapter provided comparative data on a 
range of cell parameters for different cultured rat
tissues.
different
contained
Control cells from different tissues exhibited 
growth rates, FA and prostanoid profiles, 
different concentrations of total protein, and
produced different molar amounts of 1ipoperoxides and 
eicosanoids. Variations in cell viability, total protein 
and lipoperoxide formation, FA and eicosanoid profiles, 
and desaturation capability were also demonstrated 
between different rat cell types when p-oils were 
supplemented. These findings implied variations in FA 
metabolism between different rat tissues, and that these 
differences were important in the modulation of the 
effects reported. The data indicated that different rat 
tissues in vivo probably also respond differently when 
fed identical dietary oils due to inherent variations in 
cell physiology. Careful consideration should thus be 
given to the selection of rat tissues for experimental 
purposes, and extrapolation of experimental findings 
between rat cell types should be avoided to ensure valid
interpretation of results.
